,GeneID,GO_ID,gene-symbol,GO_term,gene-score
185,43,GO:0001507,ACHE,acetylcholine catabolic process in synaptic cleft,2.0
186,43,GO:0001540,ACHE,amyloid-beta binding,2.0
187,43,GO:0001919,ACHE,regulation of receptor recycling,2.0
188,43,GO:0002076,ACHE,osteoblast development,2.0
189,43,GO:0003990,ACHE,acetylcholinesterase activity,2.0
191,43,GO:0004104,ACHE,cholinesterase activity,2.0
192,43,GO:0005515,ACHE,protein binding,2.0
193,43,GO:0005518,ACHE,collagen binding,2.0
194,43,GO:0005576,ACHE,extracellular region,2.0
196,43,GO:0005604,ACHE,basement membrane,2.0
197,43,GO:0005615,ACHE,extracellular space,2.0
198,43,GO:0005634,ACHE,nucleus,2.0
199,43,GO:0005794,ACHE,Golgi apparatus,2.0
200,43,GO:0005886,ACHE,plasma membrane,2.0
201,43,GO:0006581,ACHE,acetylcholine catabolic process,2.0
202,43,GO:0006656,ACHE,phosphatidylcholine biosynthetic process,2.0
203,43,GO:0007155,ACHE,cell adhesion,2.0
204,43,GO:0007399,ACHE,nervous system development,2.0
205,43,GO:0007416,ACHE,synapse assembly,2.0
206,43,GO:0009986,ACHE,cell surface,2.0
207,43,GO:0016020,ACHE,membrane,2.0
208,43,GO:0016787,ACHE,hydrolase activity,2.0
209,43,GO:0017171,ACHE,serine hydrolase activity,2.0
210,43,GO:0031225,ACHE,anchored component of membrane,2.0
211,43,GO:0031594,ACHE,neuromuscular junction,2.0
212,43,GO:0031623,ACHE,receptor internalization,2.0
213,43,GO:0032223,ACHE,"negative regulation of synaptic transmission, cholinergic",2.0
214,43,GO:0042136,ACHE,neurotransmitter biosynthetic process,2.0
215,43,GO:0042166,ACHE,acetylcholine binding,2.0
217,43,GO:0042803,ACHE,protein homodimerization activity,2.0
218,43,GO:0042982,ACHE,amyloid precursor protein metabolic process,2.0
219,43,GO:0043083,ACHE,synaptic cleft,2.0
220,43,GO:0043236,ACHE,laminin binding,2.0
221,43,GO:0043621,ACHE,protein self-association,2.0
222,43,GO:0045202,ACHE,synapse,2.0
223,43,GO:0048471,ACHE,perinuclear region of cytoplasm,2.0
224,43,GO:0050714,ACHE,positive regulation of protein secretion,2.0
225,43,GO:0052689,ACHE,carboxylic ester hydrolase activity,2.0
226,43,GO:0060041,ACHE,retina development in camera-type eye,2.0
227,43,GO:0120162,ACHE,positive regulation of cold-induced thermogenesis,2.0
403,100,GO:0001666,ADA,response to hypoxia,2.0
404,100,GO:0001821,ADA,histamine secretion,2.0
405,100,GO:0001829,ADA,trophectodermal cell differentiation,2.0
406,100,GO:0001883,ADA,purine nucleoside binding,2.0
407,100,GO:0001889,ADA,liver development,2.0
408,100,GO:0001890,ADA,placenta development,2.0
409,100,GO:0002314,ADA,germinal center B cell differentiation,2.0
410,100,GO:0002636,ADA,positive regulation of germinal center formation,2.0
411,100,GO:0002686,ADA,negative regulation of leukocyte migration,2.0
412,100,GO:0002906,ADA,negative regulation of mature B cell apoptotic process,2.0
413,100,GO:0004000,ADA,adenosine deaminase activity,2.0
417,100,GO:0005515,ADA,protein binding,2.0
418,100,GO:0005615,ADA,extracellular space,2.0
419,100,GO:0005764,ADA,lysosome,2.0
420,100,GO:0005829,ADA,cytosol,2.0
423,100,GO:0005886,ADA,plasma membrane,2.0
424,100,GO:0006154,ADA,adenosine catabolic process,2.0
427,100,GO:0006157,ADA,deoxyadenosine catabolic process,2.0
428,100,GO:0007155,ADA,cell adhesion,2.0
429,100,GO:0007568,ADA,aging,2.0
430,100,GO:0008270,ADA,zinc ion binding,2.0
432,100,GO:0009168,ADA,purine ribonucleoside monophosphate biosynthetic process,2.0
433,100,GO:0009897,ADA,external side of plasma membrane,2.0
435,100,GO:0009986,ADA,cell surface,2.0
436,100,GO:0010460,ADA,positive regulation of heart rate,2.0
437,100,GO:0016020,ADA,membrane,2.0
438,100,GO:0030054,ADA,cell junction,2.0
439,100,GO:0030890,ADA,positive regulation of B cell proliferation,2.0
440,100,GO:0032261,ADA,purine nucleotide salvage,2.0
441,100,GO:0032839,ADA,dendrite cytoplasm,2.0
442,100,GO:0033089,ADA,positive regulation of T cell differentiation in thymus,2.0
443,100,GO:0033197,ADA,response to vitamin E,2.0
444,100,GO:0033632,ADA,regulation of cell-cell adhesion mediated by integrin,2.0
445,100,GO:0042110,ADA,T cell activation,2.0
447,100,GO:0042323,ADA,"negative regulation of circadian sleep/wake cycle, non-REM sleep",2.0
448,100,GO:0042493,ADA,response to drug,2.0
449,100,GO:0042542,ADA,response to hydrogen peroxide,2.0
450,100,GO:0043025,ADA,neuronal cell body,2.0
451,100,GO:0043101,ADA,purine-containing compound salvage,2.0
452,100,GO:0043103,ADA,hypoxanthine salvage,2.0
453,100,GO:0043278,ADA,response to morphine,2.0
454,100,GO:0045987,ADA,positive regulation of smooth muscle contraction,2.0
455,100,GO:0046061,ADA,dATP catabolic process,2.0
456,100,GO:0046103,ADA,inosine biosynthetic process,2.0
459,100,GO:0046111,ADA,xanthine biosynthetic process,2.0
460,100,GO:0046638,ADA,positive regulation of alpha-beta T cell differentiation,2.0
461,100,GO:0048286,ADA,lung alveolus development,2.0
462,100,GO:0048541,ADA,Peyer's patch development,2.0
463,100,GO:0048566,ADA,embryonic digestive tract development,2.0
464,100,GO:0050728,ADA,negative regulation of inflammatory response,2.0
465,100,GO:0050850,ADA,positive regulation of calcium-mediated signaling,2.0
466,100,GO:0050862,ADA,positive regulation of T cell receptor signaling pathway,2.0
467,100,GO:0060169,ADA,negative regulation of adenosine receptor signaling pathway,2.0
469,100,GO:0060205,ADA,cytoplasmic vesicle lumen,2.0
470,100,GO:0060407,ADA,negative regulation of penile erection,2.0
471,100,GO:0070244,ADA,negative regulation of thymocyte apoptotic process,2.0
472,100,GO:0070256,ADA,negative regulation of mucus secretion,2.0
473,109,GO:0003091,ADCY3,renal water homeostasis,2.0
474,109,GO:0004016,ADCY3,adenylate cyclase activity,2.0
476,109,GO:0005516,ADCY3,calmodulin binding,2.0
477,109,GO:0005524,ADCY3,ATP binding,2.0
478,109,GO:0005737,ADCY3,cytoplasm,2.0
479,109,GO:0005794,ADCY3,Golgi apparatus,2.0
480,109,GO:0005886,ADCY3,plasma membrane,2.0
482,109,GO:0005887,ADCY3,integral component of plasma membrane,2.0
483,109,GO:0005929,ADCY3,cilium,2.0
484,109,GO:0006171,ADCY3,cAMP biosynthetic process,2.0
486,109,GO:0007165,ADCY3,signal transduction,2.0
487,109,GO:0007186,ADCY3,G protein-coupled receptor signaling pathway,2.0
488,109,GO:0007189,ADCY3,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
491,109,GO:0007190,ADCY3,activation of adenylate cyclase activity,2.0
492,109,GO:0007193,ADCY3,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,2.0
493,109,GO:0007338,ADCY3,single fertilization,2.0
494,109,GO:0007340,ADCY3,acrosome reaction,2.0
495,109,GO:0007608,ADCY3,sensory perception of smell,2.0
496,109,GO:0008355,ADCY3,olfactory learning,2.0
497,109,GO:0016020,ADCY3,membrane,2.0
498,109,GO:0016021,ADCY3,integral component of membrane,2.0
499,109,GO:0030317,ADCY3,flagellated sperm motility,2.0
500,109,GO:0034199,ADCY3,activation of protein kinase A activity,2.0
501,109,GO:0046872,ADCY3,metal ion binding,2.0
502,109,GO:0071377,ADCY3,cellular response to glucagon stimulus,2.0
503,109,GO:1904322,ADCY3,cellular response to forskolin,2.0
642,116986,GO:0003924,AGAP2,GTPase activity,2.0
644,116986,GO:0005096,AGAP2,GTPase activator activity,2.0
645,116986,GO:0005515,AGAP2,protein binding,2.0
646,116986,GO:0005524,AGAP2,ATP binding,2.0
647,116986,GO:0005525,AGAP2,GTP binding,2.0
648,116986,GO:0005634,AGAP2,nucleus,2.0
652,116986,GO:0005654,AGAP2,nucleoplasm,2.0
653,116986,GO:0005737,AGAP2,cytoplasm,2.0
655,116986,GO:0005768,AGAP2,endosome,2.0
656,116986,GO:0005829,AGAP2,cytosol,2.0
657,116986,GO:0015031,AGAP2,protein transport,2.0
658,116986,GO:0016020,AGAP2,membrane,2.0
659,116986,GO:0016197,AGAP2,endosomal transport,2.0
660,116986,GO:0019901,AGAP2,protein kinase binding,2.0
661,116986,GO:0030036,AGAP2,actin cytoskeleton organization,2.0
662,116986,GO:0030295,AGAP2,protein kinase activator activity,2.0
663,116986,GO:0032147,AGAP2,activation of protein kinase activity,2.0
664,116986,GO:0035014,AGAP2,phosphatidylinositol 3-kinase regulator activity,2.0
665,116986,GO:0042177,AGAP2,negative regulation of protein catabolic process,2.0
666,116986,GO:0043524,AGAP2,negative regulation of neuron apoptotic process,2.0
667,116986,GO:0043547,AGAP2,positive regulation of GTPase activity,2.0
668,116986,GO:0045860,AGAP2,positive regulation of protein kinase activity,2.0
669,116986,GO:0046872,AGAP2,metal ion binding,2.0
670,116986,GO:0061903,AGAP2,positive regulation of 1-phosphatidylinositol-3-kinase activity,2.0
671,116986,GO:0070062,AGAP2,extracellular exosome,2.0
672,116986,GO:0090543,AGAP2,Flemming body,2.0
730,26523,GO:0000932,AGO1,P-body,2.0
731,26523,GO:0000956,AGO1,nuclear-transcribed mRNA catabolic process,2.0
732,26523,GO:0000978,AGO1,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
733,26523,GO:0000993,AGO1,RNA polymerase II complex binding,2.0
734,26523,GO:0001046,AGO1,core promoter sequence-specific DNA binding,2.0
735,26523,GO:0003723,AGO1,RNA binding,2.0
737,26523,GO:0003725,AGO1,double-stranded RNA binding,2.0
738,26523,GO:0003727,AGO1,single-stranded RNA binding,2.0
739,26523,GO:0004521,AGO1,endoribonuclease activity,2.0
740,26523,GO:0005515,AGO1,protein binding,2.0
741,26523,GO:0005634,AGO1,nucleus,2.0
742,26523,GO:0005654,AGO1,nucleoplasm,2.0
743,26523,GO:0005737,AGO1,cytoplasm,2.0
744,26523,GO:0005829,AGO1,cytosol,2.0
745,26523,GO:0005844,AGO1,polysome,2.0
746,26523,GO:0007223,AGO1,"Wnt signaling pathway, calcium modulating pathway",2.0
747,26523,GO:0010501,AGO1,RNA secondary structure unwinding,2.0
749,26523,GO:0010586,AGO1,miRNA metabolic process,2.0
750,26523,GO:0010628,AGO1,positive regulation of gene expression,2.0
751,26523,GO:0010629,AGO1,negative regulation of gene expression,2.0
752,26523,GO:0016442,AGO1,RISC complex,2.0
753,26523,GO:0016525,AGO1,negative regulation of angiogenesis,2.0
754,26523,GO:0031054,AGO1,pre-miRNA processing,2.0
755,26523,GO:0035194,AGO1,post-transcriptional gene silencing by RNA,2.0
756,26523,GO:0035196,AGO1,production of miRNAs involved in gene silencing by miRNA,2.0
757,26523,GO:0035198,AGO1,miRNA binding,2.0
758,26523,GO:0035278,AGO1,miRNA mediated inhibition of translation,2.0
759,26523,GO:0035279,AGO1,mRNA cleavage involved in gene silencing by miRNA,2.0
760,26523,GO:0035280,AGO1,miRNA loading onto RISC involved in gene silencing by miRNA,2.0
761,26523,GO:0045652,AGO1,regulation of megakaryocyte differentiation,2.0
762,26523,GO:0045944,AGO1,positive regulation of transcription by RNA polymerase II,2.0
763,26523,GO:0060964,AGO1,regulation of gene silencing by miRNA,2.0
764,26523,GO:0070578,AGO1,RISC-loading complex,2.0
765,26523,GO:0090502,AGO1,"RNA phosphodiester bond hydrolysis, endonucleolytic",2.0
766,26523,GO:0090625,AGO1,mRNA cleavage involved in gene silencing by siRNA,2.0
767,26523,GO:1901224,AGO1,positive regulation of NIK/NF-kappaB signaling,2.0
768,26523,GO:1990904,AGO1,ribonucleoprotein complex,2.0
803,192670,GO:0000932,AGO4,P-body,2.0
804,192670,GO:0003725,AGO4,double-stranded RNA binding,2.0
805,192670,GO:0003727,AGO4,single-stranded RNA binding,2.0
806,192670,GO:0005515,AGO4,protein binding,2.0
807,192670,GO:0005634,AGO4,nucleus,2.0
808,192670,GO:0005737,AGO4,cytoplasm,2.0
809,192670,GO:0005829,AGO4,cytosol,2.0
810,192670,GO:0006402,AGO4,mRNA catabolic process,2.0
811,192670,GO:0007130,AGO4,synaptonemal complex assembly,2.0
812,192670,GO:0007140,AGO4,male meiotic nuclear division,2.0
813,192670,GO:0007223,AGO4,"Wnt signaling pathway, calcium modulating pathway",2.0
814,192670,GO:0008584,AGO4,male gonad development,2.0
815,192670,GO:0010501,AGO4,RNA secondary structure unwinding,2.0
817,192670,GO:0010586,AGO4,miRNA metabolic process,2.0
818,192670,GO:0010628,AGO4,positive regulation of gene expression,2.0
819,192670,GO:0010629,AGO4,negative regulation of gene expression,2.0
820,192670,GO:0016020,AGO4,membrane,2.0
821,192670,GO:0016442,AGO4,RISC complex,2.0
822,192670,GO:0022604,AGO4,regulation of cell morphogenesis,2.0
823,192670,GO:0031054,AGO4,pre-miRNA processing,2.0
824,192670,GO:0035194,AGO4,post-transcriptional gene silencing by RNA,2.0
825,192670,GO:0035196,AGO4,production of miRNAs involved in gene silencing by miRNA,2.0
826,192670,GO:0035198,AGO4,miRNA binding,2.0
827,192670,GO:0035278,AGO4,miRNA mediated inhibition of translation,2.0
828,192670,GO:0035279,AGO4,mRNA cleavage involved in gene silencing by miRNA,2.0
829,192670,GO:0035280,AGO4,miRNA loading onto RISC involved in gene silencing by miRNA,2.0
830,192670,GO:0043066,AGO4,negative regulation of apoptotic process,2.0
831,192670,GO:0045652,AGO4,regulation of megakaryocyte differentiation,2.0
832,192670,GO:0070578,AGO4,RISC-loading complex,2.0
833,192670,GO:0090625,AGO4,mRNA cleavage involved in gene silencing by siRNA,2.0
927,10142,GO:0000086,AKAP9,G2/M transition of mitotic cell cycle,2.0
928,10142,GO:0003677,AKAP9,DNA binding,2.0
929,10142,GO:0005102,AKAP9,signaling receptor binding,2.0
930,10142,GO:0005515,AKAP9,protein binding,2.0
931,10142,GO:0005794,AKAP9,Golgi apparatus,2.0
932,10142,GO:0005795,AKAP9,Golgi stack,2.0
934,10142,GO:0005801,AKAP9,cis-Golgi network,2.0
936,10142,GO:0005813,AKAP9,centrosome,2.0
938,10142,GO:0005829,AKAP9,cytosol,2.0
939,10142,GO:0005856,AKAP9,cytoskeleton,2.0
940,10142,GO:0007020,AKAP9,microtubule nucleation,2.0
941,10142,GO:0007165,AKAP9,signal transduction,2.0
942,10142,GO:0007268,AKAP9,chemical synaptic transmission,2.0
943,10142,GO:0008076,AKAP9,voltage-gated potassium channel complex,2.0
944,10142,GO:0010389,AKAP9,regulation of G2/M transition of mitotic cell cycle,2.0
945,10142,GO:0015459,AKAP9,potassium channel regulator activity,2.0
947,10142,GO:0031116,AKAP9,positive regulation of microtubule polymerization,2.0
948,10142,GO:0033138,AKAP9,positive regulation of peptidyl-serine phosphorylation,2.0
950,10142,GO:0034237,AKAP9,protein kinase A regulatory subunit binding,2.0
953,10142,GO:0043231,AKAP9,intracellular membrane-bounded organelle,2.0
954,10142,GO:0044325,AKAP9,ion channel binding,2.0
955,10142,GO:0051661,AKAP9,maintenance of centrosome location,2.0
957,10142,GO:0060090,AKAP9,molecular adaptor activity,2.0
959,10142,GO:0060306,AKAP9,regulation of membrane repolarization,2.0
960,10142,GO:0060307,AKAP9,regulation of ventricular cardiac muscle cell membrane repolarization,2.0
962,10142,GO:0061337,AKAP9,cardiac conduction,2.0
963,10142,GO:0071320,AKAP9,cellular response to cAMP,2.0
964,10142,GO:0086091,AKAP9,regulation of heart rate by cardiac conduction,2.0
965,10142,GO:0097060,AKAP9,synaptic membrane,2.0
966,10142,GO:0097711,AKAP9,ciliary basal body-plasma membrane docking,2.0
967,10142,GO:0098909,AKAP9,regulation of cardiac muscle cell action potential involved in regulation of contraction,2.0
968,10142,GO:0098962,AKAP9,regulation of postsynaptic neurotransmitter receptor activity,2.0
970,10142,GO:0098978,AKAP9,glutamatergic synapse,2.0
972,10142,GO:1901018,AKAP9,positive regulation of potassium ion transmembrane transporter activity,2.0
974,10142,GO:1903358,AKAP9,regulation of Golgi organization,2.0
1021,270,GO:0003876,AMPD1,AMP deaminase activity,2.0
1022,270,GO:0005515,AMPD1,protein binding,2.0
1023,270,GO:0005829,AMPD1,cytosol,2.0
1025,270,GO:0006188,AMPD1,IMP biosynthetic process,2.0
1026,270,GO:0010033,AMPD1,response to organic substance,2.0
1027,270,GO:0032036,AMPD1,myosin heavy chain binding,2.0
1028,270,GO:0032264,AMPD1,IMP salvage,2.0
1029,270,GO:0042802,AMPD1,identical protein binding,2.0
1030,270,GO:0043101,AMPD1,purine-containing compound salvage,2.0
1031,270,GO:0046033,AMPD1,AMP metabolic process,2.0
1032,270,GO:0046872,AMPD1,metal ion binding,2.0
1033,275,GO:0004047,AMT,aminomethyltransferase activity,2.0
1036,275,GO:0005654,AMT,nucleoplasm,2.0
1037,275,GO:0005739,AMT,mitochondrion,2.0
1040,275,GO:0005759,AMT,mitochondrial matrix,2.0
1041,275,GO:0006546,AMT,glycine catabolic process,2.0
1042,275,GO:0008483,AMT,transaminase activity,2.0
1043,275,GO:0019464,AMT,glycine decarboxylation via glycine cleavage system,2.0
1219,301,GO:0001533,ANXA1,cornified envelope,2.0
1220,301,GO:0001780,ANXA1,neutrophil homeostasis,2.0
1221,301,GO:0001891,ANXA1,phagocytic cup,2.0
1222,301,GO:0002250,ANXA1,adaptive immune response,2.0
1223,301,GO:0002548,ANXA1,monocyte chemotaxis,2.0
1224,301,GO:0002685,ANXA1,regulation of leukocyte migration,2.0
1226,301,GO:0003697,ANXA1,single-stranded DNA binding,2.0
1227,301,GO:0003727,ANXA1,single-stranded RNA binding,2.0
1228,301,GO:0005102,ANXA1,signaling receptor binding,2.0
1229,301,GO:0005509,ANXA1,calcium ion binding,2.0
1231,301,GO:0005515,ANXA1,protein binding,2.0
1232,301,GO:0005543,ANXA1,phospholipid binding,2.0
1233,301,GO:0005544,ANXA1,calcium-dependent phospholipid binding,2.0
1235,301,GO:0005576,ANXA1,extracellular region,2.0
1236,301,GO:0005615,ANXA1,extracellular space,2.0
1239,301,GO:0005634,ANXA1,nucleus,2.0
1240,301,GO:0005654,ANXA1,nucleoplasm,2.0
1241,301,GO:0005737,ANXA1,cytoplasm,2.0
1244,301,GO:0005768,ANXA1,endosome,2.0
1245,301,GO:0005829,ANXA1,cytosol,2.0
1246,301,GO:0005884,ANXA1,actin filament,2.0
1247,301,GO:0005886,ANXA1,plasma membrane,2.0
1249,301,GO:0005912,ANXA1,adherens junction,2.0
1250,301,GO:0005925,ANXA1,focal adhesion,2.0
1251,301,GO:0006909,ANXA1,phagocytosis,2.0
1252,301,GO:0006954,ANXA1,inflammatory response,2.0
1254,301,GO:0007165,ANXA1,signal transduction,2.0
1255,301,GO:0007166,ANXA1,cell surface receptor signaling pathway,2.0
1256,301,GO:0007186,ANXA1,G protein-coupled receptor signaling pathway,2.0
1257,301,GO:0007187,ANXA1,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.0
1259,301,GO:0008360,ANXA1,regulation of cell shape,2.0
1261,301,GO:0009986,ANXA1,cell surface,2.0
1262,301,GO:0010165,ANXA1,response to X-ray,2.0
1263,301,GO:0014839,ANXA1,myoblast migration involved in skeletal muscle regeneration,2.0
1264,301,GO:0016323,ANXA1,basolateral plasma membrane,2.0
1265,301,GO:0016324,ANXA1,apical plasma membrane,2.0
1266,301,GO:0016328,ANXA1,lateral plasma membrane,2.0
1267,301,GO:0018149,ANXA1,peptide cross-linking,2.0
1268,301,GO:0019221,ANXA1,cytokine-mediated signaling pathway,2.0
1269,301,GO:0019834,ANXA1,phospholipase A2 inhibitor activity,2.0
1271,301,GO:0019898,ANXA1,extrinsic component of membrane,2.0
1272,301,GO:0030073,ANXA1,insulin secretion,2.0
1273,301,GO:0030216,ANXA1,keratinocyte differentiation,2.0
1275,301,GO:0030659,ANXA1,cytoplasmic vesicle membrane,2.0
1276,301,GO:0030850,ANXA1,prostate gland development,2.0
1277,301,GO:0031018,ANXA1,endocrine pancreas development,2.0
1278,301,GO:0031232,ANXA1,extrinsic component of external side of plasma membrane,2.0
1279,301,GO:0031313,ANXA1,extrinsic component of endosome membrane,2.0
1280,301,GO:0031340,ANXA1,positive regulation of vesicle fusion,2.0
1282,301,GO:0031394,ANXA1,positive regulation of prostaglandin biosynthetic process,2.0
1283,301,GO:0031514,ANXA1,motile cilium,2.0
1284,301,GO:0031532,ANXA1,actin cytoskeleton reorganization,2.0
1286,301,GO:0031901,ANXA1,early endosome membrane,2.0
1287,301,GO:0031966,ANXA1,mitochondrial membrane,2.0
1288,301,GO:0031982,ANXA1,vesicle,2.0
1289,301,GO:0032355,ANXA1,response to estradiol,2.0
1290,301,GO:0032508,ANXA1,DNA duplex unwinding,2.0
1291,301,GO:0032652,ANXA1,regulation of interleukin-1 production,2.0
1293,301,GO:0032717,ANXA1,negative regulation of interleukin-8 production,2.0
1294,301,GO:0032743,ANXA1,positive regulation of interleukin-2 production,2.0
1296,301,GO:0032991,ANXA1,protein-containing complex,2.0
1297,301,GO:0033031,ANXA1,positive regulation of neutrophil apoptotic process,2.0
1298,301,GO:0035924,ANXA1,cellular response to vascular endothelial growth factor stimulus,2.0
1300,301,GO:0036121,ANXA1,double-stranded DNA helicase activity,2.0
1301,301,GO:0042063,ANXA1,gliogenesis,2.0
1302,301,GO:0042102,ANXA1,positive regulation of T cell proliferation,2.0
1304,301,GO:0042383,ANXA1,sarcolemma,2.0
1305,301,GO:0042493,ANXA1,response to drug,2.0
1306,301,GO:0042629,ANXA1,mast cell granule,2.0
1307,301,GO:0042802,ANXA1,identical protein binding,2.0
1308,301,GO:0043066,ANXA1,negative regulation of apoptotic process,2.0
1309,301,GO:0043434,ANXA1,response to peptide hormone,2.0
1310,301,GO:0044849,ANXA1,estrous cycle,2.0
1311,301,GO:0045087,ANXA1,innate immune response,2.0
1312,301,GO:0045627,ANXA1,positive regulation of T-helper 1 cell differentiation,2.0
1314,301,GO:0045629,ANXA1,negative regulation of T-helper 2 cell differentiation,2.0
1316,301,GO:0045920,ANXA1,negative regulation of exocytosis,2.0
1318,301,GO:0046632,ANXA1,alpha-beta T cell differentiation,2.0
1320,301,GO:0046883,ANXA1,regulation of hormone secretion,2.0
1322,301,GO:0048306,ANXA1,calcium-dependent protein binding,2.0
1323,301,GO:0050482,ANXA1,arachidonic acid secretion,2.0
1324,301,GO:0050709,ANXA1,negative regulation of protein secretion,2.0
1325,301,GO:0050727,ANXA1,regulation of inflammatory response,2.0
1327,301,GO:0062023,ANXA1,collagen-containing extracellular matrix,2.0
1328,301,GO:0070062,ANXA1,extracellular exosome,2.0
1330,301,GO:0070301,ANXA1,cellular response to hydrogen peroxide,2.0
1331,301,GO:0070365,ANXA1,hepatocyte differentiation,2.0
1332,301,GO:0070459,ANXA1,prolactin secretion,2.0
1333,301,GO:0070555,ANXA1,response to interleukin-1,2.0
1334,301,GO:0071385,ANXA1,cellular response to glucocorticoid stimulus,2.0
1336,301,GO:0071621,ANXA1,granulocyte chemotaxis,2.0
1338,301,GO:0090050,ANXA1,positive regulation of cell migration involved in sprouting angiogenesis,2.0
1340,301,GO:0090303,ANXA1,positive regulation of wound healing,2.0
1342,301,GO:0097060,ANXA1,synaptic membrane,2.0
1343,301,GO:0097350,ANXA1,neutrophil clearance,2.0
1345,301,GO:0098609,ANXA1,cell-cell adhesion,2.0
1346,301,GO:0098641,ANXA1,cadherin binding involved in cell-cell adhesion,2.0
1347,301,GO:1900087,ANXA1,positive regulation of G1/S transition of mitotic cell cycle,2.0
1348,301,GO:1900138,ANXA1,negative regulation of phospholipase A2 activity,2.0
1349,301,GO:1990814,ANXA1,DNA/DNA annealing activity,2.0
1379,322,GO:0000122,APBB1,negative regulation of transcription by RNA polymerase II,2.0
1380,322,GO:0001540,APBB1,amyloid-beta binding,2.0
1384,322,GO:0003682,APBB1,chromatin binding,2.0
1385,322,GO:0005515,APBB1,protein binding,2.0
1386,322,GO:0005634,APBB1,nucleus,2.0
1389,322,GO:0005654,APBB1,nucleoplasm,2.0
1390,322,GO:0005737,APBB1,cytoplasm,2.0
1392,322,GO:0005783,APBB1,endoplasmic reticulum,2.0
1393,322,GO:0005886,APBB1,plasma membrane,2.0
1394,322,GO:0006302,APBB1,double-strand break repair,2.0
1395,322,GO:0006355,APBB1,"regulation of transcription, DNA-templated",2.0
1396,322,GO:0006915,APBB1,apoptotic process,2.0
1397,322,GO:0006974,APBB1,cellular response to DNA damage stimulus,2.0
1398,322,GO:0007050,APBB1,cell cycle arrest,2.0
1399,322,GO:0007165,APBB1,signal transduction,2.0
1400,322,GO:0007409,APBB1,axonogenesis,2.0
1401,322,GO:0008134,APBB1,transcription factor binding,2.0
1403,322,GO:0010039,APBB1,response to iron ion,2.0
1404,322,GO:0010976,APBB1,positive regulation of neuron projection development,2.0
1405,322,GO:0016607,APBB1,nuclear speck,2.0
1406,322,GO:0030027,APBB1,lamellipodium,2.0
1407,322,GO:0030308,APBB1,negative regulation of cell growth,2.0
1408,322,GO:0030426,APBB1,growth cone,2.0
1409,322,GO:0031625,APBB1,ubiquitin protein ligase binding,2.0
1410,322,GO:0032991,APBB1,protein-containing complex,2.0
1411,322,GO:0042393,APBB1,histone binding,2.0
1412,322,GO:0042734,APBB1,presynaptic membrane,2.0
1413,322,GO:0043025,APBB1,neuronal cell body,2.0
1414,322,GO:0043065,APBB1,positive regulation of apoptotic process,2.0
1415,322,GO:0043197,APBB1,dendritic spine,2.0
1416,322,GO:0043967,APBB1,histone H4 acetylation,2.0
1417,322,GO:0044304,APBB1,main axon,2.0
1418,322,GO:0044877,APBB1,protein-containing complex binding,2.0
1419,322,GO:0045202,APBB1,synapse,2.0
1420,322,GO:0045211,APBB1,postsynaptic membrane,2.0
1421,322,GO:0045739,APBB1,positive regulation of DNA repair,2.0
1422,322,GO:0045893,APBB1,"positive regulation of transcription, DNA-templated",2.0
1423,322,GO:0045944,APBB1,positive regulation of transcription by RNA polymerase II,2.0
1424,322,GO:0048156,APBB1,tau protein binding,2.0
1425,322,GO:0048471,APBB1,perinuclear region of cytoplasm,2.0
1426,322,GO:0050714,APBB1,positive regulation of protein secretion,2.0
1427,322,GO:0070064,APBB1,proline-rich region binding,2.0
1428,322,GO:1990761,APBB1,growth cone lamellipodium,2.0
1429,322,GO:1990812,APBB1,growth cone filopodium,2.0
1430,51107,GO:0001656,APH1A,metanephros development,2.0
1431,51107,GO:0004175,APH1A,endopeptidase activity,2.0
1432,51107,GO:0005515,APH1A,protein binding,2.0
1433,51107,GO:0005783,APH1A,endoplasmic reticulum,2.0
1435,51107,GO:0005789,APH1A,endoplasmic reticulum membrane,2.0
1436,51107,GO:0005794,APH1A,Golgi apparatus,2.0
1437,51107,GO:0005886,APH1A,plasma membrane,2.0
1438,51107,GO:0005887,APH1A,integral component of plasma membrane,2.0
1440,51107,GO:0006509,APH1A,membrane protein ectodomain proteolysis,2.0
1441,51107,GO:0007219,APH1A,Notch signaling pathway,2.0
1442,51107,GO:0007220,APH1A,Notch receptor processing,2.0
1445,51107,GO:0010008,APH1A,endosome membrane,2.0
1446,51107,GO:0016020,APH1A,membrane,2.0
1447,51107,GO:0016021,APH1A,integral component of membrane,2.0
1448,51107,GO:0016485,APH1A,protein processing,2.0
1450,51107,GO:0031293,APH1A,membrane protein intracellular domain proteolysis,2.0
1452,51107,GO:0032580,APH1A,Golgi cisterna membrane,2.0
1453,51107,GO:0034205,APH1A,amyloid-beta formation,2.0
1454,51107,GO:0035333,APH1A,"Notch receptor processing, ligand-dependent",2.0
1455,51107,GO:0042982,APH1A,amyloid precursor protein metabolic process,2.0
1456,51107,GO:0042987,APH1A,amyloid precursor protein catabolic process,2.0
1458,51107,GO:0043065,APH1A,positive regulation of apoptotic process,2.0
1459,51107,GO:0043085,APH1A,positive regulation of catalytic activity,2.0
1460,51107,GO:0044267,APH1A,cellular protein metabolic process,2.0
1461,51107,GO:0048013,APH1A,ephrin receptor signaling pathway,2.0
1462,51107,GO:0070765,APH1A,gamma-secretase complex,2.0
1626,8853,GO:0005096,ASAP2,GTPase activator activity,2.0
1627,8853,GO:0005515,ASAP2,protein binding,2.0
1628,8853,GO:0005886,ASAP2,plasma membrane,2.0
1629,8853,GO:0032580,ASAP2,Golgi cisterna membrane,2.0
1630,8853,GO:0043547,ASAP2,positive regulation of GTPase activity,2.0
1631,8853,GO:0046872,ASAP2,metal ion binding,2.0
1679,259266,GO:0001764,ASPM,neuron migration,2.0
1680,259266,GO:0002052,ASPM,positive regulation of neuroblast proliferation,2.0
1681,259266,GO:0005516,ASPM,calmodulin binding,2.0
1682,259266,GO:0005634,ASPM,nucleus,2.0
1683,259266,GO:0005737,ASPM,cytoplasm,2.0
1684,259266,GO:0005813,ASPM,centrosome,2.0
1685,259266,GO:0007051,ASPM,spindle organization,2.0
1686,259266,GO:0007283,ASPM,spermatogenesis,2.0
1687,259266,GO:0008584,ASPM,male gonad development,2.0
1688,259266,GO:0016324,ASPM,apical plasma membrane,2.0
1689,259266,GO:0021873,ASPM,forebrain neuroblast division,2.0
1690,259266,GO:0021987,ASPM,cerebral cortex development,2.0
1691,259266,GO:0030496,ASPM,midbody,2.0
1692,259266,GO:0036449,ASPM,microtubule minus-end,2.0
1693,259266,GO:0045665,ASPM,negative regulation of neuron differentiation,2.0
1694,259266,GO:0045769,ASPM,negative regulation of asymmetric cell division,2.0
1695,259266,GO:0048477,ASPM,oogenesis,2.0
1696,259266,GO:0048589,ASPM,developmental growth,2.0
1697,259266,GO:0051445,ASPM,regulation of meiotic cell cycle,2.0
1698,259266,GO:0051653,ASPM,spindle localization,2.0
1699,259266,GO:0051661,ASPM,maintenance of centrosome location,2.0
1700,259266,GO:0072687,ASPM,meiotic spindle,2.0
1701,259266,GO:0090263,ASPM,positive regulation of canonical Wnt signaling pathway,2.0
1702,259266,GO:0090306,ASPM,spindle assembly involved in meiosis,2.0
1703,259266,GO:0097150,ASPM,neuronal stem cell population maintenance,2.0
1704,259266,GO:0097431,ASPM,mitotic spindle pole,2.0
1705,23245,GO:0001764,ASTN2,neuron migration,2.0
1706,23245,GO:0005509,ASTN2,calcium ion binding,2.0
1707,23245,GO:0005768,ASTN2,endosome,2.0
1708,23245,GO:0005769,ASTN2,early endosome,2.0
1709,23245,GO:0005770,ASTN2,late endosome,2.0
1710,23245,GO:0005938,ASTN2,cell cortex,2.0
1711,23245,GO:0007158,ASTN2,neuron cell-cell adhesion,2.0
1712,23245,GO:0015031,ASTN2,protein transport,2.0
1713,23245,GO:0016021,ASTN2,integral component of membrane,2.0
1714,23245,GO:0030136,ASTN2,clathrin-coated vesicle,2.0
1715,23245,GO:0043204,ASTN2,perikaryon,2.0
1716,23245,GO:0043533,ASTN2,"inositol 1,3,4,5 tetrakisphosphate binding",2.0
1718,23245,GO:0048105,ASTN2,establishment of body hair planar orientation,2.0
1719,23245,GO:0060187,ASTN2,cell pole,2.0
1720,23245,GO:2000009,ASTN2,negative regulation of protein localization to cell surface,2.0
1886,57194,GO:0000287,ATP10A,magnesium ion binding,2.0
1887,57194,GO:0005515,ATP10A,protein binding,2.0
1888,57194,GO:0005524,ATP10A,ATP binding,2.0
1889,57194,GO:0005783,ATP10A,endoplasmic reticulum,2.0
1890,57194,GO:0005789,ATP10A,endoplasmic reticulum membrane,2.0
1891,57194,GO:0005886,ATP10A,plasma membrane,2.0
1893,57194,GO:0008360,ATP10A,regulation of cell shape,2.0
1894,57194,GO:0016021,ATP10A,integral component of membrane,2.0
1895,57194,GO:0034220,ATP10A,ion transmembrane transport,2.0
1896,57194,GO:0045332,ATP10A,phospholipid translocation,2.0
1898,57194,GO:0140326,ATP10A,ATPase-coupled intramembrane lipid transporter activity,2.0
2130,491,GO:0005388,ATP2B2,"calcium transmembrane transporter activity, phosphorylative mechanism",2.0
2132,491,GO:0005515,ATP2B2,protein binding,2.0
2133,491,GO:0005516,ATP2B2,calmodulin binding,2.0
2134,491,GO:0005524,ATP2B2,ATP binding,2.0
2135,491,GO:0005737,ATP2B2,cytoplasm,2.0
2136,491,GO:0005886,ATP2B2,plasma membrane,2.0
2138,491,GO:0005887,ATP2B2,integral component of plasma membrane,2.0
2139,491,GO:0006816,ATP2B2,calcium ion transport,2.0
2141,491,GO:0006874,ATP2B2,cellular calcium ion homeostasis,2.0
2142,491,GO:0007605,ATP2B2,sensory perception of sound,2.0
2143,491,GO:0016021,ATP2B2,integral component of membrane,2.0
2144,491,GO:0019829,ATP2B2,ATPase-coupled cation transmembrane transporter activity,2.0
2145,491,GO:0030165,ATP2B2,PDZ domain binding,2.0
2146,491,GO:0030182,ATP2B2,neuron differentiation,2.0
2147,491,GO:0034220,ATP2B2,ion transmembrane transport,2.0
2148,491,GO:0043231,ATP2B2,intracellular membrane-bounded organelle,2.0
2149,491,GO:0046872,ATP2B2,metal ion binding,2.0
2150,491,GO:0051480,ATP2B2,regulation of cytosolic calcium ion concentration,2.0
2152,491,GO:0070062,ATP2B2,extracellular exosome,2.0
2153,491,GO:0070588,ATP2B2,calcium ion transmembrane transport,2.0
2154,491,GO:0098793,ATP2B2,presynapse,2.0
2155,491,GO:0098839,ATP2B2,postsynaptic density membrane,2.0
2156,491,GO:0098978,ATP2B2,glutamatergic synapse,2.0
2158,491,GO:0098982,ATP2B2,GABA-ergic synapse,2.0
2160,491,GO:0099509,ATP2B2,regulation of presynaptic cytosolic calcium ion concentration,2.0
2161,491,GO:0099566,ATP2B2,regulation of postsynaptic cytosolic calcium ion concentration,2.0
2162,491,GO:1903779,ATP2B2,regulation of cardiac conduction,2.0
2163,491,GO:1905056,ATP2B2,calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration,2.0
2164,491,GO:1905059,ATP2B2,calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration,2.0
2251,552,GO:0001992,AVPR1A,regulation of systemic arterial blood pressure by vasopressin,2.0
2252,552,GO:0002125,AVPR1A,maternal aggressive behavior,2.0
2253,552,GO:0003084,AVPR1A,positive regulation of systemic arterial blood pressure,2.0
2254,552,GO:0004930,AVPR1A,G protein-coupled receptor activity,2.0
2255,552,GO:0005000,AVPR1A,vasopressin receptor activity,2.0
2257,552,GO:0005080,AVPR1A,protein kinase C binding,2.0
2258,552,GO:0005515,AVPR1A,protein binding,2.0
2259,552,GO:0005768,AVPR1A,endosome,2.0
2260,552,GO:0005886,AVPR1A,plasma membrane,2.0
2262,552,GO:0005887,AVPR1A,integral component of plasma membrane,2.0
2263,552,GO:0006091,AVPR1A,generation of precursor metabolites and energy,2.0
2264,552,GO:0007186,AVPR1A,G protein-coupled receptor signaling pathway,2.0
2266,552,GO:0007202,AVPR1A,activation of phospholipase C activity,2.0
2267,552,GO:0007204,AVPR1A,positive regulation of cytosolic calcium ion concentration,2.0
2268,552,GO:0007621,AVPR1A,negative regulation of female receptivity,2.0
2269,552,GO:0007625,AVPR1A,grooming behavior,2.0
2270,552,GO:0008015,AVPR1A,blood circulation,2.0
2271,552,GO:0008284,AVPR1A,positive regulation of cell population proliferation,2.0
2272,552,GO:0010460,AVPR1A,positive regulation of heart rate,2.0
2273,552,GO:0014049,AVPR1A,positive regulation of glutamate secretion,2.0
2274,552,GO:0014902,AVPR1A,myotube differentiation,2.0
2275,552,GO:0017046,AVPR1A,peptide hormone binding,2.0
2276,552,GO:0019722,AVPR1A,calcium-mediated signaling,2.0
2277,552,GO:0021537,AVPR1A,telencephalon development,2.0
2278,552,GO:0030139,AVPR1A,endocytic vesicle,2.0
2279,552,GO:0030307,AVPR1A,positive regulation of cell growth,2.0
2280,552,GO:0031394,AVPR1A,positive regulation of prostaglandin biosynthetic process,2.0
2281,552,GO:0031894,AVPR1A,V1A vasopressin receptor binding,2.0
2282,552,GO:0032849,AVPR1A,positive regulation of cellular pH reduction,2.0
2283,552,GO:0035176,AVPR1A,social behavior,2.0
2284,552,GO:0035815,AVPR1A,positive regulation of renal sodium excretion,2.0
2285,552,GO:0042277,AVPR1A,peptide binding,2.0
2286,552,GO:0042631,AVPR1A,cellular response to water deprivation,2.0
2287,552,GO:0042711,AVPR1A,maternal behavior,2.0
2288,552,GO:0042713,AVPR1A,sperm ejaculation,2.0
2289,552,GO:0043084,AVPR1A,penile erection,2.0
2290,552,GO:0045907,AVPR1A,positive regulation of vasoconstriction,2.0
2291,552,GO:0051412,AVPR1A,response to corticosterone,2.0
2292,552,GO:0051970,AVPR1A,negative regulation of transmission of nerve impulse,2.0
2293,552,GO:0150104,AVPR1A,transport across blood-brain barrier,2.0
2665,9044,GO:0003677,BTAF1,DNA binding,2.0
2666,9044,GO:0003712,BTAF1,transcription coregulator activity,2.0
2667,9044,GO:0004386,BTAF1,helicase activity,2.0
2668,9044,GO:0005524,BTAF1,ATP binding,2.0
2669,9044,GO:0005654,BTAF1,nucleoplasm,2.0
2670,9044,GO:0008094,BTAF1,DNA-dependent ATPase activity,2.0
2671,9044,GO:0035562,BTAF1,negative regulation of chromatin binding,2.0
2672,9044,GO:0043231,BTAF1,intracellular membrane-bounded organelle,2.0
2673,9044,GO:0045892,BTAF1,"negative regulation of transcription, DNA-templated",2.0
2893,776,GO:0005245,CACNA1D,voltage-gated calcium channel activity,2.0
2895,776,GO:0005262,CACNA1D,calcium channel activity,2.0
2896,776,GO:0005515,CACNA1D,protein binding,2.0
2897,776,GO:0005886,CACNA1D,plasma membrane,2.0
2899,776,GO:0005891,CACNA1D,voltage-gated calcium channel complex,2.0
2900,776,GO:0006816,CACNA1D,calcium ion transport,2.0
2902,776,GO:0007188,CACNA1D,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2.0
2903,776,GO:0007605,CACNA1D,sensory perception of sound,2.0
2904,776,GO:0008331,CACNA1D,high voltage-gated calcium channel activity,2.0
2905,776,GO:0030018,CACNA1D,Z disc,2.0
2906,776,GO:0030506,CACNA1D,ankyrin binding,2.0
2907,776,GO:0045762,CACNA1D,positive regulation of adenylate cyclase activity,2.0
2908,776,GO:0046872,CACNA1D,metal ion binding,2.0
2909,776,GO:0050796,CACNA1D,regulation of insulin secretion,2.0
2910,776,GO:0051393,CACNA1D,alpha-actinin binding,2.0
2911,776,GO:0051928,CACNA1D,positive regulation of calcium ion transport,2.0
2912,776,GO:0060372,CACNA1D,regulation of atrial cardiac muscle cell membrane repolarization,2.0
2913,776,GO:0061337,CACNA1D,cardiac conduction,2.0
2914,776,GO:0070509,CACNA1D,calcium ion import,2.0
2916,776,GO:0070588,CACNA1D,calcium ion transmembrane transport,2.0
2917,776,GO:0086002,CACNA1D,cardiac muscle cell action potential involved in contraction,2.0
2918,776,GO:0086007,CACNA1D,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,2.0
2919,776,GO:0086012,CACNA1D,membrane depolarization during cardiac muscle cell action potential,2.0
2920,776,GO:0086046,CACNA1D,membrane depolarization during SA node cell action potential,2.0
2921,776,GO:0086059,CACNA1D,voltage-gated calcium channel activity involved SA node cell action potential,2.0
2922,776,GO:0086091,CACNA1D,regulation of heart rate by cardiac conduction,2.0
2923,776,GO:0098683,CACNA1D,cochlear hair cell ribbon synapse,2.0
2924,776,GO:0099059,CACNA1D,integral component of presynaptic active zone membrane,2.0
2925,776,GO:0099635,CACNA1D,voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels,2.0
2926,776,GO:0099703,CACNA1D,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,2.0
2927,776,GO:1901016,CACNA1D,regulation of potassium ion transmembrane transporter activity,2.0
2928,776,GO:1901379,CACNA1D,regulation of potassium ion transmembrane transport,2.0
2929,776,GO:1990454,CACNA1D,L-type voltage-gated calcium channel complex,2.0
3029,8912,GO:0001518,CACNA1H,voltage-gated sodium channel complex,2.0
3030,8912,GO:0005244,CACNA1H,voltage-gated ion channel activity,2.0
3031,8912,GO:0005248,CACNA1H,voltage-gated sodium channel activity,2.0
3032,8912,GO:0005515,CACNA1H,protein binding,2.0
3033,8912,GO:0005887,CACNA1H,integral component of plasma membrane,2.0
3034,8912,GO:0005891,CACNA1H,voltage-gated calcium channel complex,2.0
3035,8912,GO:0006936,CACNA1H,muscle contraction,2.0
3036,8912,GO:0007517,CACNA1H,muscle organ development,2.0
3037,8912,GO:0007520,CACNA1H,myoblast fusion,2.0
3038,8912,GO:0008016,CACNA1H,regulation of heart contraction,2.0
3039,8912,GO:0008332,CACNA1H,low voltage-gated calcium channel activity,2.0
3041,8912,GO:0016021,CACNA1H,integral component of membrane,2.0
3042,8912,GO:0019228,CACNA1H,neuronal action potential,2.0
3043,8912,GO:0032342,CACNA1H,aldosterone biosynthetic process,2.0
3044,8912,GO:0032870,CACNA1H,cellular response to hormone stimulus,2.0
3045,8912,GO:0034651,CACNA1H,cortisol biosynthetic process,2.0
3046,8912,GO:0034765,CACNA1H,regulation of ion transmembrane transport,2.0
3047,8912,GO:0035725,CACNA1H,sodium ion transmembrane transport,2.0
3048,8912,GO:0035865,CACNA1H,cellular response to potassium ion,2.0
3049,8912,GO:0042391,CACNA1H,regulation of membrane potential,2.0
3050,8912,GO:0043005,CACNA1H,neuron projection,2.0
3051,8912,GO:0045956,CACNA1H,positive regulation of calcium ion-dependent exocytosis,2.0
3052,8912,GO:0046872,CACNA1H,metal ion binding,2.0
3053,8912,GO:0070509,CACNA1H,calcium ion import,2.0
3055,8912,GO:0070588,CACNA1H,calcium ion transmembrane transport,2.0
3056,8912,GO:0086010,CACNA1H,membrane depolarization during action potential,2.0
3057,8912,GO:0097110,CACNA1H,scaffold protein binding,2.0
3058,8912,GO:0098662,CACNA1H,inorganic cation transmembrane transport,2.0
3059,8912,GO:2000344,CACNA1H,positive regulation of acrosome reaction,2.0
3112,783,GO:0005245,CACNB2,voltage-gated calcium channel activity,2.0
3113,783,GO:0005262,CACNB2,calcium channel activity,2.0
3114,783,GO:0005515,CACNB2,protein binding,2.0
3115,783,GO:0005886,CACNB2,plasma membrane,2.0
3116,783,GO:0005887,CACNB2,integral component of plasma membrane,2.0
3117,783,GO:0005891,CACNB2,voltage-gated calcium channel complex,2.0
3119,783,GO:0007268,CACNB2,chemical synaptic transmission,2.0
3120,783,GO:0007528,CACNB2,neuromuscular junction development,2.0
3121,783,GO:0007601,CACNB2,visual perception,2.0
3122,783,GO:0008331,CACNB2,high voltage-gated calcium channel activity,2.0
3123,783,GO:0051015,CACNB2,actin filament binding,2.0
3124,783,GO:0051928,CACNB2,positive regulation of calcium ion transport,2.0
3125,783,GO:0061337,CACNB2,cardiac conduction,2.0
3126,783,GO:0070509,CACNB2,calcium ion import,2.0
3127,783,GO:0070588,CACNB2,calcium ion transmembrane transport,2.0
3128,783,GO:0072659,CACNB2,protein localization to plasma membrane,2.0
3129,783,GO:0086007,CACNB2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,2.0
3130,783,GO:0086045,CACNB2,membrane depolarization during AV node cell action potential,2.0
3131,783,GO:0086056,CACNB2,voltage-gated calcium channel activity involved in AV node cell action potential,2.0
3132,783,GO:0086091,CACNB2,regulation of heart rate by cardiac conduction,2.0
3133,783,GO:0098684,CACNB2,photoreceptor ribbon synapse,2.0
3134,783,GO:0098793,CACNB2,presynapse,2.0
3135,783,GO:0098912,CACNB2,membrane depolarization during atrial cardiac muscle cell action potential,2.0
3136,783,GO:0099635,CACNB2,voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels,2.0
3137,783,GO:0099703,CACNB2,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration,2.0
3138,783,GO:1901385,CACNB2,regulation of voltage-gated calcium channel activity,2.0
3139,783,GO:1901843,CACNB2,positive regulation of high voltage-gated calcium channel activity,2.0
3140,783,GO:1904879,CACNB2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,2.0
3141,783,GO:1990454,CACNB2,L-type voltage-gated calcium channel complex,2.0
3424,54862,GO:0000978,CC2D1A,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
3426,54862,GO:0000981,CC2D1A,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
3427,54862,GO:0001227,CC2D1A,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
3428,54862,GO:0001650,CC2D1A,fibrillar center,2.0
3429,54862,GO:0005515,CC2D1A,protein binding,2.0
3430,54862,GO:0005634,CC2D1A,nucleus,2.0
3431,54862,GO:0005815,CC2D1A,microtubule organizing center,2.0
3432,54862,GO:0005829,CC2D1A,cytosol,2.0
3433,54862,GO:0005886,CC2D1A,plasma membrane,2.0
3434,54862,GO:0006357,CC2D1A,regulation of transcription by RNA polymerase II,2.0
3435,54862,GO:0016020,CC2D1A,membrane,2.0
3436,54862,GO:0043123,CC2D1A,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
3437,54862,GO:0045296,CC2D1A,cadherin binding,2.0
3438,54862,GO:0070062,CC2D1A,extracellular exosome,2.0
3439,54862,GO:1905381,CC2D1A,negative regulation of snRNA transcription by RNA polymerase II,2.0
3482,900,GO:0000079,CCNG1,regulation of cyclin-dependent protein serine/threonine kinase activity,2.0
3483,900,GO:0000307,CCNG1,cyclin-dependent protein kinase holoenzyme complex,2.0
3484,900,GO:0005515,CCNG1,protein binding,2.0
3485,900,GO:0005634,CCNG1,nucleus,2.0
3486,900,GO:0005654,CCNG1,nucleoplasm,2.0
3487,900,GO:0005737,CCNG1,cytoplasm,2.0
3488,900,GO:0016538,CCNG1,cyclin-dependent protein serine/threonine kinase regulator activity,2.0
3489,900,GO:0044772,CCNG1,mitotic cell cycle phase transition,2.0
3490,900,GO:0051301,CCNG1,cell division,2.0
3517,10575,GO:0002199,CCT4,zona pellucida receptor complex,2.0
3518,10575,GO:0003723,CCT4,RNA binding,2.0
3519,10575,GO:0005515,CCT4,protein binding,2.0
3520,10575,GO:0005524,CCT4,ATP binding,2.0
3521,10575,GO:0005654,CCT4,nucleoplasm,2.0
3522,10575,GO:0005813,CCT4,centrosome,2.0
3523,10575,GO:0005829,CCT4,cytosol,2.0
3525,10575,GO:0005832,CCT4,chaperonin-containing T-complex,2.0
3528,10575,GO:0005874,CCT4,microtubule,2.0
3529,10575,GO:0006457,CCT4,protein folding,2.0
3531,10575,GO:0007339,CCT4,binding of sperm to zona pellucida,2.0
3532,10575,GO:0032212,CCT4,positive regulation of telomere maintenance via telomerase,2.0
3533,10575,GO:0042470,CCT4,melanosome,2.0
3534,10575,GO:0042995,CCT4,cell projection,2.0
3535,10575,GO:0044297,CCT4,cell body,2.0
3536,10575,GO:0050821,CCT4,protein stabilization,2.0
3537,10575,GO:0051082,CCT4,unfolded protein binding,2.0
3538,10575,GO:0051973,CCT4,positive regulation of telomerase activity,2.0
3539,10575,GO:0070062,CCT4,extracellular exosome,2.0
3540,10575,GO:0090666,CCT4,scaRNA localization to Cajal body,2.0
3541,10575,GO:1901998,CCT4,toxin transport,2.0
3542,10575,GO:1904851,CCT4,positive regulation of establishment of protein localization to telomere,2.0
3543,10575,GO:1904871,CCT4,positive regulation of protein localization to Cajal body,2.0
3544,10575,GO:1904874,CCT4,positive regulation of telomerase RNA localization to Cajal body,2.0
3609,9578,GO:0000287,CDC42BPB,magnesium ion binding,2.0
3610,9578,GO:0004672,CDC42BPB,protein kinase activity,2.0
3611,9578,GO:0004674,CDC42BPB,protein serine/threonine kinase activity,2.0
3613,9578,GO:0005524,CDC42BPB,ATP binding,2.0
3614,9578,GO:0005737,CDC42BPB,cytoplasm,2.0
3615,9578,GO:0005856,CDC42BPB,cytoskeleton,2.0
3616,9578,GO:0005886,CDC42BPB,plasma membrane,2.0
3617,9578,GO:0005911,CDC42BPB,cell-cell junction,2.0
3618,9578,GO:0006468,CDC42BPB,protein phosphorylation,2.0
3620,9578,GO:0007010,CDC42BPB,cytoskeleton organization,2.0
3621,9578,GO:0007163,CDC42BPB,establishment or maintenance of cell polarity,2.0
3622,9578,GO:0007165,CDC42BPB,signal transduction,2.0
3623,9578,GO:0016477,CDC42BPB,cell migration,2.0
3624,9578,GO:0018107,CDC42BPB,peptidyl-threonine phosphorylation,2.0
3625,9578,GO:0030027,CDC42BPB,lamellipodium,2.0
3626,9578,GO:0031032,CDC42BPB,actomyosin structure organization,2.0
3628,9578,GO:0031252,CDC42BPB,cell leading edge,2.0
3629,9578,GO:0031267,CDC42BPB,small GTPase binding,2.0
3630,9578,GO:0031532,CDC42BPB,actin cytoskeleton reorganization,2.0
3631,9578,GO:0035556,CDC42BPB,intracellular signal transduction,2.0
3632,9578,GO:0042641,CDC42BPB,actomyosin,2.0
3634,9578,GO:0044877,CDC42BPB,protein-containing complex binding,2.0
3635,9578,GO:0070062,CDC42BPB,extracellular exosome,2.0
3636,9578,GO:0106310,CDC42BPB,protein serine kinase activity,2.0
3637,9578,GO:0106311,CDC42BPB,protein threonine kinase activity,2.0
3676,1012,GO:0000278,CDH13,mitotic cell cycle,2.0
3677,1012,GO:0001938,CDH13,positive regulation of endothelial cell proliferation,2.0
3678,1012,GO:0001954,CDH13,positive regulation of cell-matrix adhesion,2.0
3679,1012,GO:0002040,CDH13,sprouting angiogenesis,2.0
3681,1012,GO:0005509,CDH13,calcium ion binding,2.0
3682,1012,GO:0005515,CDH13,protein binding,2.0
3683,1012,GO:0005576,CDH13,extracellular region,2.0
3684,1012,GO:0005615,CDH13,extracellular space,2.0
3685,1012,GO:0005737,CDH13,cytoplasm,2.0
3686,1012,GO:0005886,CDH13,plasma membrane,2.0
3688,1012,GO:0005901,CDH13,caveola,2.0
3689,1012,GO:0005925,CDH13,focal adhesion,2.0
3690,1012,GO:0007156,CDH13,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
3692,1012,GO:0007162,CDH13,negative regulation of cell adhesion,2.0
3693,1012,GO:0007266,CDH13,Rho protein signal transduction,2.0
3694,1012,GO:0008285,CDH13,negative regulation of cell population proliferation,2.0
3695,1012,GO:0009897,CDH13,external side of plasma membrane,2.0
3696,1012,GO:0016339,CDH13,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
3697,1012,GO:0016342,CDH13,catenin complex,2.0
3698,1012,GO:0016601,CDH13,Rac protein signal transduction,2.0
3699,1012,GO:0030032,CDH13,lamellipodium assembly,2.0
3700,1012,GO:0030100,CDH13,regulation of endocytosis,2.0
3701,1012,GO:0030169,CDH13,low-density lipoprotein particle binding,2.0
3702,1012,GO:0030335,CDH13,positive regulation of cell migration,2.0
3703,1012,GO:0031225,CDH13,anchored component of membrane,2.0
3704,1012,GO:0034332,CDH13,adherens junction organization,2.0
3705,1012,GO:0042058,CDH13,regulation of epidermal growth factor receptor signaling pathway,2.0
3706,1012,GO:0042803,CDH13,protein homodimerization activity,2.0
3707,1012,GO:0043005,CDH13,neuron projection,2.0
3708,1012,GO:0043542,CDH13,endothelial cell migration,2.0
3709,1012,GO:0043616,CDH13,keratinocyte proliferation,2.0
3710,1012,GO:0045296,CDH13,cadherin binding,2.0
3712,1012,GO:0045944,CDH13,positive regulation of transcription by RNA polymerase II,2.0
3713,1012,GO:0048471,CDH13,perinuclear region of cytoplasm,2.0
3714,1012,GO:0048661,CDH13,positive regulation of smooth muscle cell proliferation,2.0
3715,1012,GO:0050850,CDH13,positive regulation of calcium-mediated signaling,2.0
3716,1012,GO:0050927,CDH13,positive regulation of positive chemotaxis,2.0
3717,1012,GO:0051668,CDH13,localization within membrane,2.0
3718,1012,GO:0055096,CDH13,low-density lipoprotein particle mediated signaling,2.0
3719,1012,GO:0055100,CDH13,adiponectin binding,2.0
3720,1012,GO:0062023,CDH13,collagen-containing extracellular matrix,2.0
3721,1012,GO:0070062,CDH13,extracellular exosome,2.0
3722,1012,GO:0071813,CDH13,lipoprotein particle binding,2.0
3723,1012,GO:0098742,CDH13,cell-cell adhesion via plasma-membrane adhesion molecules,2.0
3946,9662,GO:0000086,CEP135,G2/M transition of mitotic cell cycle,2.0
3947,9662,GO:0005515,CEP135,protein binding,2.0
3948,9662,GO:0005813,CEP135,centrosome,2.0
3949,9662,GO:0005814,CEP135,centriole,2.0
3950,9662,GO:0005829,CEP135,cytosol,2.0
3951,9662,GO:0007099,CEP135,centriole replication,2.0
3952,9662,GO:0008022,CEP135,protein C-terminus binding,2.0
3953,9662,GO:0010389,CEP135,regulation of G2/M transition of mitotic cell cycle,2.0
3954,9662,GO:0010457,CEP135,centriole-centriole cohesion,2.0
3955,9662,GO:0097711,CEP135,ciliary basal body-plasma membrane docking,2.0
3956,9662,GO:1902857,CEP135,positive regulation of non-motile cilium assembly,2.0
3957,9662,GO:1904951,CEP135,positive regulation of establishment of protein localization,2.0
3991,95681,GO:0000086,CEP41,G2/M transition of mitotic cell cycle,2.0
3992,95681,GO:0005515,CEP41,protein binding,2.0
3993,95681,GO:0005813,CEP41,centrosome,2.0
3994,95681,GO:0005814,CEP41,centriole,2.0
3995,95681,GO:0005829,CEP41,cytosol,2.0
3996,95681,GO:0005929,CEP41,cilium,2.0
3997,95681,GO:0010389,CEP41,regulation of G2/M transition of mitotic cell cycle,2.0
3998,95681,GO:0015031,CEP41,protein transport,2.0
3999,95681,GO:0016020,CEP41,membrane,2.0
4000,95681,GO:0018095,CEP41,protein polyglutamylation,2.0
4001,95681,GO:0036064,CEP41,ciliary basal body,2.0
4002,95681,GO:0060271,CEP41,cilium assembly,2.0
4003,95681,GO:0097711,CEP41,ciliary basal body-plasma membrane docking,2.0
4004,84952,GO:0003774,CGNL1,motor activity,2.0
4005,84952,GO:0005515,CGNL1,protein binding,2.0
4006,84952,GO:0005923,CGNL1,bicellular tight junction,2.0
4007,84952,GO:0007015,CGNL1,actin filament organization,2.0
4008,84952,GO:0016459,CGNL1,myosin complex,2.0
4009,84952,GO:0032991,CGNL1,protein-containing complex,2.0
4010,84952,GO:0051058,CGNL1,negative regulation of small GTPase mediated signal transduction,2.0
4011,84952,GO:0051497,CGNL1,negative regulation of stress fiber assembly,2.0
4012,84952,GO:0150105,CGNL1,protein localization to cell-cell junction,2.0
4211,5119,GO:0000794,CHMP1A,condensed nuclear chromosome,2.0
4212,5119,GO:0000815,CHMP1A,ESCRT III complex,2.0
4213,5119,GO:0005515,CHMP1A,protein binding,2.0
4214,5119,GO:0005769,CHMP1A,early endosome,2.0
4215,5119,GO:0005771,CHMP1A,multivesicular body,2.0
4216,5119,GO:0005815,CHMP1A,microtubule organizing center,2.0
4217,5119,GO:0006508,CHMP1A,proteolysis,2.0
4218,5119,GO:0006997,CHMP1A,nucleus organization,2.0
4219,5119,GO:0007076,CHMP1A,mitotic chromosome condensation,2.0
4220,5119,GO:0007080,CHMP1A,mitotic metaphase plate congression,2.0
4221,5119,GO:0008237,CHMP1A,metallopeptidase activity,2.0
4222,5119,GO:0008270,CHMP1A,zinc ion binding,2.0
4223,5119,GO:0010824,CHMP1A,regulation of centrosome duplication,2.0
4224,5119,GO:0012505,CHMP1A,endomembrane system,2.0
4225,5119,GO:0015031,CHMP1A,protein transport,2.0
4226,5119,GO:0016192,CHMP1A,vesicle-mediated transport,2.0
4227,5119,GO:0016363,CHMP1A,nuclear matrix,2.0
4228,5119,GO:0016458,CHMP1A,gene silencing,2.0
4229,5119,GO:0019904,CHMP1A,protein domain specific binding,2.0
4230,5119,GO:0032509,CHMP1A,endosome transport via multivesicular body sorting pathway,2.0
4231,5119,GO:0036258,CHMP1A,multivesicular body assembly,2.0
4232,5119,GO:0039702,CHMP1A,viral budding via host ESCRT complex,2.0
4233,5119,GO:0042802,CHMP1A,identical protein binding,2.0
4234,5119,GO:0042803,CHMP1A,protein homodimerization activity,2.0
4235,5119,GO:0045324,CHMP1A,late endosome to vacuole transport,2.0
4236,5119,GO:0045786,CHMP1A,negative regulation of cell cycle,2.0
4237,5119,GO:0045892,CHMP1A,"negative regulation of transcription, DNA-templated",2.0
4238,5119,GO:0051301,CHMP1A,cell division,2.0
4239,5119,GO:0061952,CHMP1A,midbody abscission,2.0
4240,5119,GO:0070062,CHMP1A,extracellular exosome,2.0
4241,5119,GO:1901673,CHMP1A,regulation of mitotic spindle assembly,2.0
4242,5119,GO:1904903,CHMP1A,ESCRT III complex disassembly,2.0
4275,1139,GO:0000187,CHRNA7,activation of MAPK activity,2.0
4276,1139,GO:0001540,CHRNA7,amyloid-beta binding,2.0
4277,1139,GO:0001666,CHRNA7,response to hypoxia,2.0
4278,1139,GO:0001933,CHRNA7,negative regulation of protein phosphorylation,2.0
4279,1139,GO:0001934,CHRNA7,positive regulation of protein phosphorylation,2.0
4280,1139,GO:0001988,CHRNA7,positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure,2.0
4281,1139,GO:0005216,CHRNA7,ion channel activity,2.0
4282,1139,GO:0005262,CHRNA7,calcium channel activity,2.0
4283,1139,GO:0005515,CHRNA7,protein binding,2.0
4284,1139,GO:0005886,CHRNA7,plasma membrane,2.0
4286,1139,GO:0005887,CHRNA7,integral component of plasma membrane,2.0
4287,1139,GO:0005892,CHRNA7,acetylcholine-gated channel complex,2.0
4289,1139,GO:0006811,CHRNA7,ion transport,2.0
4290,1139,GO:0006816,CHRNA7,calcium ion transport,2.0
4292,1139,GO:0006874,CHRNA7,cellular calcium ion homeostasis,2.0
4293,1139,GO:0006897,CHRNA7,endocytosis,2.0
4294,1139,GO:0007165,CHRNA7,signal transduction,2.0
4296,1139,GO:0007268,CHRNA7,chemical synaptic transmission,2.0
4297,1139,GO:0007271,CHRNA7,"synaptic transmission, cholinergic",2.0
4298,1139,GO:0007611,CHRNA7,learning or memory,2.0
4299,1139,GO:0007613,CHRNA7,memory,2.0
4301,1139,GO:0007614,CHRNA7,short-term memory,2.0
4302,1139,GO:0008284,CHRNA7,positive regulation of cell population proliferation,2.0
4303,1139,GO:0008306,CHRNA7,associative learning,2.0
4304,1139,GO:0009409,CHRNA7,response to cold,2.0
4305,1139,GO:0009897,CHRNA7,external side of plasma membrane,2.0
4306,1139,GO:0014061,CHRNA7,regulation of norepinephrine secretion,2.0
4307,1139,GO:0015464,CHRNA7,acetylcholine receptor activity,2.0
4308,1139,GO:0015643,CHRNA7,toxic substance binding,2.0
4309,1139,GO:0016021,CHRNA7,integral component of membrane,2.0
4310,1139,GO:0016324,CHRNA7,apical plasma membrane,2.0
4311,1139,GO:0017081,CHRNA7,chloride channel regulator activity,2.0
4312,1139,GO:0022848,CHRNA7,acetylcholine-gated cation-selective channel activity,2.0
4314,1139,GO:0030317,CHRNA7,flagellated sperm motility,2.0
4315,1139,GO:0030594,CHRNA7,neurotransmitter receptor activity,2.0
4316,1139,GO:0030673,CHRNA7,axolemma,2.0
4317,1139,GO:0032094,CHRNA7,response to food,2.0
4318,1139,GO:0032225,CHRNA7,"regulation of synaptic transmission, dopaminergic",2.0
4319,1139,GO:0032691,CHRNA7,negative regulation of interleukin-1 beta production,2.0
4320,1139,GO:0032715,CHRNA7,negative regulation of interleukin-6 production,2.0
4321,1139,GO:0032720,CHRNA7,negative regulation of tumor necrosis factor production,2.0
4323,1139,GO:0033138,CHRNA7,positive regulation of peptidyl-serine phosphorylation,2.0
4324,1139,GO:0034220,CHRNA7,ion transmembrane transport,2.0
4326,1139,GO:0035094,CHRNA7,response to nicotine,2.0
4328,1139,GO:0035095,CHRNA7,behavioral response to nicotine,2.0
4329,1139,GO:0042110,CHRNA7,T cell activation,2.0
4330,1139,GO:0042113,CHRNA7,B cell activation,2.0
4331,1139,GO:0042166,CHRNA7,acetylcholine binding,2.0
4333,1139,GO:0042391,CHRNA7,regulation of membrane potential,2.0
4334,1139,GO:0042803,CHRNA7,protein homodimerization activity,2.0
4335,1139,GO:0043005,CHRNA7,neuron projection,2.0
4336,1139,GO:0044853,CHRNA7,plasma membrane raft,2.0
4337,1139,GO:0045202,CHRNA7,synapse,2.0
4338,1139,GO:0045766,CHRNA7,positive regulation of angiogenesis,2.0
4339,1139,GO:0048149,CHRNA7,behavioral response to ethanol,2.0
4340,1139,GO:0050728,CHRNA7,negative regulation of inflammatory response,2.0
4341,1139,GO:0050808,CHRNA7,synapse organization,2.0
4342,1139,GO:0050877,CHRNA7,nervous system process,2.0
4343,1139,GO:0050890,CHRNA7,cognition,2.0
4345,1139,GO:0050893,CHRNA7,sensory processing,2.0
4346,1139,GO:0051247,CHRNA7,positive regulation of protein metabolic process,2.0
4347,1139,GO:0060079,CHRNA7,excitatory postsynaptic potential,2.0
4348,1139,GO:0060112,CHRNA7,generation of ovulation cycle rhythm,2.0
4349,1139,GO:0070374,CHRNA7,positive regulation of ERK1 and ERK2 cascade,2.0
4350,1139,GO:0070588,CHRNA7,calcium ion transmembrane transport,2.0
4351,1139,GO:0095500,CHRNA7,acetylcholine receptor signaling pathway,2.0
4352,1139,GO:0097061,CHRNA7,dendritic spine organization,2.0
4353,1139,GO:0098794,CHRNA7,postsynapse,2.0
4354,1139,GO:0098815,CHRNA7,modulation of excitatory postsynaptic potential,2.0
4355,1139,GO:0098981,CHRNA7,cholinergic synapse,2.0
4356,1139,GO:0099060,CHRNA7,integral component of postsynaptic specialization membrane,2.0
4357,1139,GO:0140059,CHRNA7,dendrite arborization,2.0
4358,1139,GO:1900273,CHRNA7,positive regulation of long-term synaptic potentiation,2.0
4359,1139,GO:1901214,CHRNA7,regulation of neuron death,2.0
4360,1139,GO:1902004,CHRNA7,positive regulation of amyloid-beta formation,2.0
4361,1139,GO:1902430,CHRNA7,negative regulation of amyloid-beta formation,2.0
4362,1139,GO:1902991,CHRNA7,regulation of amyloid precursor protein catabolic process,2.0
4363,1139,GO:1904645,CHRNA7,response to amyloid-beta,2.0
4364,1139,GO:1905144,CHRNA7,response to acetylcholine,2.0
4366,1139,GO:1905906,CHRNA7,regulation of amyloid fibril formation,2.0
4367,1139,GO:1905920,CHRNA7,positive regulation of CoA-transferase activity,2.0
4368,1139,GO:2000463,CHRNA7,positive regulation of excitatory postsynaptic potential,2.0
4391,10518,GO:0000287,CIB2,magnesium ion binding,2.0
4392,10518,GO:0001750,CIB2,photoreceptor outer segment,2.0
4393,10518,GO:0001917,CIB2,photoreceptor inner segment,2.0
4394,10518,GO:0005509,CIB2,calcium ion binding,2.0
4395,10518,GO:0005515,CIB2,protein binding,2.0
4396,10518,GO:0005737,CIB2,cytoplasm,2.0
4397,10518,GO:0007204,CIB2,positive regulation of cytosolic calcium ion concentration,2.0
4398,10518,GO:0032420,CIB2,stereocilium,2.0
4399,10518,GO:0032437,CIB2,cuticular plate,2.0
4400,10518,GO:0042383,CIB2,sarcolemma,2.0
4401,10518,GO:0042803,CIB2,protein homodimerization activity,2.0
4402,10518,GO:0045494,CIB2,photoreceptor cell maintenance,2.0
4403,10518,GO:0055074,CIB2,calcium ion homeostasis,2.0
4404,10518,GO:0071318,CIB2,cellular response to ATP,2.0
4405,10518,GO:0072562,CIB2,blood microparticle,2.0
4424,23332,GO:0000086,CLASP1,G2/M transition of mitotic cell cycle,2.0
4425,23332,GO:0000226,CLASP1,microtubule cytoskeleton organization,2.0
4428,23332,GO:0000776,CLASP1,kinetochore,2.0
4430,23332,GO:0000777,CLASP1,condensed chromosome kinetochore,2.0
4431,23332,GO:0001578,CLASP1,microtubule bundle formation,2.0
4432,23332,GO:0002162,CLASP1,dystroglycan binding,2.0
4433,23332,GO:0005515,CLASP1,protein binding,2.0
4434,23332,GO:0005794,CLASP1,Golgi apparatus,2.0
4435,23332,GO:0005813,CLASP1,centrosome,2.0
4436,23332,GO:0005815,CLASP1,microtubule organizing center,2.0
4437,23332,GO:0005828,CLASP1,kinetochore microtubule,2.0
4438,23332,GO:0005829,CLASP1,cytosol,2.0
4439,23332,GO:0005876,CLASP1,spindle microtubule,2.0
4441,23332,GO:0005881,CLASP1,cytoplasmic microtubule,2.0
4443,23332,GO:0005925,CLASP1,focal adhesion,2.0
4444,23332,GO:0005938,CLASP1,cell cortex,2.0
4445,23332,GO:0006903,CLASP1,vesicle targeting,2.0
4446,23332,GO:0007020,CLASP1,microtubule nucleation,2.0
4447,23332,GO:0007026,CLASP1,negative regulation of microtubule depolymerization,2.0
4449,23332,GO:0007030,CLASP1,Golgi organization,2.0
4450,23332,GO:0007052,CLASP1,mitotic spindle organization,2.0
4451,23332,GO:0007163,CLASP1,establishment or maintenance of cell polarity,2.0
4452,23332,GO:0008017,CLASP1,microtubule binding,2.0
4455,23332,GO:0010389,CLASP1,regulation of G2/M transition of mitotic cell cycle,2.0
4456,23332,GO:0010458,CLASP1,exit from mitosis,2.0
4457,23332,GO:0010470,CLASP1,regulation of gastrulation,2.0
4458,23332,GO:0010634,CLASP1,positive regulation of epithelial cell migration,2.0
4459,23332,GO:0010717,CLASP1,regulation of epithelial to mesenchymal transition,2.0
4460,23332,GO:0016020,CLASP1,membrane,2.0
4461,23332,GO:0030953,CLASP1,astral microtubule organization,2.0
4462,23332,GO:0030981,CLASP1,cortical microtubule cytoskeleton,2.0
4463,23332,GO:0031023,CLASP1,microtubule organizing center organization,2.0
4464,23332,GO:0031110,CLASP1,regulation of microtubule polymerization or depolymerization,2.0
4465,23332,GO:0031111,CLASP1,negative regulation of microtubule polymerization or depolymerization,2.0
4466,23332,GO:0031116,CLASP1,positive regulation of microtubule polymerization,2.0
4467,23332,GO:0031592,CLASP1,centrosomal corona,2.0
4468,23332,GO:0034453,CLASP1,microtubule anchoring,2.0
4469,23332,GO:0035371,CLASP1,microtubule plus-end,2.0
4470,23332,GO:0040001,CLASP1,establishment of mitotic spindle localization,2.0
4472,23332,GO:0043515,CLASP1,kinetochore binding,2.0
4474,23332,GO:0045180,CLASP1,basal cortex,2.0
4476,23332,GO:0045921,CLASP1,positive regulation of exocytosis,2.0
4477,23332,GO:0051010,CLASP1,microtubule plus-end binding,2.0
4478,23332,GO:0051294,CLASP1,establishment of spindle orientation,2.0
4481,23332,GO:0051301,CLASP1,cell division,2.0
4482,23332,GO:0051497,CLASP1,negative regulation of stress fiber assembly,2.0
4483,23332,GO:0051893,CLASP1,regulation of focal adhesion assembly,2.0
4484,23332,GO:0070507,CLASP1,regulation of microtubule cytoskeleton organization,2.0
4485,23332,GO:0072686,CLASP1,mitotic spindle,2.0
4486,23332,GO:0090091,CLASP1,positive regulation of extracellular matrix disassembly,2.0
4487,23332,GO:0090162,CLASP1,establishment of epithelial cell polarity,2.0
4488,23332,GO:0090307,CLASP1,mitotic spindle assembly,2.0
4490,23332,GO:0097711,CLASP1,ciliary basal body-plasma membrane docking,2.0
4491,23332,GO:1903690,CLASP1,"negative regulation of wound healing, spreading of epidermal cells",2.0
4492,23332,GO:1904261,CLASP1,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,2.0
4622,22866,GO:0005515,CNKSR2,protein binding,2.0
4623,22866,GO:0005737,CNKSR2,cytoplasm,2.0
4624,22866,GO:0005886,CNKSR2,plasma membrane,2.0
4625,22866,GO:0009966,CNKSR2,regulation of signal transduction,2.0
4626,22866,GO:0014069,CNKSR2,postsynaptic density,2.0
4627,22866,GO:0019901,CNKSR2,protein kinase binding,2.0
4628,22866,GO:0035556,CNKSR2,intracellular signal transduction,2.0
4629,22866,GO:0070062,CNKSR2,extracellular exosome,2.0
4647,1268,GO:0002866,CNR1,positive regulation of acute inflammatory response to antigenic stimulus,2.0
4648,1268,GO:0004930,CNR1,G protein-coupled receptor activity,2.0
4649,1268,GO:0004949,CNR1,cannabinoid receptor activity,2.0
4651,1268,GO:0005515,CNR1,protein binding,2.0
4652,1268,GO:0005737,CNR1,cytoplasm,2.0
4653,1268,GO:0005741,CNR1,mitochondrial outer membrane,2.0
4654,1268,GO:0005886,CNR1,plasma membrane,2.0
4657,1268,GO:0005887,CNR1,integral component of plasma membrane,2.0
4658,1268,GO:0007186,CNR1,G protein-coupled receptor signaling pathway,2.0
4659,1268,GO:0007187,CNR1,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",2.0
4660,1268,GO:0007188,CNR1,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,2.0
4661,1268,GO:0007189,CNR1,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2.0
4662,1268,GO:0007283,CNR1,spermatogenesis,2.0
4663,1268,GO:0007413,CNR1,axonal fasciculation,2.0
4664,1268,GO:0007568,CNR1,aging,2.0
4665,1268,GO:0007584,CNR1,response to nutrient,2.0
4666,1268,GO:0007613,CNR1,memory,2.0
4667,1268,GO:0008144,CNR1,drug binding,2.0
4668,1268,GO:0010976,CNR1,positive regulation of neuron projection development,2.0
4669,1268,GO:0014063,CNR1,negative regulation of serotonin secretion,2.0
4670,1268,GO:0015629,CNR1,actin cytoskeleton,2.0
4671,1268,GO:0019222,CNR1,regulation of metabolic process,2.0
4672,1268,GO:0019233,CNR1,sensory perception of pain,2.0
4673,1268,GO:0030426,CNR1,growth cone,2.0
4674,1268,GO:0031622,CNR1,positive regulation of fever generation,2.0
4675,1268,GO:0031999,CNR1,negative regulation of fatty acid beta-oxidation,2.0
4676,1268,GO:0032228,CNR1,"regulation of synaptic transmission, GABAergic",2.0
4677,1268,GO:0032496,CNR1,response to lipopolysaccharide,2.0
4678,1268,GO:0033004,CNR1,negative regulation of mast cell activation,2.0
4679,1268,GO:0033602,CNR1,negative regulation of dopamine secretion,2.0
4680,1268,GO:0035094,CNR1,response to nicotine,2.0
4681,1268,GO:0038171,CNR1,cannabinoid signaling pathway,2.0
4683,1268,GO:0042220,CNR1,response to cocaine,2.0
4684,1268,GO:0042593,CNR1,glucose homeostasis,2.0
4685,1268,GO:0042734,CNR1,presynaptic membrane,2.0
4686,1268,GO:0042802,CNR1,identical protein binding,2.0
4687,1268,GO:0043065,CNR1,positive regulation of apoptotic process,2.0
4688,1268,GO:0043278,CNR1,response to morphine,2.0
4689,1268,GO:0045121,CNR1,membrane raft,2.0
4690,1268,GO:0045471,CNR1,response to ethanol,2.0
4691,1268,GO:0045759,CNR1,negative regulation of action potential,2.0
4692,1268,GO:0045776,CNR1,negative regulation of blood pressure,2.0
4693,1268,GO:0045777,CNR1,positive regulation of blood pressure,2.0
4694,1268,GO:0050796,CNR1,regulation of insulin secretion,2.0
4695,1268,GO:0051001,CNR1,negative regulation of nitric-oxide synthase activity,2.0
4696,1268,GO:0051966,CNR1,"regulation of synaptic transmission, glutamatergic",2.0
4697,1268,GO:0060135,CNR1,maternal process involved in female pregnancy,2.0
4698,1268,GO:0060259,CNR1,regulation of feeding behavior,2.0
4699,1268,GO:0060405,CNR1,regulation of penile erection,2.0
4700,1268,GO:0099553,CNR1,"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission",2.0
4707,152330,GO:0005576,CNTN4,extracellular region,2.0
4708,152330,GO:0005886,CNTN4,plasma membrane,2.0
4711,152330,GO:0007156,CNTN4,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4712,152330,GO:0007158,CNTN4,neuron cell-cell adhesion,2.0
4713,152330,GO:0007399,CNTN4,nervous system development,2.0
4714,152330,GO:0007409,CNTN4,axonogenesis,2.0
4715,152330,GO:0007411,CNTN4,axon guidance,2.0
4717,152330,GO:0007413,CNTN4,axonal fasciculation,2.0
4718,152330,GO:0007420,CNTN4,brain development,2.0
4719,152330,GO:0030424,CNTN4,axon,2.0
4721,152330,GO:0031175,CNTN4,neuron projection development,2.0
4722,152330,GO:0031225,CNTN4,anchored component of membrane,2.0
4723,152330,GO:0045665,CNTN4,negative regulation of neuron differentiation,2.0
4724,152330,GO:0048167,CNTN4,regulation of synaptic plasticity,2.0
4725,152330,GO:0070593,CNTN4,dendrite self-avoidance,2.0
4726,152330,GO:0098632,CNTN4,cell-cell adhesion mediator activity,2.0
4727,53942,GO:0005576,CNTN5,extracellular region,2.0
4728,53942,GO:0005886,CNTN5,plasma membrane,2.0
4729,53942,GO:0007155,CNTN5,cell adhesion,2.0
4730,53942,GO:0007605,CNTN5,sensory perception of sound,2.0
4731,53942,GO:0031225,CNTN5,anchored component of membrane,2.0
4732,53942,GO:0098982,CNTN5,GABA-ergic synapse,2.0
4733,53942,GO:0099054,CNTN5,presynapse assembly,2.0
4734,27255,GO:0005112,CNTN6,Notch binding,2.0
4735,27255,GO:0005886,CNTN6,plasma membrane,2.0
4736,27255,GO:0007155,CNTN6,cell adhesion,2.0
4737,27255,GO:0007156,CNTN6,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
4738,27255,GO:0007219,CNTN6,Notch signaling pathway,2.0
4739,27255,GO:0007411,CNTN6,axon guidance,2.0
4740,27255,GO:0007417,CNTN6,central nervous system development,2.0
4741,27255,GO:0030424,CNTN6,axon,2.0
4742,27255,GO:0031225,CNTN6,anchored component of membrane,2.0
4743,27255,GO:0045747,CNTN6,positive regulation of Notch signaling pathway,2.0
4744,27255,GO:0070593,CNTN6,dendrite self-avoidance,2.0
4745,27255,GO:0098632,CNTN6,cell-cell adhesion mediator activity,2.0
4746,26047,GO:0005515,CNTNAP2,protein binding,2.0
4747,26047,GO:0005769,CNTNAP2,early endosome,2.0
4748,26047,GO:0005794,CNTNAP2,Golgi apparatus,2.0
4749,26047,GO:0007155,CNTNAP2,cell adhesion,2.0
4750,26047,GO:0007420,CNTNAP2,brain development,2.0
4751,26047,GO:0007612,CNTNAP2,learning,2.0
4752,26047,GO:0008038,CNTNAP2,neuron recognition,2.0
4753,26047,GO:0008076,CNTNAP2,voltage-gated potassium channel complex,2.0
4755,26047,GO:0009986,CNTNAP2,cell surface,2.0
4756,26047,GO:0016020,CNTNAP2,membrane,2.0
4757,26047,GO:0016021,CNTNAP2,integral component of membrane,2.0
4758,26047,GO:0019226,CNTNAP2,transmission of nerve impulse,2.0
4759,26047,GO:0019899,CNTNAP2,enzyme binding,2.0
4760,26047,GO:0021756,CNTNAP2,striatum development,2.0
4761,26047,GO:0021761,CNTNAP2,limbic system development,2.0
4762,26047,GO:0021794,CNTNAP2,thalamus development,2.0
4763,26047,GO:0021987,CNTNAP2,cerebral cortex development,2.0
4764,26047,GO:0030424,CNTNAP2,axon,2.0
4765,26047,GO:0030425,CNTNAP2,dendrite,2.0
4766,26047,GO:0030534,CNTNAP2,adult behavior,2.0
4767,26047,GO:0030673,CNTNAP2,axolemma,2.0
4768,26047,GO:0031175,CNTNAP2,neuron projection development,2.0
4769,26047,GO:0033010,CNTNAP2,paranodal junction,2.0
4770,26047,GO:0035176,CNTNAP2,social behavior,2.0
4771,26047,GO:0042297,CNTNAP2,vocal learning,2.0
4772,26047,GO:0043025,CNTNAP2,neuronal cell body,2.0
4773,26047,GO:0043204,CNTNAP2,perikaryon,2.0
4774,26047,GO:0044224,CNTNAP2,juxtaparanode region of axon,2.0
4775,26047,GO:0045163,CNTNAP2,clustering of voltage-gated potassium channels,2.0
4776,26047,GO:0048812,CNTNAP2,neuron projection morphogenesis,2.0
4777,26047,GO:0071109,CNTNAP2,superior temporal gyrus development,2.0
4778,26047,GO:0071205,CNTNAP2,protein localization to juxtaparanode region of axon,2.0
4779,26047,GO:0071625,CNTNAP2,vocalization behavior,2.0
4780,79937,GO:0005576,CNTNAP3,extracellular region,2.0
4781,79937,GO:0005886,CNTNAP3,plasma membrane,2.0
4782,79937,GO:0007155,CNTNAP3,cell adhesion,2.0
4783,79937,GO:0008037,CNTNAP3,cell recognition,2.0
4784,79937,GO:0016021,CNTNAP3,integral component of membrane,2.0
4785,85445,GO:0007155,CNTNAP4,cell adhesion,2.0
4786,85445,GO:0016021,CNTNAP4,integral component of membrane,2.0
4787,85445,GO:0032225,CNTNAP4,"regulation of synaptic transmission, dopaminergic",2.0
4788,85445,GO:0032228,CNTNAP4,"regulation of synaptic transmission, GABAergic",2.0
4789,85445,GO:0042734,CNTNAP4,presynaptic membrane,2.0
4790,85445,GO:0042995,CNTNAP4,cell projection,2.0
4791,85445,GO:2000821,CNTNAP4,regulation of grooming behavior,2.0
4901,23019,GO:0000122,CNOT1,negative regulation of transcription by RNA polymerase II,2.0
4902,23019,GO:0000288,CNOT1,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
4903,23019,GO:0000289,CNOT1,nuclear-transcribed mRNA poly(A) tail shortening,2.0
4904,23019,GO:0000932,CNOT1,P-body,2.0
4907,23019,GO:0003723,CNOT1,RNA binding,2.0
4908,23019,GO:0004535,CNOT1,poly(A)-specific ribonuclease activity,2.0
4909,23019,GO:0005515,CNOT1,protein binding,2.0
4910,23019,GO:0005615,CNOT1,extracellular space,2.0
4911,23019,GO:0005634,CNOT1,nucleus,2.0
4912,23019,GO:0005829,CNOT1,cytosol,2.0
4914,23019,GO:0006977,CNOT1,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",2.0
4915,23019,GO:0007275,CNOT1,multicellular organism development,2.0
4916,23019,GO:0010606,CNOT1,positive regulation of cytoplasmic mRNA processing body assembly,2.0
4917,23019,GO:0016020,CNOT1,membrane,2.0
4918,23019,GO:0017148,CNOT1,negative regulation of translation,2.0
4920,23019,GO:0019904,CNOT1,protein domain specific binding,2.0
4921,23019,GO:0030014,CNOT1,CCR4-NOT complex,2.0
4922,23019,GO:0030015,CNOT1,CCR4-NOT core complex,2.0
4923,23019,GO:0030331,CNOT1,estrogen receptor binding,2.0
4924,23019,GO:0033147,CNOT1,negative regulation of intracellular estrogen receptor signaling pathway,2.0
4925,23019,GO:0035195,CNOT1,gene silencing by miRNA,2.0
4926,23019,GO:0042974,CNOT1,retinoic acid receptor binding,2.0
4927,23019,GO:0048387,CNOT1,negative regulation of retinoic acid receptor signaling pathway,2.0
4928,23019,GO:0060090,CNOT1,molecular adaptor activity,2.0
4930,23019,GO:0060213,CNOT1,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,2.0
4932,23019,GO:0061014,CNOT1,positive regulation of mRNA catabolic process,2.0
4933,23019,GO:0070016,CNOT1,armadillo repeat domain binding,2.0
4934,23019,GO:0090503,CNOT1,"RNA phosphodiester bond hydrolysis, exonucleolytic",2.0
4935,23019,GO:1900153,CNOT1,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
4936,23019,GO:2000036,CNOT1,regulation of stem cell population maintenance,2.0
5133,80315,GO:0000900,CPEB4,"translation repressor activity, mRNA regulatory element binding",2.0
5134,80315,GO:0002931,CPEB4,response to ischemia,2.0
5135,80315,GO:0003723,CPEB4,RNA binding,2.0
5136,80315,GO:0003730,CPEB4,mRNA 3'-UTR binding,2.0
5137,80315,GO:0005515,CPEB4,protein binding,2.0
5138,80315,GO:0005634,CPEB4,nucleus,2.0
5141,80315,GO:0005737,CPEB4,cytoplasm,2.0
5144,80315,GO:0005783,CPEB4,endoplasmic reticulum,2.0
5145,80315,GO:0006412,CPEB4,translation,2.0
5146,80315,GO:0008135,CPEB4,"translation factor activity, RNA binding",2.0
5147,80315,GO:0014069,CPEB4,postsynaptic density,2.0
5148,80315,GO:0030425,CPEB4,dendrite,2.0
5149,80315,GO:0030426,CPEB4,growth cone,2.0
5150,80315,GO:0035235,CPEB4,ionotropic glutamate receptor signaling pathway,2.0
5151,80315,GO:0036294,CPEB4,cellular response to decreased oxygen levels,2.0
5152,80315,GO:0042149,CPEB4,cellular response to glucose starvation,2.0
5153,80315,GO:0043005,CPEB4,neuron projection,2.0
5154,80315,GO:0043022,CPEB4,ribosome binding,2.0
5155,80315,GO:0043197,CPEB4,dendritic spine,2.0
5156,80315,GO:0043524,CPEB4,negative regulation of neuron apoptotic process,2.0
5157,80315,GO:0045202,CPEB4,synapse,2.0
5158,80315,GO:0046872,CPEB4,metal ion binding,2.0
5159,80315,GO:0048471,CPEB4,perinuclear region of cytoplasm,2.0
5160,80315,GO:0071230,CPEB4,cellular response to amino acid stimulus,2.0
5161,80315,GO:1990124,CPEB4,messenger ribonucleoprotein complex,2.0
5162,80315,GO:2000766,CPEB4,negative regulation of cytoplasmic translation,2.0
5437,1501,GO:0005515,CTNND2,protein binding,2.0
5438,1501,GO:0005634,CTNND2,nucleus,2.0
5439,1501,GO:0005737,CTNND2,cytoplasm,2.0
5440,1501,GO:0005886,CTNND2,plasma membrane,2.0
5441,1501,GO:0005912,CTNND2,adherens junction,2.0
5442,1501,GO:0007043,CTNND2,cell-cell junction assembly,2.0
5443,1501,GO:0007155,CTNND2,cell adhesion,2.0
5444,1501,GO:0007165,CTNND2,signal transduction,2.0
5445,1501,GO:0008013,CTNND2,beta-catenin binding,2.0
5446,1501,GO:0014069,CTNND2,postsynaptic density,2.0
5447,1501,GO:0016055,CTNND2,Wnt signaling pathway,2.0
5448,1501,GO:0030425,CTNND2,dendrite,2.0
5449,1501,GO:0043204,CTNND2,perikaryon,2.0
5450,1501,GO:0045296,CTNND2,cadherin binding,2.0
5451,1501,GO:0050808,CTNND2,synapse organization,2.0
5452,1501,GO:0060828,CTNND2,regulation of canonical Wnt signaling pathway,2.0
5453,1501,GO:0060997,CTNND2,dendritic spine morphogenesis,2.0
5455,1501,GO:0098609,CTNND2,cell-cell adhesion,2.0
5456,83992,GO:0005515,CTTNBP2,protein binding,2.0
5457,83992,GO:0005938,CTTNBP2,cell cortex,2.0
5458,83992,GO:0007420,CTTNBP2,brain development,2.0
5459,83992,GO:0008021,CTTNBP2,synaptic vesicle,2.0
5460,83992,GO:0017124,CTTNBP2,SH3 domain binding,2.0
5461,83992,GO:0043197,CTTNBP2,dendritic spine,2.0
5462,83992,GO:0050807,CTTNBP2,regulation of synapse organization,2.0
5463,83992,GO:0098978,CTTNBP2,glutamatergic synapse,2.0
5532,9820,GO:0000226,CUL7,microtubule cytoskeleton organization,2.0
5533,9820,GO:0000281,CUL7,mitotic cytokinesis,2.0
5534,9820,GO:0001570,CUL7,vasculogenesis,2.0
5535,9820,GO:0001837,CUL7,epithelial to mesenchymal transition,2.0
5536,9820,GO:0001890,CUL7,placenta development,2.0
5537,9820,GO:0005515,CUL7,protein binding,2.0
5538,9820,GO:0005680,CUL7,anaphase-promoting complex,2.0
5539,9820,GO:0005737,CUL7,cytoplasm,2.0
5540,9820,GO:0005794,CUL7,Golgi apparatus,2.0
5542,9820,GO:0005813,CUL7,centrosome,2.0
5543,9820,GO:0005829,CUL7,cytosol,2.0
5544,9820,GO:0006508,CUL7,proteolysis,2.0
5545,9820,GO:0006511,CUL7,ubiquitin-dependent protein catabolic process,2.0
5546,9820,GO:0007030,CUL7,Golgi organization,2.0
5547,9820,GO:0007088,CUL7,regulation of mitotic nuclear division,2.0
5549,9820,GO:0016032,CUL7,viral process,2.0
5550,9820,GO:0016567,CUL7,protein ubiquitination,2.0
5554,9820,GO:0031461,CUL7,cullin-RING ubiquitin ligase complex,2.0
5555,9820,GO:0031467,CUL7,Cul7-RING ubiquitin ligase complex,2.0
5556,9820,GO:0031625,CUL7,ubiquitin protein ligase binding,2.0
5557,9820,GO:0036498,CUL7,IRE1-mediated unfolded protein response,2.0
5558,9820,GO:0043687,CUL7,post-translational protein modification,2.0
5559,9820,GO:0048471,CUL7,perinuclear region of cytoplasm,2.0
5560,9820,GO:0050775,CUL7,positive regulation of dendrite morphogenesis,2.0
5562,9820,GO:1990393,CUL7,3M complex,2.0
5563,1523,GO:0000301,CUX1,"retrograde transport, vesicle recycling within Golgi",2.0
5564,1523,GO:0000785,CUX1,chromatin,2.0
5565,1523,GO:0000977,CUX1,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
5567,1523,GO:0000981,CUX1,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
5569,1523,GO:0005634,CUX1,nucleus,2.0
5571,1523,GO:0005654,CUX1,nucleoplasm,2.0
5572,1523,GO:0005794,CUX1,Golgi apparatus,2.0
5573,1523,GO:0005829,CUX1,cytosol,2.0
5574,1523,GO:0006357,CUX1,regulation of transcription by RNA polymerase II,2.0
5576,1523,GO:0007275,CUX1,multicellular organism development,2.0
5577,1523,GO:0030674,CUX1,protein-macromolecule adaptor activity,2.0
5578,1523,GO:0043565,CUX1,sequence-specific DNA binding,2.0
5579,1523,GO:0050775,CUX1,positive regulation of dendrite morphogenesis,2.0
5580,1523,GO:1990837,CUX1,sequence-specific double-stranded DNA binding,2.0
5666,23191,GO:0000340,CYFIP1,RNA 7-methylguanosine cap binding,2.0
5667,23191,GO:0000902,CYFIP1,cell morphogenesis,2.0
5668,23191,GO:0001726,CYFIP1,ruffle,2.0
5669,23191,GO:0005515,CYFIP1,protein binding,2.0
5670,23191,GO:0005576,CYFIP1,extracellular region,2.0
5671,23191,GO:0005829,CYFIP1,cytosol,2.0
5672,23191,GO:0005845,CYFIP1,mRNA cap binding complex,2.0
5673,23191,GO:0005925,CYFIP1,focal adhesion,2.0
5674,23191,GO:0006417,CYFIP1,regulation of translation,2.0
5675,23191,GO:0007411,CYFIP1,axon guidance,2.0
5676,23191,GO:0008360,CYFIP1,regulation of cell shape,2.0
5677,23191,GO:0016601,CYFIP1,Rac protein signal transduction,2.0
5678,23191,GO:0030027,CYFIP1,lamellipodium,2.0
5679,23191,GO:0030031,CYFIP1,cell projection assembly,2.0
5680,23191,GO:0030032,CYFIP1,lamellipodium assembly,2.0
5682,23191,GO:0031209,CYFIP1,SCAR complex,2.0
5684,23191,GO:0031267,CYFIP1,small GTPase binding,2.0
5686,23191,GO:0031529,CYFIP1,ruffle organization,2.0
5687,23191,GO:0031641,CYFIP1,regulation of myelination,2.0
5688,23191,GO:0032433,CYFIP1,filopodium tip,2.0
5689,23191,GO:0032869,CYFIP1,cellular response to insulin stimulus,2.0
5690,23191,GO:0034774,CYFIP1,secretory granule lumen,2.0
5691,23191,GO:0035580,CYFIP1,specific granule lumen,2.0
5692,23191,GO:0038096,CYFIP1,Fc-gamma receptor signaling pathway involved in phagocytosis,2.0
5693,23191,GO:0043005,CYFIP1,neuron projection,2.0
5695,23191,GO:0043025,CYFIP1,neuronal cell body,2.0
5696,23191,GO:0043195,CYFIP1,terminal bouton,2.0
5697,23191,GO:0043197,CYFIP1,dendritic spine,2.0
5698,23191,GO:0043312,CYFIP1,neutrophil degranulation,2.0
5699,23191,GO:0044294,CYFIP1,dendritic growth cone,2.0
5700,23191,GO:0044295,CYFIP1,axonal growth cone,2.0
5701,23191,GO:0045202,CYFIP1,synapse,2.0
5702,23191,GO:0045773,CYFIP1,positive regulation of axon extension,2.0
5703,23191,GO:0048010,CYFIP1,vascular endothelial growth factor receptor signaling pathway,2.0
5704,23191,GO:0048471,CYFIP1,perinuclear region of cytoplasm,2.0
5705,23191,GO:0048675,CYFIP1,axon extension,2.0
5706,23191,GO:0050890,CYFIP1,cognition,2.0
5707,23191,GO:0051015,CYFIP1,actin filament binding,2.0
5708,23191,GO:0051388,CYFIP1,positive regulation of neurotrophin TRK receptor signaling pathway,2.0
5709,23191,GO:0051602,CYFIP1,response to electrical stimulus,2.0
5710,23191,GO:0060076,CYFIP1,excitatory synapse,2.0
5711,23191,GO:0070062,CYFIP1,extracellular exosome,2.0
5712,23191,GO:0090724,CYFIP1,central region of growth cone,2.0
5713,23191,GO:0090725,CYFIP1,peripheral region of growth cone,2.0
5714,23191,GO:0097484,CYFIP1,dendrite extension,2.0
5715,23191,GO:0099563,CYFIP1,modification of synaptic structure,2.0
5716,23191,GO:1900006,CYFIP1,positive regulation of dendrite development,2.0
5717,23191,GO:1900029,CYFIP1,positive regulation of ruffle assembly,2.0
5718,23191,GO:1903422,CYFIP1,negative regulation of synaptic vesicle recycling,2.0
5719,23191,GO:1904724,CYFIP1,tertiary granule lumen,2.0
5720,23191,GO:1905274,CYFIP1,regulation of modification of postsynaptic actin cytoskeleton,2.0
5721,23191,GO:2000601,CYFIP1,positive regulation of Arp2/3 complex-mediated actin nucleation,2.0
5804,27071,GO:0005515,DAPP1,protein binding,2.0
5805,27071,GO:0005543,DAPP1,phospholipid binding,2.0
5806,27071,GO:0005547,DAPP1,"phosphatidylinositol-3,4,5-trisphosphate binding",2.0
5807,27071,GO:0005829,DAPP1,cytosol,2.0
5808,27071,GO:0005886,DAPP1,plasma membrane,2.0
5810,27071,GO:0006470,DAPP1,protein dephosphorylation,2.0
5811,27071,GO:0007165,DAPP1,signal transduction,2.0
5812,27071,GO:0043325,DAPP1,"phosphatidylinositol-3,4-bisphosphate binding",2.0
5940,8562,GO:0001731,DENR,formation of translation preinitiation complex,2.0
5942,8562,GO:0002188,DENR,translation reinitiation,2.0
5943,8562,GO:0003674,DENR,molecular_function,2.0
5944,8562,GO:0003729,DENR,mRNA binding,2.0
5945,8562,GO:0003743,DENR,translation initiation factor activity,2.0
5946,8562,GO:0005515,DENR,protein binding,2.0
5947,8562,GO:0005575,DENR,cellular_component,2.0
5948,8562,GO:0032790,DENR,ribosome disassembly,2.0
5949,8562,GO:0075522,DENR,IRES-dependent viral translational initiation,2.0
6020,22982,GO:0003674,DIP2C,molecular_function,2.0
6021,22982,GO:0005575,DIP2C,cellular_component,2.0
6022,22982,GO:0008150,DIP2C,biological_process,2.0
6023,27185,GO:0000226,DISC1,microtubule cytoskeleton organization,2.0
6024,27185,GO:0001764,DISC1,neuron migration,2.0
6026,27185,GO:0001954,DISC1,positive regulation of cell-matrix adhesion,2.0
6027,27185,GO:0002052,DISC1,positive regulation of neuroblast proliferation,2.0
6028,27185,GO:0005515,DISC1,protein binding,2.0
6029,27185,GO:0005634,DISC1,nucleus,2.0
6030,27185,GO:0005739,DISC1,mitochondrion,2.0
6032,27185,GO:0005783,DISC1,endoplasmic reticulum,2.0
6033,27185,GO:0005813,DISC1,centrosome,2.0
6035,27185,GO:0005829,DISC1,cytosol,2.0
6036,27185,GO:0005871,DISC1,kinesin complex,2.0
6037,27185,GO:0005874,DISC1,microtubule,2.0
6038,27185,GO:0008021,DISC1,synaptic vesicle,2.0
6039,27185,GO:0010975,DISC1,regulation of neuron projection development,2.0
6040,27185,GO:0014069,DISC1,postsynaptic density,2.0
6041,27185,GO:0019894,DISC1,kinesin binding,2.0
6042,27185,GO:0021846,DISC1,cell proliferation in forebrain,2.0
6043,27185,GO:0021852,DISC1,pyramidal neuron migration,2.0
6044,27185,GO:0030177,DISC1,positive regulation of Wnt signaling pathway,2.0
6045,27185,GO:0030286,DISC1,dynein complex,2.0
6046,27185,GO:0031929,DISC1,TOR signaling,2.0
6047,27185,GO:0032091,DISC1,negative regulation of protein binding,2.0
6048,27185,GO:0036064,DISC1,ciliary basal body,2.0
6049,27185,GO:0044297,DISC1,cell body,2.0
6050,27185,GO:0044877,DISC1,protein-containing complex binding,2.0
6051,27185,GO:0045111,DISC1,intermediate filament cytoskeleton,2.0
6053,27185,GO:0045773,DISC1,positive regulation of axon extension,2.0
6054,27185,GO:0048471,DISC1,perinuclear region of cytoplasm,2.0
6055,27185,GO:0051560,DISC1,mitochondrial calcium ion homeostasis,2.0
6056,27185,GO:0051602,DISC1,response to electrical stimulus,2.0
6057,27185,GO:0051966,DISC1,"regulation of synaptic transmission, glutamatergic",2.0
6058,27185,GO:0060070,DISC1,canonical Wnt signaling pathway,2.0
6059,27185,GO:0060090,DISC1,molecular adaptor activity,2.0
6060,27185,GO:0060271,DISC1,cilium assembly,2.0
6061,27185,GO:0060998,DISC1,regulation of dendritic spine development,2.0
6062,27185,GO:0071539,DISC1,protein localization to centrosome,2.0
6063,27185,GO:0090128,DISC1,regulation of synapse maturation,2.0
6064,27185,GO:0090724,DISC1,central region of growth cone,2.0
6065,27185,GO:0097546,DISC1,ciliary base,2.0
6066,27185,GO:1905515,DISC1,non-motile cilium assembly,2.0
6067,27185,GO:2000060,DISC1,positive regulation of ubiquitin-dependent protein catabolic process,2.0
6079,23259,GO:0004620,DDHD2,phospholipase activity,2.0
6080,23259,GO:0004806,DDHD2,triglyceride lipase activity,2.0
6081,23259,GO:0005737,DDHD2,cytoplasm,2.0
6082,23259,GO:0005793,DDHD2,endoplasmic reticulum-Golgi intermediate compartment,2.0
6083,23259,GO:0005794,DDHD2,Golgi apparatus,2.0
6084,23259,GO:0005829,DDHD2,cytosol,2.0
6086,23259,GO:0006654,DDHD2,phosphatidic acid biosynthetic process,2.0
6087,23259,GO:0007626,DDHD2,locomotory behavior,2.0
6088,23259,GO:0008542,DDHD2,visual learning,2.0
6089,23259,GO:0016020,DDHD2,membrane,2.0
6090,23259,GO:0019433,DDHD2,triglyceride catabolic process,2.0
6091,23259,GO:0030134,DDHD2,COPII-coated ER to Golgi transport vesicle,2.0
6092,23259,GO:0034389,DDHD2,lipid droplet organization,2.0
6093,23259,GO:0034451,DDHD2,centriolar satellite,2.0
6094,23259,GO:0046872,DDHD2,metal ion binding,2.0
6095,23259,GO:0090141,DDHD2,positive regulation of mitochondrial fission,2.0
6225,1740,GO:0000165,DLG2,MAPK cascade,2.0
6226,1740,GO:0004385,DLG2,guanylate kinase activity,2.0
6227,1740,GO:0005515,DLG2,protein binding,2.0
6228,1740,GO:0005829,DLG2,cytosol,2.0
6229,1740,GO:0005886,DLG2,plasma membrane,2.0
6230,1740,GO:0007268,DLG2,chemical synaptic transmission,2.0
6231,1740,GO:0008076,DLG2,voltage-gated potassium channel complex,2.0
6232,1740,GO:0008328,DLG2,ionotropic glutamate receptor complex,2.0
6233,1740,GO:0009790,DLG2,embryo development,2.0
6234,1740,GO:0010923,DLG2,negative regulation of phosphatase activity,2.0
6235,1740,GO:0014069,DLG2,postsynaptic density,2.0
6236,1740,GO:0016020,DLG2,membrane,2.0
6237,1740,GO:0016323,DLG2,basolateral plasma membrane,2.0
6238,1740,GO:0019233,DLG2,sensory perception of pain,2.0
6239,1740,GO:0019900,DLG2,kinase binding,2.0
6240,1740,GO:0030054,DLG2,cell junction,2.0
6241,1740,GO:0030672,DLG2,synaptic vesicle membrane,2.0
6242,1740,GO:0031594,DLG2,neuromuscular junction,2.0
6243,1740,GO:0035865,DLG2,cellular response to potassium ion,2.0
6244,1740,GO:0043005,DLG2,neuron projection,2.0
6245,1740,GO:0043113,DLG2,receptor clustering,2.0
6246,1740,GO:0043204,DLG2,perikaryon,2.0
6247,1740,GO:0044224,DLG2,juxtaparanode region of axon,2.0
6248,1740,GO:0045197,DLG2,establishment or maintenance of epithelial cell apical/basal polarity,2.0
6249,1740,GO:0046037,DLG2,GMP metabolic process,2.0
6250,1740,GO:0046710,DLG2,GDP metabolic process,2.0
6251,1740,GO:0097120,DLG2,receptor localization to synapse,2.0
6252,1740,GO:0098609,DLG2,cell-cell adhesion,2.0
6253,1740,GO:0098839,DLG2,postsynaptic density membrane,2.0
6254,1740,GO:0098919,DLG2,structural constituent of postsynaptic density,2.0
6255,1740,GO:0098978,DLG2,glutamatergic synapse,2.0
6256,1740,GO:0099562,DLG2,maintenance of postsynaptic density structure,2.0
6257,1740,GO:0099641,DLG2,anterograde axonal protein transport,2.0
6258,1740,GO:0099642,DLG2,retrograde axonal protein transport,2.0
6259,1740,GO:1904115,DLG2,axon cytoplasm,2.0
6260,1740,GO:2000310,DLG2,regulation of NMDA receptor activity,2.0
6338,9229,GO:0005515,DLGAP1,protein binding,2.0
6339,9229,GO:0005575,DLGAP1,cellular_component,2.0
6340,9229,GO:0005886,DLGAP1,plasma membrane,2.0
6341,9229,GO:0007268,DLGAP1,chemical synaptic transmission,2.0
6342,9229,GO:0014069,DLGAP1,postsynaptic density,2.0
6343,9229,GO:0044877,DLGAP1,protein-containing complex binding,2.0
6344,9229,GO:0060090,DLGAP1,molecular adaptor activity,2.0
6345,9229,GO:0098962,DLGAP1,regulation of postsynaptic neurotransmitter receptor activity,2.0
6346,9229,GO:0098978,DLGAP1,glutamatergic synapse,2.0
6347,9229,GO:0099572,DLGAP1,postsynaptic specialization,2.0
6445,1747,GO:0000785,DLX3,chromatin,2.0
6447,1747,GO:0000978,DLX3,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
6448,1747,GO:0000981,DLX3,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
6450,1747,GO:0001228,DLX3,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
6451,1747,GO:0001568,DLX3,blood vessel development,2.0
6452,1747,GO:0001890,DLX3,placenta development,2.0
6453,1747,GO:0003677,DLX3,DNA binding,2.0
6454,1747,GO:0003682,DLX3,chromatin binding,2.0
6455,1747,GO:0003700,DLX3,DNA-binding transcription factor activity,2.0
6456,1747,GO:0005515,DLX3,protein binding,2.0
6457,1747,GO:0006357,DLX3,regulation of transcription by RNA polymerase II,2.0
6458,1747,GO:0009790,DLX3,embryo development,2.0
6459,1747,GO:0030154,DLX3,cell differentiation,2.0
6460,1747,GO:0030855,DLX3,epithelial cell differentiation,2.0
6461,1747,GO:0042475,DLX3,odontogenesis of dentin-containing tooth,2.0
6462,1747,GO:0071895,DLX3,odontoblast differentiation,2.0
6463,1747,GO:1990837,DLX3,sequence-specific double-stranded DNA binding,2.0
6721,81704,GO:0001771,DOCK8,immunological synapse formation,2.0
6722,81704,GO:0005085,DOCK8,guanyl-nucleotide exchange factor activity,2.0
6723,81704,GO:0005515,DOCK8,protein binding,2.0
6724,81704,GO:0005737,DOCK8,cytoplasm,2.0
6725,81704,GO:0005829,DOCK8,cytosol,2.0
6726,81704,GO:0007264,DOCK8,small GTPase mediated signal transduction,2.0
6727,81704,GO:0007596,DOCK8,blood coagulation,2.0
6728,81704,GO:0016020,DOCK8,membrane,2.0
6729,81704,GO:0031256,DOCK8,leading edge membrane,2.0
6730,81704,GO:0031258,DOCK8,lamellipodium membrane,2.0
6731,81704,GO:0036336,DOCK8,dendritic cell migration,2.0
6732,81704,GO:0043547,DOCK8,positive regulation of GTPase activity,2.0
6733,81704,GO:0061485,DOCK8,memory T cell proliferation,2.0
6734,81704,GO:0070233,DOCK8,negative regulation of T cell apoptotic process,2.0
6735,81704,GO:1903905,DOCK8,positive regulation of establishment of T cell polarity,2.0
6736,81704,GO:1990869,DOCK8,cellular response to chemokine,2.0
6737,81704,GO:2000406,DOCK8,positive regulation of T cell migration,2.0
6749,57628,GO:0005886,DPP10,plasma membrane,2.0
6750,57628,GO:0006508,DPP10,proteolysis,2.0
6751,57628,GO:0008076,DPP10,voltage-gated potassium channel complex,2.0
6752,57628,GO:0008236,DPP10,serine-type peptidase activity,2.0
6753,57628,GO:0008239,DPP10,dipeptidyl-peptidase activity,2.0
6754,57628,GO:0015459,DPP10,potassium channel regulator activity,2.0
6755,57628,GO:0016020,DPP10,membrane,2.0
6756,57628,GO:0044325,DPP10,ion channel binding,2.0
6757,57628,GO:0072659,DPP10,protein localization to plasma membrane,2.0
6758,57628,GO:1901379,DPP10,regulation of potassium ion transmembrane transport,2.0
6759,57628,GO:1903078,DPP10,positive regulation of protein localization to plasma membrane,2.0
7504,23167,GO:0005829,EFR3A,cytosol,2.0
7505,23167,GO:0005886,EFR3A,plasma membrane,2.0
7507,23167,GO:0046854,EFR3A,phosphatidylinositol phosphorylation,2.0
7508,23167,GO:0072659,EFR3A,protein localization to plasma membrane,2.0
7564,1630,GO:0001764,DCC,neuron migration,2.0
7565,1630,GO:0004888,DCC,transmembrane signaling receptor activity,2.0
7566,1630,GO:0005042,DCC,netrin receptor activity,2.0
7567,1630,GO:0005515,DCC,protein binding,2.0
7568,1630,GO:0005829,DCC,cytosol,2.0
7569,1630,GO:0005886,DCC,plasma membrane,2.0
7570,1630,GO:0006915,DCC,apoptotic process,2.0
7571,1630,GO:0007409,DCC,axonogenesis,2.0
7572,1630,GO:0007411,DCC,axon guidance,2.0
7573,1630,GO:0010977,DCC,negative regulation of neuron projection development,2.0
7574,1630,GO:0021965,DCC,spinal cord ventral commissure morphogenesis,2.0
7575,1630,GO:0030424,DCC,axon,2.0
7576,1630,GO:0033563,DCC,dorsal/ventral axon guidance,2.0
7577,1630,GO:0033564,DCC,anterior/posterior axon guidance,2.0
7578,1630,GO:0038007,DCC,netrin-activated signaling pathway,2.0
7579,1630,GO:0048671,DCC,negative regulation of collateral sprouting,2.0
7580,1630,GO:0097192,DCC,extrinsic apoptotic signaling pathway in absence of ligand,2.0
7581,1630,GO:0098685,DCC,Schaffer collateral - CA1 synapse,2.0
7582,1630,GO:0099061,DCC,integral component of postsynaptic density membrane,2.0
7583,1630,GO:0099170,DCC,postsynaptic modulation of chemical synaptic transmission,2.0
7584,1630,GO:1901214,DCC,regulation of neuron death,2.0
7585,1630,GO:1902842,DCC,negative regulation of netrin-activated signaling pathway,2.0
7586,1630,GO:2000171,DCC,negative regulation of dendrite development,2.0
7713,26610,GO:0000993,ELP4,RNA polymerase II complex binding,2.0
7714,26610,GO:0002098,ELP4,tRNA wobble uridine modification,2.0
7715,26610,GO:0005515,ELP4,protein binding,2.0
7716,26610,GO:0005654,ELP4,nucleoplasm,2.0
7717,26610,GO:0005737,ELP4,cytoplasm,2.0
7719,26610,GO:0006357,ELP4,regulation of transcription by RNA polymerase II,2.0
7722,26610,GO:0006368,ELP4,transcription elongation from RNA polymerase II promoter,2.0
7723,26610,GO:0008023,ELP4,transcription elongation factor complex,2.0
7725,26610,GO:0008607,ELP4,phosphorylase kinase regulator activity,2.0
7726,26610,GO:0033588,ELP4,elongator holoenzyme complex,2.0
7728,26610,GO:0045859,ELP4,regulation of protein kinase activity,2.0
7873,56946,GO:0005515,EMSY,protein binding,2.0
7874,56946,GO:0005654,EMSY,nucleoplasm,2.0
7876,56946,GO:0006281,EMSY,DNA repair,2.0
7877,56946,GO:0006325,EMSY,chromatin organization,2.0
7878,56946,GO:0006355,EMSY,"regulation of transcription, DNA-templated",2.0
7879,56946,GO:0042802,EMSY,identical protein binding,2.0
7880,57634,GO:0000812,EP400,Swr1 complex,2.0
7881,57634,GO:0003677,EP400,DNA binding,2.0
7882,57634,GO:0004386,EP400,helicase activity,2.0
7883,57634,GO:0005515,EP400,protein binding,2.0
7884,57634,GO:0005524,EP400,ATP binding,2.0
7885,57634,GO:0005654,EP400,nucleoplasm,2.0
7886,57634,GO:0016607,EP400,nuclear speck,2.0
7887,57634,GO:0035267,EP400,NuA4 histone acetyltransferase complex,2.0
7888,57634,GO:0043967,EP400,histone H4 acetylation,2.0
7889,57634,GO:0043968,EP400,histone H2A acetylation,2.0
8096,2109,GO:0005515,ETFB,protein binding,2.0
8097,2109,GO:0005739,ETFB,mitochondrion,2.0
8098,2109,GO:0005759,ETFB,mitochondrial matrix,2.0
8100,2109,GO:0009055,ETFB,electron transfer activity,2.0
8102,2109,GO:0022904,ETFB,respiratory electron transport chain,2.0
8103,2109,GO:0033539,ETFB,fatty acid beta-oxidation using acyl-CoA dehydrogenase,2.0
8254,55914,GO:0005102,ERBIN,signaling receptor binding,2.0
8256,55914,GO:0005176,ERBIN,ErbB-2 class receptor binding,2.0
8257,55914,GO:0005200,ERBIN,structural constituent of cytoskeleton,2.0
8258,55914,GO:0005515,ERBIN,protein binding,2.0
8259,55914,GO:0005604,ERBIN,basement membrane,2.0
8260,55914,GO:0005634,ERBIN,nucleus,2.0
8261,55914,GO:0005737,ERBIN,cytoplasm,2.0
8262,55914,GO:0005886,ERBIN,plasma membrane,2.0
8264,55914,GO:0006605,ERBIN,protein targeting,2.0
8265,55914,GO:0007155,ERBIN,cell adhesion,2.0
8266,55914,GO:0007165,ERBIN,signal transduction,2.0
8267,55914,GO:0007173,ERBIN,epidermal growth factor receptor signaling pathway,2.0
8268,55914,GO:0007229,ERBIN,integrin-mediated signaling pathway,2.0
8269,55914,GO:0009925,ERBIN,basal plasma membrane,2.0
8270,55914,GO:0016323,ERBIN,basolateral plasma membrane,2.0
8272,55914,GO:0016607,ERBIN,nuclear speck,2.0
8273,55914,GO:0030054,ERBIN,cell junction,2.0
8274,55914,GO:0030056,ERBIN,hemidesmosome,2.0
8275,55914,GO:0031965,ERBIN,nuclear membrane,2.0
8276,55914,GO:0032088,ERBIN,negative regulation of NF-kappaB transcription factor activity,2.0
8278,55914,GO:0032495,ERBIN,response to muramyl dipeptide,2.0
8279,55914,GO:0032496,ERBIN,response to lipopolysaccharide,2.0
8280,55914,GO:0038128,ERBIN,ERBB2 signaling pathway,2.0
8281,55914,GO:0045104,ERBIN,intermediate filament cytoskeleton organization,2.0
8282,55914,GO:0045175,ERBIN,basal protein localization,2.0
8283,55914,GO:0045197,ERBIN,establishment or maintenance of epithelial cell apical/basal polarity,2.0
8284,55914,GO:0046579,ERBIN,positive regulation of Ras protein signal transduction,2.0
8285,55914,GO:0070433,ERBIN,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,2.0
8286,55914,GO:0071356,ERBIN,cellular response to tumor necrosis factor,2.0
8288,55914,GO:0071638,ERBIN,negative regulation of monocyte chemotactic protein-1 production,2.0
8289,55914,GO:0098978,ERBIN,glutamatergic synapse,2.0
8290,55914,GO:0099072,ERBIN,regulation of postsynaptic membrane neurotransmitter receptor levels,2.0
8341,2200,GO:0001501,FBN1,skeletal system development,2.0
8342,2200,GO:0001527,FBN1,microfibril,2.0
8343,2200,GO:0001656,FBN1,metanephros development,2.0
8344,2200,GO:0005178,FBN1,integrin binding,2.0
8345,2200,GO:0005179,FBN1,hormone activity,2.0
8346,2200,GO:0005201,FBN1,extracellular matrix structural constituent,2.0
8349,2200,GO:0005509,FBN1,calcium ion binding,2.0
8350,2200,GO:0005515,FBN1,protein binding,2.0
8351,2200,GO:0005576,FBN1,extracellular region,2.0
8354,2200,GO:0005604,FBN1,basement membrane,2.0
8355,2200,GO:0005615,FBN1,extracellular space,2.0
8357,2200,GO:0005788,FBN1,endoplasmic reticulum lumen,2.0
8358,2200,GO:0007165,FBN1,signal transduction,2.0
8359,2200,GO:0007507,FBN1,heart development,2.0
8360,2200,GO:0008201,FBN1,heparin binding,2.0
8361,2200,GO:0009653,FBN1,anatomical structure morphogenesis,2.0
8362,2200,GO:0030023,FBN1,extracellular matrix constituent conferring elasticity,2.0
8363,2200,GO:0030198,FBN1,extracellular matrix organization,2.0
8364,2200,GO:0031012,FBN1,extracellular matrix,2.0
8366,2200,GO:0033627,FBN1,cell adhesion mediated by integrin,2.0
8367,2200,GO:0035582,FBN1,sequestering of BMP in extracellular matrix,2.0
8368,2200,GO:0035583,FBN1,sequestering of TGFbeta in extracellular matrix,2.0
8369,2200,GO:0042802,FBN1,identical protein binding,2.0
8370,2200,GO:0043010,FBN1,camera-type eye development,2.0
8371,2200,GO:0043687,FBN1,post-translational protein modification,2.0
8372,2200,GO:0044267,FBN1,cellular protein metabolic process,2.0
8373,2200,GO:0044877,FBN1,protein-containing complex binding,2.0
8374,2200,GO:0045671,FBN1,negative regulation of osteoclast differentiation,2.0
8375,2200,GO:0048048,FBN1,embryonic eye morphogenesis,2.0
8376,2200,GO:0048050,FBN1,post-embryonic eye morphogenesis,2.0
8377,2200,GO:0062023,FBN1,collagen-containing extracellular matrix,2.0
8379,2200,GO:0071560,FBN1,cellular response to transforming growth factor beta stimulus,2.0
8380,2200,GO:1990314,FBN1,cellular response to insulin-like growth factor stimulus,2.0
8381,2200,GO:2001205,FBN1,negative regulation of osteoclast development,2.0
9024,2567,GO:0004890,GABRG3,GABA-A receptor activity,2.0
9025,2567,GO:0005237,GABRG3,inhibitory extracellular ligand-gated ion channel activity,2.0
9026,2567,GO:0005254,GABRG3,chloride channel activity,2.0
9027,2567,GO:0005886,GABRG3,plasma membrane,2.0
9028,2567,GO:0005887,GABRG3,integral component of plasma membrane,2.0
9029,2567,GO:0007165,GABRG3,signal transduction,2.0
9030,2567,GO:0007214,GABRG3,gamma-aminobutyric acid signaling pathway,2.0
9031,2567,GO:0007268,GABRG3,chemical synaptic transmission,2.0
9032,2567,GO:0008503,GABRG3,benzodiazepine receptor activity,2.0
9033,2567,GO:0022851,GABRG3,GABA-gated chloride ion channel activity,2.0
9034,2567,GO:0030594,GABRG3,neurotransmitter receptor activity,2.0
9035,2567,GO:0032590,GABRG3,dendrite membrane,2.0
9036,2567,GO:0034220,GABRG3,ion transmembrane transport,2.0
9037,2567,GO:0034707,GABRG3,chloride channel complex,2.0
9038,2567,GO:0042391,GABRG3,regulation of membrane potential,2.0
9039,2567,GO:0042493,GABRG3,response to drug,2.0
9040,2567,GO:0043005,GABRG3,neuron projection,2.0
9041,2567,GO:0045202,GABRG3,synapse,2.0
9042,2567,GO:0045211,GABRG3,postsynaptic membrane,2.0
9043,2567,GO:0050877,GABRG3,nervous system process,2.0
9044,2567,GO:0051932,GABRG3,"synaptic transmission, GABAergic",2.0
9045,2567,GO:0060078,GABRG3,regulation of postsynaptic membrane potential,2.0
9046,2567,GO:0098794,GABRG3,postsynapse,2.0
9047,2567,GO:0098982,GABRG3,GABA-ergic synapse,2.0
9048,2567,GO:0099699,GABRG3,integral component of synaptic membrane,2.0
9049,2567,GO:1902476,GABRG3,chloride transmembrane transport,2.0
9050,2567,GO:1902711,GABRG3,GABA-A receptor complex,2.0
9051,2567,GO:1904315,GABRG3,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
9068,26290,GO:0000139,GALNT8,Golgi membrane,2.0
9069,26290,GO:0004653,GALNT8,polypeptide N-acetylgalactosaminyltransferase activity,2.0
9070,26290,GO:0005794,GALNT8,Golgi apparatus,2.0
9071,26290,GO:0016021,GALNT8,integral component of membrane,2.0
9072,26290,GO:0016266,GALNT8,O-glycan processing,2.0
9073,26290,GO:0030246,GALNT8,carbohydrate binding,2.0
9074,26290,GO:0046872,GALNT8,metal ion binding,2.0
9120,79893,GO:0005634,GGNBP2,nucleus,2.0
9121,79893,GO:0005737,GGNBP2,cytoplasm,2.0
9122,79893,GO:0007283,GGNBP2,spermatogenesis,2.0
9123,79893,GO:0008285,GGNBP2,negative regulation of cell population proliferation,2.0
9124,79893,GO:0010629,GGNBP2,negative regulation of gene expression,2.0
9125,79893,GO:0030154,GGNBP2,cell differentiation,2.0
9126,79893,GO:0031410,GGNBP2,cytoplasmic vesicle,2.0
9127,79893,GO:0033140,GGNBP2,negative regulation of peptidyl-serine phosphorylation of STAT protein,2.0
9128,79893,GO:0042532,GGNBP2,negative regulation of tyrosine phosphorylation of STAT protein,2.0
9129,79893,GO:0060716,GGNBP2,labyrinthine layer blood vessel development,2.0
9130,79893,GO:0061099,GGNBP2,negative regulation of protein tyrosine kinase activity,2.0
9279,2239,GO:0001523,GPC4,retinoid metabolic process,2.0
9280,2239,GO:0005515,GPC4,protein binding,2.0
9281,2239,GO:0005576,GPC4,extracellular region,2.0
9282,2239,GO:0005634,GPC4,nucleus,2.0
9283,2239,GO:0005796,GPC4,Golgi lumen,2.0
9284,2239,GO:0005886,GPC4,plasma membrane,2.0
9285,2239,GO:0006024,GPC4,glycosaminoglycan biosynthetic process,2.0
9286,2239,GO:0006027,GPC4,glycosaminoglycan catabolic process,2.0
9287,2239,GO:0009897,GPC4,external side of plasma membrane,2.0
9288,2239,GO:0009966,GPC4,regulation of signal transduction,2.0
9289,2239,GO:0009986,GPC4,cell surface,2.0
9290,2239,GO:0016055,GPC4,Wnt signaling pathway,2.0
9291,2239,GO:0016477,GPC4,cell migration,2.0
9292,2239,GO:0043202,GPC4,lysosomal lumen,2.0
9293,2239,GO:0045202,GPC4,synapse,2.0
9294,2239,GO:0060071,GPC4,"Wnt signaling pathway, planar cell polarity pathway",2.0
9295,2239,GO:0062023,GPC4,collagen-containing extracellular matrix,2.0
9296,2239,GO:0070062,GPC4,extracellular exosome,2.0
9297,2239,GO:0098696,GPC4,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane,2.0
9298,2239,GO:0098978,GPC4,glutamatergic synapse,2.0
9299,2239,GO:0099026,GPC4,anchored component of presynaptic membrane,2.0
9300,2239,GO:0099560,GPC4,synaptic membrane adhesion,2.0
9301,2239,GO:1904929,GPC4,"coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway",2.0
9302,2239,GO:1905475,GPC4,regulation of protein localization to membrane,2.0
9303,2239,GO:1905606,GPC4,regulation of presynapse assembly,2.0
9339,10243,GO:0005515,GPHN,protein binding,2.0
9340,10243,GO:0005524,GPHN,ATP binding,2.0
9341,10243,GO:0005737,GPHN,cytoplasm,2.0
9342,10243,GO:0005829,GPHN,cytosol,2.0
9344,10243,GO:0005856,GPHN,cytoskeleton,2.0
9345,10243,GO:0005886,GPHN,plasma membrane,2.0
9346,10243,GO:0006777,GPHN,Mo-molybdopterin cofactor biosynthetic process,2.0
9347,10243,GO:0007529,GPHN,establishment of synaptic specificity at neuromuscular junction,2.0
9348,10243,GO:0008940,GPHN,nitrate reductase activity,2.0
9349,10243,GO:0010038,GPHN,response to metal ion,2.0
9350,10243,GO:0014069,GPHN,postsynaptic density,2.0
9351,10243,GO:0018315,GPHN,molybdenum incorporation into molybdenum-molybdopterin complex,2.0
9352,10243,GO:0030425,GPHN,dendrite,2.0
9354,10243,GO:0032324,GPHN,molybdopterin cofactor biosynthetic process,2.0
9358,10243,GO:0042802,GPHN,identical protein binding,2.0
9359,10243,GO:0043546,GPHN,molybdopterin cofactor binding,2.0
9360,10243,GO:0045211,GPHN,postsynaptic membrane,2.0
9362,10243,GO:0046872,GPHN,metal ion binding,2.0
9363,10243,GO:0055114,GPHN,oxidation-reduction process,2.0
9364,10243,GO:0061598,GPHN,molybdopterin adenylyltransferase activity,2.0
9365,10243,GO:0061599,GPHN,molybdopterin molybdotransferase activity,2.0
9366,10243,GO:0072579,GPHN,glycine receptor clustering,2.0
9367,10243,GO:0097060,GPHN,synaptic membrane,2.0
9368,10243,GO:0097112,GPHN,gamma-aminobutyric acid receptor clustering,2.0
9371,10243,GO:0098970,GPHN,postsynaptic neurotransmitter receptor diffusion trapping,2.0
9372,10243,GO:0099144,GPHN,anchored component of synaptic membrane,2.0
9373,10243,GO:0099572,GPHN,postsynaptic specialization,2.0
9374,10243,GO:0099634,GPHN,postsynaptic specialization membrane,2.0
9474,2890,GO:0000139,GRIA1,Golgi membrane,2.0
9475,2890,GO:0001540,GRIA1,amyloid-beta binding,2.0
9476,2890,GO:0004971,GRIA1,AMPA glutamate receptor activity,2.0
9478,2890,GO:0005515,GRIA1,protein binding,2.0
9479,2890,GO:0005789,GRIA1,endoplasmic reticulum membrane,2.0
9481,2890,GO:0005886,GRIA1,plasma membrane,2.0
9484,2890,GO:0006888,GRIA1,endoplasmic reticulum to Golgi vesicle-mediated transport,2.0
9485,2890,GO:0007165,GRIA1,signal transduction,2.0
9486,2890,GO:0007268,GRIA1,chemical synaptic transmission,2.0
9487,2890,GO:0007616,GRIA1,long-term memory,2.0
9488,2890,GO:0008066,GRIA1,glutamate receptor activity,2.0
9489,2890,GO:0009986,GRIA1,cell surface,2.0
9490,2890,GO:0012507,GRIA1,ER to Golgi transport vesicle membrane,2.0
9491,2890,GO:0014069,GRIA1,postsynaptic density,2.0
9492,2890,GO:0015276,GRIA1,ligand-gated ion channel activity,2.0
9493,2890,GO:0030165,GRIA1,PDZ domain binding,2.0
9494,2890,GO:0030425,GRIA1,dendrite,2.0
9495,2890,GO:0030666,GRIA1,endocytic vesicle membrane,2.0
9496,2890,GO:0030672,GRIA1,synaptic vesicle membrane,2.0
9497,2890,GO:0031623,GRIA1,receptor internalization,2.0
9498,2890,GO:0031901,GRIA1,early endosome membrane,2.0
9499,2890,GO:0032281,GRIA1,AMPA glutamate receptor complex,2.0
9501,2890,GO:0032591,GRIA1,dendritic spine membrane,2.0
9502,2890,GO:0033116,GRIA1,endoplasmic reticulum-Golgi intermediate compartment membrane,2.0
9503,2890,GO:0034220,GRIA1,ion transmembrane transport,2.0
9504,2890,GO:0035235,GRIA1,ionotropic glutamate receptor signaling pathway,2.0
9505,2890,GO:0038023,GRIA1,signaling receptor activity,2.0
9506,2890,GO:0043025,GRIA1,neuronal cell body,2.0
9507,2890,GO:0043197,GRIA1,dendritic spine,2.0
9509,2890,GO:0044308,GRIA1,axonal spine,2.0
9510,2890,GO:0044309,GRIA1,neuron spine,2.0
9511,2890,GO:0048208,GRIA1,COPII vesicle coating,2.0
9512,2890,GO:0055037,GRIA1,recycling endosome,2.0
9513,2890,GO:0055038,GRIA1,recycling endosome membrane,2.0
9514,2890,GO:0060078,GRIA1,regulation of postsynaptic membrane potential,2.0
9515,2890,GO:0060292,GRIA1,long-term synaptic depression,2.0
9516,2890,GO:0097060,GRIA1,synaptic membrane,2.0
9517,2890,GO:0098839,GRIA1,postsynaptic density membrane,2.0
9518,2890,GO:0098978,GRIA1,glutamatergic synapse,2.0
9519,2890,GO:0099544,GRIA1,perisynaptic space,2.0
9520,2890,GO:0099566,GRIA1,regulation of postsynaptic cytosolic calcium ion concentration,2.0
9521,2890,GO:0099583,GRIA1,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,2.0
9522,2890,GO:1904315,GRIA1,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
9523,2890,GO:2000310,GRIA1,regulation of NMDA receptor activity,2.0
9557,2894,GO:0004970,GRID1,ionotropic glutamate receptor activity,2.0
9558,2894,GO:0005886,GRID1,plasma membrane,2.0
9559,2894,GO:0008066,GRID1,glutamate receptor activity,2.0
9560,2894,GO:0015276,GRID1,ligand-gated ion channel activity,2.0
9561,2894,GO:0034220,GRID1,ion transmembrane transport,2.0
9562,2894,GO:0035176,GRID1,social behavior,2.0
9563,2894,GO:0035235,GRID1,ionotropic glutamate receptor signaling pathway,2.0
9564,2894,GO:0035249,GRID1,"synaptic transmission, glutamatergic",2.0
9565,2894,GO:0038023,GRID1,signaling receptor activity,2.0
9566,2894,GO:0045211,GRID1,postsynaptic membrane,2.0
9567,2894,GO:0050804,GRID1,modulation of chemical synaptic transmission,2.0
9568,2894,GO:0060078,GRID1,regulation of postsynaptic membrane potential,2.0
9569,2894,GO:0070062,GRID1,extracellular exosome,2.0
9570,2894,GO:0098978,GRID1,glutamatergic synapse,2.0
9571,2894,GO:0099061,GRID1,integral component of postsynaptic density membrane,2.0
9572,2894,GO:1904315,GRID1,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
9608,2898,GO:0001662,GRIK2,behavioral fear response,2.0
9609,2898,GO:0005234,GRIK2,extracellularly glutamate-gated ion channel activity,2.0
9610,2898,GO:0005886,GRIK2,plasma membrane,2.0
9612,2898,GO:0005887,GRIK2,integral component of plasma membrane,2.0
9613,2898,GO:0006874,GRIK2,cellular calcium ion homeostasis,2.0
9614,2898,GO:0007215,GRIK2,glutamate receptor signaling pathway,2.0
9615,2898,GO:0007268,GRIK2,chemical synaptic transmission,2.0
9616,2898,GO:0008066,GRIK2,glutamate receptor activity,2.0
9617,2898,GO:0014069,GRIK2,postsynaptic density,2.0
9618,2898,GO:0015276,GRIK2,ligand-gated ion channel activity,2.0
9619,2898,GO:0015277,GRIK2,kainate selective glutamate receptor activity,2.0
9621,2898,GO:0019228,GRIK2,neuronal action potential,2.0
9622,2898,GO:0030165,GRIK2,PDZ domain binding,2.0
9623,2898,GO:0031624,GRIK2,ubiquitin conjugating enzyme binding,2.0
9624,2898,GO:0031625,GRIK2,ubiquitin protein ligase binding,2.0
9625,2898,GO:0032839,GRIK2,dendrite cytoplasm,2.0
9626,2898,GO:0032983,GRIK2,kainate selective glutamate receptor complex,2.0
9627,2898,GO:0034220,GRIK2,ion transmembrane transport,2.0
9628,2898,GO:0035235,GRIK2,ionotropic glutamate receptor signaling pathway,2.0
9629,2898,GO:0035249,GRIK2,"synaptic transmission, glutamatergic",2.0
9630,2898,GO:0038023,GRIK2,signaling receptor activity,2.0
9631,2898,GO:0042734,GRIK2,presynaptic membrane,2.0
9632,2898,GO:0042802,GRIK2,identical protein binding,2.0
9633,2898,GO:0043113,GRIK2,receptor clustering,2.0
9634,2898,GO:0043195,GRIK2,terminal bouton,2.0
9635,2898,GO:0043204,GRIK2,perikaryon,2.0
9636,2898,GO:0043524,GRIK2,negative regulation of neuron apoptotic process,2.0
9637,2898,GO:0043525,GRIK2,positive regulation of neuron apoptotic process,2.0
9638,2898,GO:0045211,GRIK2,postsynaptic membrane,2.0
9639,2898,GO:0046328,GRIK2,regulation of JNK cascade,2.0
9640,2898,GO:0048169,GRIK2,regulation of long-term neuronal synaptic plasticity,2.0
9641,2898,GO:0048172,GRIK2,regulation of short-term neuronal synaptic plasticity,2.0
9642,2898,GO:0050804,GRIK2,modulation of chemical synaptic transmission,2.0
9644,2898,GO:0050806,GRIK2,positive regulation of synaptic transmission,2.0
9645,2898,GO:0051402,GRIK2,neuron apoptotic process,2.0
9646,2898,GO:0051967,GRIK2,"negative regulation of synaptic transmission, glutamatergic",2.0
9647,2898,GO:0060079,GRIK2,excitatory postsynaptic potential,2.0
9648,2898,GO:0060080,GRIK2,inhibitory postsynaptic potential,2.0
9649,2898,GO:0098686,GRIK2,hippocampal mossy fiber to CA3 synapse,2.0
9650,2898,GO:0098978,GRIK2,glutamatergic synapse,2.0
9651,2898,GO:0099505,GRIK2,regulation of presynaptic membrane potential,2.0
9652,2898,GO:0099507,GRIK2,ligand-gated ion channel activity involved in regulation of presynaptic membrane potential,2.0
9653,2898,GO:0120169,GRIK2,detection of cold stimulus involved in thermoception,2.0
9654,2898,GO:1904315,GRIK2,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
9655,2260,GO:0000122,FGFR1,negative regulation of transcription by RNA polymerase II,2.0
9656,2260,GO:0000165,FGFR1,MAPK cascade,2.0
9657,2260,GO:0001501,FGFR1,skeletal system development,2.0
9658,2260,GO:0001525,FGFR1,angiogenesis,2.0
9659,2260,GO:0001657,FGFR1,ureteric bud development,2.0
9660,2260,GO:0001701,FGFR1,in utero embryonic development,2.0
9661,2260,GO:0001759,FGFR1,organ induction,2.0
9662,2260,GO:0001764,FGFR1,neuron migration,2.0
9663,2260,GO:0001837,FGFR1,epithelial to mesenchymal transition,2.0
9664,2260,GO:0002053,FGFR1,positive regulation of mesenchymal cell proliferation,2.0
9665,2260,GO:0002062,FGFR1,chondrocyte differentiation,2.0
9666,2260,GO:0004713,FGFR1,protein tyrosine kinase activity,2.0
9667,2260,GO:0004714,FGFR1,transmembrane receptor protein tyrosine kinase activity,2.0
9668,2260,GO:0005007,FGFR1,fibroblast growth factor-activated receptor activity,2.0
9671,2260,GO:0005515,FGFR1,protein binding,2.0
9672,2260,GO:0005524,FGFR1,ATP binding,2.0
9673,2260,GO:0005576,FGFR1,extracellular region,2.0
9674,2260,GO:0005634,FGFR1,nucleus,2.0
9675,2260,GO:0005829,FGFR1,cytosol,2.0
9676,2260,GO:0005886,FGFR1,plasma membrane,2.0
9678,2260,GO:0005887,FGFR1,integral component of plasma membrane,2.0
9679,2260,GO:0006468,FGFR1,protein phosphorylation,2.0
9680,2260,GO:0007169,FGFR1,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
9681,2260,GO:0007275,FGFR1,multicellular organism development,2.0
9682,2260,GO:0007605,FGFR1,sensory perception of sound,2.0
9683,2260,GO:0008201,FGFR1,heparin binding,2.0
9684,2260,GO:0008284,FGFR1,positive regulation of cell population proliferation,2.0
9687,2260,GO:0008543,FGFR1,fibroblast growth factor receptor signaling pathway,2.0
9691,2260,GO:0010518,FGFR1,positive regulation of phospholipase activity,2.0
9692,2260,GO:0010863,FGFR1,positive regulation of phospholipase C activity,2.0
9693,2260,GO:0010966,FGFR1,regulation of phosphate transport,2.0
9694,2260,GO:0010976,FGFR1,positive regulation of neuron projection development,2.0
9695,2260,GO:0014068,FGFR1,positive regulation of phosphatidylinositol 3-kinase signaling,2.0
9696,2260,GO:0016021,FGFR1,integral component of membrane,2.0
9697,2260,GO:0016477,FGFR1,cell migration,2.0
9698,2260,GO:0017134,FGFR1,fibroblast growth factor binding,2.0
9700,2260,GO:0018108,FGFR1,peptidyl-tyrosine phosphorylation,2.0
9701,2260,GO:0021847,FGFR1,ventricular zone neuroblast division,2.0
9702,2260,GO:0030326,FGFR1,embryonic limb morphogenesis,2.0
9703,2260,GO:0030901,FGFR1,midbrain development,2.0
9704,2260,GO:0031410,FGFR1,cytoplasmic vesicle,2.0
9705,2260,GO:0033674,FGFR1,positive regulation of kinase activity,2.0
9706,2260,GO:0035607,FGFR1,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,2.0
9707,2260,GO:0042169,FGFR1,SH2 domain binding,2.0
9708,2260,GO:0042472,FGFR1,inner ear morphogenesis,2.0
9709,2260,GO:0042473,FGFR1,outer ear morphogenesis,2.0
9710,2260,GO:0042474,FGFR1,middle ear morphogenesis,2.0
9711,2260,GO:0042802,FGFR1,identical protein binding,2.0
9712,2260,GO:0042803,FGFR1,protein homodimerization activity,2.0
9713,2260,GO:0043009,FGFR1,chordate embryonic development,2.0
9714,2260,GO:0043235,FGFR1,receptor complex,2.0
9716,2260,GO:0043406,FGFR1,positive regulation of MAP kinase activity,2.0
9717,2260,GO:0043410,FGFR1,positive regulation of MAPK cascade,2.0
9719,2260,GO:0043536,FGFR1,positive regulation of blood vessel endothelial cell migration,2.0
9720,2260,GO:0045595,FGFR1,regulation of cell differentiation,2.0
9721,2260,GO:0045597,FGFR1,positive regulation of cell differentiation,2.0
9722,2260,GO:0045666,FGFR1,positive regulation of neuron differentiation,2.0
9723,2260,GO:0046777,FGFR1,protein autophosphorylation,2.0
9724,2260,GO:0048015,FGFR1,phosphatidylinositol-mediated signaling,2.0
9725,2260,GO:0048339,FGFR1,paraxial mesoderm development,2.0
9726,2260,GO:0048378,FGFR1,regulation of lateral mesodermal cell fate specification,2.0
9727,2260,GO:0048469,FGFR1,cell maturation,2.0
9728,2260,GO:0048705,FGFR1,skeletal system morphogenesis,2.0
9729,2260,GO:0051897,FGFR1,positive regulation of protein kinase B signaling,2.0
9731,2260,GO:0060045,FGFR1,positive regulation of cardiac muscle cell proliferation,2.0
9732,2260,GO:0060117,FGFR1,auditory receptor cell development,2.0
9733,2260,GO:0060445,FGFR1,branching involved in salivary gland morphogenesis,2.0
9734,2260,GO:0060484,FGFR1,lung-associated mesenchyme development,2.0
9735,2260,GO:0060665,FGFR1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,2.0
9736,2260,GO:0070640,FGFR1,vitamin D3 metabolic process,2.0
9737,2260,GO:0090080,FGFR1,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,2.0
9738,2260,GO:0090272,FGFR1,negative regulation of fibroblast growth factor production,2.0
9739,2260,GO:0090722,FGFR1,receptor-receptor interaction,2.0
9740,2260,GO:1903465,FGFR1,positive regulation of mitotic cell cycle DNA replication,2.0
9741,2260,GO:1905564,FGFR1,positive regulation of vascular endothelial cell proliferation,2.0
9742,2260,GO:2000546,FGFR1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,2.0
9743,2260,GO:2000830,FGFR1,positive regulation of parathyroid hormone secretion,2.0
9744,2260,GO:2001239,FGFR1,regulation of extrinsic apoptotic signaling pathway in absence of ligand,2.0
9831,55568,GO:0000139,GALNT10,Golgi membrane,2.0
9832,55568,GO:0004653,GALNT10,polypeptide N-acetylgalactosaminyltransferase activity,2.0
9833,55568,GO:0005794,GALNT10,Golgi apparatus,2.0
9834,55568,GO:0006493,GALNT10,protein O-linked glycosylation,2.0
9835,55568,GO:0016021,GALNT10,integral component of membrane,2.0
9836,55568,GO:0016266,GALNT10,O-glycan processing,2.0
9838,55568,GO:0030246,GALNT10,carbohydrate binding,2.0
9839,55568,GO:0046872,GALNT10,metal ion binding,2.0
9961,2901,GO:0005654,GRIK5,nucleoplasm,2.0
9962,2901,GO:0005783,GRIK5,endoplasmic reticulum,2.0
9963,2901,GO:0005886,GRIK5,plasma membrane,2.0
9966,2901,GO:0006621,GRIK5,protein retention in ER lumen,2.0
9967,2901,GO:0008066,GRIK5,glutamate receptor activity,2.0
9968,2901,GO:0014069,GRIK5,postsynaptic density,2.0
9969,2901,GO:0015276,GRIK5,ligand-gated ion channel activity,2.0
9970,2901,GO:0015277,GRIK5,kainate selective glutamate receptor activity,2.0
9971,2901,GO:0017124,GRIK5,SH3 domain binding,2.0
9972,2901,GO:0030165,GRIK5,PDZ domain binding,2.0
9973,2901,GO:0030425,GRIK5,dendrite,2.0
9974,2901,GO:0031630,GRIK5,regulation of synaptic vesicle fusion to presynaptic active zone membrane,2.0
9975,2901,GO:0032983,GRIK5,kainate selective glutamate receptor complex,2.0
9976,2901,GO:0034220,GRIK5,ion transmembrane transport,2.0
9977,2901,GO:0035235,GRIK5,ionotropic glutamate receptor signaling pathway,2.0
9978,2901,GO:0035249,GRIK5,"synaptic transmission, glutamatergic",2.0
9979,2901,GO:0038023,GRIK5,signaling receptor activity,2.0
9980,2901,GO:0042802,GRIK5,identical protein binding,2.0
9981,2901,GO:0043113,GRIK5,receptor clustering,2.0
9982,2901,GO:0043195,GRIK5,terminal bouton,2.0
9983,2901,GO:0043204,GRIK5,perikaryon,2.0
9984,2901,GO:0043525,GRIK5,positive regulation of neuron apoptotic process,2.0
9985,2901,GO:0045211,GRIK5,postsynaptic membrane,2.0
9986,2901,GO:0050804,GRIK5,modulation of chemical synaptic transmission,2.0
9987,2901,GO:0051649,GRIK5,establishment of localization in cell,2.0
9988,2901,GO:0060079,GRIK5,excitatory postsynaptic potential,2.0
9989,2901,GO:0071333,GRIK5,cellular response to glucose stimulus,2.0
9990,2901,GO:0098686,GRIK5,hippocampal mossy fiber to CA3 synapse,2.0
9991,2901,GO:0098978,GRIK5,glutamatergic synapse,2.0
9992,2901,GO:0099056,GRIK5,integral component of presynaptic membrane,2.0
9993,2901,GO:1904315,GRIK5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
9994,2902,GO:0000165,GRIN1,MAPK cascade,2.0
9995,2902,GO:0001540,GRIN1,amyloid-beta binding,2.0
9996,2902,GO:0001661,GRIN1,conditioned taste aversion,2.0
9997,2902,GO:0001967,GRIN1,suckling behavior,2.0
9998,2902,GO:0001975,GRIN1,response to amphetamine,2.0
9999,2902,GO:0004972,GRIN1,NMDA glutamate receptor activity,2.0
10005,2902,GO:0005102,GRIN1,signaling receptor binding,2.0
10006,2902,GO:0005262,GRIN1,calcium channel activity,2.0
10007,2902,GO:0005509,GRIN1,calcium ion binding,2.0
10008,2902,GO:0005515,GRIN1,protein binding,2.0
10009,2902,GO:0005516,GRIN1,calmodulin binding,2.0
10010,2902,GO:0005737,GRIN1,cytoplasm,2.0
10011,2902,GO:0005783,GRIN1,endoplasmic reticulum,2.0
10012,2902,GO:0005886,GRIN1,plasma membrane,2.0
10015,2902,GO:0005887,GRIN1,integral component of plasma membrane,2.0
10016,2902,GO:0006812,GRIN1,cation transport,2.0
10017,2902,GO:0007268,GRIN1,chemical synaptic transmission,2.0
10018,2902,GO:0007420,GRIN1,brain development,2.0
10019,2902,GO:0007616,GRIN1,long-term memory,2.0
10020,2902,GO:0008021,GRIN1,synaptic vesicle,2.0
10021,2902,GO:0008344,GRIN1,adult locomotory behavior,2.0
10022,2902,GO:0008355,GRIN1,olfactory learning,2.0
10023,2902,GO:0008542,GRIN1,visual learning,2.0
10024,2902,GO:0009986,GRIN1,cell surface,2.0
10025,2902,GO:0010524,GRIN1,positive regulation of calcium ion transport into cytosol,2.0
10026,2902,GO:0014069,GRIN1,postsynaptic density,2.0
10027,2902,GO:0015276,GRIN1,ligand-gated ion channel activity,2.0
10028,2902,GO:0016594,GRIN1,glycine binding,2.0
10030,2902,GO:0016595,GRIN1,glutamate binding,2.0
10031,2902,GO:0017146,GRIN1,NMDA selective glutamate receptor complex,2.0
10034,2902,GO:0018964,GRIN1,propylene metabolic process,2.0
10035,2902,GO:0019233,GRIN1,sensory perception of pain,2.0
10036,2902,GO:0019722,GRIN1,calcium-mediated signaling,2.0
10037,2902,GO:0021586,GRIN1,pons maturation,2.0
10038,2902,GO:0021987,GRIN1,cerebral cortex development,2.0
10039,2902,GO:0022849,GRIN1,glutamate-gated calcium ion channel activity,2.0
10040,2902,GO:0030425,GRIN1,dendrite,2.0
10041,2902,GO:0030672,GRIN1,synaptic vesicle membrane,2.0
10042,2902,GO:0035176,GRIN1,social behavior,2.0
10043,2902,GO:0035235,GRIN1,ionotropic glutamate receptor signaling pathway,2.0
10046,2902,GO:0035249,GRIN1,"synaptic transmission, glutamatergic",2.0
10047,2902,GO:0038023,GRIN1,signaling receptor activity,2.0
10048,2902,GO:0042165,GRIN1,neurotransmitter binding,2.0
10049,2902,GO:0042391,GRIN1,regulation of membrane potential,2.0
10051,2902,GO:0043005,GRIN1,neuron projection,2.0
10053,2902,GO:0043065,GRIN1,positive regulation of apoptotic process,2.0
10054,2902,GO:0043083,GRIN1,synaptic cleft,2.0
10055,2902,GO:0043195,GRIN1,terminal bouton,2.0
10056,2902,GO:0043197,GRIN1,dendritic spine,2.0
10057,2902,GO:0043278,GRIN1,response to morphine,2.0
10058,2902,GO:0043524,GRIN1,negative regulation of neuron apoptotic process,2.0
10059,2902,GO:0043576,GRIN1,regulation of respiratory gaseous exchange,2.0
10060,2902,GO:0044877,GRIN1,protein-containing complex binding,2.0
10061,2902,GO:0045202,GRIN1,synapse,2.0
10063,2902,GO:0045211,GRIN1,postsynaptic membrane,2.0
10064,2902,GO:0045471,GRIN1,response to ethanol,2.0
10065,2902,GO:0045944,GRIN1,positive regulation of transcription by RNA polymerase II,2.0
10066,2902,GO:0048013,GRIN1,ephrin receptor signaling pathway,2.0
10067,2902,GO:0048167,GRIN1,regulation of synaptic plasticity,2.0
10068,2902,GO:0048169,GRIN1,regulation of long-term neuronal synaptic plasticity,2.0
10069,2902,GO:0048814,GRIN1,regulation of dendrite morphogenesis,2.0
10070,2902,GO:0050770,GRIN1,regulation of axonogenesis,2.0
10071,2902,GO:0051290,GRIN1,protein heterotetramerization,2.0
10072,2902,GO:0051963,GRIN1,regulation of synapse assembly,2.0
10073,2902,GO:0055074,GRIN1,calcium ion homeostasis,2.0
10074,2902,GO:0060076,GRIN1,excitatory synapse,2.0
10075,2902,GO:0060079,GRIN1,excitatory postsynaptic potential,2.0
10076,2902,GO:0060134,GRIN1,prepulse inhibition,2.0
10077,2902,GO:0060179,GRIN1,male mating behavior,2.0
10078,2902,GO:0097060,GRIN1,synaptic membrane,2.0
10079,2902,GO:0097553,GRIN1,calcium ion transmembrane import into cytosol,2.0
10080,2902,GO:0098976,GRIN1,excitatory chemical synaptic transmission,2.0
10081,2902,GO:0098978,GRIN1,glutamatergic synapse,2.0
10082,2902,GO:0099061,GRIN1,integral component of postsynaptic density membrane,2.0
10083,2902,GO:1903428,GRIN1,positive regulation of reactive oxygen species biosynthetic process,2.0
10084,2902,GO:1903539,GRIN1,protein localization to postsynaptic membrane,2.0
10085,2902,GO:1904315,GRIN1,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,2.0
10086,2902,GO:1904646,GRIN1,cellular response to amyloid-beta,2.0
10087,2902,GO:1905429,GRIN1,response to glycine,2.0
10088,2902,GO:2000310,GRIN1,regulation of NMDA receptor activity,2.0
10089,2902,GO:2000463,GRIN1,positive regulation of excitatory postsynaptic potential,2.0
10090,2902,GO:2001056,GRIN1,positive regulation of cysteine-type endopeptidase activity,2.0
10091,2903,GO:0001540,GRIN2A,amyloid-beta binding,2.0
10092,2903,GO:0001964,GRIN2A,startle response,2.0
10093,2903,GO:0001975,GRIN2A,response to amphetamine,2.0
10094,2903,GO:0004972,GRIN2A,NMDA glutamate receptor activity,2.0
10097,2903,GO:0005515,GRIN2A,protein binding,2.0
10098,2903,GO:0005783,GRIN2A,endoplasmic reticulum,2.0
10099,2903,GO:0005886,GRIN2A,plasma membrane,2.0
10102,2903,GO:0005887,GRIN2A,integral component of plasma membrane,2.0
10103,2903,GO:0007215,GRIN2A,glutamate receptor signaling pathway,2.0
10104,2903,GO:0007268,GRIN2A,chemical synaptic transmission,2.0
10105,2903,GO:0007420,GRIN2A,brain development,2.0
10106,2903,GO:0007611,GRIN2A,learning or memory,2.0
10107,2903,GO:0007613,GRIN2A,memory,2.0
10108,2903,GO:0008021,GRIN2A,synaptic vesicle,2.0
10109,2903,GO:0008270,GRIN2A,zinc ion binding,2.0
10110,2903,GO:0008542,GRIN2A,visual learning,2.0
10111,2903,GO:0009611,GRIN2A,response to wounding,2.0
10112,2903,GO:0009986,GRIN2A,cell surface,2.0
10113,2903,GO:0014069,GRIN2A,postsynaptic density,2.0
10114,2903,GO:0015276,GRIN2A,ligand-gated ion channel activity,2.0
10115,2903,GO:0017146,GRIN2A,NMDA selective glutamate receptor complex,2.0
10118,2903,GO:0019233,GRIN2A,sensory perception of pain,2.0
10119,2903,GO:0019722,GRIN2A,calcium-mediated signaling,2.0
10120,2903,GO:0022008,GRIN2A,neurogenesis,2.0
10121,2903,GO:0022849,GRIN2A,glutamate-gated calcium ion channel activity,2.0
10123,2903,GO:0030431,GRIN2A,sleep,2.0
10124,2903,GO:0030659,GRIN2A,cytoplasmic vesicle membrane,2.0
10125,2903,GO:0033058,GRIN2A,directional locomotion,2.0
10126,2903,GO:0035235,GRIN2A,ionotropic glutamate receptor signaling pathway,2.0
10127,2903,GO:0038023,GRIN2A,signaling receptor activity,2.0
10128,2903,GO:0042177,GRIN2A,negative regulation of protein catabolic process,2.0
10129,2903,GO:0042417,GRIN2A,dopamine metabolic process,2.0
10130,2903,GO:0042428,GRIN2A,serotonin metabolic process,2.0
10131,2903,GO:0042493,GRIN2A,response to drug,2.0
10132,2903,GO:0042734,GRIN2A,presynaptic membrane,2.0
10133,2903,GO:0043065,GRIN2A,positive regulation of apoptotic process,2.0
10134,2903,GO:0043197,GRIN2A,dendritic spine,2.0
10135,2903,GO:0045471,GRIN2A,response to ethanol,2.0
10136,2903,GO:0048167,GRIN2A,regulation of synaptic plasticity,2.0
10137,2903,GO:0060079,GRIN2A,excitatory postsynaptic potential,2.0
10138,2903,GO:0060291,GRIN2A,long-term synaptic potentiation,2.0
10139,2903,GO:0097060,GRIN2A,synaptic membrane,2.0
10140,2903,GO:0097202,GRIN2A,activation of cysteine-type endopeptidase activity,2.0
10141,2903,GO:0097553,GRIN2A,calcium ion transmembrane import into cytosol,2.0
10143,2903,GO:0098839,GRIN2A,postsynaptic density membrane,2.0
10144,2903,GO:0098976,GRIN2A,excitatory chemical synaptic transmission,2.0
10145,2903,GO:0099061,GRIN2A,integral component of postsynaptic density membrane,2.0
10146,2903,GO:1903539,GRIN2A,protein localization to postsynaptic membrane,2.0
10147,2903,GO:1904646,GRIN2A,cellular response to amyloid-beta,2.0
10148,2903,GO:2000310,GRIN2A,regulation of NMDA receptor activity,2.0
10201,23426,GO:0005515,GRIP1,protein binding,2.0
10202,23426,GO:0005789,GRIP1,endoplasmic reticulum membrane,2.0
10203,23426,GO:0005829,GRIP1,cytosol,2.0
10204,23426,GO:0005886,GRIP1,plasma membrane,2.0
10206,23426,GO:0008013,GRIP1,beta-catenin binding,2.0
10207,23426,GO:0008022,GRIP1,protein C-terminus binding,2.0
10208,23426,GO:0014069,GRIP1,postsynaptic density,2.0
10209,23426,GO:0016358,GRIP1,dendrite development,2.0
10210,23426,GO:0030159,GRIP1,signaling receptor complex adaptor activity,2.0
10211,23426,GO:0030425,GRIP1,dendrite,2.0
10212,23426,GO:0031410,GRIP1,cytoplasmic vesicle,2.0
10213,23426,GO:0035259,GRIP1,glucocorticoid receptor binding,2.0
10215,23426,GO:0035556,GRIP1,intracellular signal transduction,2.0
10216,23426,GO:0043005,GRIP1,neuron projection,2.0
10217,23426,GO:0043204,GRIP1,perikaryon,2.0
10218,23426,GO:0045121,GRIP1,membrane raft,2.0
10219,23426,GO:0045211,GRIP1,postsynaptic membrane,2.0
10220,23426,GO:0098887,GRIP1,"neurotransmitter receptor transport, endosome to postsynaptic membrane",2.0
10221,23426,GO:0098978,GRIP1,glutamatergic synapse,2.0
10222,23426,GO:0099003,GRIP1,vesicle-mediated transport in synapse,2.0
10223,23426,GO:0150012,GRIP1,positive regulation of neuron projection arborization,2.0
10535,57520,GO:0000209,HECW2,protein polyubiquitination,2.0
10536,57520,GO:0005515,HECW2,protein binding,2.0
10537,57520,GO:0005737,HECW2,cytoplasm,2.0
10538,57520,GO:0016567,HECW2,protein ubiquitination,2.0
10539,57520,GO:0030071,HECW2,regulation of mitotic metaphase/anaphase transition,2.0
10540,57520,GO:0043161,HECW2,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
10541,57520,GO:0045732,HECW2,positive regulation of protein catabolic process,2.0
10542,57520,GO:0048814,HECW2,regulation of dendrite morphogenesis,2.0
10543,57520,GO:0061630,HECW2,ubiquitin protein ligase activity,2.0
10544,57520,GO:0072686,HECW2,mitotic spindle,2.0
10545,57520,GO:2000650,HECW2,negative regulation of sodium ion transmembrane transporter activity,2.0
10581,59269,GO:0000978,HIVEP3,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
10582,59269,GO:0000981,HIVEP3,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
10583,59269,GO:0003677,HIVEP3,DNA binding,2.0
10584,59269,GO:0005634,HIVEP3,nucleus,2.0
10586,59269,GO:0005737,HIVEP3,cytoplasm,2.0
10587,59269,GO:0006357,HIVEP3,regulation of transcription by RNA polymerase II,2.0
10588,59269,GO:0035914,HIVEP3,skeletal muscle cell differentiation,2.0
10589,59269,GO:0045893,HIVEP3,"positive regulation of transcription, DNA-templated",2.0
10590,59269,GO:0046872,HIVEP3,metal ion binding,2.0
11116,3150,GO:0000720,HMGN1,pyrimidine dimer repair by nucleotide-excision repair,2.0
11117,3150,GO:0000785,HMGN1,chromatin,2.0
11118,3150,GO:0003677,HMGN1,DNA binding,2.0
11119,3150,GO:0003682,HMGN1,chromatin binding,2.0
11120,3150,GO:0005634,HMGN1,nucleus,2.0
11122,3150,GO:0005654,HMGN1,nucleoplasm,2.0
11124,3150,GO:0005737,HMGN1,cytoplasm,2.0
11125,3150,GO:0006283,HMGN1,transcription-coupled nucleotide-excision repair,2.0
11126,3150,GO:0006325,HMGN1,chromatin organization,2.0
11128,3150,GO:0006357,HMGN1,regulation of transcription by RNA polymerase II,2.0
11129,3150,GO:0010224,HMGN1,response to UV-B,2.0
11130,3150,GO:0010225,HMGN1,response to UV-C,2.0
11131,3150,GO:0031492,HMGN1,nucleosomal DNA binding,2.0
11132,3150,GO:0032786,HMGN1,"positive regulation of DNA-templated transcription, elongation",2.0
11133,3150,GO:0040034,HMGN1,"regulation of development, heterochronic",2.0
11134,3150,GO:0048597,HMGN1,post-embryonic camera-type eye morphogenesis,2.0
11135,3150,GO:0050678,HMGN1,regulation of epithelial cell proliferation,2.0
11136,3150,GO:1901666,HMGN1,positive regulation of NAD+ ADP-ribosyltransferase activity,2.0
11291,3382,GO:0000139,ICA1,Golgi membrane,2.0
11292,3382,GO:0005515,ICA1,protein binding,2.0
11293,3382,GO:0005737,ICA1,cytoplasm,2.0
11294,3382,GO:0005794,ICA1,Golgi apparatus,2.0
11295,3382,GO:0005829,ICA1,cytosol,2.0
11297,3382,GO:0006836,ICA1,neurotransmitter transport,2.0
11298,3382,GO:0019904,ICA1,protein domain specific binding,2.0
11299,3382,GO:0030667,ICA1,secretory granule membrane,2.0
11300,3382,GO:0030672,ICA1,synaptic vesicle membrane,2.0
11301,3382,GO:0043231,ICA1,intracellular membrane-bounded organelle,2.0
11302,3382,GO:0050796,ICA1,regulation of insulin secretion,2.0
11303,3382,GO:0051049,ICA1,regulation of transport,2.0
11304,3382,GO:0140090,ICA1,membrane curvature sensor activity,2.0
11363,3608,GO:0003677,ILF2,DNA binding,2.0
11364,3608,GO:0003723,ILF2,RNA binding,2.0
11365,3608,GO:0003725,ILF2,double-stranded RNA binding,2.0
11366,3608,GO:0005515,ILF2,protein binding,2.0
11367,3608,GO:0005576,ILF2,extracellular region,2.0
11369,3608,GO:0005634,ILF2,nucleus,2.0
11370,3608,GO:0005654,ILF2,nucleoplasm,2.0
11371,3608,GO:0005730,ILF2,nucleolus,2.0
11372,3608,GO:0016020,ILF2,membrane,2.0
11373,3608,GO:0035580,ILF2,specific granule lumen,2.0
11374,3608,GO:0043312,ILF2,neutrophil degranulation,2.0
11375,3608,GO:0045893,ILF2,"positive regulation of transcription, DNA-templated",2.0
11376,3608,GO:1904724,ILF2,tertiary granule lumen,2.0
11377,3608,GO:1904813,ILF2,ficolin-1-rich granule lumen,2.0
11378,3608,GO:1990904,ILF2,ribonucleoprotein complex,2.0
11415,26512,GO:0004888,INTS6,transmembrane signaling receptor activity,2.0
11416,26512,GO:0005515,INTS6,protein binding,2.0
11417,26512,GO:0005634,INTS6,nucleus,2.0
11418,26512,GO:0005654,INTS6,nucleoplasm,2.0
11420,26512,GO:0015629,INTS6,actin cytoskeleton,2.0
11421,26512,GO:0016180,INTS6,snRNA processing,2.0
11422,26512,GO:0032039,INTS6,integrator complex,2.0
11424,26512,GO:0034472,INTS6,snRNA 3'-end processing,2.0
11425,26512,GO:0042795,INTS6,snRNA transcription by RNA polymerase II,2.0
11473,3690,GO:0001618,ITGB3,virus receptor activity,2.0
11474,3690,GO:0001934,ITGB3,positive regulation of protein phosphorylation,2.0
11475,3690,GO:0001938,ITGB3,positive regulation of endothelial cell proliferation,2.0
11476,3690,GO:0001968,ITGB3,fibronectin binding,2.0
11478,3690,GO:0002020,ITGB3,protease binding,2.0
11479,3690,GO:0002576,ITGB3,platelet degranulation,2.0
11480,3690,GO:0003756,ITGB3,protein disulfide isomerase activity,2.0
11481,3690,GO:0005161,ITGB3,platelet-derived growth factor receptor binding,2.0
11482,3690,GO:0005178,ITGB3,integrin binding,2.0
11484,3690,GO:0005515,ITGB3,protein binding,2.0
11485,3690,GO:0005634,ITGB3,nucleus,2.0
11486,3690,GO:0005654,ITGB3,nucleoplasm,2.0
11487,3690,GO:0005886,ITGB3,plasma membrane,2.0
11489,3690,GO:0005887,ITGB3,integral component of plasma membrane,2.0
11490,3690,GO:0005911,ITGB3,cell-cell junction,2.0
11491,3690,GO:0005925,ITGB3,focal adhesion,2.0
11494,3690,GO:0007155,ITGB3,cell adhesion,2.0
11495,3690,GO:0007160,ITGB3,cell-matrix adhesion,2.0
11497,3690,GO:0007229,ITGB3,integrin-mediated signaling pathway,2.0
11500,3690,GO:0007596,ITGB3,blood coagulation,2.0
11501,3690,GO:0008305,ITGB3,integrin complex,2.0
11503,3690,GO:0009986,ITGB3,cell surface,2.0
11506,3690,GO:0010595,ITGB3,positive regulation of endothelial cell migration,2.0
11507,3690,GO:0010745,ITGB3,negative regulation of macrophage derived foam cell differentiation,2.0
11508,3690,GO:0010888,ITGB3,negative regulation of lipid storage,2.0
11509,3690,GO:0014909,ITGB3,smooth muscle cell migration,2.0
11510,3690,GO:0015026,ITGB3,coreceptor activity,2.0
11511,3690,GO:0016477,ITGB3,cell migration,2.0
11512,3690,GO:0017134,ITGB3,fibroblast growth factor binding,2.0
11513,3690,GO:0019899,ITGB3,enzyme binding,2.0
11514,3690,GO:0019960,ITGB3,C-X3-C chemokine binding,2.0
11515,3690,GO:0030168,ITGB3,platelet activation,2.0
11516,3690,GO:0030198,ITGB3,extracellular matrix organization,2.0
11517,3690,GO:0030949,ITGB3,positive regulation of vascular endothelial growth factor receptor signaling pathway,2.0
11518,3690,GO:0031092,ITGB3,platelet alpha granule membrane,2.0
11519,3690,GO:0031258,ITGB3,lamellipodium membrane,2.0
11520,3690,GO:0031527,ITGB3,filopodium membrane,2.0
11521,3690,GO:0031528,ITGB3,microvillus membrane,2.0
11522,3690,GO:0031589,ITGB3,cell-substrate adhesion,2.0
11523,3690,GO:0031994,ITGB3,insulin-like growth factor I binding,2.0
11524,3690,GO:0032147,ITGB3,activation of protein kinase activity,2.0
11525,3690,GO:0032369,ITGB3,negative regulation of lipid transport,2.0
11526,3690,GO:0032587,ITGB3,ruffle membrane,2.0
11527,3690,GO:0032880,ITGB3,regulation of protein localization,2.0
11528,3690,GO:0032991,ITGB3,protein-containing complex,2.0
11529,3690,GO:0033627,ITGB3,cell adhesion mediated by integrin,2.0
11531,3690,GO:0034113,ITGB3,heterotypic cell-cell adhesion,2.0
11532,3690,GO:0034446,ITGB3,substrate adhesion-dependent cell spreading,2.0
11533,3690,GO:0034683,ITGB3,integrin alphav-beta3 complex,2.0
11534,3690,GO:0035295,ITGB3,tube development,2.0
11535,3690,GO:0035866,ITGB3,alphav-beta3 integrin-PKCalpha complex,2.0
11536,3690,GO:0035867,ITGB3,alphav-beta3 integrin-IGF-1-IGF1R complex,2.0
11537,3690,GO:0035868,ITGB3,alphav-beta3 integrin-HMGB1 complex,2.0
11538,3690,GO:0038027,ITGB3,apolipoprotein A-I-mediated signaling pathway,2.0
11539,3690,GO:0038132,ITGB3,neuregulin binding,2.0
11540,3690,GO:0042060,ITGB3,wound healing,2.0
11541,3690,GO:0042470,ITGB3,melanosome,2.0
11542,3690,GO:0042802,ITGB3,identical protein binding,2.0
11543,3690,GO:0043184,ITGB3,vascular endothelial growth factor receptor 2 binding,2.0
11545,3690,GO:0043235,ITGB3,receptor complex,2.0
11546,3690,GO:0043277,ITGB3,apoptotic cell clearance,2.0
11547,3690,GO:0045124,ITGB3,regulation of bone resorption,2.0
11548,3690,GO:0045202,ITGB3,synapse,2.0
11549,3690,GO:0045211,ITGB3,postsynaptic membrane,2.0
11550,3690,GO:0046718,ITGB3,viral entry into host cell,2.0
11551,3690,GO:0048010,ITGB3,vascular endothelial growth factor receptor signaling pathway,2.0
11552,3690,GO:0048333,ITGB3,mesodermal cell differentiation,2.0
11553,3690,GO:0050731,ITGB3,positive regulation of peptidyl-tyrosine phosphorylation,2.0
11554,3690,GO:0050748,ITGB3,negative regulation of lipoprotein metabolic process,2.0
11555,3690,GO:0050839,ITGB3,cell adhesion molecule binding,2.0
11556,3690,GO:0050840,ITGB3,extracellular matrix binding,2.0
11557,3690,GO:0050900,ITGB3,leukocyte migration,2.0
11558,3690,GO:0050919,ITGB3,negative chemotaxis,2.0
11559,3690,GO:0051611,ITGB3,regulation of serotonin uptake,2.0
11560,3690,GO:0060055,ITGB3,angiogenesis involved in wound healing,2.0
11561,3690,GO:0070051,ITGB3,fibrinogen binding,2.0
11562,3690,GO:0070062,ITGB3,extracellular exosome,2.0
11563,3690,GO:0070527,ITGB3,platelet aggregation,2.0
11564,3690,GO:0071062,ITGB3,alphav-beta3 integrin-vitronectin complex,2.0
11565,3690,GO:0098978,ITGB3,glutamatergic synapse,2.0
11568,3690,GO:0099149,ITGB3,regulation of postsynaptic neurotransmitter receptor internalization,2.0
11658,3720,GO:0000122,JARID2,negative regulation of transcription by RNA polymerase II,2.0
11659,3720,GO:0000977,JARID2,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
11660,3720,GO:0001227,JARID2,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
11661,3720,GO:0001889,JARID2,liver development,2.0
11662,3720,GO:0003682,JARID2,chromatin binding,2.0
11663,3720,GO:0005634,JARID2,nucleus,2.0
11664,3720,GO:0005654,JARID2,nucleoplasm,2.0
11666,3720,GO:0005739,JARID2,mitochondrion,2.0
11667,3720,GO:0006338,JARID2,chromatin remodeling,2.0
11668,3720,GO:0007417,JARID2,central nervous system development,2.0
11669,3720,GO:0008134,JARID2,transcription factor binding,2.0
11670,3720,GO:0010614,JARID2,negative regulation of cardiac muscle hypertrophy,2.0
11671,3720,GO:0031061,JARID2,negative regulation of histone methylation,2.0
11672,3720,GO:0032452,JARID2,histone demethylase activity,2.0
11674,3720,GO:0034647,JARID2,histone demethylase activity (H3-trimethyl-K4 specific),2.0
11675,3720,GO:0034721,JARID2,"histone H3-K4 demethylation, trimethyl-H3-K4-specific",2.0
11676,3720,GO:0035097,JARID2,histone methyltransferase complex,2.0
11678,3720,GO:0035098,JARID2,ESC/E(Z) complex,2.0
11679,3720,GO:0045814,JARID2,"negative regulation of gene expression, epigenetic",2.0
11680,3720,GO:0045892,JARID2,"negative regulation of transcription, DNA-templated",2.0
11681,3720,GO:0048536,JARID2,spleen development,2.0
11682,3720,GO:0048538,JARID2,thymus development,2.0
11683,3720,GO:0048863,JARID2,stem cell differentiation,2.0
11684,3720,GO:0051574,JARID2,positive regulation of histone H3-K9 methylation,2.0
11685,3720,GO:0060044,JARID2,negative regulation of cardiac muscle cell proliferation,2.0
11686,3720,GO:1990830,JARID2,cellular response to leukemia inhibitory factor,2.0
11746,8850,GO:0000125,KAT2B,PCAF complex,2.0
11747,8850,GO:0000776,KAT2B,kinetochore,2.0
11748,8850,GO:0000977,KAT2B,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
11749,8850,GO:0003682,KAT2B,chromatin binding,2.0
11750,8850,GO:0003712,KAT2B,transcription coregulator activity,2.0
11751,8850,GO:0003713,KAT2B,transcription coactivator activity,2.0
11752,8850,GO:0004145,KAT2B,diamine N-acetyltransferase activity,2.0
11753,8850,GO:0004402,KAT2B,histone acetyltransferase activity,2.0
11756,8850,GO:0004468,KAT2B,"lysine N-acetyltransferase activity, acting on acetyl phosphate as donor",2.0
11758,8850,GO:0004861,KAT2B,cyclin-dependent protein serine/threonine kinase inhibitor activity,2.0
11759,8850,GO:0005515,KAT2B,protein binding,2.0
11760,8850,GO:0005634,KAT2B,nucleus,2.0
11762,8850,GO:0005654,KAT2B,nucleoplasm,2.0
11764,8850,GO:0005671,KAT2B,Ada2/Gcn5/Ada3 transcription activator complex,2.0
11765,8850,GO:0005813,KAT2B,centrosome,2.0
11766,8850,GO:0006338,KAT2B,chromatin remodeling,2.0
11768,8850,GO:0006367,KAT2B,transcription initiation from RNA polymerase II promoter,2.0
11769,8850,GO:0006473,KAT2B,protein acetylation,2.0
11770,8850,GO:0007050,KAT2B,cell cycle arrest,2.0
11771,8850,GO:0007219,KAT2B,Notch signaling pathway,2.0
11772,8850,GO:0007221,KAT2B,positive regulation of transcription of Notch receptor target,2.0
11773,8850,GO:0007507,KAT2B,heart development,2.0
11774,8850,GO:0008134,KAT2B,transcription factor binding,2.0
11775,8850,GO:0008285,KAT2B,negative regulation of cell population proliferation,2.0
11776,8850,GO:0010835,KAT2B,regulation of protein ADP-ribosylation,2.0
11777,8850,GO:0016032,KAT2B,viral process,2.0
11778,8850,GO:0016407,KAT2B,acetyltransferase activity,2.0
11779,8850,GO:0016579,KAT2B,protein deubiquitination,2.0
11780,8850,GO:0018076,KAT2B,N-terminal peptidyl-lysine acetylation,2.0
11781,8850,GO:0018393,KAT2B,internal peptidyl-lysine acetylation,2.0
11782,8850,GO:0018394,KAT2B,peptidyl-lysine acetylation,2.0
11783,8850,GO:0019901,KAT2B,protein kinase binding,2.0
11784,8850,GO:0031672,KAT2B,A band,2.0
11785,8850,GO:0031674,KAT2B,I band,2.0
11786,8850,GO:0032869,KAT2B,cellular response to insulin stimulus,2.0
11787,8850,GO:0032991,KAT2B,protein-containing complex,2.0
11789,8850,GO:0042641,KAT2B,actomyosin,2.0
11790,8850,GO:0042826,KAT2B,histone deacetylase binding,2.0
11791,8850,GO:0043966,KAT2B,histone H3 acetylation,2.0
11792,8850,GO:0043970,KAT2B,histone H3-K9 acetylation,2.0
11793,8850,GO:0045652,KAT2B,regulation of megakaryocyte differentiation,2.0
11794,8850,GO:0045722,KAT2B,positive regulation of gluconeogenesis,2.0
11795,8850,GO:0045736,KAT2B,negative regulation of cyclin-dependent protein serine/threonine kinase activity,2.0
11796,8850,GO:0045747,KAT2B,positive regulation of Notch signaling pathway,2.0
11797,8850,GO:0045815,KAT2B,"positive regulation of gene expression, epigenetic",2.0
11798,8850,GO:0045944,KAT2B,positive regulation of transcription by RNA polymerase II,2.0
11799,8850,GO:0046600,KAT2B,negative regulation of centriole replication,2.0
11800,8850,GO:0048511,KAT2B,rhythmic process,2.0
11801,8850,GO:0060173,KAT2B,limb development,2.0
11802,8850,GO:0061733,KAT2B,peptide-lysine-N-acetyltransferase activity,2.0
11803,8850,GO:2000233,KAT2B,negative regulation of rRNA processing,2.0
11804,7994,GO:0000785,KAT6A,chromatin,2.0
11805,7994,GO:0000786,KAT6A,nucleosome,2.0
11806,7994,GO:0003677,KAT6A,DNA binding,2.0
11807,7994,GO:0003712,KAT6A,transcription coregulator activity,2.0
11808,7994,GO:0003713,KAT6A,transcription coactivator activity,2.0
11809,7994,GO:0004402,KAT6A,histone acetyltransferase activity,2.0
11811,7994,GO:0005515,KAT6A,protein binding,2.0
11812,7994,GO:0005634,KAT6A,nucleus,2.0
11813,7994,GO:0005654,KAT6A,nucleoplasm,2.0
11814,7994,GO:0005730,KAT6A,nucleolus,2.0
11815,7994,GO:0005829,KAT6A,cytosol,2.0
11816,7994,GO:0006323,KAT6A,DNA packaging,2.0
11817,7994,GO:0006334,KAT6A,nucleosome assembly,2.0
11818,7994,GO:0006473,KAT6A,protein acetylation,2.0
11819,7994,GO:0008134,KAT6A,transcription factor binding,2.0
11820,7994,GO:0008270,KAT6A,zinc ion binding,2.0
11821,7994,GO:0016407,KAT6A,acetyltransferase activity,2.0
11823,7994,GO:0016573,KAT6A,histone acetylation,2.0
11824,7994,GO:0016605,KAT6A,PML body,2.0
11825,7994,GO:0016607,KAT6A,nuclear speck,2.0
11826,7994,GO:0030099,KAT6A,myeloid cell differentiation,2.0
11827,7994,GO:0042393,KAT6A,histone binding,2.0
11828,7994,GO:0043966,KAT6A,histone H3 acetylation,2.0
11830,7994,GO:0045892,KAT6A,"negative regulation of transcription, DNA-templated",2.0
11832,7994,GO:0045893,KAT6A,"positive regulation of transcription, DNA-templated",2.0
11833,7994,GO:0045944,KAT6A,positive regulation of transcription by RNA polymerase II,2.0
11834,7994,GO:0070776,KAT6A,MOZ/MORF histone acetyltransferase complex,2.0
11836,7994,GO:0090398,KAT6A,cellular senescence,2.0
11837,7994,GO:1901796,KAT6A,regulation of signal transduction by p53 class mediator,2.0
12015,3766,GO:0005242,KCNJ10,inward rectifier potassium channel activity,2.0
12016,3766,GO:0005515,KCNJ10,protein binding,2.0
12017,3766,GO:0005524,KCNJ10,ATP binding,2.0
12018,3766,GO:0005886,KCNJ10,plasma membrane,2.0
12020,3766,GO:0005887,KCNJ10,integral component of plasma membrane,2.0
12021,3766,GO:0006813,KCNJ10,potassium ion transport,2.0
12022,3766,GO:0007601,KCNJ10,visual perception,2.0
12023,3766,GO:0007628,KCNJ10,adult walking behavior,2.0
12024,3766,GO:0015272,KCNJ10,ATP-activated inward rectifier potassium channel activity,2.0
12025,3766,GO:0016323,KCNJ10,basolateral plasma membrane,2.0
12026,3766,GO:0022010,KCNJ10,central nervous system myelination,2.0
12027,3766,GO:0034765,KCNJ10,regulation of ion transmembrane transport,2.0
12028,3766,GO:0044297,KCNJ10,cell body,2.0
12029,3766,GO:0048169,KCNJ10,regulation of long-term neuronal synaptic plasticity,2.0
12030,3766,GO:0051935,KCNJ10,glutamate reuptake,2.0
12031,3766,GO:0055075,KCNJ10,potassium ion homeostasis,2.0
12032,3766,GO:0060075,KCNJ10,regulation of resting membrane potential,2.0
12033,3766,GO:0097449,KCNJ10,astrocyte projection,2.0
12034,3766,GO:0098793,KCNJ10,presynapse,2.0
12035,3766,GO:1990573,KCNJ10,potassium ion import across plasma membrane,2.0
12174,3785,GO:0005249,KCNQ2,voltage-gated potassium channel activity,2.0
12176,3785,GO:0005251,KCNQ2,delayed rectifier potassium channel activity,2.0
12177,3785,GO:0005515,KCNQ2,protein binding,2.0
12178,3785,GO:0005516,KCNQ2,calmodulin binding,2.0
12180,3785,GO:0005886,KCNQ2,plasma membrane,2.0
12182,3785,GO:0005887,KCNQ2,integral component of plasma membrane,2.0
12183,3785,GO:0007268,KCNQ2,chemical synaptic transmission,2.0
12184,3785,GO:0007399,KCNQ2,nervous system development,2.0
12185,3785,GO:0008076,KCNQ2,voltage-gated potassium channel complex,2.0
12187,3785,GO:0016021,KCNQ2,integral component of membrane,2.0
12188,3785,GO:0030506,KCNQ2,ankyrin binding,2.0
12189,3785,GO:0033268,KCNQ2,node of Ranvier,2.0
12190,3785,GO:0034765,KCNQ2,regulation of ion transmembrane transport,2.0
12191,3785,GO:0043194,KCNQ2,axon initial segment,2.0
12193,3785,GO:0045202,KCNQ2,synapse,2.0
12194,3785,GO:0071805,KCNQ2,potassium ion transmembrane transport,2.0
12218,3790,GO:0005249,KCNS3,voltage-gated potassium channel activity,2.0
12219,3790,GO:0005251,KCNS3,delayed rectifier potassium channel activity,2.0
12220,3790,GO:0005794,KCNS3,Golgi apparatus,2.0
12221,3790,GO:0005829,KCNS3,cytosol,2.0
12222,3790,GO:0005886,KCNS3,plasma membrane,2.0
12224,3790,GO:0006813,KCNS3,potassium ion transport,2.0
12225,3790,GO:0008076,KCNS3,voltage-gated potassium channel complex,2.0
12226,3790,GO:0015459,KCNS3,potassium channel regulator activity,2.0
12227,3790,GO:0016021,KCNS3,integral component of membrane,2.0
12228,3790,GO:0034765,KCNS3,regulation of ion transmembrane transport,2.0
12229,3790,GO:0050796,KCNS3,regulation of insulin secretion,2.0
12230,3790,GO:0051260,KCNS3,protein homooligomerization,2.0
12231,3790,GO:0071805,KCNS3,potassium ion transmembrane transport,2.0
12314,23081,GO:0000785,KDM4C,chromatin,2.0
12315,23081,GO:0001825,KDM4C,blastocyst formation,2.0
12316,23081,GO:0003682,KDM4C,chromatin binding,2.0
12317,23081,GO:0005654,KDM4C,nucleoplasm,2.0
12318,23081,GO:0005721,KDM4C,pericentric heterochromatin,2.0
12319,23081,GO:0006338,KDM4C,chromatin remodeling,2.0
12320,23081,GO:0006357,KDM4C,regulation of transcription by RNA polymerase II,2.0
12321,23081,GO:0008270,KDM4C,zinc ion binding,2.0
12322,23081,GO:0008284,KDM4C,positive regulation of cell population proliferation,2.0
12323,23081,GO:0010628,KDM4C,positive regulation of gene expression,2.0
12324,23081,GO:0019827,KDM4C,stem cell population maintenance,2.0
12325,23081,GO:0019899,KDM4C,enzyme binding,2.0
12326,23081,GO:0032452,KDM4C,histone demethylase activity,2.0
12328,23081,GO:0032454,KDM4C,histone demethylase activity (H3-K9 specific),2.0
12331,23081,GO:0033169,KDM4C,histone H3-K9 demethylation,2.0
12333,23081,GO:0035097,KDM4C,histone methyltransferase complex,2.0
12334,23081,GO:0045666,KDM4C,positive regulation of neuron differentiation,2.0
12335,23081,GO:0050681,KDM4C,androgen receptor binding,2.0
12336,23081,GO:0051864,KDM4C,histone demethylase activity (H3-K36 specific),2.0
12338,23081,GO:0055114,KDM4C,oxidation-reduction process,2.0
12339,23081,GO:0070544,KDM4C,histone H3-K36 demethylation,2.0
12340,23081,GO:1900113,KDM4C,negative regulation of histone H3-K9 trimethylation,2.0
12341,23081,GO:2000736,KDM4C,regulation of stem cell differentiation,2.0
12379,8242,GO:0003677,KDM5C,DNA binding,2.0
12380,8242,GO:0005515,KDM5C,protein binding,2.0
12381,8242,GO:0005634,KDM5C,nucleus,2.0
12382,8242,GO:0005654,KDM5C,nucleoplasm,2.0
12384,8242,GO:0005829,KDM5C,cytosol,2.0
12385,8242,GO:0006338,KDM5C,chromatin remodeling,2.0
12386,8242,GO:0008270,KDM5C,zinc ion binding,2.0
12387,8242,GO:0032452,KDM5C,histone demethylase activity,2.0
12388,8242,GO:0032453,KDM5C,histone demethylase activity (H3-K4 specific),2.0
12390,8242,GO:0034647,KDM5C,histone demethylase activity (H3-trimethyl-K4 specific),2.0
12391,8242,GO:0034720,KDM5C,histone H3-K4 demethylation,2.0
12393,8242,GO:0034721,KDM5C,"histone H3-K4 demethylation, trimethyl-H3-K4-specific",2.0
12394,8242,GO:0035097,KDM5C,histone methyltransferase complex,2.0
12395,8242,GO:0045892,KDM5C,"negative regulation of transcription, DNA-templated",2.0
12396,8242,GO:0048511,KDM5C,rhythmic process,2.0
12397,8242,GO:0051213,KDM5C,dioxygenase activity,2.0
12398,8242,GO:0055114,KDM5C,oxidation-reduction process,2.0
12399,7403,GO:0000785,KDM6A,chromatin,2.0
12400,7403,GO:0000978,KDM6A,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
12401,7403,GO:0001701,KDM6A,in utero embryonic development,2.0
12402,7403,GO:0001843,KDM6A,neural tube closure,2.0
12403,7403,GO:0003007,KDM6A,heart morphogenesis,2.0
12404,7403,GO:0003016,KDM6A,respiratory system process,2.0
12405,7403,GO:0005515,KDM6A,protein binding,2.0
12406,7403,GO:0005634,KDM6A,nucleus,2.0
12407,7403,GO:0005654,KDM6A,nucleoplasm,2.0
12408,7403,GO:0006338,KDM6A,chromatin remodeling,2.0
12409,7403,GO:0010628,KDM6A,positive regulation of gene expression,2.0
12410,7403,GO:0031490,KDM6A,chromatin DNA binding,2.0
12411,7403,GO:0032525,KDM6A,somite rostral/caudal axis specification,2.0
12412,7403,GO:0035097,KDM6A,histone methyltransferase complex,2.0
12413,7403,GO:0035264,KDM6A,multicellular organism growth,2.0
12414,7403,GO:0042802,KDM6A,identical protein binding,2.0
12415,7403,GO:0044666,KDM6A,MLL3/4 complex,2.0
12417,7403,GO:0046872,KDM6A,metal ion binding,2.0
12418,7403,GO:0048333,KDM6A,mesodermal cell differentiation,2.0
12419,7403,GO:0048570,KDM6A,notochord morphogenesis,2.0
12420,7403,GO:0051213,KDM6A,dioxygenase activity,2.0
12421,7403,GO:0051568,KDM6A,histone H3-K4 methylation,2.0
12422,7403,GO:0055114,KDM6A,oxidation-reduction process,2.0
12423,7403,GO:0060070,KDM6A,canonical Wnt signaling pathway,2.0
12424,7403,GO:0071557,KDM6A,histone H3-K27 demethylation,2.0
12425,7403,GO:0071558,KDM6A,histone demethylase activity (H3-K27 specific),2.0
12462,57691,GO:0016925,KIAA1586,protein sumoylation,2.0
12465,57691,GO:0061665,KIAA1586,SUMO ligase activity,2.0
12485,9928,GO:0001558,KIF14,regulation of cell growth,2.0
12486,9928,GO:0003777,KIF14,microtubule motor activity,2.0
12487,9928,GO:0005515,KIF14,protein binding,2.0
12488,9928,GO:0005524,KIF14,ATP binding,2.0
12489,9928,GO:0005634,KIF14,nucleus,2.0
12490,9928,GO:0005829,KIF14,cytosol,2.0
12492,9928,GO:0005871,KIF14,kinesin complex,2.0
12493,9928,GO:0005874,KIF14,microtubule,2.0
12495,9928,GO:0005886,KIF14,plasma membrane,2.0
12496,9928,GO:0007018,KIF14,microtubule-based movement,2.0
12497,9928,GO:0007019,KIF14,microtubule depolymerization,2.0
12498,9928,GO:0007080,KIF14,mitotic metaphase plate congression,2.0
12499,9928,GO:0008017,KIF14,microtubule binding,2.0
12501,9928,GO:0008284,KIF14,positive regulation of cell population proliferation,2.0
12503,9928,GO:0008574,KIF14,"ATP-dependent microtubule motor activity, plus-end-directed",2.0
12504,9928,GO:0010389,KIF14,regulation of G2/M transition of mitotic cell cycle,2.0
12505,9928,GO:0015631,KIF14,tubulin binding,2.0
12506,9928,GO:0016020,KIF14,membrane,2.0
12507,9928,GO:0016887,KIF14,ATPase activity,2.0
12509,9928,GO:0019901,KIF14,protein kinase binding,2.0
12510,9928,GO:0021685,KIF14,cerebellar granular layer structural organization,2.0
12511,9928,GO:0021693,KIF14,cerebellar Purkinje cell layer structural organization,2.0
12512,9928,GO:0021695,KIF14,cerebellar cortex development,2.0
12513,9928,GO:0021766,KIF14,hippocampus development,2.0
12514,9928,GO:0021772,KIF14,olfactory bulb development,2.0
12515,9928,GO:0021846,KIF14,cell proliferation in forebrain,2.0
12516,9928,GO:0021987,KIF14,cerebral cortex development,2.0
12517,9928,GO:0030155,KIF14,regulation of cell adhesion,2.0
12518,9928,GO:0030165,KIF14,PDZ domain binding,2.0
12519,9928,GO:0030334,KIF14,regulation of cell migration,2.0
12520,9928,GO:0030496,KIF14,midbody,2.0
12521,9928,GO:0031146,KIF14,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,2.0
12522,9928,GO:0031641,KIF14,regulation of myelination,2.0
12523,9928,GO:0032147,KIF14,activation of protein kinase activity,2.0
12524,9928,GO:0032467,KIF14,positive regulation of cytokinesis,2.0
12525,9928,GO:0032487,KIF14,regulation of Rap protein signal transduction,2.0
12526,9928,GO:0033624,KIF14,negative regulation of integrin activation,2.0
12527,9928,GO:0034446,KIF14,substrate adhesion-dependent cell spreading,2.0
12528,9928,GO:0043066,KIF14,negative regulation of apoptotic process,2.0
12529,9928,GO:0043161,KIF14,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
12530,9928,GO:0043523,KIF14,regulation of neuron apoptotic process,2.0
12531,9928,GO:0043524,KIF14,negative regulation of neuron apoptotic process,2.0
12532,9928,GO:0045184,KIF14,establishment of protein localization,2.0
12533,9928,GO:0051233,KIF14,spindle midzone,2.0
12534,9928,GO:0051301,KIF14,cell division,2.0
12535,9928,GO:0090543,KIF14,Flemming body,2.0
12536,9928,GO:1903429,KIF14,regulation of cell maturation,2.0
12537,9928,GO:2000045,KIF14,regulation of G1/S transition of mitotic cell cycle,2.0
12561,84623,GO:0001764,KIRREL3,neuron migration,2.0
12562,84623,GO:0002121,KIRREL3,inter-male aggressive behavior,2.0
12563,84623,GO:0005515,KIRREL3,protein binding,2.0
12564,84623,GO:0005576,KIRREL3,extracellular region,2.0
12565,84623,GO:0005886,KIRREL3,plasma membrane,2.0
12566,84623,GO:0005887,KIRREL3,integral component of plasma membrane,2.0
12567,84623,GO:0005911,KIRREL3,cell-cell junction,2.0
12568,84623,GO:0007156,KIRREL3,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
12569,84623,GO:0007416,KIRREL3,synapse assembly,2.0
12571,84623,GO:0008021,KIRREL3,synaptic vesicle,2.0
12572,84623,GO:0016021,KIRREL3,integral component of membrane,2.0
12573,84623,GO:0021740,KIRREL3,principal sensory nucleus of trigeminal nerve development,2.0
12574,84623,GO:0021766,KIRREL3,hippocampus development,2.0
12575,84623,GO:0030097,KIRREL3,hemopoiesis,2.0
12576,84623,GO:0030424,KIRREL3,axon,2.0
12577,84623,GO:0030425,KIRREL3,dendrite,2.0
12578,84623,GO:0043198,KIRREL3,dendritic shaft,2.0
12579,84623,GO:0048812,KIRREL3,neuron projection morphogenesis,2.0
12580,84623,GO:0050839,KIRREL3,cell adhesion molecule binding,2.0
12581,84623,GO:0072102,KIRREL3,glomerulus morphogenesis,2.0
12582,84623,GO:0098609,KIRREL3,cell-cell adhesion,2.0
12805,3912,GO:0005178,LAMB1,integrin binding,2.0
12806,3912,GO:0005198,LAMB1,structural molecule activity,2.0
12807,3912,GO:0005201,LAMB1,extracellular matrix structural constituent,2.0
12811,3912,GO:0005515,LAMB1,protein binding,2.0
12812,3912,GO:0005576,LAMB1,extracellular region,2.0
12813,3912,GO:0005604,LAMB1,basement membrane,2.0
12815,3912,GO:0005606,LAMB1,laminin-1 complex,2.0
12818,3912,GO:0005607,LAMB1,laminin-2 complex,2.0
12820,3912,GO:0005615,LAMB1,extracellular space,2.0
12821,3912,GO:0005788,LAMB1,endoplasmic reticulum lumen,2.0
12822,3912,GO:0007155,LAMB1,cell adhesion,2.0
12823,3912,GO:0009887,LAMB1,animal organ morphogenesis,2.0
12824,3912,GO:0009888,LAMB1,tissue development,2.0
12825,3912,GO:0016477,LAMB1,cell migration,2.0
12826,3912,GO:0021812,LAMB1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,2.0
12827,3912,GO:0030198,LAMB1,extracellular matrix organization,2.0
12828,3912,GO:0030335,LAMB1,positive regulation of cell migration,2.0
12829,3912,GO:0031175,LAMB1,neuron projection development,2.0
12830,3912,GO:0034446,LAMB1,substrate adhesion-dependent cell spreading,2.0
12832,3912,GO:0035987,LAMB1,endodermal cell differentiation,2.0
12833,3912,GO:0042476,LAMB1,odontogenesis,2.0
12834,3912,GO:0043256,LAMB1,laminin complex,2.0
12835,3912,GO:0043257,LAMB1,laminin-8 complex,2.0
12837,3912,GO:0043259,LAMB1,laminin-10 complex,2.0
12838,3912,GO:0043687,LAMB1,post-translational protein modification,2.0
12839,3912,GO:0044267,LAMB1,cellular protein metabolic process,2.0
12840,3912,GO:0048471,LAMB1,perinuclear region of cytoplasm,2.0
12841,3912,GO:0050679,LAMB1,positive regulation of epithelial cell proliferation,2.0
12842,3912,GO:0062023,LAMB1,collagen-containing extracellular matrix,2.0
12844,3912,GO:0070062,LAMB1,extracellular exosome,2.0
12845,3912,GO:0070831,LAMB1,basement membrane assembly,2.0
12975,123169,GO:0001650,LEO1,fibrillar center,2.0
12976,123169,GO:0001711,LEO1,endodermal cell fate commitment,2.0
12977,123169,GO:0005515,LEO1,protein binding,2.0
12978,123169,GO:0005634,LEO1,nucleus,2.0
12979,123169,GO:0005654,LEO1,nucleoplasm,2.0
12981,123169,GO:0005813,LEO1,centrosome,2.0
12982,123169,GO:0006366,LEO1,transcription by RNA polymerase II,2.0
12983,123169,GO:0006368,LEO1,transcription elongation from RNA polymerase II promoter,2.0
12985,123169,GO:0006378,LEO1,mRNA polyadenylation,2.0
12986,123169,GO:0010390,LEO1,histone monoubiquitination,2.0
12987,123169,GO:0016055,LEO1,Wnt signaling pathway,2.0
12988,123169,GO:0016567,LEO1,protein ubiquitination,2.0
12989,123169,GO:0016593,LEO1,Cdc73/Paf1 complex,2.0
12990,123169,GO:0019827,LEO1,stem cell population maintenance,2.0
12991,123169,GO:0031442,LEO1,positive regulation of mRNA 3'-end processing,2.0
12992,123169,GO:0032968,LEO1,positive regulation of transcription elongation from RNA polymerase II promoter,2.0
12993,123169,GO:0033523,LEO1,histone H2B ubiquitination,2.0
12994,123169,GO:0045638,LEO1,negative regulation of myeloid cell differentiation,2.0
12995,123169,GO:1904837,LEO1,beta-catenin-TCF complex assembly,2.0
12996,123169,GO:1990269,LEO1,RNA polymerase II C-terminal domain phosphoserine binding,2.0
13208,4035,GO:0001523,LRP1,retinoid metabolic process,2.0
13209,4035,GO:0001540,LRP1,amyloid-beta binding,2.0
13210,4035,GO:0002020,LRP1,protease binding,2.0
13211,4035,GO:0002265,LRP1,astrocyte activation involved in immune response,2.0
13212,4035,GO:0003723,LRP1,RNA binding,2.0
13213,4035,GO:0005041,LRP1,low-density lipoprotein particle receptor activity,2.0
13214,4035,GO:0005044,LRP1,scavenger receptor activity,2.0
13215,4035,GO:0005509,LRP1,calcium ion binding,2.0
13216,4035,GO:0005515,LRP1,protein binding,2.0
13217,4035,GO:0005634,LRP1,nucleus,2.0
13218,4035,GO:0005765,LRP1,lysosomal membrane,2.0
13219,4035,GO:0005769,LRP1,early endosome,2.0
13220,4035,GO:0005856,LRP1,cytoskeleton,2.0
13221,4035,GO:0005886,LRP1,plasma membrane,2.0
13222,4035,GO:0005887,LRP1,integral component of plasma membrane,2.0
13223,4035,GO:0005905,LRP1,clathrin-coated pit,2.0
13224,4035,GO:0005925,LRP1,focal adhesion,2.0
13225,4035,GO:0006629,LRP1,lipid metabolic process,2.0
13226,4035,GO:0006898,LRP1,receptor-mediated endocytosis,2.0
13229,4035,GO:0006909,LRP1,phagocytosis,2.0
13231,4035,GO:0007041,LRP1,lysosomal transport,2.0
13232,4035,GO:0007204,LRP1,positive regulation of cytosolic calcium ion concentration,2.0
13233,4035,GO:0007205,LRP1,protein kinase C-activating G protein-coupled receptor signaling pathway,2.0
13234,4035,GO:0007568,LRP1,aging,2.0
13235,4035,GO:0008283,LRP1,cell population proliferation,2.0
13236,4035,GO:0010715,LRP1,regulation of extracellular matrix disassembly,2.0
13237,4035,GO:0010875,LRP1,positive regulation of cholesterol efflux,2.0
13238,4035,GO:0010942,LRP1,positive regulation of cell death,2.0
13239,4035,GO:0010977,LRP1,negative regulation of neuron projection development,2.0
13240,4035,GO:0014912,LRP1,negative regulation of smooth muscle cell migration,2.0
13241,4035,GO:0015026,LRP1,coreceptor activity,2.0
13242,4035,GO:0016020,LRP1,membrane,2.0
13243,4035,GO:0016323,LRP1,basolateral plasma membrane,2.0
13244,4035,GO:0016964,LRP1,alpha-2 macroglobulin receptor activity,2.0
13246,4035,GO:0021987,LRP1,cerebral cortex development,2.0
13247,4035,GO:0030136,LRP1,clathrin-coated vesicle,2.0
13248,4035,GO:0030178,LRP1,negative regulation of Wnt signaling pathway,2.0
13249,4035,GO:0030226,LRP1,apolipoprotein receptor activity,2.0
13250,4035,GO:0030425,LRP1,dendrite,2.0
13251,4035,GO:0030666,LRP1,endocytic vesicle membrane,2.0
13252,4035,GO:0031623,LRP1,receptor internalization,2.0
13253,4035,GO:0032050,LRP1,clathrin heavy chain binding,2.0
13254,4035,GO:0032092,LRP1,positive regulation of protein binding,2.0
13255,4035,GO:0032370,LRP1,positive regulation of lipid transport,2.0
13256,4035,GO:0032374,LRP1,regulation of cholesterol transport,2.0
13257,4035,GO:0032429,LRP1,regulation of phospholipase A2 activity,2.0
13258,4035,GO:0032593,LRP1,insulin-responsive compartment,2.0
13259,4035,GO:0032956,LRP1,regulation of actin cytoskeleton organization,2.0
13260,4035,GO:0034185,LRP1,apolipoprotein binding,2.0
13262,4035,GO:0035774,LRP1,positive regulation of insulin secretion involved in cellular response to glucose stimulus,2.0
13263,4035,GO:0035909,LRP1,aorta morphogenesis,2.0
13264,4035,GO:0038023,LRP1,signaling receptor activity,2.0
13265,4035,GO:0038024,LRP1,cargo receptor activity,2.0
13268,4035,GO:0042157,LRP1,lipoprotein metabolic process,2.0
13269,4035,GO:0042953,LRP1,lipoprotein transport,2.0
13270,4035,GO:0043025,LRP1,neuronal cell body,2.0
13271,4035,GO:0043235,LRP1,receptor complex,2.0
13272,4035,GO:0043277,LRP1,apoptotic cell clearance,2.0
13273,4035,GO:0043395,LRP1,heparan sulfate proteoglycan binding,2.0
13274,4035,GO:0043524,LRP1,negative regulation of neuron apoptotic process,2.0
13275,4035,GO:0044242,LRP1,cellular lipid catabolic process,2.0
13276,4035,GO:0044295,LRP1,axonal growth cone,2.0
13277,4035,GO:0044877,LRP1,protein-containing complex binding,2.0
13278,4035,GO:0045056,LRP1,transcytosis,2.0
13279,4035,GO:0045177,LRP1,apical part of cell,2.0
13280,4035,GO:0045807,LRP1,positive regulation of endocytosis,2.0
13281,4035,GO:0048691,LRP1,positive regulation of axon extension involved in regeneration,2.0
13282,4035,GO:0048694,LRP1,positive regulation of collateral sprouting of injured axon,2.0
13283,4035,GO:0050766,LRP1,positive regulation of phagocytosis,2.0
13284,4035,GO:0051481,LRP1,negative regulation of cytosolic calcium ion concentration,2.0
13285,4035,GO:0051895,LRP1,negative regulation of focal adhesion assembly,2.0
13286,4035,GO:0061642,LRP1,chemoattraction of axon,2.0
13287,4035,GO:0070325,LRP1,lipoprotein particle receptor binding,2.0
13288,4035,GO:0070374,LRP1,positive regulation of ERK1 and ERK2 cascade,2.0
13289,4035,GO:0097242,LRP1,amyloid-beta clearance,2.0
13291,4035,GO:0098797,LRP1,plasma membrane protein complex,2.0
13292,4035,GO:0150051,LRP1,postsynaptic Golgi apparatus,2.0
13293,4035,GO:0150093,LRP1,amyloid-beta clearance by transcytosis,2.0
13295,4035,GO:0150094,LRP1,amyloid-beta clearance by cellular catabolic process,2.0
13297,4035,GO:0150104,LRP1,transport across blood-brain barrier,2.0
13299,4035,GO:1900149,LRP1,positive regulation of Schwann cell migration,2.0
13300,4035,GO:1900223,LRP1,positive regulation of amyloid-beta clearance,2.0
13302,4035,GO:1903078,LRP1,positive regulation of protein localization to plasma membrane,2.0
13303,4035,GO:1904109,LRP1,positive regulation of cholesterol import,2.0
13304,4035,GO:1904300,LRP1,positive regulation of transcytosis,2.0
13305,4035,GO:1904646,LRP1,cellular response to amyloid-beta,2.0
13306,4035,GO:1904754,LRP1,positive regulation of vascular associated smooth muscle cell migration,2.0
13307,4035,GO:1905049,LRP1,negative regulation of metallopeptidase activity,2.0
13308,4035,GO:1905167,LRP1,positive regulation of lysosomal protein catabolic process,2.0
13309,4035,GO:2000587,LRP1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,2.0
13417,140733,GO:0005634,MACROD2,nucleus,2.0
13418,140733,GO:0005654,MACROD2,nucleoplasm,2.0
13420,140733,GO:0005730,MACROD2,nucleolus,2.0
13421,140733,GO:0006974,MACROD2,cellular response to DNA damage stimulus,2.0
13423,140733,GO:0007420,MACROD2,brain development,2.0
13424,140733,GO:0009617,MACROD2,response to bacterium,2.0
13425,140733,GO:0016798,MACROD2,"hydrolase activity, acting on glycosyl bonds",2.0
13426,140733,GO:0019213,MACROD2,deacetylase activity,2.0
13427,140733,GO:0042278,MACROD2,purine nucleoside metabolic process,2.0
13429,140733,GO:0051725,MACROD2,protein de-ADP-ribosylation,2.0
13430,140733,GO:0140291,MACROD2,peptidyl-glutamate ADP-deribosylation,2.0
13432,140733,GO:0140293,MACROD2,ADP-ribosylglutamate hydrolase activity,2.0
13825,4010,GO:0000785,LMX1B,chromatin,2.0
13826,4010,GO:0000977,LMX1B,RNA polymerase II transcription regulatory region sequence-specific DNA binding,2.0
13828,4010,GO:0000981,LMX1B,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
13831,4010,GO:0001701,LMX1B,in utero embryonic development,2.0
13832,4010,GO:0003700,LMX1B,DNA-binding transcription factor activity,2.0
13833,4010,GO:0005515,LMX1B,protein binding,2.0
13834,4010,GO:0005634,LMX1B,nucleus,2.0
13836,4010,GO:0006355,LMX1B,"regulation of transcription, DNA-templated",2.0
13837,4010,GO:0006357,LMX1B,regulation of transcription by RNA polymerase II,2.0
13838,4010,GO:0007275,LMX1B,multicellular organism development,2.0
13839,4010,GO:0009953,LMX1B,dorsal/ventral pattern formation,2.0
13840,4010,GO:0030182,LMX1B,neuron differentiation,2.0
13842,4010,GO:0045944,LMX1B,positive regulation of transcription by RNA polymerase II,2.0
13844,4010,GO:0046872,LMX1B,metal ion binding,2.0
13845,4010,GO:0071542,LMX1B,dopaminergic neuron differentiation,2.0
13846,4010,GO:1990837,LMX1B,sequence-specific double-stranded DNA binding,2.0
13919,100128977,GO:0031047,MAPT-AS1,gene silencing by RNA,2.0
13920,100128977,GO:1905642,MAPT-AS1,negative regulation of DNA methylation,2.0
14144,4233,GO:0000165,MET,MAPK cascade,2.0
14145,4233,GO:0001886,MET,endothelial cell morphogenesis,2.0
14146,4233,GO:0001889,MET,liver development,2.0
14147,4233,GO:0004713,MET,protein tyrosine kinase activity,2.0
14149,4233,GO:0004714,MET,transmembrane receptor protein tyrosine kinase activity,2.0
14150,4233,GO:0005008,MET,hepatocyte growth factor-activated receptor activity,2.0
14151,4233,GO:0005515,MET,protein binding,2.0
14152,4233,GO:0005524,MET,ATP binding,2.0
14153,4233,GO:0005576,MET,extracellular region,2.0
14154,4233,GO:0005886,MET,plasma membrane,2.0
14155,4233,GO:0005887,MET,integral component of plasma membrane,2.0
14156,4233,GO:0006909,MET,phagocytosis,2.0
14157,4233,GO:0007165,MET,signal transduction,2.0
14158,4233,GO:0007166,MET,cell surface receptor signaling pathway,2.0
14159,4233,GO:0007169,MET,transmembrane receptor protein tyrosine kinase signaling pathway,2.0
14160,4233,GO:0007275,MET,multicellular organism development,2.0
14161,4233,GO:0007399,MET,nervous system development,2.0
14162,4233,GO:0009925,MET,basal plasma membrane,2.0
14164,4233,GO:0009986,MET,cell surface,2.0
14165,4233,GO:0010507,MET,negative regulation of autophagy,2.0
14166,4233,GO:0016021,MET,integral component of membrane,2.0
14167,4233,GO:0016477,MET,cell migration,2.0
14168,4233,GO:0017154,MET,semaphorin receptor activity,2.0
14169,4233,GO:0018108,MET,peptidyl-tyrosine phosphorylation,2.0
14170,4233,GO:0019903,MET,protein phosphatase binding,2.0
14171,4233,GO:0030182,MET,neuron differentiation,2.0
14172,4233,GO:0031016,MET,pancreas development,2.0
14173,4233,GO:0031116,MET,positive regulation of microtubule polymerization,2.0
14174,4233,GO:0033674,MET,positive regulation of kinase activity,2.0
14175,4233,GO:0035024,MET,negative regulation of Rho protein signal transduction,2.0
14176,4233,GO:0035635,MET,entry of bacterium into host cell,2.0
14177,4233,GO:0042802,MET,identical protein binding,2.0
14178,4233,GO:0043235,MET,receptor complex,2.0
14179,4233,GO:0045944,MET,positive regulation of transcription by RNA polymerase II,2.0
14180,4233,GO:0048012,MET,hepatocyte growth factor receptor signaling pathway,2.0
14181,4233,GO:0048754,MET,branching morphogenesis of an epithelial tube,2.0
14182,4233,GO:0050918,MET,positive chemotaxis,2.0
14183,4233,GO:0051497,MET,negative regulation of stress fiber assembly,2.0
14184,4233,GO:0051897,MET,positive regulation of protein kinase B signaling,2.0
14186,4233,GO:0061436,MET,establishment of skin barrier,2.0
14187,4233,GO:0070495,MET,negative regulation of thrombin-activated receptor signaling pathway,2.0
14188,4233,GO:0071526,MET,semaphorin-plexin signaling pathway,2.0
14189,4233,GO:1901299,MET,negative regulation of hydrogen peroxide-mediated programmed cell death,2.0
14190,4233,GO:1905098,MET,negative regulation of guanyl-nucleotide exchange factor activity,2.0
14191,4233,GO:2001028,MET,positive regulation of endothelial cell chemotaxis,2.0
14192,83552,GO:0003674,MFRP,molecular_function,2.0
14193,83552,GO:0007601,MFRP,visual perception,2.0
14194,83552,GO:0009792,MFRP,embryo development ending in birth or egg hatching,2.0
14195,83552,GO:0016021,MFRP,integral component of membrane,2.0
14196,83552,GO:0016324,MFRP,apical plasma membrane,2.0
14197,83552,GO:0042462,MFRP,eye photoreceptor cell development,2.0
14198,83552,GO:0060041,MFRP,retina development in camera-type eye,2.0
14256,406928,GO:0001933,MIR137,negative regulation of protein phosphorylation,2.0
14257,406928,GO:0007406,MIR137,negative regulation of neuroblast proliferation,2.0
14258,406928,GO:0008285,MIR137,negative regulation of cell population proliferation,2.0
14259,406928,GO:0016525,MIR137,negative regulation of angiogenesis,2.0
14260,406928,GO:0030336,MIR137,negative regulation of cell migration,2.0
14261,406928,GO:0035195,MIR137,gene silencing by miRNA,2.0
14263,406928,GO:0043065,MIR137,positive regulation of apoptotic process,2.0
14264,406928,GO:0043537,MIR137,negative regulation of blood vessel endothelial cell migration,2.0
14265,406928,GO:0045666,MIR137,positive regulation of neuron differentiation,2.0
14266,406928,GO:0051898,MIR137,negative regulation of protein kinase B signaling,2.0
14267,406928,GO:1903231,MIR137,mRNA binding involved in posttranscriptional gene silencing,2.0
14268,406928,GO:1904706,MIR137,negative regulation of vascular associated smooth muscle cell proliferation,2.0
14269,406928,GO:1904753,MIR137,negative regulation of vascular associated smooth muscle cell migration,2.0
14270,406928,GO:2000134,MIR137,negative regulation of G1/S transition of mitotic cell cycle,2.0
14369,2475,GO:0000139,MTOR,Golgi membrane,2.0
14370,2475,GO:0001002,MTOR,RNA polymerase III type 1 promoter sequence-specific DNA binding,2.0
14371,2475,GO:0001003,MTOR,RNA polymerase III type 2 promoter sequence-specific DNA binding,2.0
14372,2475,GO:0001006,MTOR,RNA polymerase III type 3 promoter sequence-specific DNA binding,2.0
14373,2475,GO:0001156,MTOR,TFIIIC-class transcription factor complex binding,2.0
14374,2475,GO:0001558,MTOR,regulation of cell growth,2.0
14375,2475,GO:0001933,MTOR,negative regulation of protein phosphorylation,2.0
14376,2475,GO:0001938,MTOR,positive regulation of endothelial cell proliferation,2.0
14377,2475,GO:0003007,MTOR,heart morphogenesis,2.0
14378,2475,GO:0003179,MTOR,heart valve morphogenesis,2.0
14379,2475,GO:0004672,MTOR,protein kinase activity,2.0
14380,2475,GO:0004674,MTOR,protein serine/threonine kinase activity,2.0
14384,2475,GO:0005515,MTOR,protein binding,2.0
14385,2475,GO:0005524,MTOR,ATP binding,2.0
14386,2475,GO:0005634,MTOR,nucleus,2.0
14387,2475,GO:0005635,MTOR,nuclear envelope,2.0
14388,2475,GO:0005654,MTOR,nucleoplasm,2.0
14389,2475,GO:0005737,MTOR,cytoplasm,2.0
14390,2475,GO:0005741,MTOR,mitochondrial outer membrane,2.0
14391,2475,GO:0005764,MTOR,lysosome,2.0
14393,2475,GO:0005765,MTOR,lysosomal membrane,2.0
14395,2475,GO:0005789,MTOR,endoplasmic reticulum membrane,2.0
14396,2475,GO:0005829,MTOR,cytosol,2.0
14397,2475,GO:0005979,MTOR,regulation of glycogen biosynthetic process,2.0
14398,2475,GO:0006112,MTOR,energy reserve metabolic process,2.0
14399,2475,GO:0006207,MTOR,'de novo' pyrimidine nucleobase biosynthetic process,2.0
14400,2475,GO:0006468,MTOR,protein phosphorylation,2.0
14402,2475,GO:0007040,MTOR,lysosome organization,2.0
14403,2475,GO:0007050,MTOR,cell cycle arrest,2.0
14404,2475,GO:0007281,MTOR,germ cell development,2.0
14405,2475,GO:0007420,MTOR,brain development,2.0
14406,2475,GO:0007569,MTOR,cell aging,2.0
14407,2475,GO:0007584,MTOR,response to nutrient,2.0
14408,2475,GO:0007616,MTOR,long-term memory,2.0
14409,2475,GO:0008361,MTOR,regulation of cell size,2.0
14410,2475,GO:0008542,MTOR,visual learning,2.0
14411,2475,GO:0009267,MTOR,cellular response to starvation,2.0
14412,2475,GO:0009791,MTOR,post-embryonic development,2.0
14413,2475,GO:0010507,MTOR,negative regulation of autophagy,2.0
14416,2475,GO:0010592,MTOR,positive regulation of lamellipodium assembly,2.0
14417,2475,GO:0010628,MTOR,positive regulation of gene expression,2.0
14418,2475,GO:0010718,MTOR,positive regulation of epithelial to mesenchymal transition,2.0
14419,2475,GO:0010831,MTOR,positive regulation of myotube differentiation,2.0
14420,2475,GO:0012505,MTOR,endomembrane system,2.0
14421,2475,GO:0014042,MTOR,positive regulation of neuron maturation,2.0
14422,2475,GO:0014736,MTOR,negative regulation of muscle atrophy,2.0
14423,2475,GO:0014823,MTOR,response to activity,2.0
14424,2475,GO:0016020,MTOR,membrane,2.0
14426,2475,GO:0016241,MTOR,regulation of macroautophagy,2.0
14427,2475,GO:0016242,MTOR,negative regulation of macroautophagy,2.0
14429,2475,GO:0016301,MTOR,kinase activity,2.0
14431,2475,GO:0016310,MTOR,phosphorylation,2.0
14432,2475,GO:0016605,MTOR,PML body,2.0
14433,2475,GO:0018105,MTOR,peptidyl-serine phosphorylation,2.0
14436,2475,GO:0018107,MTOR,peptidyl-threonine phosphorylation,2.0
14437,2475,GO:0019901,MTOR,protein kinase binding,2.0
14438,2475,GO:0019904,MTOR,protein domain specific binding,2.0
14439,2475,GO:0021510,MTOR,spinal cord development,2.0
14440,2475,GO:0030163,MTOR,protein catabolic process,2.0
14441,2475,GO:0030425,MTOR,dendrite,2.0
14442,2475,GO:0030838,MTOR,positive regulation of actin filament polymerization,2.0
14443,2475,GO:0031397,MTOR,negative regulation of protein ubiquitination,2.0
14444,2475,GO:0031529,MTOR,ruffle organization,2.0
14445,2475,GO:0031641,MTOR,regulation of myelination,2.0
14446,2475,GO:0031667,MTOR,response to nutrient levels,2.0
14447,2475,GO:0031669,MTOR,cellular response to nutrient levels,2.0
14448,2475,GO:0031929,MTOR,TOR signaling,2.0
14450,2475,GO:0031931,MTOR,TORC1 complex,2.0
14453,2475,GO:0031932,MTOR,TORC2 complex,2.0
14455,2475,GO:0031998,MTOR,regulation of fatty acid beta-oxidation,2.0
14456,2475,GO:0032095,MTOR,regulation of response to food,2.0
14457,2475,GO:0032148,MTOR,activation of protein kinase B activity,2.0
14458,2475,GO:0032516,MTOR,positive regulation of phosphoprotein phosphatase activity,2.0
14459,2475,GO:0032868,MTOR,response to insulin,2.0
14460,2475,GO:0032956,MTOR,regulation of actin cytoskeleton organization,2.0
14461,2475,GO:0034198,MTOR,cellular response to amino acid starvation,2.0
14462,2475,GO:0035176,MTOR,social behavior,2.0
14463,2475,GO:0035264,MTOR,multicellular organism growth,2.0
14464,2475,GO:0038202,MTOR,TORC1 signaling,2.0
14467,2475,GO:0042060,MTOR,wound healing,2.0
14468,2475,GO:0042220,MTOR,response to cocaine,2.0
14469,2475,GO:0042752,MTOR,regulation of circadian rhythm,2.0
14470,2475,GO:0042802,MTOR,identical protein binding,2.0
14471,2475,GO:0043022,MTOR,ribosome binding,2.0
14472,2475,GO:0043025,MTOR,neuronal cell body,2.0
14473,2475,GO:0043087,MTOR,regulation of GTPase activity,2.0
14474,2475,GO:0043200,MTOR,response to amino acid,2.0
14475,2475,GO:0043276,MTOR,anoikis,2.0
14476,2475,GO:0043278,MTOR,response to morphine,2.0
14477,2475,GO:0043610,MTOR,regulation of carbohydrate utilization,2.0
14478,2475,GO:0045335,MTOR,phagocytic vesicle,2.0
14479,2475,GO:0045429,MTOR,positive regulation of nitric oxide biosynthetic process,2.0
14480,2475,GO:0045670,MTOR,regulation of osteoclast differentiation,2.0
14481,2475,GO:0045727,MTOR,positive regulation of translation,2.0
14482,2475,GO:0045792,MTOR,negative regulation of cell size,2.0
14483,2475,GO:0045945,MTOR,positive regulation of transcription by RNA polymerase III,2.0
14484,2475,GO:0046777,MTOR,protein autophosphorylation,2.0
14485,2475,GO:0046889,MTOR,positive regulation of lipid biosynthetic process,2.0
14486,2475,GO:0048255,MTOR,mRNA stabilization,2.0
14487,2475,GO:0048511,MTOR,rhythmic process,2.0
14488,2475,GO:0048661,MTOR,positive regulation of smooth muscle cell proliferation,2.0
14489,2475,GO:0048714,MTOR,positive regulation of oligodendrocyte differentiation,2.0
14490,2475,GO:0050731,MTOR,positive regulation of peptidyl-tyrosine phosphorylation,2.0
14491,2475,GO:0050882,MTOR,voluntary musculoskeletal movement,2.0
14492,2475,GO:0051219,MTOR,phosphoprotein binding,2.0
14493,2475,GO:0051496,MTOR,positive regulation of stress fiber assembly,2.0
14494,2475,GO:0051549,MTOR,positive regulation of keratinocyte migration,2.0
14495,2475,GO:0051647,MTOR,nucleus localization,2.0
14496,2475,GO:0051897,MTOR,positive regulation of protein kinase B signaling,2.0
14497,2475,GO:0055013,MTOR,cardiac muscle cell development,2.0
14498,2475,GO:0060048,MTOR,cardiac muscle contraction,2.0
14499,2475,GO:0060135,MTOR,maternal process involved in female pregnancy,2.0
14500,2475,GO:0060252,MTOR,positive regulation of glial cell proliferation,2.0
14501,2475,GO:0060999,MTOR,positive regulation of dendritic spine development,2.0
14502,2475,GO:0061051,MTOR,positive regulation of cell growth involved in cardiac muscle cell development,2.0
14503,2475,GO:0070885,MTOR,negative regulation of calcineurin-NFAT signaling cascade,2.0
14504,2475,GO:0071230,MTOR,cellular response to amino acid stimulus,2.0
14505,2475,GO:0071233,MTOR,cellular response to leucine,2.0
14506,2475,GO:0071456,MTOR,cellular response to hypoxia,2.0
14507,2475,GO:0090335,MTOR,regulation of brown fat cell differentiation,2.0
14508,2475,GO:0090559,MTOR,regulation of membrane permeability,2.0
14509,2475,GO:0098978,MTOR,glutamatergic synapse,2.0
14510,2475,GO:0099524,MTOR,postsynaptic cytosol,2.0
14511,2475,GO:0106310,MTOR,protein serine kinase activity,2.0
14512,2475,GO:0106311,MTOR,protein threonine kinase activity,2.0
14513,2475,GO:1900034,MTOR,regulation of cellular response to heat,2.0
14514,2475,GO:1901216,MTOR,positive regulation of neuron death,2.0
14515,2475,GO:1901838,MTOR,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,2.0
14516,2475,GO:1903691,MTOR,"positive regulation of wound healing, spreading of epidermal cells",2.0
14517,2475,GO:1904000,MTOR,positive regulation of eating behavior,2.0
14518,2475,GO:1904056,MTOR,positive regulation of cholangiocyte proliferation,2.0
14519,2475,GO:1904058,MTOR,positive regulation of sensory perception of pain,2.0
14520,2475,GO:1904059,MTOR,regulation of locomotor rhythm,2.0
14521,2475,GO:1904193,MTOR,negative regulation of cholangiocyte apoptotic process,2.0
14522,2475,GO:1904197,MTOR,positive regulation of granulosa cell proliferation,2.0
14523,2475,GO:1904206,MTOR,positive regulation of skeletal muscle hypertrophy,2.0
14524,2475,GO:1904213,MTOR,negative regulation of iodide transmembrane transport,2.0
14525,2475,GO:1904690,MTOR,positive regulation of cytoplasmic translational initiation,2.0
14526,2475,GO:1990253,MTOR,cellular response to leucine starvation,2.0
14550,4628,GO:0000146,MYH10,microfilament motor activity,2.0
14551,4628,GO:0000281,MYH10,mitotic cytokinesis,2.0
14552,4628,GO:0001701,MYH10,in utero embryonic development,2.0
14553,4628,GO:0001725,MYH10,stress fiber,2.0
14554,4628,GO:0001764,MYH10,neuron migration,2.0
14555,4628,GO:0001778,MYH10,plasma membrane repair,2.0
14556,4628,GO:0003279,MYH10,cardiac septum development,2.0
14557,4628,GO:0003779,MYH10,actin binding,2.0
14558,4628,GO:0005515,MYH10,protein binding,2.0
14559,4628,GO:0005516,MYH10,calmodulin binding,2.0
14560,4628,GO:0005524,MYH10,ATP binding,2.0
14562,4628,GO:0005634,MYH10,nucleus,2.0
14563,4628,GO:0005737,MYH10,cytoplasm,2.0
14564,4628,GO:0005819,MYH10,spindle,2.0
14565,4628,GO:0005829,MYH10,cytosol,2.0
14567,4628,GO:0005844,MYH10,polysome,2.0
14568,4628,GO:0005903,MYH10,brush border,2.0
14569,4628,GO:0005938,MYH10,cell cortex,2.0
14570,4628,GO:0006887,MYH10,exocytosis,2.0
14571,4628,GO:0006930,MYH10,"substrate-dependent cell migration, cell extension",2.0
14572,4628,GO:0007097,MYH10,nuclear migration,2.0
14573,4628,GO:0007155,MYH10,cell adhesion,2.0
14574,4628,GO:0007411,MYH10,axon guidance,2.0
14575,4628,GO:0007512,MYH10,adult heart development,2.0
14576,4628,GO:0008283,MYH10,cell population proliferation,2.0
14577,4628,GO:0008360,MYH10,regulation of cell shape,2.0
14578,4628,GO:0016459,MYH10,myosin complex,2.0
14579,4628,GO:0016460,MYH10,myosin II complex,2.0
14580,4628,GO:0016887,MYH10,ATPase activity,2.0
14581,4628,GO:0021592,MYH10,fourth ventricle development,2.0
14582,4628,GO:0021670,MYH10,lateral ventricle development,2.0
14583,4628,GO:0021678,MYH10,third ventricle development,2.0
14584,4628,GO:0021680,MYH10,cerebellar Purkinje cell layer development,2.0
14585,4628,GO:0030027,MYH10,lamellipodium,2.0
14586,4628,GO:0030048,MYH10,actin filament-based movement,2.0
14587,4628,GO:0030426,MYH10,growth cone,2.0
14588,4628,GO:0030496,MYH10,midbody,2.0
14589,4628,GO:0030898,MYH10,actin-dependent ATPase activity,2.0
14591,4628,GO:0031032,MYH10,actomyosin structure organization,2.0
14592,4628,GO:0031594,MYH10,neuromuscular junction,2.0
14593,4628,GO:0032154,MYH10,cleavage furrow,2.0
14594,4628,GO:0035613,MYH10,RNA stem-loop binding,2.0
14595,4628,GO:0035904,MYH10,aorta development,2.0
14596,4628,GO:0042641,MYH10,actomyosin,2.0
14597,4628,GO:0043025,MYH10,neuronal cell body,2.0
14598,4628,GO:0043197,MYH10,dendritic spine,2.0
14599,4628,GO:0043531,MYH10,ADP binding,2.0
14600,4628,GO:0048027,MYH10,mRNA 5'-UTR binding,2.0
14601,4628,GO:0050714,MYH10,positive regulation of protein secretion,2.0
14602,4628,GO:0050885,MYH10,neuromuscular process controlling balance,2.0
14603,4628,GO:0051015,MYH10,actin filament binding,2.0
14605,4628,GO:0055003,MYH10,cardiac myofibril assembly,2.0
14606,4628,GO:0055015,MYH10,ventricular cardiac muscle cell development,2.0
14607,4628,GO:0060041,MYH10,retina development in camera-type eye,2.0
14608,4628,GO:0060976,MYH10,coronary vasculature development,2.0
14609,4628,GO:0070062,MYH10,extracellular exosome,2.0
14610,4628,GO:0097513,MYH10,myosin II filament,2.0
14611,4628,GO:0098885,MYH10,modification of postsynaptic actin cytoskeleton,2.0
14680,4644,GO:0000146,MYO5A,microfilament motor activity,2.0
14682,4644,GO:0001726,MYO5A,ruffle,2.0
14683,4644,GO:0001750,MYO5A,photoreceptor outer segment,2.0
14684,4644,GO:0003723,MYO5A,RNA binding,2.0
14685,4644,GO:0005509,MYO5A,calcium ion binding,2.0
14686,4644,GO:0005515,MYO5A,protein binding,2.0
14687,4644,GO:0005516,MYO5A,calmodulin binding,2.0
14688,4644,GO:0005524,MYO5A,ATP binding,2.0
14689,4644,GO:0005737,MYO5A,cytoplasm,2.0
14691,4644,GO:0005764,MYO5A,lysosome,2.0
14692,4644,GO:0005769,MYO5A,early endosome,2.0
14693,4644,GO:0005770,MYO5A,late endosome,2.0
14694,4644,GO:0005777,MYO5A,peroxisome,2.0
14695,4644,GO:0005783,MYO5A,endoplasmic reticulum,2.0
14696,4644,GO:0005794,MYO5A,Golgi apparatus,2.0
14697,4644,GO:0005829,MYO5A,cytosol,2.0
14698,4644,GO:0005882,MYO5A,intermediate filament,2.0
14699,4644,GO:0005884,MYO5A,actin filament,2.0
14700,4644,GO:0006887,MYO5A,exocytosis,2.0
14701,4644,GO:0006892,MYO5A,post-Golgi vesicle-mediated transport,2.0
14702,4644,GO:0007015,MYO5A,actin filament organization,2.0
14703,4644,GO:0007268,MYO5A,chemical synaptic transmission,2.0
14704,4644,GO:0007601,MYO5A,visual perception,2.0
14705,4644,GO:0015629,MYO5A,actin cytoskeleton,2.0
14706,4644,GO:0016020,MYO5A,membrane,2.0
14708,4644,GO:0016192,MYO5A,vesicle-mediated transport,2.0
14709,4644,GO:0016461,MYO5A,unconventional myosin complex,2.0
14710,4644,GO:0030048,MYO5A,actin filament-based movement,2.0
14711,4644,GO:0030050,MYO5A,vesicle transport along actin filament,2.0
14713,4644,GO:0030073,MYO5A,insulin secretion,2.0
14714,4644,GO:0030318,MYO5A,melanocyte differentiation,2.0
14715,4644,GO:0030426,MYO5A,growth cone,2.0
14716,4644,GO:0030898,MYO5A,actin-dependent ATPase activity,2.0
14717,4644,GO:0031267,MYO5A,small GTPase binding,2.0
14718,4644,GO:0031585,MYO5A,"regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",2.0
14719,4644,GO:0031982,MYO5A,vesicle,2.0
14720,4644,GO:0031987,MYO5A,locomotion involved in locomotory behavior,2.0
14721,4644,GO:0032252,MYO5A,secretory granule localization,2.0
14722,4644,GO:0032402,MYO5A,melanosome transport,2.0
14723,4644,GO:0032433,MYO5A,filopodium tip,2.0
14724,4644,GO:0032593,MYO5A,insulin-responsive compartment,2.0
14725,4644,GO:0032869,MYO5A,cellular response to insulin stimulus,2.0
14726,4644,GO:0035371,MYO5A,microtubule plus-end,2.0
14727,4644,GO:0042438,MYO5A,melanin biosynthetic process,2.0
14728,4644,GO:0042470,MYO5A,melanosome,2.0
14729,4644,GO:0042476,MYO5A,odontogenesis,2.0
14730,4644,GO:0042552,MYO5A,myelination,2.0
14731,4644,GO:0042641,MYO5A,actomyosin,2.0
14732,4644,GO:0042759,MYO5A,long-chain fatty acid biosynthetic process,2.0
14733,4644,GO:0042802,MYO5A,identical protein binding,2.0
14734,4644,GO:0043005,MYO5A,neuron projection,2.0
14735,4644,GO:0043025,MYO5A,neuronal cell body,2.0
14736,4644,GO:0048820,MYO5A,hair follicle maturation,2.0
14737,4644,GO:0050808,MYO5A,synapse organization,2.0
14738,4644,GO:0051015,MYO5A,actin filament binding,2.0
14739,4644,GO:0055037,MYO5A,recycling endosome,2.0
14740,4644,GO:0070062,MYO5A,extracellular exosome,2.0
14741,4644,GO:0072659,MYO5A,protein localization to plasma membrane,2.0
14742,4644,GO:0097718,MYO5A,disordered domain specific binding,2.0
14743,4644,GO:0098794,MYO5A,postsynapse,2.0
14744,4644,GO:0098978,MYO5A,glutamatergic synapse,2.0
14745,4644,GO:0099089,MYO5A,establishment of endoplasmic reticulum localization to postsynapse,2.0
14746,4644,GO:0099566,MYO5A,regulation of postsynaptic cytosolic calcium ion concentration,2.0
14747,4644,GO:1903358,MYO5A,regulation of Golgi organization,2.0
14760,4650,GO:0000146,MYO9B,microfilament motor activity,2.0
14761,4650,GO:0003779,MYO9B,actin binding,2.0
14762,4650,GO:0005096,MYO9B,GTPase activator activity,2.0
14764,4650,GO:0005515,MYO9B,protein binding,2.0
14765,4650,GO:0005516,MYO9B,calmodulin binding,2.0
14766,4650,GO:0005524,MYO9B,ATP binding,2.0
14767,4650,GO:0005737,MYO9B,cytoplasm,2.0
14768,4650,GO:0005829,MYO9B,cytosol,2.0
14770,4650,GO:0005884,MYO9B,actin filament,2.0
14771,4650,GO:0005938,MYO9B,cell cortex,2.0
14772,4650,GO:0007266,MYO9B,Rho protein signal transduction,2.0
14773,4650,GO:0015629,MYO9B,actin cytoskeleton,2.0
14774,4650,GO:0016020,MYO9B,membrane,2.0
14775,4650,GO:0016459,MYO9B,myosin complex,2.0
14776,4650,GO:0016887,MYO9B,ATPase activity,2.0
14777,4650,GO:0030048,MYO9B,actin filament-based movement,2.0
14779,4650,GO:0031267,MYO9B,small GTPase binding,2.0
14780,4650,GO:0032011,MYO9B,ARF protein signal transduction,2.0
14781,4650,GO:0035023,MYO9B,regulation of Rho protein signal transduction,2.0
14782,4650,GO:0035385,MYO9B,Roundabout signaling pathway,2.0
14783,4650,GO:0042803,MYO9B,protein homodimerization activity,2.0
14784,4650,GO:0043531,MYO9B,ADP binding,2.0
14785,4650,GO:0043547,MYO9B,positive regulation of GTPase activity,2.0
14786,4650,GO:0046872,MYO9B,metal ion binding,2.0
14787,4650,GO:0048471,MYO9B,perinuclear region of cytoplasm,2.0
14788,4650,GO:0048495,MYO9B,Roundabout binding,2.0
14789,4650,GO:0051056,MYO9B,regulation of small GTPase mediated signal transduction,2.0
14992,89797,GO:0003678,NAV2,DNA helicase activity,2.0
14993,89797,GO:0005515,NAV2,protein binding,2.0
14994,89797,GO:0005524,NAV2,ATP binding,2.0
14995,89797,GO:0005654,NAV2,nucleoplasm,2.0
14996,89797,GO:0007399,NAV2,nervous system development,2.0
14997,89797,GO:0022008,NAV2,neurogenesis,2.0
14998,89797,GO:0032508,NAV2,DNA duplex unwinding,2.0
15041,9611,GO:0000118,NCOR1,histone deacetylase complex,2.0
15043,9611,GO:0000122,NCOR1,negative regulation of transcription by RNA polymerase II,2.0
15046,9611,GO:0000785,NCOR1,chromatin,2.0
15048,9611,GO:0000976,NCOR1,transcription regulatory region sequence-specific DNA binding,2.0
15049,9611,GO:0001102,NCOR1,RNA polymerase II activating transcription factor binding,2.0
15050,9611,GO:0003714,NCOR1,transcription corepressor activity,2.0
15053,9611,GO:0005515,NCOR1,protein binding,2.0
15054,9611,GO:0005634,NCOR1,nucleus,2.0
15056,9611,GO:0005654,NCOR1,nucleoplasm,2.0
15058,9611,GO:0005829,NCOR1,cytosol,2.0
15059,9611,GO:0006325,NCOR1,chromatin organization,2.0
15060,9611,GO:0007623,NCOR1,circadian rhythm,2.0
15061,9611,GO:0016020,NCOR1,membrane,2.0
15062,9611,GO:0016580,NCOR1,Sin3 complex,2.0
15064,9611,GO:0017053,NCOR1,transcription repressor complex,2.0
15066,9611,GO:0019216,NCOR1,regulation of lipid metabolic process,2.0
15067,9611,GO:0035257,NCOR1,nuclear hormone receptor binding,2.0
15069,9611,GO:0042826,NCOR1,histone deacetylase binding,2.0
15071,9611,GO:0045475,NCOR1,locomotor rhythm,2.0
15072,9611,GO:0045820,NCOR1,negative regulation of glycolytic process,2.0
15073,9611,GO:0045892,NCOR1,"negative regulation of transcription, DNA-templated",2.0
15075,9611,GO:0045922,NCOR1,negative regulation of fatty acid metabolic process,2.0
15076,9611,GO:0046329,NCOR1,negative regulation of JNK cascade,2.0
15077,9611,GO:0046966,NCOR1,thyroid hormone receptor binding,2.0
15078,9611,GO:0051225,NCOR1,spindle assembly,2.0
15079,9611,GO:0060766,NCOR1,negative regulation of androgen receptor signaling pathway,2.0
15080,9611,GO:0072686,NCOR1,mitotic spindle,2.0
15081,9611,GO:1903799,NCOR1,negative regulation of production of miRNAs involved in gene silencing by miRNA,2.0
15188,9603,GO:0000122,NFE2L3,negative regulation of transcription by RNA polymerase II,2.0
15189,9603,GO:0000785,NFE2L3,chromatin,2.0
15190,9603,GO:0000978,NFE2L3,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
15192,9603,GO:0000981,NFE2L3,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
15194,9603,GO:0001227,NFE2L3,"DNA-binding transcription repressor activity, RNA polymerase II-specific",2.0
15195,9603,GO:0005515,NFE2L3,protein binding,2.0
15196,9603,GO:0005634,NFE2L3,nucleus,2.0
15197,9603,GO:0006357,NFE2L3,regulation of transcription by RNA polymerase II,2.0
15198,9603,GO:0006366,NFE2L3,transcription by RNA polymerase II,2.0
15268,22981,GO:0000086,NINL,G2/M transition of mitotic cell cycle,2.0
15269,22981,GO:0005509,NINL,calcium ion binding,2.0
15270,22981,GO:0005515,NINL,protein binding,2.0
15271,22981,GO:0005813,NINL,centrosome,2.0
15272,22981,GO:0005829,NINL,cytosol,2.0
15274,22981,GO:0005874,NINL,microtubule,2.0
15275,22981,GO:0010389,NINL,regulation of G2/M transition of mitotic cell cycle,2.0
15276,22981,GO:0034454,NINL,microtubule anchoring at centrosome,2.0
15277,22981,GO:0045171,NINL,intercellular bridge,2.0
15278,22981,GO:0097711,NINL,ciliary basal body-plasma membrane docking,2.0
15358,340533,GO:0001953,NEXMIF,negative regulation of cell-matrix adhesion,2.0
15359,340533,GO:0005634,NEXMIF,nucleus,2.0
15360,340533,GO:0005654,NEXMIF,nucleoplasm,2.0
15361,340533,GO:0005829,NEXMIF,cytosol,2.0
15362,340533,GO:0030496,NEXMIF,midbody,2.0
15363,340533,GO:0033629,NEXMIF,negative regulation of cell adhesion mediated by integrin,2.0
15364,340533,GO:0072686,NEXMIF,mitotic spindle,2.0
15365,340533,GO:2000048,NEXMIF,negative regulation of cell-cell adhesion mediated by cadherin,2.0
15366,340533,GO:2001223,NEXMIF,negative regulation of neuron migration,2.0
15367,22871,GO:0001540,NLGN1,amyloid-beta binding,2.0
15368,22871,GO:0002087,NLGN1,regulation of respiratory gaseous exchange by nervous system process,2.0
15369,22871,GO:0005794,NLGN1,Golgi apparatus,2.0
15370,22871,GO:0005886,NLGN1,plasma membrane,2.0
15372,22871,GO:0005887,NLGN1,integral component of plasma membrane,2.0
15375,22871,GO:0006605,NLGN1,protein targeting,2.0
15376,22871,GO:0007157,NLGN1,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
15377,22871,GO:0007158,NLGN1,neuron cell-cell adhesion,2.0
15381,22871,GO:0007268,NLGN1,chemical synaptic transmission,2.0
15382,22871,GO:0007399,NLGN1,nervous system development,2.0
15383,22871,GO:0007416,NLGN1,synapse assembly,2.0
15384,22871,GO:0009897,NLGN1,external side of plasma membrane,2.0
15385,22871,GO:0009986,NLGN1,cell surface,2.0
15387,22871,GO:0010841,NLGN1,"positive regulation of circadian sleep/wake cycle, wakefulness",2.0
15388,22871,GO:0014069,NLGN1,postsynaptic density,2.0
15390,22871,GO:0016080,NLGN1,synaptic vesicle targeting,2.0
15391,22871,GO:0016339,NLGN1,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,2.0
15392,22871,GO:0017146,NLGN1,NMDA selective glutamate receptor complex,2.0
15393,22871,GO:0023041,NLGN1,neuronal signal transduction,2.0
15394,22871,GO:0030165,NLGN1,PDZ domain binding,2.0
15395,22871,GO:0030425,NLGN1,dendrite,2.0
15396,22871,GO:0031175,NLGN1,neuron projection development,2.0
15398,22871,GO:0032230,NLGN1,"positive regulation of synaptic transmission, GABAergic",2.0
15399,22871,GO:0032433,NLGN1,filopodium tip,2.0
15400,22871,GO:0035418,NLGN1,protein localization to synapse,2.0
15401,22871,GO:0038023,NLGN1,signaling receptor activity,2.0
15403,22871,GO:0042043,NLGN1,neurexin family protein binding,2.0
15406,22871,GO:0042802,NLGN1,identical protein binding,2.0
15407,22871,GO:0043083,NLGN1,synaptic cleft,2.0
15408,22871,GO:0043197,NLGN1,dendritic spine,2.0
15409,22871,GO:0043198,NLGN1,dendritic shaft,2.0
15410,22871,GO:0043235,NLGN1,receptor complex,2.0
15411,22871,GO:0044877,NLGN1,protein-containing complex binding,2.0
15412,22871,GO:0045184,NLGN1,establishment of protein localization,2.0
15413,22871,GO:0045202,NLGN1,synapse,2.0
15415,22871,GO:0045664,NLGN1,regulation of neuron differentiation,2.0
15416,22871,GO:0048488,NLGN1,synaptic vesicle endocytosis,2.0
15417,22871,GO:0048489,NLGN1,synaptic vesicle transport,2.0
15418,22871,GO:0048511,NLGN1,rhythmic process,2.0
15419,22871,GO:0048789,NLGN1,cytoskeletal matrix organization at active zone,2.0
15420,22871,GO:0050804,NLGN1,modulation of chemical synaptic transmission,2.0
15422,22871,GO:0050839,NLGN1,cell adhesion molecule binding,2.0
15423,22871,GO:0051491,NLGN1,positive regulation of filopodium assembly,2.0
15424,22871,GO:0051965,NLGN1,positive regulation of synapse assembly,2.0
15426,22871,GO:0051968,NLGN1,"positive regulation of synaptic transmission, glutamatergic",2.0
15427,22871,GO:0060076,NLGN1,excitatory synapse,2.0
15428,22871,GO:0060291,NLGN1,long-term synaptic potentiation,2.0
15429,22871,GO:0060999,NLGN1,positive regulation of dendritic spine development,2.0
15431,22871,GO:0061002,NLGN1,negative regulation of dendritic spine morphogenesis,2.0
15432,22871,GO:0071277,NLGN1,cellular response to calcium ion,2.0
15433,22871,GO:0072553,NLGN1,terminal button organization,2.0
15434,22871,GO:0089717,NLGN1,spanning component of membrane,2.0
15435,22871,GO:0097091,NLGN1,synaptic vesicle clustering,2.0
15436,22871,GO:0097104,NLGN1,postsynaptic membrane assembly,2.0
15438,22871,GO:0097105,NLGN1,presynaptic membrane assembly,2.0
15440,22871,GO:0097110,NLGN1,scaffold protein binding,2.0
15441,22871,GO:0097113,NLGN1,AMPA glutamate receptor clustering,2.0
15442,22871,GO:0097114,NLGN1,NMDA glutamate receptor clustering,2.0
15443,22871,GO:0097115,NLGN1,neurexin clustering involved in presynaptic membrane assembly,2.0
15444,22871,GO:0097119,NLGN1,postsynaptic density protein 95 clustering,2.0
15445,22871,GO:0097120,NLGN1,receptor localization to synapse,2.0
15446,22871,GO:0098793,NLGN1,presynapse,2.0
15447,22871,GO:0098794,NLGN1,postsynapse,2.0
15448,22871,GO:0098942,NLGN1,retrograde trans-synaptic signaling by trans-synaptic protein complex,2.0
15449,22871,GO:0098985,NLGN1,"asymmetric, glutamatergic, excitatory synapse",2.0
15450,22871,GO:0099054,NLGN1,presynapse assembly,2.0
15451,22871,GO:0099055,NLGN1,integral component of postsynaptic membrane,2.0
15452,22871,GO:0099560,NLGN1,synaptic membrane adhesion,2.0
15453,22871,GO:0140058,NLGN1,neuron projection arborization,2.0
15454,22871,GO:1900029,NLGN1,positive regulation of ruffle assembly,2.0
15455,22871,GO:1900244,NLGN1,positive regulation of synaptic vesicle endocytosis,2.0
15456,22871,GO:1902474,NLGN1,positive regulation of protein localization to synapse,2.0
15457,22871,GO:1902533,NLGN1,positive regulation of intracellular signal transduction,2.0
15458,22871,GO:1904861,NLGN1,excitatory synapse assembly,2.0
15459,22871,GO:1905520,NLGN1,positive regulation of presynaptic active zone assembly,2.0
15460,22871,GO:2000302,NLGN1,positive regulation of synaptic vesicle exocytosis,2.0
15461,22871,GO:2000310,NLGN1,regulation of NMDA receptor activity,2.0
15463,22871,GO:2000311,NLGN1,regulation of AMPA receptor activity,2.0
15464,22871,GO:2000463,NLGN1,positive regulation of excitatory postsynaptic potential,2.0
15466,22871,GO:2000809,NLGN1,positive regulation of synaptic vesicle clustering,2.0
15580,57502,GO:0003360,NLGN4X,brainstem development,2.0
15581,57502,GO:0005515,NLGN4X,protein binding,2.0
15582,57502,GO:0005886,NLGN4X,plasma membrane,2.0
15584,57502,GO:0005887,NLGN4X,integral component of plasma membrane,2.0
15586,57502,GO:0007158,NLGN4X,neuron cell-cell adhesion,2.0
15588,57502,GO:0007268,NLGN4X,chemical synaptic transmission,2.0
15589,57502,GO:0007612,NLGN4X,learning,2.0
15590,57502,GO:0009986,NLGN4X,cell surface,2.0
15592,57502,GO:0016021,NLGN4X,integral component of membrane,2.0
15593,57502,GO:0021549,NLGN4X,cerebellum development,2.0
15594,57502,GO:0030182,NLGN4X,neuron differentiation,2.0
15595,57502,GO:0030425,NLGN4X,dendrite,2.0
15596,57502,GO:0030534,NLGN4X,adult behavior,2.0
15597,57502,GO:0031404,NLGN4X,chloride ion binding,2.0
15598,57502,GO:0035176,NLGN4X,social behavior,2.0
15599,57502,GO:0035265,NLGN4X,organ growth,2.0
15600,57502,GO:0038023,NLGN4X,signaling receptor activity,2.0
15601,57502,GO:0042043,NLGN4X,neurexin family protein binding,2.0
15604,57502,GO:0042803,NLGN4X,protein homodimerization activity,2.0
15605,57502,GO:0045202,NLGN4X,synapse,2.0
15607,57502,GO:0045216,NLGN4X,cell-cell junction organization,2.0
15608,57502,GO:0048488,NLGN4X,synaptic vesicle endocytosis,2.0
15609,57502,GO:0050804,NLGN4X,modulation of chemical synaptic transmission,2.0
15610,57502,GO:0050808,NLGN4X,synapse organization,2.0
15612,57502,GO:0050839,NLGN4X,cell adhesion molecule binding,2.0
15613,57502,GO:0060076,NLGN4X,excitatory synapse,2.0
15614,57502,GO:0071625,NLGN4X,vocalization behavior,2.0
15616,57502,GO:0089717,NLGN4X,spanning component of membrane,2.0
15617,57502,GO:0090394,NLGN4X,negative regulation of excitatory postsynaptic potential,2.0
15618,57502,GO:0097104,NLGN4X,postsynaptic membrane assembly,2.0
15619,57502,GO:0097105,NLGN4X,presynaptic membrane assembly,2.0
15621,57502,GO:0097110,NLGN4X,scaffold protein binding,2.0
15622,57502,GO:0098793,NLGN4X,presynapse,2.0
15623,57502,GO:0098839,NLGN4X,postsynaptic density membrane,2.0
15624,57502,GO:0098983,NLGN4X,"symmetric, GABA-ergic, inhibitory synapse",2.0
15625,57502,GO:0098985,NLGN4X,"asymmetric, glutamatergic, excitatory synapse",2.0
15626,57502,GO:0099054,NLGN4X,presynapse assembly,2.0
16408,9891,GO:0001650,NUAK1,fibrillar center,2.0
16409,9891,GO:0002039,NUAK1,p53 binding,2.0
16410,9891,GO:0004674,NUAK1,protein serine/threonine kinase activity,2.0
16413,9891,GO:0005515,NUAK1,protein binding,2.0
16414,9891,GO:0005524,NUAK1,ATP binding,2.0
16415,9891,GO:0005634,NUAK1,nucleus,2.0
16417,9891,GO:0005654,NUAK1,nucleoplasm,2.0
16419,9891,GO:0005737,NUAK1,cytoplasm,2.0
16421,9891,GO:0006468,NUAK1,protein phosphorylation,2.0
16423,9891,GO:0006974,NUAK1,cellular response to DNA damage stimulus,2.0
16424,9891,GO:0007155,NUAK1,cell adhesion,2.0
16425,9891,GO:0015630,NUAK1,microtubule cytoskeleton,2.0
16426,9891,GO:0030155,NUAK1,regulation of cell adhesion,2.0
16427,9891,GO:0035507,NUAK1,regulation of myosin-light-chain-phosphatase activity,2.0
16428,9891,GO:0035556,NUAK1,intracellular signal transduction,2.0
16429,9891,GO:0042127,NUAK1,regulation of cell population proliferation,2.0
16430,9891,GO:0042149,NUAK1,cellular response to glucose starvation,2.0
16431,9891,GO:0046872,NUAK1,metal ion binding,2.0
16432,9891,GO:0106310,NUAK1,protein serine kinase activity,2.0
16433,9891,GO:0106311,NUAK1,protein threonine kinase activity,2.0
16434,9891,GO:1901796,NUAK1,regulation of signal transduction by p53 class mediator,2.0
16435,9891,GO:2000772,NUAK1,regulation of cellular senescence,2.0
16436,134492,GO:0000777,NUDCD2,condensed chromosome kinetochore,2.0
16437,134492,GO:0000922,NUDCD2,spindle pole,2.0
16438,134492,GO:0005515,NUDCD2,protein binding,2.0
16439,134492,GO:0005737,NUDCD2,cytoplasm,2.0
16440,134492,GO:0005815,NUDCD2,microtubule organizing center,2.0
16441,134492,GO:0005829,NUDCD2,cytosol,2.0
16442,134492,GO:0006457,NUDCD2,protein folding,2.0
16443,134492,GO:0015630,NUDCD2,microtubule cytoskeleton,2.0
16444,134492,GO:0032502,NUDCD2,developmental process,2.0
16445,134492,GO:0045171,NUDCD2,intercellular bridge,2.0
16446,134492,GO:0051082,NUDCD2,unfolded protein binding,2.0
16447,134492,GO:0072686,NUDCD2,mitotic spindle,2.0
16550,4983,GO:0003779,OPHN1,actin binding,2.0
16551,4983,GO:0005096,OPHN1,GTPase activator activity,2.0
16552,4983,GO:0005543,OPHN1,phospholipid binding,2.0
16553,4983,GO:0005737,OPHN1,cytoplasm,2.0
16554,4983,GO:0005829,OPHN1,cytosol,2.0
16555,4983,GO:0006930,OPHN1,"substrate-dependent cell migration, cell extension",2.0
16556,4983,GO:0007165,OPHN1,signal transduction,2.0
16557,4983,GO:0007399,OPHN1,nervous system development,2.0
16558,4983,GO:0007411,OPHN1,axon guidance,2.0
16559,4983,GO:0015629,OPHN1,actin cytoskeleton,2.0
16560,4983,GO:0021707,OPHN1,cerebellar granule cell differentiation,2.0
16561,4983,GO:0021895,OPHN1,cerebral cortex neuron differentiation,2.0
16562,4983,GO:0030036,OPHN1,actin cytoskeleton organization,2.0
16563,4983,GO:0030100,OPHN1,regulation of endocytosis,2.0
16564,4983,GO:0030182,OPHN1,neuron differentiation,2.0
16565,4983,GO:0031175,OPHN1,neuron projection development,2.0
16566,4983,GO:0034329,OPHN1,cell junction assembly,2.0
16567,4983,GO:0035023,OPHN1,regulation of Rho protein signal transduction,2.0
16568,4983,GO:0035255,OPHN1,ionotropic glutamate receptor binding,2.0
16569,4983,GO:0043195,OPHN1,terminal bouton,2.0
16570,4983,GO:0043197,OPHN1,dendritic spine,2.0
16571,4983,GO:0043547,OPHN1,positive regulation of GTPase activity,2.0
16572,4983,GO:0045198,OPHN1,establishment of epithelial cell apical/basal polarity,2.0
16573,4983,GO:0048488,OPHN1,synaptic vesicle endocytosis,2.0
16574,4983,GO:0048667,OPHN1,cell morphogenesis involved in neuron differentiation,2.0
16575,4983,GO:0051056,OPHN1,regulation of small GTPase mediated signal transduction,2.0
16576,4983,GO:0051966,OPHN1,"regulation of synaptic transmission, glutamatergic",2.0
16577,4983,GO:0098978,OPHN1,glutamatergic synapse,2.0
16580,4983,GO:0099149,OPHN1,regulation of postsynaptic neurotransmitter receptor internalization,2.0
16583,4983,GO:1901799,OPHN1,negative regulation of proteasomal protein catabolic process,2.0
16605,119772,GO:0004930,OR52M1,G protein-coupled receptor activity,2.0
16606,119772,GO:0004984,OR52M1,olfactory receptor activity,2.0
16607,119772,GO:0005886,OR52M1,plasma membrane,2.0
16608,119772,GO:0007186,OR52M1,G protein-coupled receptor signaling pathway,2.0
16609,119772,GO:0016021,OR52M1,integral component of membrane,2.0
16610,119772,GO:0050911,OR52M1,detection of chemical stimulus involved in sensory perception of smell,2.0
16611,161725,GO:0003677,OTUD7A,DNA binding,2.0
16612,161725,GO:0004843,OTUD7A,thiol-dependent ubiquitin-specific protease activity,2.0
16614,161725,GO:0005634,OTUD7A,nucleus,2.0
16615,161725,GO:0005737,OTUD7A,cytoplasm,2.0
16616,161725,GO:0005829,OTUD7A,cytosol,2.0
16617,161725,GO:0008234,OTUD7A,cysteine-type peptidase activity,2.0
16618,161725,GO:0008270,OTUD7A,zinc ion binding,2.0
16619,161725,GO:0016579,OTUD7A,protein deubiquitination,2.0
16620,161725,GO:0035871,OTUD7A,protein K11-linked deubiquitination,2.0
16622,161725,GO:0043124,OTUD7A,negative regulation of I-kappaB kinase/NF-kappaB signaling,2.0
16623,161725,GO:0070530,OTUD7A,K63-linked polyubiquitin modification-dependent protein binding,2.0
16624,161725,GO:0070536,OTUD7A,protein K63-linked deubiquitination,2.0
16625,161725,GO:0071108,OTUD7A,protein K48-linked deubiquitination,2.0
16626,161725,GO:0071947,OTUD7A,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,2.0
16741,5021,GO:0001967,OXTR,suckling behavior,2.0
16742,5021,GO:0001975,OXTR,response to amphetamine,2.0
16743,5021,GO:0001992,OXTR,regulation of systemic arterial blood pressure by vasopressin,2.0
16744,5021,GO:0004930,OXTR,G protein-coupled receptor activity,2.0
16745,5021,GO:0004990,OXTR,oxytocin receptor activity,2.0
16746,5021,GO:0005000,OXTR,vasopressin receptor activity,2.0
16747,5021,GO:0005886,OXTR,plasma membrane,2.0
16748,5021,GO:0005887,OXTR,integral component of plasma membrane,2.0
16749,5021,GO:0005902,OXTR,microvillus,2.0
16750,5021,GO:0005912,OXTR,adherens junction,2.0
16751,5021,GO:0006936,OXTR,muscle contraction,2.0
16752,5021,GO:0007166,OXTR,cell surface receptor signaling pathway,2.0
16753,5021,GO:0007186,OXTR,G protein-coupled receptor signaling pathway,2.0
16755,5021,GO:0007204,OXTR,positive regulation of cytosolic calcium ion concentration,2.0
16756,5021,GO:0007507,OXTR,heart development,2.0
16757,5021,GO:0007565,OXTR,female pregnancy,2.0
16758,5021,GO:0007595,OXTR,lactation,2.0
16759,5021,GO:0007613,OXTR,memory,2.0
16760,5021,GO:0010701,OXTR,positive regulation of norepinephrine secretion,2.0
16761,5021,GO:0016324,OXTR,apical plasma membrane,2.0
16762,5021,GO:0017046,OXTR,peptide hormone binding,2.0
16763,5021,GO:0021537,OXTR,telencephalon development,2.0
16764,5021,GO:0030431,OXTR,sleep,2.0
16765,5021,GO:0032230,OXTR,"positive regulation of synaptic transmission, GABAergic",2.0
16766,5021,GO:0032355,OXTR,response to estradiol,2.0
16767,5021,GO:0032570,OXTR,response to progesterone,2.0
16768,5021,GO:0034059,OXTR,response to anoxia,2.0
16769,5021,GO:0034097,OXTR,response to cytokine,2.0
16770,5021,GO:0035176,OXTR,social behavior,2.0
16771,5021,GO:0042220,OXTR,response to cocaine,2.0
16772,5021,GO:0042277,OXTR,peptide binding,2.0
16773,5021,GO:0042493,OXTR,response to drug,2.0
16774,5021,GO:0042711,OXTR,maternal behavior,2.0
16775,5021,GO:0042713,OXTR,sperm ejaculation,2.0
16776,5021,GO:0042755,OXTR,eating behavior,2.0
16777,5021,GO:0043434,OXTR,response to peptide hormone,2.0
16778,5021,GO:0044849,OXTR,estrous cycle,2.0
16779,5021,GO:0045777,OXTR,positive regulation of blood pressure,2.0
16780,5021,GO:0045907,OXTR,positive regulation of vasoconstriction,2.0
16781,5021,GO:0048565,OXTR,digestive tract development,2.0
16782,5021,GO:0051965,OXTR,positive regulation of synapse assembly,2.0
16783,5021,GO:0051968,OXTR,"positive regulation of synaptic transmission, glutamatergic",2.0
16784,5021,GO:0060137,OXTR,maternal process involved in parturition,2.0
16785,5021,GO:0060406,OXTR,positive regulation of penile erection,2.0
16786,5021,GO:0060455,OXTR,negative regulation of gastric acid secretion,2.0
16787,5021,GO:0070371,OXTR,ERK1 and ERK2 cascade,2.0
16788,5021,GO:0070474,OXTR,positive regulation of uterine smooth muscle contraction,2.0
16789,5021,GO:0120162,OXTR,positive regulation of cold-induced thermogenesis,2.0
16790,5026,GO:0001614,P2RX5,purinergic nucleotide receptor activity,2.0
16791,5026,GO:0004888,P2RX5,transmembrane signaling receptor activity,2.0
16792,5026,GO:0004931,P2RX5,extracellularly ATP-gated cation channel activity,2.0
16794,5026,GO:0005216,P2RX5,ion channel activity,2.0
16795,5026,GO:0005524,P2RX5,ATP binding,2.0
16796,5026,GO:0005639,P2RX5,integral component of nuclear inner membrane,2.0
16797,5026,GO:0005829,P2RX5,cytosol,2.0
16798,5026,GO:0005886,P2RX5,plasma membrane,2.0
16799,5026,GO:0005887,P2RX5,integral component of plasma membrane,2.0
16800,5026,GO:0007165,P2RX5,signal transduction,2.0
16801,5026,GO:0007399,P2RX5,nervous system development,2.0
16802,5026,GO:0007596,P2RX5,blood coagulation,2.0
16803,5026,GO:0010524,P2RX5,positive regulation of calcium ion transport into cytosol,2.0
16804,5026,GO:0033198,P2RX5,response to ATP,2.0
16805,5026,GO:0035590,P2RX5,purinergic nucleotide receptor signaling pathway,2.0
16806,5026,GO:0050850,P2RX5,positive regulation of calcium-mediated signaling,2.0
16807,5026,GO:0060079,P2RX5,excitatory postsynaptic potential,2.0
16808,5026,GO:0098655,P2RX5,cation transmembrane transport,2.0
16809,5026,GO:0098794,P2RX5,postsynapse,2.0
16810,8974,GO:0004656,P4HA2,procollagen-proline 4-dioxygenase activity,2.0
16811,8974,GO:0005506,P4HA2,iron ion binding,2.0
16812,8974,GO:0005654,P4HA2,nucleoplasm,2.0
16813,8974,GO:0005783,P4HA2,endoplasmic reticulum,2.0
16815,8974,GO:0005788,P4HA2,endoplasmic reticulum lumen,2.0
16816,8974,GO:0005829,P4HA2,cytosol,2.0
16817,8974,GO:0009055,P4HA2,electron transfer activity,2.0
16818,8974,GO:0016702,P4HA2,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",2.0
16819,8974,GO:0018401,P4HA2,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,2.0
16820,8974,GO:0022900,P4HA2,electron transport chain,2.0
16821,8974,GO:0031418,P4HA2,L-ascorbic acid binding,2.0
16822,8974,GO:0043231,P4HA2,intracellular membrane-bounded organelle,2.0
16869,5053,GO:0004505,PAH,phenylalanine 4-monooxygenase activity,2.0
16871,5053,GO:0005506,PAH,iron ion binding,2.0
16872,5053,GO:0005829,PAH,cytosol,2.0
16873,5053,GO:0006559,PAH,L-phenylalanine catabolic process,2.0
16875,5053,GO:0006571,PAH,tyrosine biosynthetic process,2.0
16876,5053,GO:0008652,PAH,cellular amino acid biosynthetic process,2.0
16877,5053,GO:0042136,PAH,neurotransmitter biosynthetic process,2.0
16878,5053,GO:0042423,PAH,catecholamine biosynthetic process,2.0
16879,5053,GO:0055114,PAH,oxidation-reduction process,2.0
16957,5062,GO:0002223,PAK2,stimulatory C-type lectin receptor signaling pathway,2.0
16958,5062,GO:0004672,PAK2,protein kinase activity,2.0
16959,5062,GO:0004674,PAK2,protein serine/threonine kinase activity,2.0
16963,5062,GO:0005515,PAK2,protein binding,2.0
16964,5062,GO:0005524,PAK2,ATP binding,2.0
16965,5062,GO:0005634,PAK2,nucleus,2.0
16966,5062,GO:0005737,PAK2,cytoplasm,2.0
16968,5062,GO:0005829,PAK2,cytosol,2.0
16970,5062,GO:0005886,PAK2,plasma membrane,2.0
16971,5062,GO:0005911,PAK2,cell-cell junction,2.0
16972,5062,GO:0006468,PAK2,protein phosphorylation,2.0
16973,5062,GO:0006469,PAK2,negative regulation of protein kinase activity,2.0
16974,5062,GO:0006915,PAK2,apoptotic process,2.0
16975,5062,GO:0007165,PAK2,signal transduction,2.0
16976,5062,GO:0014069,PAK2,postsynaptic density,2.0
16977,5062,GO:0016310,PAK2,phosphorylation,2.0
16978,5062,GO:0018105,PAK2,peptidyl-serine phosphorylation,2.0
16979,5062,GO:0019901,PAK2,protein kinase binding,2.0
16980,5062,GO:0023014,PAK2,signal transduction by protein phosphorylation,2.0
16981,5062,GO:0030296,PAK2,protein tyrosine kinase activator activity,2.0
16982,5062,GO:0031098,PAK2,stress-activated protein kinase signaling cascade,2.0
16983,5062,GO:0031267,PAK2,small GTPase binding,2.0
16984,5062,GO:0031295,PAK2,T cell costimulation,2.0
16985,5062,GO:0032147,PAK2,activation of protein kinase activity,2.0
16986,5062,GO:0034333,PAK2,adherens junction assembly,2.0
16987,5062,GO:0035722,PAK2,interleukin-12-mediated signaling pathway,2.0
16988,5062,GO:0038095,PAK2,Fc-epsilon receptor signaling pathway,2.0
16989,5062,GO:0040008,PAK2,regulation of growth,2.0
16990,5062,GO:0042802,PAK2,identical protein binding,2.0
16991,5062,GO:0043066,PAK2,negative regulation of apoptotic process,2.0
16992,5062,GO:0045296,PAK2,cadherin binding,2.0
16993,5062,GO:0046777,PAK2,protein autophosphorylation,2.0
16994,5062,GO:0048010,PAK2,vascular endothelial growth factor receptor signaling pathway,2.0
16995,5062,GO:0048471,PAK2,perinuclear region of cytoplasm,2.0
16996,5062,GO:0050690,PAK2,regulation of defense response to virus by virus,2.0
16997,5062,GO:0050731,PAK2,positive regulation of peptidyl-tyrosine phosphorylation,2.0
16998,5062,GO:0050770,PAK2,regulation of axonogenesis,2.0
16999,5062,GO:0050852,PAK2,T cell receptor signaling pathway,2.0
17000,5062,GO:0051493,PAK2,regulation of cytoskeleton organization,2.0
17001,5062,GO:0051497,PAK2,negative regulation of stress fiber assembly,2.0
17002,5062,GO:0060996,PAK2,dendritic spine development,2.0
17003,5062,GO:0061098,PAK2,positive regulation of protein tyrosine kinase activity,2.0
17004,5062,GO:0070830,PAK2,bicellular tight junction assembly,2.0
17005,5062,GO:0071407,PAK2,cellular response to organic cyclic compound,2.0
17006,5062,GO:0098978,PAK2,glutamatergic synapse,2.0
17007,5062,GO:0106310,PAK2,protein serine kinase activity,2.0
17008,5062,GO:0106311,PAK2,protein threonine kinase activity,2.0
17009,5062,GO:0150105,PAK2,protein localization to cell-cell junction,2.0
17010,5062,GO:2001238,PAK2,positive regulation of extrinsic apoptotic signaling pathway,2.0
17011,5062,GO:2001271,PAK2,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,2.0
17025,117583,GO:0000226,PARD3B,microtubule cytoskeleton organization,2.0
17026,117583,GO:0005515,PARD3B,protein binding,2.0
17027,117583,GO:0005912,PARD3B,adherens junction,2.0
17028,117583,GO:0005923,PARD3B,bicellular tight junction,2.0
17029,117583,GO:0005938,PARD3B,cell cortex,2.0
17030,117583,GO:0007049,PARD3B,cell cycle,2.0
17031,117583,GO:0007155,PARD3B,cell adhesion,2.0
17032,117583,GO:0008104,PARD3B,protein localization,2.0
17033,117583,GO:0012505,PARD3B,endomembrane system,2.0
17034,117583,GO:0016324,PARD3B,apical plasma membrane,2.0
17035,117583,GO:0030010,PARD3B,establishment of cell polarity,2.0
17036,117583,GO:0030054,PARD3B,cell junction,2.0
17037,117583,GO:0032991,PARD3B,protein-containing complex,2.0
17038,117583,GO:0035091,PARD3B,phosphatidylinositol binding,2.0
17039,117583,GO:0043296,PARD3B,apical junction complex,2.0
17040,117583,GO:0045197,PARD3B,establishment or maintenance of epithelial cell apical/basal polarity,2.0
17041,117583,GO:0051301,PARD3B,cell division,2.0
17042,117583,GO:0051660,PARD3B,establishment of centrosome localization,2.0
17475,8864,GO:0000122,PER2,negative regulation of transcription by RNA polymerase II,2.0
17477,8864,GO:0000976,PER2,transcription regulatory region sequence-specific DNA binding,2.0
17479,8864,GO:0001222,PER2,transcription corepressor binding,2.0
17480,8864,GO:0002931,PER2,response to ischemia,2.0
17481,8864,GO:0003713,PER2,transcription coactivator activity,2.0
17482,8864,GO:0005515,PER2,protein binding,2.0
17483,8864,GO:0005634,PER2,nucleus,2.0
17486,8864,GO:0005730,PER2,nucleolus,2.0
17487,8864,GO:0005737,PER2,cytoplasm,2.0
17488,8864,GO:0005978,PER2,glycogen biosynthetic process,2.0
17489,8864,GO:0006094,PER2,gluconeogenesis,2.0
17490,8864,GO:0006631,PER2,fatty acid metabolic process,2.0
17491,8864,GO:0007623,PER2,circadian rhythm,2.0
17492,8864,GO:0019229,PER2,regulation of vasoconstriction,2.0
17493,8864,GO:0019249,PER2,lactate biosynthetic process,2.0
17494,8864,GO:0031397,PER2,negative regulation of protein ubiquitination,2.0
17495,8864,GO:0032922,PER2,circadian regulation of gene expression,2.0
17497,8864,GO:0042752,PER2,regulation of circadian rhythm,2.0
17498,8864,GO:0042754,PER2,negative regulation of circadian rhythm,2.0
17499,8864,GO:0043153,PER2,entrainment of circadian clock by photoperiod,2.0
17500,8864,GO:0045892,PER2,"negative regulation of transcription, DNA-templated",2.0
17501,8864,GO:0048471,PER2,perinuclear region of cytoplasm,2.0
17502,8864,GO:0050767,PER2,regulation of neurogenesis,2.0
17503,8864,GO:0050796,PER2,regulation of insulin secretion,2.0
17504,8864,GO:0050872,PER2,white fat cell differentiation,2.0
17505,8864,GO:0051726,PER2,regulation of cell cycle,2.0
17506,8864,GO:0051946,PER2,regulation of glutamate uptake involved in transmission of nerve impulse,2.0
17507,8864,GO:0070345,PER2,negative regulation of fat cell proliferation,2.0
17508,8864,GO:0070932,PER2,histone H3 deacetylation,2.0
17509,8864,GO:0097167,PER2,circadian regulation of translation,2.0
17510,8864,GO:0120162,PER2,positive regulation of cold-induced thermogenesis,2.0
17511,8864,GO:1903508,PER2,positive regulation of nucleic acid-templated transcription,2.0
17512,8864,GO:2000678,PER2,negative regulation of transcription regulatory region DNA binding,2.0
17645,57661,GO:0006366,PHRF1,transcription by RNA polymerase II,2.0
17646,57661,GO:0006397,PHRF1,mRNA processing,2.0
17647,57661,GO:0016020,PHRF1,membrane,2.0
17648,57661,GO:0019904,PHRF1,protein domain specific binding,2.0
17649,57661,GO:0046872,PHRF1,metal ion binding,2.0
17650,57661,GO:0070063,PHRF1,RNA polymerase binding,2.0
17739,23236,GO:0000086,PLCB1,G2/M transition of mitotic cell cycle,2.0
17740,23236,GO:0000785,PLCB1,chromatin,2.0
17741,23236,GO:0004435,PLCB1,phosphatidylinositol phospholipase C activity,2.0
17745,23236,GO:0004629,PLCB1,phospholipase C activity,2.0
17746,23236,GO:0005096,PLCB1,GTPase activator activity,2.0
17747,23236,GO:0005509,PLCB1,calcium ion binding,2.0
17748,23236,GO:0005515,PLCB1,protein binding,2.0
17749,23236,GO:0005516,PLCB1,calmodulin binding,2.0
17751,23236,GO:0005546,PLCB1,"phosphatidylinositol-4,5-bisphosphate binding",2.0
17752,23236,GO:0005634,PLCB1,nucleus,2.0
17753,23236,GO:0005737,PLCB1,cytoplasm,2.0
17755,23236,GO:0005829,PLCB1,cytosol,2.0
17756,23236,GO:0007165,PLCB1,signal transduction,2.0
17757,23236,GO:0007186,PLCB1,G protein-coupled receptor signaling pathway,2.0
17758,23236,GO:0007213,PLCB1,G protein-coupled acetylcholine receptor signaling pathway,2.0
17759,23236,GO:0007215,PLCB1,glutamate receptor signaling pathway,2.0
17760,23236,GO:0007223,PLCB1,"Wnt signaling pathway, calcium modulating pathway",2.0
17761,23236,GO:0007613,PLCB1,memory,2.0
17763,23236,GO:0008277,PLCB1,regulation of G protein-coupled receptor signaling pathway,2.0
17764,23236,GO:0016042,PLCB1,lipid catabolic process,2.0
17765,23236,GO:0016607,PLCB1,nuclear speck,2.0
17767,23236,GO:0019899,PLCB1,enzyme binding,2.0
17768,23236,GO:0021987,PLCB1,cerebral cortex development,2.0
17769,23236,GO:0031965,PLCB1,nuclear membrane,2.0
17770,23236,GO:0032735,PLCB1,positive regulation of interleukin-12 production,2.0
17771,23236,GO:0035722,PLCB1,interleukin-12-mediated signaling pathway,2.0
17772,23236,GO:0035723,PLCB1,interleukin-15-mediated signaling pathway,2.0
17773,23236,GO:0040019,PLCB1,positive regulation of embryonic development,2.0
17774,23236,GO:0042802,PLCB1,identical protein binding,2.0
17775,23236,GO:0043547,PLCB1,positive regulation of GTPase activity,2.0
17776,23236,GO:0043647,PLCB1,inositol phosphate metabolic process,2.0
17777,23236,GO:0045202,PLCB1,synapse,2.0
17778,23236,GO:0045663,PLCB1,positive regulation of myoblast differentiation,2.0
17779,23236,GO:0045892,PLCB1,"negative regulation of transcription, DNA-templated",2.0
17780,23236,GO:0045893,PLCB1,"positive regulation of transcription, DNA-templated",2.0
17781,23236,GO:0046330,PLCB1,positive regulation of JNK cascade,2.0
17782,23236,GO:0046488,PLCB1,phosphatidylinositol metabolic process,2.0
17784,23236,GO:0048009,PLCB1,insulin-like growth factor receptor signaling pathway,2.0
17785,23236,GO:0048015,PLCB1,phosphatidylinositol-mediated signaling,2.0
17786,23236,GO:0048639,PLCB1,positive regulation of developmental growth,2.0
17787,23236,GO:0060466,PLCB1,activation of meiosis involved in egg activation,2.0
17788,23236,GO:0070062,PLCB1,extracellular exosome,2.0
17789,23236,GO:0070498,PLCB1,interleukin-1-mediated signaling pathway,2.0
17790,23236,GO:0080154,PLCB1,regulation of fertilization,2.0
17791,23236,GO:1900087,PLCB1,positive regulation of G1/S transition of mitotic cell cycle,2.0
17792,23236,GO:2000344,PLCB1,positive regulation of acrosome reaction,2.0
17793,23236,GO:2000438,PLCB1,negative regulation of monocyte extravasation,2.0
17794,23236,GO:2000560,PLCB1,positive regulation of CD24 production,2.0
17882,91584,GO:0002116,PLXNA4,semaphorin receptor complex,2.0
17884,91584,GO:0005886,PLXNA4,plasma membrane,2.0
17885,91584,GO:0005887,PLXNA4,integral component of plasma membrane,2.0
17886,91584,GO:0007162,PLXNA4,negative regulation of cell adhesion,2.0
17887,91584,GO:0008360,PLXNA4,regulation of cell shape,2.0
17888,91584,GO:0017154,PLXNA4,semaphorin receptor activity,2.0
17889,91584,GO:0021612,PLXNA4,facial nerve structural organization,2.0
17890,91584,GO:0021615,PLXNA4,glossopharyngeal nerve morphogenesis,2.0
17891,91584,GO:0021637,PLXNA4,trigeminal nerve structural organization,2.0
17892,91584,GO:0021644,PLXNA4,vagus nerve morphogenesis,2.0
17893,91584,GO:0021784,PLXNA4,postganglionic parasympathetic fiber development,2.0
17894,91584,GO:0021793,PLXNA4,chemorepulsion of branchiomotor axon,2.0
17895,91584,GO:0021960,PLXNA4,anterior commissure morphogenesis,2.0
17896,91584,GO:0030334,PLXNA4,regulation of cell migration,2.0
17897,91584,GO:0043087,PLXNA4,regulation of GTPase activity,2.0
17898,91584,GO:0048485,PLXNA4,sympathetic nervous system development,2.0
17899,91584,GO:0048841,PLXNA4,regulation of axon extension involved in axon guidance,2.0
17900,91584,GO:0050772,PLXNA4,positive regulation of axonogenesis,2.0
17901,91584,GO:0050923,PLXNA4,regulation of negative chemotaxis,2.0
17902,91584,GO:0071526,PLXNA4,semaphorin-plexin signaling pathway,2.0
17903,91584,GO:1902287,PLXNA4,semaphorin-plexin signaling pathway involved in axon guidance,2.0
17904,5364,GO:0002116,PLXNB1,semaphorin receptor complex,2.0
17907,5364,GO:0004888,PLXNB1,transmembrane signaling receptor activity,2.0
17908,5364,GO:0005096,PLXNB1,GTPase activator activity,2.0
17909,5364,GO:0005515,PLXNB1,protein binding,2.0
17910,5364,GO:0005576,PLXNB1,extracellular region,2.0
17911,5364,GO:0005886,PLXNB1,plasma membrane,2.0
17912,5364,GO:0005887,PLXNB1,integral component of plasma membrane,2.0
17915,5364,GO:0007162,PLXNB1,negative regulation of cell adhesion,2.0
17917,5364,GO:0007165,PLXNB1,signal transduction,2.0
17918,5364,GO:0007186,PLXNB1,G protein-coupled receptor signaling pathway,2.0
17919,5364,GO:0008360,PLXNB1,regulation of cell shape,2.0
17921,5364,GO:0014068,PLXNB1,positive regulation of phosphatidylinositol 3-kinase signaling,2.0
17922,5364,GO:0016477,PLXNB1,cell migration,2.0
17923,5364,GO:0017154,PLXNB1,semaphorin receptor activity,2.0
17926,5364,GO:0030215,PLXNB1,semaphorin receptor binding,2.0
17927,5364,GO:0030334,PLXNB1,regulation of cell migration,2.0
17928,5364,GO:0032794,PLXNB1,GTPase activating protein binding,2.0
17929,5364,GO:0033689,PLXNB1,negative regulation of osteoblast proliferation,2.0
17930,5364,GO:0035556,PLXNB1,intracellular signal transduction,2.0
17931,5364,GO:0038023,PLXNB1,signaling receptor activity,2.0
17932,5364,GO:0043087,PLXNB1,regulation of GTPase activity,2.0
17933,5364,GO:0043547,PLXNB1,positive regulation of GTPase activity,2.0
17934,5364,GO:0043931,PLXNB1,ossification involved in bone maturation,2.0
17935,5364,GO:0048812,PLXNB1,neuron projection morphogenesis,2.0
17936,5364,GO:0050772,PLXNB1,positive regulation of axonogenesis,2.0
17937,5364,GO:0051493,PLXNB1,regulation of cytoskeleton organization,2.0
17938,5364,GO:0071526,PLXNB1,semaphorin-plexin signaling pathway,2.0
17939,5364,GO:1900220,PLXNB1,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,2.0
17940,5364,GO:1902287,PLXNB1,semaphorin-plexin signaling pathway involved in axon guidance,2.0
17941,5364,GO:1904862,PLXNB1,inhibitory synapse assembly,2.0
18205,57580,GO:0005085,PREX1,guanyl-nucleotide exchange factor activity,2.0
18207,57580,GO:0005096,PREX1,GTPase activator activity,2.0
18208,57580,GO:0005515,PREX1,protein binding,2.0
18209,57580,GO:0005543,PREX1,phospholipid binding,2.0
18210,57580,GO:0005829,PREX1,cytosol,2.0
18212,57580,GO:0005886,PREX1,plasma membrane,2.0
18214,57580,GO:0006801,PREX1,superoxide metabolic process,2.0
18215,57580,GO:0007186,PREX1,G protein-coupled receptor signaling pathway,2.0
18217,57580,GO:0019899,PREX1,enzyme binding,2.0
18218,57580,GO:0030041,PREX1,actin filament polymerization,2.0
18219,57580,GO:0030217,PREX1,T cell differentiation,2.0
18220,57580,GO:0030335,PREX1,positive regulation of cell migration,2.0
18221,57580,GO:0030426,PREX1,growth cone,2.0
18222,57580,GO:0030593,PREX1,neutrophil chemotaxis,2.0
18223,57580,GO:0030833,PREX1,regulation of actin filament polymerization,2.0
18224,57580,GO:0035556,PREX1,intracellular signal transduction,2.0
18225,57580,GO:0042119,PREX1,neutrophil activation,2.0
18226,57580,GO:0043065,PREX1,positive regulation of apoptotic process,2.0
18227,57580,GO:0043198,PREX1,dendritic shaft,2.0
18228,57580,GO:0043547,PREX1,positive regulation of GTPase activity,2.0
18229,57580,GO:0048471,PREX1,perinuclear region of cytoplasm,2.0
18230,57580,GO:0050773,PREX1,regulation of dendrite development,2.0
18231,57580,GO:0051056,PREX1,regulation of small GTPase mediated signal transduction,2.0
18232,57580,GO:1900026,PREX1,positive regulation of substrate adhesion-dependent cell spreading,2.0
18233,144165,GO:0001843,PRICKLE1,neural tube closure,2.0
18234,144165,GO:0005515,PRICKLE1,protein binding,2.0
18235,144165,GO:0005634,PRICKLE1,nucleus,2.0
18236,144165,GO:0005829,PRICKLE1,cytosol,2.0
18238,144165,GO:0006606,PRICKLE1,protein import into nucleus,2.0
18240,144165,GO:0008270,PRICKLE1,zinc ion binding,2.0
18241,144165,GO:0031398,PRICKLE1,positive regulation of protein ubiquitination,2.0
18242,144165,GO:0031965,PRICKLE1,nuclear membrane,2.0
18243,144165,GO:0032436,PRICKLE1,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
18244,144165,GO:0035904,PRICKLE1,aorta development,2.0
18245,144165,GO:0045892,PRICKLE1,"negative regulation of transcription, DNA-templated",2.0
18246,144165,GO:0060071,PRICKLE1,"Wnt signaling pathway, planar cell polarity pathway",2.0
18247,144165,GO:0060976,PRICKLE1,coronary vasculature development,2.0
18248,144165,GO:0090090,PRICKLE1,negative regulation of canonical Wnt signaling pathway,2.0
18249,144165,GO:2000691,PRICKLE1,negative regulation of cardiac muscle cell myoblast differentiation,2.0
18250,166336,GO:0005737,PRICKLE2,cytoplasm,2.0
18251,166336,GO:0008270,PRICKLE2,zinc ion binding,2.0
18252,166336,GO:0031965,PRICKLE2,nuclear membrane,2.0
18253,166336,GO:0060071,PRICKLE2,"Wnt signaling pathway, planar cell polarity pathway",2.0
18338,5579,GO:0002250,PRKCB,adaptive immune response,2.0
18339,5579,GO:0003682,PRKCB,chromatin binding,2.0
18340,5579,GO:0004674,PRKCB,protein serine/threonine kinase activity,2.0
18343,5579,GO:0004697,PRKCB,protein kinase C activity,2.0
18344,5579,GO:0004698,PRKCB,calcium-dependent protein kinase C activity,2.0
18345,5579,GO:0005080,PRKCB,protein kinase C binding,2.0
18346,5579,GO:0005246,PRKCB,calcium channel regulator activity,2.0
18347,5579,GO:0005515,PRKCB,protein binding,2.0
18348,5579,GO:0005524,PRKCB,ATP binding,2.0
18349,5579,GO:0005634,PRKCB,nucleus,2.0
18350,5579,GO:0005654,PRKCB,nucleoplasm,2.0
18352,5579,GO:0005737,PRKCB,cytoplasm,2.0
18353,5579,GO:0005829,PRKCB,cytosol,2.0
18355,5579,GO:0005886,PRKCB,plasma membrane,2.0
18357,5579,GO:0006357,PRKCB,regulation of transcription by RNA polymerase II,2.0
18358,5579,GO:0006468,PRKCB,protein phosphorylation,2.0
18359,5579,GO:0006816,PRKCB,calcium ion transport,2.0
18360,5579,GO:0006874,PRKCB,cellular calcium ion homeostasis,2.0
18361,5579,GO:0006915,PRKCB,apoptotic process,2.0
18362,5579,GO:0007077,PRKCB,mitotic nuclear envelope disassembly,2.0
18363,5579,GO:0007165,PRKCB,signal transduction,2.0
18364,5579,GO:0008091,PRKCB,spectrin,2.0
18365,5579,GO:0008270,PRKCB,zinc ion binding,2.0
18366,5579,GO:0010827,PRKCB,regulation of glucose transmembrane transport,2.0
18367,5579,GO:0010829,PRKCB,negative regulation of glucose transmembrane transport,2.0
18368,5579,GO:0018105,PRKCB,peptidyl-serine phosphorylation,2.0
18369,5579,GO:0030168,PRKCB,platelet activation,2.0
18370,5579,GO:0030374,PRKCB,nuclear receptor coactivator activity,2.0
18371,5579,GO:0030949,PRKCB,positive regulation of vascular endothelial growth factor receptor signaling pathway,2.0
18372,5579,GO:0035403,PRKCB,histone kinase activity (H3-T6 specific),2.0
18373,5579,GO:0035408,PRKCB,histone H3-T6 phosphorylation,2.0
18374,5579,GO:0035556,PRKCB,intracellular signal transduction,2.0
18375,5579,GO:0042113,PRKCB,B cell activation,2.0
18376,5579,GO:0042393,PRKCB,histone binding,2.0
18377,5579,GO:0042953,PRKCB,lipoprotein transport,2.0
18378,5579,GO:0043123,PRKCB,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
18379,5579,GO:0044305,PRKCB,calyx of Held,2.0
18380,5579,GO:0045637,PRKCB,regulation of myeloid cell differentiation,2.0
18381,5579,GO:0045766,PRKCB,positive regulation of angiogenesis,2.0
18382,5579,GO:0046627,PRKCB,negative regulation of insulin receptor signaling pathway,2.0
18383,5579,GO:0050681,PRKCB,androgen receptor binding,2.0
18384,5579,GO:0050853,PRKCB,B cell receptor signaling pathway,2.0
18385,5579,GO:0050861,PRKCB,positive regulation of B cell receptor signaling pathway,2.0
18386,5579,GO:0051092,PRKCB,positive regulation of NF-kappaB transcription factor activity,2.0
18387,5579,GO:0070062,PRKCB,extracellular exosome,2.0
18388,5579,GO:0071322,PRKCB,cellular response to carbohydrate stimulus,2.0
18389,5579,GO:0099171,PRKCB,presynaptic modulation of chemical synaptic transmission,2.0
18390,5579,GO:1903508,PRKCB,positive regulation of nucleic acid-templated transcription,2.0
18391,5579,GO:2000300,PRKCB,regulation of synaptic vesicle exocytosis,2.0
18460,25865,GO:0001525,PRKD2,angiogenesis,2.0
18461,25865,GO:0001938,PRKD2,positive regulation of endothelial cell proliferation,2.0
18463,25865,GO:0002250,PRKD2,adaptive immune response,2.0
18464,25865,GO:0004672,PRKD2,protein kinase activity,2.0
18465,25865,GO:0004674,PRKD2,protein serine/threonine kinase activity,2.0
18468,25865,GO:0004698,PRKD2,calcium-dependent protein kinase C activity,2.0
18469,25865,GO:0005080,PRKD2,protein kinase C binding,2.0
18470,25865,GO:0005515,PRKD2,protein binding,2.0
18471,25865,GO:0005524,PRKD2,ATP binding,2.0
18472,25865,GO:0005634,PRKD2,nucleus,2.0
18473,25865,GO:0005654,PRKD2,nucleoplasm,2.0
18474,25865,GO:0005737,PRKD2,cytoplasm,2.0
18475,25865,GO:0005794,PRKD2,Golgi apparatus,2.0
18476,25865,GO:0005829,PRKD2,cytosol,2.0
18478,25865,GO:0005886,PRKD2,plasma membrane,2.0
18479,25865,GO:0006468,PRKD2,protein phosphorylation,2.0
18481,25865,GO:0007155,PRKD2,cell adhesion,2.0
18482,25865,GO:0008219,PRKD2,cell death,2.0
18483,25865,GO:0010595,PRKD2,positive regulation of endothelial cell migration,2.0
18484,25865,GO:0018105,PRKD2,peptidyl-serine phosphorylation,2.0
18486,25865,GO:0018107,PRKD2,peptidyl-threonine phosphorylation,2.0
18487,25865,GO:0030148,PRKD2,sphingolipid biosynthetic process,2.0
18488,25865,GO:0030949,PRKD2,positive regulation of vascular endothelial growth factor receptor signaling pathway,2.0
18489,25865,GO:0032743,PRKD2,positive regulation of interleukin-2 production,2.0
18490,25865,GO:0032757,PRKD2,positive regulation of interleukin-8 production,2.0
18491,25865,GO:0032793,PRKD2,positive regulation of CREB transcription factor activity,2.0
18492,25865,GO:0033138,PRKD2,positive regulation of peptidyl-serine phosphorylation,2.0
18493,25865,GO:0035556,PRKD2,intracellular signal transduction,2.0
18494,25865,GO:0035924,PRKD2,cellular response to vascular endothelial growth factor stimulus,2.0
18496,25865,GO:0038033,PRKD2,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,2.0
18498,25865,GO:0043536,PRKD2,positive regulation of blood vessel endothelial cell migration,2.0
18500,25865,GO:0045743,PRKD2,positive regulation of fibroblast growth factor receptor signaling pathway,2.0
18501,25865,GO:0045766,PRKD2,positive regulation of angiogenesis,2.0
18503,25865,GO:0045785,PRKD2,positive regulation of cell adhesion,2.0
18504,25865,GO:0045944,PRKD2,positive regulation of transcription by RNA polymerase II,2.0
18506,25865,GO:0046777,PRKD2,protein autophosphorylation,2.0
18508,25865,GO:0046872,PRKD2,metal ion binding,2.0
18509,25865,GO:0048010,PRKD2,vascular endothelial growth factor receptor signaling pathway,2.0
18510,25865,GO:0050852,PRKD2,T cell receptor signaling pathway,2.0
18511,25865,GO:0050862,PRKD2,positive regulation of T cell receptor signaling pathway,2.0
18512,25865,GO:0051091,PRKD2,positive regulation of DNA-binding transcription factor activity,2.0
18513,25865,GO:0051092,PRKD2,positive regulation of NF-kappaB transcription factor activity,2.0
18514,25865,GO:0061154,PRKD2,endothelial tube morphogenesis,2.0
18515,25865,GO:0070374,PRKD2,positive regulation of ERK1 and ERK2 cascade,2.0
18516,25865,GO:0089700,PRKD2,protein kinase D signaling,2.0
18518,25865,GO:1901727,PRKD2,positive regulation of histone deacetylase activity,2.0
18519,25865,GO:1902533,PRKD2,positive regulation of intracellular signal transduction,2.0
18520,25865,GO:2000573,PRKD2,positive regulation of DNA biosynthetic process,2.0
18521,25865,GO:2001028,PRKD2,positive regulation of endothelial cell chemotaxis,2.0
18607,5071,GO:0000122,PRKN,negative regulation of transcription by RNA polymerase II,2.0
18608,5071,GO:0000151,PRKN,ubiquitin ligase complex,2.0
18610,5071,GO:0000209,PRKN,protein polyubiquitination,2.0
18613,5071,GO:0000266,PRKN,mitochondrial fission,2.0
18614,5071,GO:0000422,PRKN,autophagy of mitochondrion,2.0
18617,5071,GO:0000423,PRKN,mitophagy,2.0
18618,5071,GO:0001664,PRKN,G protein-coupled receptor binding,2.0
18619,5071,GO:0001933,PRKN,negative regulation of protein phosphorylation,2.0
18621,5071,GO:0001964,PRKN,startle response,2.0
18622,5071,GO:0003714,PRKN,transcription corepressor activity,2.0
18623,5071,GO:0003779,PRKN,actin binding,2.0
18624,5071,GO:0004842,PRKN,ubiquitin-protein transferase activity,2.0
18626,5071,GO:0005515,PRKN,protein binding,2.0
18627,5071,GO:0005634,PRKN,nucleus,2.0
18628,5071,GO:0005737,PRKN,cytoplasm,2.0
18630,5071,GO:0005739,PRKN,mitochondrion,2.0
18633,5071,GO:0005783,PRKN,endoplasmic reticulum,2.0
18635,5071,GO:0005794,PRKN,Golgi apparatus,2.0
18637,5071,GO:0005829,PRKN,cytosol,2.0
18641,5071,GO:0006511,PRKN,ubiquitin-dependent protein catabolic process,2.0
18646,5071,GO:0006513,PRKN,protein monoubiquitination,2.0
18648,5071,GO:0006979,PRKN,response to oxidative stress,2.0
18649,5071,GO:0007005,PRKN,mitochondrion organization,2.0
18650,5071,GO:0007417,PRKN,central nervous system development,2.0
18651,5071,GO:0007612,PRKN,learning,2.0
18652,5071,GO:0008013,PRKN,beta-catenin binding,2.0
18653,5071,GO:0008270,PRKN,zinc ion binding,2.0
18654,5071,GO:0008344,PRKN,adult locomotory behavior,2.0
18655,5071,GO:0010498,PRKN,proteasomal protein catabolic process,2.0
18656,5071,GO:0010506,PRKN,regulation of autophagy,2.0
18657,5071,GO:0010628,PRKN,positive regulation of gene expression,2.0
18658,5071,GO:0010629,PRKN,negative regulation of gene expression,2.0
18659,5071,GO:0010636,PRKN,positive regulation of mitochondrial fusion,2.0
18660,5071,GO:0010637,PRKN,negative regulation of mitochondrial fusion,2.0
18661,5071,GO:0010821,PRKN,regulation of mitochondrion organization,2.0
18665,5071,GO:0010906,PRKN,regulation of glucose metabolic process,2.0
18666,5071,GO:0010994,PRKN,free ubiquitin chain polymerization,2.0
18667,5071,GO:0014059,PRKN,regulation of dopamine secretion,2.0
18668,5071,GO:0015631,PRKN,tubulin binding,2.0
18669,5071,GO:0016235,PRKN,aggresome,2.0
18670,5071,GO:0016236,PRKN,macroautophagy,2.0
18671,5071,GO:0016567,PRKN,protein ubiquitination,2.0
18673,5071,GO:0016579,PRKN,protein deubiquitination,2.0
18674,5071,GO:0016607,PRKN,nuclear speck,2.0
18675,5071,GO:0017124,PRKN,SH3 domain binding,2.0
18676,5071,GO:0019005,PRKN,SCF ubiquitin ligase complex,2.0
18677,5071,GO:0019899,PRKN,enzyme binding,2.0
18678,5071,GO:0019900,PRKN,kinase binding,2.0
18679,5071,GO:0019901,PRKN,protein kinase binding,2.0
18680,5071,GO:0030165,PRKN,PDZ domain binding,2.0
18681,5071,GO:0030544,PRKN,Hsp70 protein binding,2.0
18682,5071,GO:0031072,PRKN,heat shock protein binding,2.0
18683,5071,GO:0031396,PRKN,regulation of protein ubiquitination,2.0
18685,5071,GO:0031624,PRKN,ubiquitin conjugating enzyme binding,2.0
18688,5071,GO:0031625,PRKN,ubiquitin protein ligase binding,2.0
18689,5071,GO:0031647,PRKN,regulation of protein stability,2.0
18690,5071,GO:0031648,PRKN,protein destabilization,2.0
18691,5071,GO:0032092,PRKN,positive regulation of protein binding,2.0
18692,5071,GO:0032232,PRKN,negative regulation of actin filament bundle assembly,2.0
18693,5071,GO:0032368,PRKN,regulation of lipid transport,2.0
18694,5071,GO:0032436,PRKN,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
18696,5071,GO:0033132,PRKN,negative regulation of glucokinase activity,2.0
18697,5071,GO:0034620,PRKN,cellular response to unfolded protein,2.0
18698,5071,GO:0034976,PRKN,response to endoplasmic reticulum stress,2.0
18699,5071,GO:0035249,PRKN,"synaptic transmission, glutamatergic",2.0
18700,5071,GO:0035519,PRKN,protein K29-linked ubiquitination,2.0
18701,5071,GO:0036503,PRKN,ERAD pathway,2.0
18702,5071,GO:0042053,PRKN,regulation of dopamine metabolic process,2.0
18703,5071,GO:0042415,PRKN,norepinephrine metabolic process,2.0
18704,5071,GO:0042417,PRKN,dopamine metabolic process,2.0
18705,5071,GO:0042802,PRKN,identical protein binding,2.0
18706,5071,GO:0042826,PRKN,histone deacetylase binding,2.0
18707,5071,GO:0042981,PRKN,regulation of apoptotic process,2.0
18708,5071,GO:0043005,PRKN,neuron projection,2.0
18709,5071,GO:0043123,PRKN,positive regulation of I-kappaB kinase/NF-kappaB signaling,2.0
18711,5071,GO:0043130,PRKN,ubiquitin binding,2.0
18712,5071,GO:0043161,PRKN,proteasome-mediated ubiquitin-dependent protein catabolic process,2.0
18713,5071,GO:0043274,PRKN,phospholipase binding,2.0
18714,5071,GO:0043388,PRKN,positive regulation of DNA binding,2.0
18715,5071,GO:0043524,PRKN,negative regulation of neuron apoptotic process,2.0
18716,5071,GO:0044257,PRKN,cellular protein catabolic process,2.0
18717,5071,GO:0044267,PRKN,cellular protein metabolic process,2.0
18718,5071,GO:0044314,PRKN,protein K27-linked ubiquitination,2.0
18719,5071,GO:0044828,PRKN,negative regulation by host of viral genome replication,2.0
18720,5071,GO:0044877,PRKN,protein-containing complex binding,2.0
18721,5071,GO:0045732,PRKN,positive regulation of protein catabolic process,2.0
18722,5071,GO:0045944,PRKN,positive regulation of transcription by RNA polymerase II,2.0
18723,5071,GO:0046329,PRKN,negative regulation of JNK cascade,2.0
18724,5071,GO:0046676,PRKN,negative regulation of insulin secretion,2.0
18725,5071,GO:0048471,PRKN,perinuclear region of cytoplasm,2.0
18726,5071,GO:0050821,PRKN,protein stabilization,2.0
18727,5071,GO:0051087,PRKN,chaperone binding,2.0
18728,5071,GO:0051582,PRKN,positive regulation of neurotransmitter uptake,2.0
18729,5071,GO:0051583,PRKN,dopamine uptake involved in synaptic transmission,2.0
18730,5071,GO:0051865,PRKN,protein autoubiquitination,2.0
18731,5071,GO:0051881,PRKN,regulation of mitochondrial membrane potential,2.0
18732,5071,GO:0055069,PRKN,zinc ion homeostasis,2.0
18733,5071,GO:0060548,PRKN,negative regulation of cell death,2.0
18734,5071,GO:0060828,PRKN,regulation of canonical Wnt signaling pathway,2.0
18735,5071,GO:0061630,PRKN,ubiquitin protein ligase activity,2.0
18740,5071,GO:0061734,PRKN,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,2.0
18741,5071,GO:0070050,PRKN,neuron cellular homeostasis,2.0
18742,5071,GO:0070534,PRKN,protein K63-linked ubiquitination,2.0
18745,5071,GO:0070585,PRKN,protein localization to mitochondrion,2.0
18746,5071,GO:0070842,PRKN,aggresome assembly,2.0
18747,5071,GO:0070936,PRKN,protein K48-linked ubiquitination,2.0
18748,5071,GO:0070979,PRKN,protein K11-linked ubiquitination,2.0
18749,5071,GO:0071287,PRKN,cellular response to manganese ion,2.0
18750,5071,GO:0085020,PRKN,protein K6-linked ubiquitination,2.0
18752,5071,GO:0090090,PRKN,negative regulation of canonical Wnt signaling pathway,2.0
18754,5071,GO:0090141,PRKN,positive regulation of mitochondrial fission,2.0
18755,5071,GO:0090201,PRKN,negative regulation of release of cytochrome c from mitochondria,2.0
18756,5071,GO:0097237,PRKN,cellular response to toxic substance,2.0
18757,5071,GO:0097413,PRKN,Lewy body,2.0
18758,5071,GO:0097602,PRKN,cullin family protein binding,2.0
18759,5071,GO:0098779,PRKN,positive regulation of mitophagy in response to mitochondrial depolarization,2.0
18761,5071,GO:0098793,PRKN,presynapse,2.0
18762,5071,GO:0099073,PRKN,mitochondrion-derived vesicle,2.0
18763,5071,GO:0099074,PRKN,mitochondrion to lysosome transport,2.0
18764,5071,GO:1900407,PRKN,regulation of cellular response to oxidative stress,2.0
18768,5071,GO:1901215,PRKN,negative regulation of neuron death,2.0
18769,5071,GO:1901800,PRKN,positive regulation of proteasomal protein catabolic process,2.0
18770,5071,GO:1902236,PRKN,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,2.0
18772,5071,GO:1902254,PRKN,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,2.0
18773,5071,GO:1902283,PRKN,negative regulation of primary amine oxidase activity,2.0
18774,5071,GO:1902530,PRKN,positive regulation of protein linear polyubiquitination,2.0
18775,5071,GO:1902803,PRKN,regulation of synaptic vesicle transport,2.0
18776,5071,GO:1903202,PRKN,negative regulation of oxidative stress-induced cell death,2.0
18778,5071,GO:1903214,PRKN,regulation of protein targeting to mitochondrion,2.0
18779,5071,GO:1903265,PRKN,positive regulation of tumor necrosis factor-mediated signaling pathway,2.0
18780,5071,GO:1903351,PRKN,cellular response to dopamine,2.0
18781,5071,GO:1903377,PRKN,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,2.0
18782,5071,GO:1903382,PRKN,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,2.0
18783,5071,GO:1903542,PRKN,negative regulation of exosomal secretion,2.0
18784,5071,GO:1903599,PRKN,positive regulation of autophagy of mitochondrion,2.0
18785,5071,GO:1903861,PRKN,positive regulation of dendrite extension,2.0
18786,5071,GO:1904049,PRKN,negative regulation of spontaneous neurotransmitter secretion,2.0
18787,5071,GO:1905281,PRKN,"positive regulation of retrograde transport, endosome to Golgi",2.0
18788,5071,GO:1905366,PRKN,negative regulation of intralumenal vesicle formation,2.0
18789,5071,GO:1905477,PRKN,positive regulation of protein localization to membrane,2.0
18791,5071,GO:1990381,PRKN,ubiquitin-specific protease binding,2.0
18792,5071,GO:1990444,PRKN,F-box domain binding,2.0
18793,5071,GO:1990452,PRKN,Parkin-FBXW7-Cul1 ubiquitin ligase complex,2.0
18794,5071,GO:2000377,PRKN,regulation of reactive oxygen species metabolic process,2.0
18795,5071,GO:2000378,PRKN,negative regulation of reactive oxygen species metabolic process,2.0
18796,5625,GO:0004657,PRODH,proline dehydrogenase activity,2.0
18799,5625,GO:0005739,PRODH,mitochondrion,2.0
18800,5625,GO:0005743,PRODH,mitochondrial inner membrane,2.0
18801,5625,GO:0005759,PRODH,mitochondrial matrix,2.0
18802,5625,GO:0006560,PRODH,proline metabolic process,2.0
18803,5625,GO:0006562,PRODH,proline catabolic process,2.0
18804,5625,GO:0008631,PRODH,intrinsic apoptotic signaling pathway in response to oxidative stress,2.0
18805,5625,GO:0010133,PRODH,proline catabolic process to glutamate,2.0
18807,5625,GO:0010942,PRODH,positive regulation of cell death,2.0
18808,5625,GO:0019470,PRODH,4-hydroxyproline catabolic process,2.0
18809,5625,GO:0055114,PRODH,oxidation-reduction process,2.0
18810,5625,GO:0071949,PRODH,FAD binding,2.0
19073,5245,GO:0000122,PHB,negative regulation of transcription by RNA polymerase II,2.0
19074,5245,GO:0001541,PHB,ovarian follicle development,2.0
19075,5245,GO:0001552,PHB,ovarian follicle atresia,2.0
19076,5245,GO:0001649,PHB,osteoblast differentiation,2.0
19077,5245,GO:0001850,PHB,complement component C3a binding,2.0
19078,5245,GO:0001851,PHB,complement component C3b binding,2.0
19079,5245,GO:0002377,PHB,immunoglobulin production,2.0
19080,5245,GO:0003714,PHB,transcription corepressor activity,2.0
19081,5245,GO:0005515,PHB,protein binding,2.0
19082,5245,GO:0005634,PHB,nucleus,2.0
19084,5245,GO:0005654,PHB,nucleoplasm,2.0
19085,5245,GO:0005737,PHB,cytoplasm,2.0
19086,5245,GO:0005739,PHB,mitochondrion,2.0
19088,5245,GO:0005743,PHB,mitochondrial inner membrane,2.0
19090,5245,GO:0005769,PHB,early endosome,2.0
19091,5245,GO:0005886,PHB,plasma membrane,2.0
19092,5245,GO:0005887,PHB,integral component of plasma membrane,2.0
19093,5245,GO:0006355,PHB,"regulation of transcription, DNA-templated",2.0
19094,5245,GO:0006851,PHB,mitochondrial calcium ion transmembrane transport,2.0
19095,5245,GO:0007005,PHB,mitochondrion organization,2.0
19096,5245,GO:0007165,PHB,signal transduction,2.0
19097,5245,GO:0007202,PHB,activation of phospholipase C activity,2.0
19098,5245,GO:0008022,PHB,protein C-terminus binding,2.0
19099,5245,GO:0008285,PHB,negative regulation of cell population proliferation,2.0
19100,5245,GO:0009986,PHB,cell surface,2.0
19101,5245,GO:0010628,PHB,positive regulation of gene expression,2.0
19102,5245,GO:0010942,PHB,positive regulation of cell death,2.0
19103,5245,GO:0010944,PHB,negative regulation of transcription by competitive promoter binding,2.0
19104,5245,GO:0014069,PHB,postsynaptic density,2.0
19105,5245,GO:0016020,PHB,membrane,2.0
19106,5245,GO:0016575,PHB,histone deacetylation,2.0
19107,5245,GO:0019899,PHB,enzyme binding,2.0
19108,5245,GO:0023035,PHB,CD40 signaling pathway,2.0
19109,5245,GO:0030061,PHB,mitochondrial crista,2.0
19110,5245,GO:0030308,PHB,negative regulation of cell growth,2.0
19111,5245,GO:0031100,PHB,animal organ regeneration,2.0
19112,5245,GO:0031315,PHB,extrinsic component of mitochondrial outer membrane,2.0
19113,5245,GO:0031871,PHB,proteinase activated receptor binding,2.0
19114,5245,GO:0032620,PHB,interleukin-17 production,2.0
19115,5245,GO:0035632,PHB,mitochondrial prohibitin complex,2.0
19116,5245,GO:0035902,PHB,response to immobilization stress,2.0
19117,5245,GO:0039529,PHB,RIG-I signaling pathway,2.0
19118,5245,GO:0042113,PHB,B cell activation,2.0
19119,5245,GO:0042177,PHB,negative regulation of protein catabolic process,2.0
19120,5245,GO:0042493,PHB,response to drug,2.0
19121,5245,GO:0042826,PHB,histone deacetylase binding,2.0
19122,5245,GO:0042981,PHB,regulation of apoptotic process,2.0
19123,5245,GO:0043066,PHB,negative regulation of apoptotic process,2.0
19124,5245,GO:0043434,PHB,response to peptide hormone,2.0
19125,5245,GO:0044830,PHB,modulation by host of viral RNA genome replication,2.0
19126,5245,GO:0045471,PHB,response to ethanol,2.0
19127,5245,GO:0045745,PHB,positive regulation of G protein-coupled receptor signaling pathway,2.0
19128,5245,GO:0045892,PHB,"negative regulation of transcription, DNA-templated",2.0
19130,5245,GO:0045893,PHB,"positive regulation of transcription, DNA-templated",2.0
19131,5245,GO:0045917,PHB,positive regulation of complement activation,2.0
19132,5245,GO:0046718,PHB,viral entry into host cell,2.0
19133,5245,GO:0046982,PHB,protein heterodimerization activity,2.0
19134,5245,GO:0048661,PHB,positive regulation of smooth muscle cell proliferation,2.0
19135,5245,GO:0050821,PHB,protein stabilization,2.0
19136,5245,GO:0050847,PHB,progesterone receptor signaling pathway,2.0
19137,5245,GO:0051897,PHB,positive regulation of protein kinase B signaling,2.0
19138,5245,GO:0060766,PHB,negative regulation of androgen receptor signaling pathway,2.0
19140,5245,GO:0070062,PHB,extracellular exosome,2.0
19141,5245,GO:0070373,PHB,negative regulation of ERK1 and ERK2 cascade,2.0
19142,5245,GO:0070374,PHB,positive regulation of ERK1 and ERK2 cascade,2.0
19143,5245,GO:0071354,PHB,cellular response to interleukin-6,2.0
19144,5245,GO:0071897,PHB,DNA biosynthetic process,2.0
19145,5245,GO:0072538,PHB,T-helper 17 type immune response,2.0
19146,5245,GO:0098978,PHB,glutamatergic synapse,2.0
19147,5245,GO:0140374,PHB,antiviral innate immune response,2.0
19148,5245,GO:1901224,PHB,positive regulation of NIK/NF-kappaB signaling,2.0
19149,5245,GO:1990051,PHB,activation of protein kinase C activity,2.0
19150,5245,GO:2000323,PHB,negative regulation of glucocorticoid receptor signaling pathway,2.0
19247,5444,GO:0004063,PON1,aryldialkylphosphatase activity,2.0
19249,5444,GO:0004064,PON1,arylesterase activity,2.0
19252,5444,GO:0005509,PON1,calcium ion binding,2.0
19253,5444,GO:0005543,PON1,phospholipid binding,2.0
19254,5444,GO:0005576,PON1,extracellular region,2.0
19256,5444,GO:0005615,PON1,extracellular space,2.0
19258,5444,GO:0008203,PON1,cholesterol metabolic process,2.0
19259,5444,GO:0009636,PON1,response to toxic substance,2.0
19260,5444,GO:0010875,PON1,positive regulation of cholesterol efflux,2.0
19261,5444,GO:0016311,PON1,dephosphorylation,2.0
19262,5444,GO:0019372,PON1,lipoxygenase pathway,2.0
19263,5444,GO:0019439,PON1,aromatic compound catabolic process,2.0
19264,5444,GO:0031667,PON1,response to nutrient levels,2.0
19265,5444,GO:0032411,PON1,positive regulation of transporter activity,2.0
19266,5444,GO:0034364,PON1,high-density lipoprotein particle,2.0
19268,5444,GO:0034366,PON1,spherical high-density lipoprotein particle,2.0
19269,5444,GO:0034445,PON1,negative regulation of plasma lipoprotein oxidation,2.0
19270,5444,GO:0042803,PON1,protein homodimerization activity,2.0
19271,5444,GO:0043231,PON1,intracellular membrane-bounded organelle,2.0
19272,5444,GO:0046395,PON1,carboxylic acid catabolic process,2.0
19273,5444,GO:0046434,PON1,organophosphate catabolic process,2.0
19274,5444,GO:0046470,PON1,phosphatidylcholine metabolic process,2.0
19275,5444,GO:0051099,PON1,positive regulation of binding,2.0
19276,5444,GO:0070062,PON1,extracellular exosome,2.0
19277,5444,GO:0070542,PON1,response to fatty acid,2.0
19278,5444,GO:0072562,PON1,blood microparticle,2.0
19279,5444,GO:0102007,PON1,acyl-L-homoserine-lactone lactonohydrolase activity,2.0
19280,5444,GO:1902617,PON1,response to fluoride,2.0
19803,149628,GO:0002218,PYHIN1,activation of innate immune response,2.0
19804,149628,GO:0003690,PYHIN1,double-stranded DNA binding,2.0
19805,149628,GO:0005730,PYHIN1,nucleolus,2.0
19806,149628,GO:0007049,PYHIN1,cell cycle,2.0
19807,149628,GO:0016607,PYHIN1,nuclear speck,2.0
19808,149628,GO:0031625,PYHIN1,ubiquitin protein ligase binding,2.0
19809,149628,GO:0031648,PYHIN1,protein destabilization,2.0
19810,149628,GO:0032731,PYHIN1,positive regulation of interleukin-1 beta production,2.0
19811,149628,GO:0032991,PYHIN1,protein-containing complex,2.0
19812,149628,GO:0035457,PYHIN1,cellular response to interferon-alpha,2.0
19813,149628,GO:0035458,PYHIN1,cellular response to interferon-beta,2.0
19814,149628,GO:0043388,PYHIN1,positive regulation of DNA binding,2.0
19815,149628,GO:0045893,PYHIN1,"positive regulation of transcription, DNA-templated",2.0
19816,149628,GO:0050821,PYHIN1,protein stabilization,2.0
19817,149628,GO:1900182,PYHIN1,positive regulation of protein localization to nucleus,2.0
19818,149628,GO:1902164,PYHIN1,"positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",2.0
19819,149628,GO:2000060,PYHIN1,positive regulation of ubiquitin-dependent protein catabolic process,2.0
19821,54870,GO:0003674,QRICH1,molecular_function,2.0
19822,54870,GO:0005515,QRICH1,protein binding,2.0
19823,54870,GO:0005654,QRICH1,nucleoplasm,2.0
19824,54870,GO:0008150,QRICH1,biological_process,2.0
19851,5862,GO:0000139,RAB2A,Golgi membrane,2.0
19853,5862,GO:0003924,RAB2A,GTPase activity,2.0
19854,5862,GO:0005515,RAB2A,protein binding,2.0
19855,5862,GO:0005525,RAB2A,GTP binding,2.0
19856,5862,GO:0005634,RAB2A,nucleus,2.0
19857,5862,GO:0005765,RAB2A,lysosomal membrane,2.0
19858,5862,GO:0005789,RAB2A,endoplasmic reticulum membrane,2.0
19859,5862,GO:0005794,RAB2A,Golgi apparatus,2.0
19860,5862,GO:0005829,RAB2A,cytosol,2.0
19861,5862,GO:0006888,RAB2A,endoplasmic reticulum to Golgi vesicle-mediated transport,2.0
19862,5862,GO:0007030,RAB2A,Golgi organization,2.0
19863,5862,GO:0015031,RAB2A,protein transport,2.0
19864,5862,GO:0019003,RAB2A,GDP binding,2.0
19865,5862,GO:0033116,RAB2A,endoplasmic reticulum-Golgi intermediate compartment membrane,2.0
19866,5862,GO:0042470,RAB2A,melanosome,2.0
19867,5862,GO:0043687,RAB2A,post-translational protein modification,2.0
19868,5862,GO:0070062,RAB2A,extracellular exosome,2.0
19886,339122,GO:0000045,RAB43,autophagosome assembly,2.0
19887,339122,GO:0003924,RAB43,GTPase activity,2.0
19889,339122,GO:0005515,RAB43,protein binding,2.0
19890,339122,GO:0005525,RAB43,GTP binding,2.0
19891,339122,GO:0005794,RAB43,Golgi apparatus,2.0
19892,339122,GO:0006886,RAB43,intracellular protein transport,2.0
19893,339122,GO:0007030,RAB43,Golgi organization,2.0
19894,339122,GO:0012505,RAB43,endomembrane system,2.0
19895,339122,GO:0019068,RAB43,virion assembly,2.0
19896,339122,GO:0030670,RAB43,phagocytic vesicle membrane,2.0
19897,339122,GO:0032588,RAB43,trans-Golgi network membrane,2.0
19898,339122,GO:0035526,RAB43,"retrograde transport, plasma membrane to Golgi",2.0
19899,339122,GO:0045335,RAB43,phagocytic vesicle,2.0
19900,339122,GO:0070062,RAB43,extracellular exosome,2.0
19901,339122,GO:0071346,RAB43,cellular response to interferon-gamma,2.0
19902,339122,GO:0090382,RAB43,phagosome maturation,2.0
19903,339122,GO:1901998,RAB43,toxin transport,2.0
20085,57148,GO:0005096,RALGAPB,GTPase activator activity,2.0
20087,57148,GO:0005515,RALGAPB,protein binding,2.0
20088,57148,GO:0046982,RALGAPB,protein heterodimerization activity,2.0
20090,57148,GO:0051056,RALGAPB,regulation of small GTPase mediated signal transduction,2.0
20091,57148,GO:0090630,RALGAPB,activation of GTPase activity,2.0
20093,64901,GO:0005049,RANBP17,nuclear export signal receptor activity,2.0
20094,64901,GO:0005525,RANBP17,GTP binding,2.0
20095,64901,GO:0005643,RANBP17,nuclear pore,2.0
20097,64901,GO:0005737,RANBP17,cytoplasm,2.0
20098,64901,GO:0006606,RANBP17,protein import into nucleus,2.0
20099,64901,GO:0006611,RANBP17,protein export from nucleus,2.0
20100,64901,GO:0031267,RANBP17,small GTPase binding,2.0
20101,64901,GO:0051028,RANBP17,mRNA transport,2.0
20133,54715,GO:0000381,RBFOX1,"regulation of alternative mRNA splicing, via spliceosome",2.0
20134,54715,GO:0003723,RBFOX1,RNA binding,2.0
20135,54715,GO:0003729,RBFOX1,mRNA binding,2.0
20136,54715,GO:0005515,RBFOX1,protein binding,2.0
20137,54715,GO:0005634,RBFOX1,nucleus,2.0
20138,54715,GO:0005737,RBFOX1,cytoplasm,2.0
20140,54715,GO:0005802,RBFOX1,trans-Golgi network,2.0
20141,54715,GO:0006397,RBFOX1,mRNA processing,2.0
20142,54715,GO:0007399,RBFOX1,nervous system development,2.0
20143,54715,GO:0008022,RBFOX1,protein C-terminus binding,2.0
20144,54715,GO:0008380,RBFOX1,RNA splicing,2.0
20145,54715,GO:0010494,RBFOX1,cytoplasmic stress granule,2.0
20146,54715,GO:0050658,RBFOX1,RNA transport,2.0
20147,54715,GO:0097165,RBFOX1,nuclear stress granule,2.0
20148,54439,GO:0003723,RBM27,RNA binding,2.0
20149,54439,GO:0003729,RBM27,mRNA binding,2.0
20150,54439,GO:0005634,RBM27,nucleus,2.0
20151,54439,GO:0005737,RBM27,cytoplasm,2.0
20152,54439,GO:0006397,RBM27,mRNA processing,2.0
20153,54439,GO:0016607,RBM27,nuclear speck,2.0
20154,54439,GO:0046833,RBM27,positive regulation of RNA export from nucleus,2.0
20155,54439,GO:0046872,RBM27,metal ion binding,2.0
20435,6092,GO:0001656,ROBO2,metanephros development,2.0
20436,6092,GO:0001657,ROBO2,ureteric bud development,2.0
20437,6092,GO:0003148,ROBO2,outflow tract septum morphogenesis,2.0
20438,6092,GO:0003180,ROBO2,aortic valve morphogenesis,2.0
20439,6092,GO:0003184,ROBO2,pulmonary valve morphogenesis,2.0
20440,6092,GO:0003272,ROBO2,endocardial cushion formation,2.0
20441,6092,GO:0005515,ROBO2,protein binding,2.0
20442,6092,GO:0005886,ROBO2,plasma membrane,2.0
20443,6092,GO:0007156,ROBO2,homophilic cell adhesion via plasma membrane adhesion molecules,2.0
20444,6092,GO:0007411,ROBO2,axon guidance,2.0
20446,6092,GO:0007417,ROBO2,central nervous system development,2.0
20447,6092,GO:0007420,ROBO2,brain development,2.0
20448,6092,GO:0008046,ROBO2,axon guidance receptor activity,2.0
20450,6092,GO:0009986,ROBO2,cell surface,2.0
20451,6092,GO:0016021,ROBO2,integral component of membrane,2.0
20452,6092,GO:0016199,ROBO2,axon midline choice point recognition,2.0
20453,6092,GO:0021891,ROBO2,olfactory bulb interneuron development,2.0
20454,6092,GO:0030673,ROBO2,axolemma,2.0
20455,6092,GO:0031290,ROBO2,retinal ganglion cell axon guidance,2.0
20456,6092,GO:0032870,ROBO2,cellular response to hormone stimulus,2.0
20457,6092,GO:0035481,ROBO2,positive regulation of Notch signaling pathway involved in heart induction,2.0
20458,6092,GO:0035904,ROBO2,aorta development,2.0
20459,6092,GO:0042802,ROBO2,identical protein binding,2.0
20460,6092,GO:0050772,ROBO2,positive regulation of axonogenesis,2.0
20461,6092,GO:0050925,ROBO2,negative regulation of negative chemotaxis,2.0
20462,6092,GO:0051964,ROBO2,negative regulation of synapse assembly,2.0
20463,6092,GO:0060412,ROBO2,ventricular septum morphogenesis,2.0
20464,6092,GO:0061364,ROBO2,apoptotic process involved in luteolysis,2.0
20465,6092,GO:0070062,ROBO2,extracellular exosome,2.0
20640,10055,GO:0004839,SAE1,ubiquitin activating enzyme activity,2.0
20641,10055,GO:0005515,SAE1,protein binding,2.0
20642,10055,GO:0005634,SAE1,nucleus,2.0
20643,10055,GO:0005654,SAE1,nucleoplasm,2.0
20644,10055,GO:0005737,SAE1,cytoplasm,2.0
20645,10055,GO:0008022,SAE1,protein C-terminus binding,2.0
20646,10055,GO:0008047,SAE1,enzyme activator activity,2.0
20647,10055,GO:0016567,SAE1,protein ubiquitination,2.0
20648,10055,GO:0016925,SAE1,protein sumoylation,2.0
20653,10055,GO:0019948,SAE1,SUMO activating enzyme activity,2.0
20654,10055,GO:0031510,SAE1,SUMO activating enzyme complex,2.0
20656,10055,GO:0032446,SAE1,protein modification by small protein conjugation,2.0
20657,10055,GO:0033235,SAE1,positive regulation of protein sumoylation,2.0
20658,10055,GO:0043008,SAE1,ATP-dependent protein binding,2.0
20659,10055,GO:0043085,SAE1,positive regulation of catalytic activity,2.0
20660,10055,GO:0044388,SAE1,small protein activating enzyme binding,2.0
20661,10055,GO:0046982,SAE1,protein heterodimerization activity,2.0
20662,10055,GO:1903955,SAE1,positive regulation of protein targeting to mitochondrion,2.0
20785,6305,GO:0005085,SBF1,guanyl-nucleotide exchange factor activity,2.0
20787,6305,GO:0005737,SBF1,cytoplasm,2.0
20789,6305,GO:0005789,SBF1,endoplasmic reticulum membrane,2.0
20790,6305,GO:0005829,SBF1,cytosol,2.0
20791,6305,GO:0006470,SBF1,protein dephosphorylation,2.0
20792,6305,GO:0006661,SBF1,phosphatidylinositol biosynthetic process,2.0
20793,6305,GO:0007283,SBF1,spermatogenesis,2.0
20794,6305,GO:0008138,SBF1,protein tyrosine/serine/threonine phosphatase activity,2.0
20795,6305,GO:0016020,SBF1,membrane,2.0
20796,6305,GO:0016021,SBF1,integral component of membrane,2.0
20797,6305,GO:0016604,SBF1,nuclear body,2.0
20798,6305,GO:0016791,SBF1,phosphatase activity,2.0
20799,6305,GO:0019208,SBF1,phosphatase regulator activity,2.0
20800,6305,GO:0043087,SBF1,regulation of GTPase activity,2.0
20801,6305,GO:0048471,SBF1,perinuclear region of cytoplasm,2.0
20802,57466,GO:0003723,SCAF4,RNA binding,2.0
20804,57466,GO:0005634,SCAF4,nucleus,2.0
20805,57466,GO:0005654,SCAF4,nucleoplasm,2.0
20806,57466,GO:0006397,SCAF4,mRNA processing,2.0
20807,57466,GO:0008022,SCAF4,protein C-terminus binding,2.0
20808,57466,GO:1990269,SCAF4,RNA polymerase II C-terminal domain phosphoserine binding,2.0
20809,57466,GO:2000805,SCAF4,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled",2.0
21000,6335,GO:0001518,SCN9A,voltage-gated sodium channel complex,2.0
21001,6335,GO:0005244,SCN9A,voltage-gated ion channel activity,2.0
21002,6335,GO:0005248,SCN9A,voltage-gated sodium channel activity,2.0
21004,6335,GO:0005887,SCN9A,integral component of plasma membrane,2.0
21005,6335,GO:0006814,SCN9A,sodium ion transport,2.0
21006,6335,GO:0006954,SCN9A,inflammatory response,2.0
21007,6335,GO:0009636,SCN9A,response to toxic substance,2.0
21008,6335,GO:0009791,SCN9A,post-embryonic development,2.0
21009,6335,GO:0019228,SCN9A,neuronal action potential,2.0
21010,6335,GO:0019233,SCN9A,sensory perception of pain,2.0
21011,6335,GO:0030424,SCN9A,axon,2.0
21013,6335,GO:0031402,SCN9A,sodium ion binding,2.0
21014,6335,GO:0034765,SCN9A,regulation of ion transmembrane transport,2.0
21015,6335,GO:0035725,SCN9A,sodium ion transmembrane transport,2.0
21017,6335,GO:0048266,SCN9A,behavioral response to pain,2.0
21018,6335,GO:0086010,SCN9A,membrane depolarization during action potential,2.0
21071,9037,GO:0001755,SEMA5A,neural crest cell migration,2.0
21072,9037,GO:0001938,SEMA5A,positive regulation of endothelial cell proliferation,2.0
21073,9037,GO:0002043,SEMA5A,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,2.0
21074,9037,GO:0005886,SEMA5A,plasma membrane,2.0
21075,9037,GO:0007155,SEMA5A,cell adhesion,2.0
21076,9037,GO:0007162,SEMA5A,negative regulation of cell adhesion,2.0
21077,9037,GO:0007267,SEMA5A,cell-cell signaling,2.0
21078,9037,GO:0007399,SEMA5A,nervous system development,2.0
21079,9037,GO:0007411,SEMA5A,axon guidance,2.0
21080,9037,GO:0007413,SEMA5A,axonal fasciculation,2.0
21081,9037,GO:0016020,SEMA5A,membrane,2.0
21082,9037,GO:0016021,SEMA5A,integral component of membrane,2.0
21083,9037,GO:0021536,SEMA5A,diencephalon development,2.0
21084,9037,GO:0030215,SEMA5A,semaphorin receptor binding,2.0
21086,9037,GO:0030335,SEMA5A,positive regulation of cell migration,2.0
21087,9037,GO:0030836,SEMA5A,positive regulation of actin filament depolymerization,2.0
21088,9037,GO:0035373,SEMA5A,chondroitin sulfate proteoglycan binding,2.0
21089,9037,GO:0043395,SEMA5A,heparan sulfate proteoglycan binding,2.0
21090,9037,GO:0045499,SEMA5A,chemorepellent activity,2.0
21091,9037,GO:0045545,SEMA5A,syndecan binding,2.0
21092,9037,GO:0045766,SEMA5A,positive regulation of angiogenesis,2.0
21093,9037,GO:0048675,SEMA5A,axon extension,2.0
21094,9037,GO:0048842,SEMA5A,positive regulation of axon extension involved in axon guidance,2.0
21095,9037,GO:0048843,SEMA5A,negative regulation of axon extension involved in axon guidance,2.0
21097,9037,GO:0050918,SEMA5A,positive chemotaxis,2.0
21098,9037,GO:0050919,SEMA5A,negative chemotaxis,2.0
21099,9037,GO:0051897,SEMA5A,positive regulation of protein kinase B signaling,2.0
21100,9037,GO:0060326,SEMA5A,cell chemotaxis,2.0
21101,9037,GO:0070062,SEMA5A,extracellular exosome,2.0
21102,9037,GO:0071526,SEMA5A,semaphorin-plexin signaling pathway,2.0
21103,9037,GO:0090263,SEMA5A,positive regulation of canonical Wnt signaling pathway,2.0
21104,9037,GO:1990256,SEMA5A,signal clustering,2.0
21105,9037,GO:2000352,SEMA5A,negative regulation of endothelial cell apoptotic process,2.0
21106,9037,GO:2001028,SEMA5A,positive regulation of endothelial cell chemotaxis,2.0
21155,6418,GO:0003677,SET,DNA binding,2.0
21156,6418,GO:0003682,SET,chromatin binding,2.0
21157,6418,GO:0004864,SET,protein phosphatase inhibitor activity,2.0
21158,6418,GO:0005515,SET,protein binding,2.0
21159,6418,GO:0005634,SET,nucleus,2.0
21163,6418,GO:0005654,SET,nucleoplasm,2.0
21165,6418,GO:0005737,SET,cytoplasm,2.0
21166,6418,GO:0005783,SET,endoplasmic reticulum,2.0
21167,6418,GO:0005811,SET,lipid droplet,2.0
21168,6418,GO:0005829,SET,cytosol,2.0
21169,6418,GO:0006260,SET,DNA replication,2.0
21170,6418,GO:0006334,SET,nucleosome assembly,2.0
21171,6418,GO:0006337,SET,nucleosome disassembly,2.0
21172,6418,GO:0016032,SET,viral process,2.0
21173,6418,GO:0019888,SET,protein phosphatase regulator activity,2.0
21174,6418,GO:0032515,SET,negative regulation of phosphoprotein phosphatase activity,2.0
21175,6418,GO:0032991,SET,protein-containing complex,2.0
21176,6418,GO:0035067,SET,negative regulation of histone acetylation,2.0
21177,6418,GO:0042393,SET,histone binding,2.0
21179,6418,GO:0043488,SET,regulation of mRNA stability,2.0
21180,6418,GO:0043524,SET,negative regulation of neuron apoptotic process,2.0
21181,6418,GO:0045892,SET,"negative regulation of transcription, DNA-templated",2.0
21182,6418,GO:0048471,SET,perinuclear region of cytoplasm,2.0
21368,50944,GO:0005515,SHANK1,protein binding,2.0
21369,50944,GO:0005829,SHANK1,cytosol,2.0
21370,50944,GO:0005886,SHANK1,plasma membrane,2.0
21372,50944,GO:0007610,SHANK1,behavior,2.0
21373,50944,GO:0007616,SHANK1,long-term memory,2.0
21374,50944,GO:0008022,SHANK1,protein C-terminus binding,2.0
21375,50944,GO:0008306,SHANK1,associative learning,2.0
21376,50944,GO:0008328,SHANK1,ionotropic glutamate receptor complex,2.0
21378,50944,GO:0014069,SHANK1,postsynaptic density,2.0
21380,50944,GO:0016020,SHANK1,membrane,2.0
21381,50944,GO:0017124,SHANK1,SH3 domain binding,2.0
21382,50944,GO:0017146,SHANK1,NMDA selective glutamate receptor complex,2.0
21383,50944,GO:0030160,SHANK1,synaptic receptor adaptor activity,2.0
21385,50944,GO:0030425,SHANK1,dendrite,2.0
21386,50944,GO:0030534,SHANK1,adult behavior,2.0
21387,50944,GO:0031877,SHANK1,somatostatin receptor binding,2.0
21388,50944,GO:0032232,SHANK1,negative regulation of actin filament bundle assembly,2.0
21389,50944,GO:0035176,SHANK1,social behavior,2.0
21390,50944,GO:0035255,SHANK1,ionotropic glutamate receptor binding,2.0
21392,50944,GO:0035418,SHANK1,protein localization to synapse,2.0
21393,50944,GO:0042048,SHANK1,olfactory behavior,2.0
21394,50944,GO:0042802,SHANK1,identical protein binding,2.0
21395,50944,GO:0043005,SHANK1,neuron projection,2.0
21396,50944,GO:0043197,SHANK1,dendritic spine,2.0
21398,50944,GO:0044877,SHANK1,protein-containing complex binding,2.0
21399,50944,GO:0045211,SHANK1,postsynaptic membrane,2.0
21402,50944,GO:0046959,SHANK1,habituation,2.0
21403,50944,GO:0048854,SHANK1,brain morphogenesis,2.0
21404,50944,GO:0050885,SHANK1,neuromuscular process controlling balance,2.0
21405,50944,GO:0050894,SHANK1,determination of affect,2.0
21406,50944,GO:0051124,SHANK1,synaptic growth at neuromuscular junction,2.0
21407,50944,GO:0051968,SHANK1,"positive regulation of synaptic transmission, glutamatergic",2.0
21408,50944,GO:0060013,SHANK1,righting reflex,2.0
21409,50944,GO:0060074,SHANK1,synapse maturation,2.0
21410,50944,GO:0060076,SHANK1,excitatory synapse,2.0
21411,50944,GO:0060291,SHANK1,long-term synaptic potentiation,2.0
21412,50944,GO:0060997,SHANK1,dendritic spine morphogenesis,2.0
21414,50944,GO:0060999,SHANK1,positive regulation of dendritic spine development,2.0
21416,50944,GO:0065003,SHANK1,protein-containing complex assembly,2.0
21417,50944,GO:0071532,SHANK1,ankyrin repeat binding,2.0
21418,50944,GO:0071625,SHANK1,vocalization behavior,2.0
21419,50944,GO:0097107,SHANK1,postsynaptic density assembly,2.0
21420,50944,GO:0097110,SHANK1,scaffold protein binding,2.0
21421,50944,GO:0098978,SHANK1,glutamatergic synapse,2.0
21422,50944,GO:2000311,SHANK1,regulation of AMPA receptor activity,2.0
21424,50944,GO:2000463,SHANK1,positive regulation of excitatory postsynaptic potential,2.0
21554,6473,GO:0000785,SHOX,chromatin,2.0
21555,6473,GO:0000981,SHOX,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
21557,6473,GO:0001228,SHOX,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
21559,6473,GO:0001501,SHOX,skeletal system development,2.0
21560,6473,GO:0005515,SHOX,protein binding,2.0
21561,6473,GO:0005634,SHOX,nucleus,2.0
21562,6473,GO:0005654,SHOX,nucleoplasm,2.0
21563,6473,GO:0006357,SHOX,regulation of transcription by RNA polymerase II,2.0
21564,6473,GO:0043231,SHOX,intracellular membrane-bounded organelle,2.0
21565,6473,GO:0043565,SHOX,sequence-specific DNA binding,2.0
21567,6473,GO:0045944,SHOX,positive regulation of transcription by RNA polymerase II,2.0
21568,6473,GO:1990837,SHOX,sequence-specific double-stranded DNA binding,2.0
21654,57468,GO:0005886,SLC12A5,plasma membrane,2.0
21655,57468,GO:0005887,SLC12A5,integral component of plasma membrane,2.0
21656,57468,GO:0006811,SLC12A5,ion transport,2.0
21658,57468,GO:0006873,SLC12A5,cellular ion homeostasis,2.0
21659,57468,GO:0006884,SLC12A5,cell volume homeostasis,2.0
21660,57468,GO:0006971,SLC12A5,hypotonic response,2.0
21661,57468,GO:0007268,SLC12A5,chemical synaptic transmission,2.0
21662,57468,GO:0007612,SLC12A5,learning,2.0
21663,57468,GO:0015108,SLC12A5,chloride transmembrane transporter activity,2.0
21664,57468,GO:0015379,SLC12A5,potassium:chloride symporter activity,2.0
21666,57468,GO:0016021,SLC12A5,integral component of membrane,2.0
21667,57468,GO:0030644,SLC12A5,cellular chloride ion homeostasis,2.0
21668,57468,GO:0035264,SLC12A5,multicellular organism growth,2.0
21669,57468,GO:0040040,SLC12A5,thermosensory behavior,2.0
21670,57468,GO:0042493,SLC12A5,response to drug,2.0
21671,57468,GO:0043005,SLC12A5,neuron projection,2.0
21672,57468,GO:0043025,SLC12A5,neuronal cell body,2.0
21674,57468,GO:0045202,SLC12A5,synapse,2.0
21675,57468,GO:0055064,SLC12A5,chloride ion homeostasis,2.0
21676,57468,GO:0055075,SLC12A5,potassium ion homeostasis,2.0
21677,57468,GO:0060996,SLC12A5,dendritic spine development,2.0
21678,57468,GO:0071944,SLC12A5,cell periphery,2.0
21680,57468,GO:1902476,SLC12A5,chloride transmembrane transport,2.0
21681,57468,GO:1990573,SLC12A5,potassium ion import across plasma membrane,2.0
21955,10237,GO:0005459,SLC35B1,UDP-galactose transmembrane transporter activity,2.0
21956,10237,GO:0005460,SLC35B1,UDP-glucose transmembrane transporter activity,2.0
21957,10237,GO:0005515,SLC35B1,protein binding,2.0
21958,10237,GO:0008643,SLC35B1,carbohydrate transport,2.0
21959,10237,GO:0015786,SLC35B1,UDP-glucose transmembrane transport,2.0
21960,10237,GO:0022857,SLC35B1,transmembrane transporter activity,2.0
21961,10237,GO:0030173,SLC35B1,integral component of Golgi membrane,2.0
21962,10237,GO:0030176,SLC35B1,integral component of endoplasmic reticulum membrane,2.0
21963,10237,GO:0043231,SLC35B1,intracellular membrane-bounded organelle,2.0
21964,10237,GO:0072334,SLC35B1,UDP-galactose transmembrane transport,2.0
21965,124565,GO:0003333,SLC38A10,amino acid transmembrane transport,2.0
21966,124565,GO:0005794,SLC38A10,Golgi apparatus,2.0
21967,124565,GO:0006814,SLC38A10,sodium ion transport,2.0
21968,124565,GO:0015171,SLC38A10,amino acid transmembrane transporter activity,2.0
21969,124565,GO:0016021,SLC38A10,integral component of membrane,2.0
21970,124565,GO:0060348,SLC38A10,bone development,2.0
22125,6531,GO:0002020,SLC6A3,protease binding,2.0
22126,6531,GO:0005102,SLC6A3,signaling receptor binding,2.0
22127,6531,GO:0005326,SLC6A3,neurotransmitter transmembrane transporter activity,2.0
22128,6531,GO:0005330,SLC6A3,dopamine:sodium symporter activity,2.0
22130,6531,GO:0005334,SLC6A3,norepinephrine:sodium symporter activity,2.0
22131,6531,GO:0005515,SLC6A3,protein binding,2.0
22132,6531,GO:0005737,SLC6A3,cytoplasm,2.0
22133,6531,GO:0005886,SLC6A3,plasma membrane,2.0
22136,6531,GO:0005887,SLC6A3,integral component of plasma membrane,2.0
22137,6531,GO:0006836,SLC6A3,neurotransmitter transport,2.0
22138,6531,GO:0007568,SLC6A3,aging,2.0
22139,6531,GO:0007595,SLC6A3,lactation,2.0
22140,6531,GO:0007608,SLC6A3,sensory perception of smell,2.0
22141,6531,GO:0007626,SLC6A3,locomotory behavior,2.0
22142,6531,GO:0008144,SLC6A3,drug binding,2.0
22143,6531,GO:0008504,SLC6A3,monoamine transmembrane transporter activity,2.0
22146,6531,GO:0009986,SLC6A3,cell surface,2.0
22147,6531,GO:0010039,SLC6A3,response to iron ion,2.0
22148,6531,GO:0015844,SLC6A3,monoamine transport,2.0
22149,6531,GO:0015872,SLC6A3,dopamine transport,2.0
22150,6531,GO:0015874,SLC6A3,norepinephrine transport,2.0
22151,6531,GO:0016021,SLC6A3,integral component of membrane,2.0
22152,6531,GO:0016600,SLC6A3,flotillin complex,2.0
22153,6531,GO:0021984,SLC6A3,adenohypophysis development,2.0
22154,6531,GO:0030424,SLC6A3,axon,2.0
22155,6531,GO:0032809,SLC6A3,neuronal cell body membrane,2.0
22156,6531,GO:0035094,SLC6A3,response to nicotine,2.0
22157,6531,GO:0035240,SLC6A3,dopamine binding,2.0
22158,6531,GO:0035725,SLC6A3,sodium ion transmembrane transport,2.0
22159,6531,GO:0040018,SLC6A3,positive regulation of multicellular organism growth,2.0
22160,6531,GO:0042053,SLC6A3,regulation of dopamine metabolic process,2.0
22161,6531,GO:0042136,SLC6A3,neurotransmitter biosynthetic process,2.0
22162,6531,GO:0042220,SLC6A3,response to cocaine,2.0
22163,6531,GO:0042416,SLC6A3,dopamine biosynthetic process,2.0
22164,6531,GO:0042420,SLC6A3,dopamine catabolic process,2.0
22165,6531,GO:0042734,SLC6A3,presynaptic membrane,2.0
22166,6531,GO:0043005,SLC6A3,neuron projection,2.0
22168,6531,GO:0043025,SLC6A3,neuronal cell body,2.0
22169,6531,GO:0044877,SLC6A3,protein-containing complex binding,2.0
22170,6531,GO:0045121,SLC6A3,membrane raft,2.0
22171,6531,GO:0045471,SLC6A3,response to ethanol,2.0
22172,6531,GO:0046872,SLC6A3,metal ion binding,2.0
22173,6531,GO:0047485,SLC6A3,protein N-terminus binding,2.0
22174,6531,GO:0051583,SLC6A3,dopamine uptake involved in synaptic transmission,2.0
22175,6531,GO:0051591,SLC6A3,response to cAMP,2.0
22176,6531,GO:0051620,SLC6A3,norepinephrine uptake,2.0
22177,6531,GO:0051721,SLC6A3,protein phosphatase 2A binding,2.0
22178,6531,GO:0060134,SLC6A3,prepulse inhibition,2.0
22179,6531,GO:0090494,SLC6A3,dopamine uptake,2.0
22181,6531,GO:1990384,SLC6A3,hyaloid vascular plexus regression,2.0
22251,84889,GO:0000064,SLC7A3,L-ornithine transmembrane transporter activity,2.0
22253,84889,GO:0005515,SLC7A3,protein binding,2.0
22254,84889,GO:0005886,SLC7A3,plasma membrane,2.0
22257,84889,GO:0006865,SLC7A3,amino acid transport,2.0
22259,84889,GO:0015171,SLC7A3,amino acid transmembrane transporter activity,2.0
22261,84889,GO:0015181,SLC7A3,arginine transmembrane transporter activity,2.0
22262,84889,GO:0015189,SLC7A3,L-lysine transmembrane transporter activity,2.0
22264,84889,GO:0016021,SLC7A3,integral component of membrane,2.0
22265,84889,GO:0061459,SLC7A3,L-arginine transmembrane transporter activity,2.0
22266,84889,GO:0097638,SLC7A3,L-arginine import across plasma membrane,2.0
22268,84889,GO:0097639,SLC7A3,L-lysine import across plasma membrane,2.0
22269,84889,GO:0097640,SLC7A3,L-ornithine import across plasma membrane,2.0
22270,84889,GO:0150104,SLC7A3,transport across blood-brain barrier,2.0
22271,84889,GO:1903352,SLC7A3,L-ornithine transmembrane transport,2.0
22272,8140,GO:0002720,SLC7A5,positive regulation of cytokine production involved in immune response,2.0
22273,8140,GO:0003333,SLC7A5,amino acid transmembrane transport,2.0
22274,8140,GO:0005515,SLC7A5,protein binding,2.0
22275,8140,GO:0005765,SLC7A5,lysosomal membrane,2.0
22276,8140,GO:0005829,SLC7A5,cytosol,2.0
22277,8140,GO:0005886,SLC7A5,plasma membrane,2.0
22279,8140,GO:0009925,SLC7A5,basal plasma membrane,2.0
22280,8140,GO:0010629,SLC7A5,negative regulation of gene expression,2.0
22281,8140,GO:0015171,SLC7A5,amino acid transmembrane transporter activity,2.0
22284,8140,GO:0015173,SLC7A5,aromatic amino acid transmembrane transporter activity,2.0
22285,8140,GO:0015175,SLC7A5,neutral amino acid transmembrane transporter activity,2.0
22287,8140,GO:0015179,SLC7A5,L-amino acid transmembrane transporter activity,2.0
22288,8140,GO:0015190,SLC7A5,L-leucine transmembrane transporter activity,2.0
22290,8140,GO:0015196,SLC7A5,L-tryptophan transmembrane transporter activity,2.0
22291,8140,GO:0015349,SLC7A5,thyroid hormone transmembrane transporter activity,2.0
22292,8140,GO:0015804,SLC7A5,neutral amino acid transport,2.0
22293,8140,GO:0015823,SLC7A5,phenylalanine transport,2.0
22294,8140,GO:0016020,SLC7A5,membrane,2.0
22295,8140,GO:0016021,SLC7A5,integral component of membrane,2.0
22296,8140,GO:0016323,SLC7A5,basolateral plasma membrane,2.0
22297,8140,GO:0016324,SLC7A5,apical plasma membrane,2.0
22299,8140,GO:0031528,SLC7A5,microvillus membrane,2.0
22300,8140,GO:0032729,SLC7A5,positive regulation of interferon-gamma production,2.0
22301,8140,GO:0032740,SLC7A5,positive regulation of interleukin-17 production,2.0
22302,8140,GO:0032753,SLC7A5,positive regulation of interleukin-4 production,2.0
22303,8140,GO:0042605,SLC7A5,peptide antigen binding,2.0
22304,8140,GO:0042908,SLC7A5,xenobiotic transport,2.0
22305,8140,GO:0043231,SLC7A5,intracellular membrane-bounded organelle,2.0
22306,8140,GO:0050900,SLC7A5,leukocyte migration,2.0
22307,8140,GO:0070062,SLC7A5,extracellular exosome,2.0
22308,8140,GO:0070327,SLC7A5,thyroid hormone transport,2.0
22309,8140,GO:0089718,SLC7A5,amino acid import across plasma membrane,2.0
22312,8140,GO:0098591,SLC7A5,external side of apical plasma membrane,2.0
22313,8140,GO:0098713,SLC7A5,leucine import across plasma membrane,2.0
22315,8140,GO:0150104,SLC7A5,transport across blood-brain barrier,2.0
22316,8140,GO:1902475,SLC7A5,L-alpha-amino acid transmembrane transport,2.0
22317,8140,GO:1903801,SLC7A5,L-leucine import across plasma membrane,2.0
22319,8140,GO:1904556,SLC7A5,L-tryptophan transmembrane transport,2.0
22320,8140,GO:1990184,SLC7A5,amino acid transport complex,2.0
22391,26050,GO:0005515,SLITRK5,protein binding,2.0
22392,26050,GO:0005886,SLITRK5,plasma membrane,2.0
22393,26050,GO:0007268,SLITRK5,chemical synaptic transmission,2.0
22394,26050,GO:0007409,SLITRK5,axonogenesis,2.0
22395,26050,GO:0007625,SLITRK5,grooming behavior,2.0
22396,26050,GO:0009410,SLITRK5,response to xenobiotic stimulus,2.0
22397,26050,GO:0016021,SLITRK5,integral component of membrane,2.0
22398,26050,GO:0021756,SLITRK5,striatum development,2.0
22399,26050,GO:0030534,SLITRK5,adult behavior,2.0
22400,26050,GO:0043235,SLITRK5,receptor complex,2.0
22401,26050,GO:0043588,SLITRK5,skin development,2.0
22402,26050,GO:0045202,SLITRK5,synapse,2.0
22403,26050,GO:0048813,SLITRK5,dendrite morphogenesis,2.0
22404,26050,GO:0051965,SLITRK5,positive regulation of synapse assembly,2.0
22405,26050,GO:1905606,SLITRK5,regulation of presynapse assembly,2.0
22406,4089,GO:0000122,SMAD4,negative regulation of transcription by RNA polymerase II,2.0
22408,4089,GO:0000785,SMAD4,chromatin,2.0
22411,4089,GO:0000976,SMAD4,transcription regulatory region sequence-specific DNA binding,2.0
22412,4089,GO:0000978,SMAD4,RNA polymerase II cis-regulatory region sequence-specific DNA binding,2.0
22414,4089,GO:0000981,SMAD4,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
22416,4089,GO:0001085,SMAD4,RNA polymerase II transcription factor binding,2.0
22417,4089,GO:0001223,SMAD4,transcription coactivator binding,2.0
22418,4089,GO:0001228,SMAD4,"DNA-binding transcription activator activity, RNA polymerase II-specific",2.0
22419,4089,GO:0001541,SMAD4,ovarian follicle development,2.0
22420,4089,GO:0001658,SMAD4,branching involved in ureteric bud morphogenesis,2.0
22421,4089,GO:0001666,SMAD4,response to hypoxia,2.0
22422,4089,GO:0001701,SMAD4,in utero embryonic development,2.0
22423,4089,GO:0001702,SMAD4,gastrulation with mouth forming second,2.0
22424,4089,GO:0003148,SMAD4,outflow tract septum morphogenesis,2.0
22425,4089,GO:0003190,SMAD4,atrioventricular valve formation,2.0
22426,4089,GO:0003198,SMAD4,epithelial to mesenchymal transition involved in endocardial cushion formation,2.0
22427,4089,GO:0003220,SMAD4,left ventricular cardiac muscle tissue morphogenesis,2.0
22428,4089,GO:0003251,SMAD4,positive regulation of cell proliferation involved in heart valve morphogenesis,2.0
22429,4089,GO:0003360,SMAD4,brainstem development,2.0
22430,4089,GO:0003677,SMAD4,DNA binding,2.0
22431,4089,GO:0003682,SMAD4,chromatin binding,2.0
22432,4089,GO:0003700,SMAD4,DNA-binding transcription factor activity,2.0
22433,4089,GO:0005515,SMAD4,protein binding,2.0
22434,4089,GO:0005518,SMAD4,collagen binding,2.0
22435,4089,GO:0005634,SMAD4,nucleus,2.0
22436,4089,GO:0005654,SMAD4,nucleoplasm,2.0
22438,4089,GO:0005667,SMAD4,transcription regulator complex,2.0
22440,4089,GO:0005737,SMAD4,cytoplasm,2.0
22441,4089,GO:0005813,SMAD4,centrosome,2.0
22442,4089,GO:0005829,SMAD4,cytosol,2.0
22444,4089,GO:0006357,SMAD4,regulation of transcription by RNA polymerase II,2.0
22445,4089,GO:0006879,SMAD4,cellular iron ion homeostasis,2.0
22446,4089,GO:0007179,SMAD4,transforming growth factor beta receptor signaling pathway,2.0
22451,4089,GO:0007183,SMAD4,SMAD protein complex assembly,2.0
22452,4089,GO:0007283,SMAD4,spermatogenesis,2.0
22453,4089,GO:0007338,SMAD4,single fertilization,2.0
22454,4089,GO:0007411,SMAD4,axon guidance,2.0
22455,4089,GO:0007492,SMAD4,endoderm development,2.0
22456,4089,GO:0007498,SMAD4,mesoderm development,2.0
22457,4089,GO:0008283,SMAD4,cell population proliferation,2.0
22458,4089,GO:0008285,SMAD4,negative regulation of cell population proliferation,2.0
22459,4089,GO:0009653,SMAD4,anatomical structure morphogenesis,2.0
22460,4089,GO:0010614,SMAD4,negative regulation of cardiac muscle hypertrophy,2.0
22461,4089,GO:0010718,SMAD4,positive regulation of epithelial to mesenchymal transition,2.0
22462,4089,GO:0010862,SMAD4,positive regulation of pathway-restricted SMAD protein phosphorylation,2.0
22463,4089,GO:0014033,SMAD4,neural crest cell differentiation,2.0
22464,4089,GO:0016579,SMAD4,protein deubiquitination,2.0
22465,4089,GO:0017015,SMAD4,regulation of transforming growth factor beta receptor signaling pathway,2.0
22466,4089,GO:0030154,SMAD4,cell differentiation,2.0
22467,4089,GO:0030308,SMAD4,negative regulation of cell growth,2.0
22468,4089,GO:0030509,SMAD4,BMP signaling pathway,2.0
22472,4089,GO:0030511,SMAD4,positive regulation of transforming growth factor beta receptor signaling pathway,2.0
22473,4089,GO:0030513,SMAD4,positive regulation of BMP signaling pathway,2.0
22474,4089,GO:0032444,SMAD4,activin responsive factor complex,2.0
22475,4089,GO:0032525,SMAD4,somite rostral/caudal axis specification,2.0
22476,4089,GO:0032909,SMAD4,regulation of transforming growth factor beta2 production,2.0
22477,4089,GO:0033686,SMAD4,positive regulation of luteinizing hormone secretion,2.0
22478,4089,GO:0035019,SMAD4,somatic stem cell population maintenance,2.0
22479,4089,GO:0035556,SMAD4,intracellular signal transduction,2.0
22480,4089,GO:0036302,SMAD4,atrioventricular canal development,2.0
22481,4089,GO:0042118,SMAD4,endothelial cell activation,2.0
22482,4089,GO:0042733,SMAD4,embryonic digit morphogenesis,2.0
22483,4089,GO:0042802,SMAD4,identical protein binding,2.0
22484,4089,GO:0042803,SMAD4,protein homodimerization activity,2.0
22485,4089,GO:0043199,SMAD4,sulfate binding,2.0
22486,4089,GO:0043565,SMAD4,sequence-specific DNA binding,2.0
22487,4089,GO:0045892,SMAD4,"negative regulation of transcription, DNA-templated",2.0
22488,4089,GO:0045893,SMAD4,"positive regulation of transcription, DNA-templated",2.0
22489,4089,GO:0045944,SMAD4,positive regulation of transcription by RNA polymerase II,2.0
22492,4089,GO:0046872,SMAD4,metal ion binding,2.0
22493,4089,GO:0046881,SMAD4,positive regulation of follicle-stimulating hormone secretion,2.0
22494,4089,GO:0048589,SMAD4,developmental growth,2.0
22495,4089,GO:0048663,SMAD4,neuron fate commitment,2.0
22496,4089,GO:0048733,SMAD4,sebaceous gland development,2.0
22497,4089,GO:0048859,SMAD4,formation of anatomical boundary,2.0
22498,4089,GO:0051098,SMAD4,regulation of binding,2.0
22499,4089,GO:0051571,SMAD4,positive regulation of histone H3-K4 methylation,2.0
22500,4089,GO:0051797,SMAD4,regulation of hair follicle development,2.0
22501,4089,GO:0060065,SMAD4,uterus development,2.0
22502,4089,GO:0060391,SMAD4,positive regulation of SMAD protein signal transduction,2.0
22503,4089,GO:0060395,SMAD4,SMAD protein signal transduction,2.0
22505,4089,GO:0060412,SMAD4,ventricular septum morphogenesis,2.0
22506,4089,GO:0060548,SMAD4,negative regulation of cell death,2.0
22507,4089,GO:0060956,SMAD4,endocardial cell differentiation,2.0
22508,4089,GO:0061040,SMAD4,female gonad morphogenesis,2.0
22509,4089,GO:0062009,SMAD4,secondary palate development,2.0
22510,4089,GO:0070102,SMAD4,interleukin-6-mediated signaling pathway,2.0
22511,4089,GO:0070373,SMAD4,negative regulation of ERK1 and ERK2 cascade,2.0
22512,4089,GO:0070411,SMAD4,I-SMAD binding,2.0
22514,4089,GO:0070412,SMAD4,R-SMAD binding,2.0
22515,4089,GO:0071141,SMAD4,SMAD protein complex,2.0
22517,4089,GO:0071144,SMAD4,heteromeric SMAD protein complex,2.0
22518,4089,GO:0071559,SMAD4,response to transforming growth factor beta,2.0
22519,4089,GO:0071773,SMAD4,cellular response to BMP stimulus,2.0
22520,4089,GO:0072133,SMAD4,metanephric mesenchyme morphogenesis,2.0
22521,4089,GO:0072134,SMAD4,nephrogenic mesenchyme morphogenesis,2.0
22522,4089,GO:0072520,SMAD4,seminiferous tubule development,2.0
22523,4089,GO:1901522,SMAD4,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,2.0
22524,4089,GO:1902895,SMAD4,positive regulation of pri-miRNA transcription by RNA polymerase II,2.0
22525,4089,GO:1905305,SMAD4,negative regulation of cardiac myofibril assembly,2.0
22526,4089,GO:2000617,SMAD4,positive regulation of histone H3-K9 acetylation,2.0
22563,6597,GO:0000122,SMARCA4,negative regulation of transcription by RNA polymerase II,2.0
22564,6597,GO:0000785,SMARCA4,chromatin,2.0
22566,6597,GO:0001164,SMARCA4,RNA polymerase I core promoter sequence-specific DNA binding,2.0
22567,6597,GO:0001188,SMARCA4,RNA polymerase I preinitiation complex assembly,2.0
22568,6597,GO:0002039,SMARCA4,p53 binding,2.0
22569,6597,GO:0003407,SMARCA4,neural retina development,2.0
22570,6597,GO:0003677,SMARCA4,DNA binding,2.0
22571,6597,GO:0003713,SMARCA4,transcription coactivator activity,2.0
22574,6597,GO:0003714,SMARCA4,transcription corepressor activity,2.0
22575,6597,GO:0003723,SMARCA4,RNA binding,2.0
22576,6597,GO:0004386,SMARCA4,helicase activity,2.0
22577,6597,GO:0005515,SMARCA4,protein binding,2.0
22578,6597,GO:0005524,SMARCA4,ATP binding,2.0
22579,6597,GO:0005615,SMARCA4,extracellular space,2.0
22580,6597,GO:0005634,SMARCA4,nucleus,2.0
22582,6597,GO:0005654,SMARCA4,nucleoplasm,2.0
22583,6597,GO:0005730,SMARCA4,nucleolus,2.0
22584,6597,GO:0006325,SMARCA4,chromatin organization,2.0
22585,6597,GO:0006337,SMARCA4,nucleosome disassembly,2.0
22586,6597,GO:0006338,SMARCA4,chromatin remodeling,2.0
22589,6597,GO:0006357,SMARCA4,regulation of transcription by RNA polymerase II,2.0
22590,6597,GO:0007399,SMARCA4,nervous system development,2.0
22591,6597,GO:0008094,SMARCA4,DNA-dependent ATPase activity,2.0
22593,6597,GO:0008134,SMARCA4,transcription factor binding,2.0
22595,6597,GO:0016020,SMARCA4,membrane,2.0
22596,6597,GO:0016514,SMARCA4,SWI/SNF complex,2.0
22597,6597,GO:0030177,SMARCA4,positive regulation of Wnt signaling pathway,2.0
22598,6597,GO:0030308,SMARCA4,negative regulation of cell growth,2.0
22599,6597,GO:0030957,SMARCA4,Tat protein binding,2.0
22600,6597,GO:0031492,SMARCA4,nucleosomal DNA binding,2.0
22601,6597,GO:0032991,SMARCA4,protein-containing complex,2.0
22602,6597,GO:0038111,SMARCA4,interleukin-7-mediated signaling pathway,2.0
22603,6597,GO:0043044,SMARCA4,ATP-dependent chromatin remodeling,2.0
22605,6597,GO:0043923,SMARCA4,positive regulation by host of viral transcription,2.0
22606,6597,GO:0045892,SMARCA4,"negative regulation of transcription, DNA-templated",2.0
22608,6597,GO:0045893,SMARCA4,"positive regulation of transcription, DNA-templated",2.0
22609,6597,GO:0045944,SMARCA4,positive regulation of transcription by RNA polymerase II,2.0
22612,6597,GO:0047485,SMARCA4,protein N-terminus binding,2.0
22613,6597,GO:0050681,SMARCA4,androgen receptor binding,2.0
22614,6597,GO:0051091,SMARCA4,positive regulation of DNA-binding transcription factor activity,2.0
22615,6597,GO:0060766,SMARCA4,negative regulation of androgen receptor signaling pathway,2.0
22616,6597,GO:0070182,SMARCA4,DNA polymerase binding,2.0
22617,6597,GO:0070577,SMARCA4,lysine-acetylated histone binding,2.0
22618,6597,GO:0071564,SMARCA4,npBAF complex,2.0
22620,6597,GO:0071565,SMARCA4,nBAF complex,2.0
22621,6597,GO:1901838,SMARCA4,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,2.0
22622,6597,GO:1902661,SMARCA4,positive regulation of glucose mediated signaling pathway,2.0
22623,6597,GO:1902895,SMARCA4,positive regulation of pri-miRNA transcription by RNA polymerase II,2.0
22624,6597,GO:1904837,SMARCA4,beta-catenin-TCF complex assembly,2.0
22890,27131,GO:0001726,SNX5,ruffle,2.0
22891,27131,GO:0001891,SNX5,phagocytic cup,2.0
22892,27131,GO:0005515,SNX5,protein binding,2.0
22893,27131,GO:0005768,SNX5,endosome,2.0
22894,27131,GO:0005829,SNX5,cytosol,2.0
22895,27131,GO:0005903,SNX5,brush border,2.0
22896,27131,GO:0006886,SNX5,intracellular protein transport,2.0
22897,27131,GO:0006907,SNX5,pinocytosis,2.0
22899,27131,GO:0007174,SNX5,epidermal growth factor catabolic process,2.0
22900,27131,GO:0010314,SNX5,phosphatidylinositol-5-phosphate binding,2.0
22901,27131,GO:0016241,SNX5,regulation of macroautophagy,2.0
22902,27131,GO:0030659,SNX5,cytoplasmic vesicle membrane,2.0
22903,27131,GO:0030904,SNX5,retromer complex,2.0
22904,27131,GO:0030905,SNX5,"retromer, tubulation complex",2.0
22905,27131,GO:0031234,SNX5,extrinsic component of cytoplasmic side of plasma membrane,2.0
22906,27131,GO:0031313,SNX5,extrinsic component of endosome membrane,2.0
22907,27131,GO:0031748,SNX5,D1 dopamine receptor binding,2.0
22908,27131,GO:0031901,SNX5,early endosome membrane,2.0
22909,27131,GO:0034452,SNX5,dynactin binding,2.0
22911,27131,GO:0035091,SNX5,phosphatidylinositol binding,2.0
22914,27131,GO:0035815,SNX5,positive regulation of renal sodium excretion,2.0
22915,27131,GO:0042147,SNX5,"retrograde transport, endosome to Golgi",2.0
22918,27131,GO:0043231,SNX5,intracellular membrane-bounded organelle,2.0
22919,27131,GO:0045296,SNX5,cadherin binding,2.0
22920,27131,GO:0045776,SNX5,negative regulation of blood pressure,2.0
22921,27131,GO:0045893,SNX5,"positive regulation of transcription, DNA-templated",2.0
22922,27131,GO:0046628,SNX5,positive regulation of insulin receptor signaling pathway,2.0
22923,27131,GO:0048471,SNX5,perinuclear region of cytoplasm,2.0
22924,27131,GO:0070273,SNX5,phosphatidylinositol-4-phosphate binding,2.0
22925,27131,GO:0070685,SNX5,macropinocytic cup,2.0
22926,27131,GO:0080025,SNX5,"phosphatidylinositol-3,5-bisphosphate binding",2.0
22927,27131,GO:0097422,SNX5,tubular endosome,2.0
22965,8404,GO:0005509,SPARCL1,calcium ion binding,2.0
22966,8404,GO:0005515,SPARCL1,protein binding,2.0
22967,8404,GO:0005518,SPARCL1,collagen binding,2.0
22968,8404,GO:0005576,SPARCL1,extracellular region,2.0
22969,8404,GO:0005615,SPARCL1,extracellular space,2.0
22971,8404,GO:0005788,SPARCL1,endoplasmic reticulum lumen,2.0
22972,8404,GO:0007165,SPARCL1,signal transduction,2.0
22973,8404,GO:0043687,SPARCL1,post-translational protein modification,2.0
22974,8404,GO:0044267,SPARCL1,cellular protein metabolic process,2.0
22975,8404,GO:0048856,SPARCL1,anatomical structure development,2.0
22976,8404,GO:0050840,SPARCL1,extracellular matrix binding,2.0
22977,8404,GO:0062023,SPARCL1,collagen-containing extracellular matrix,2.0
23032,23013,GO:0000122,SPEN,negative regulation of transcription by RNA polymerase II,2.0
23033,23013,GO:0000398,SPEN,"mRNA splicing, via spliceosome",2.0
23034,23013,GO:0001085,SPEN,RNA polymerase II transcription factor binding,2.0
23035,23013,GO:0003676,SPEN,nucleic acid binding,2.0
23036,23013,GO:0003677,SPEN,DNA binding,2.0
23037,23013,GO:0003714,SPEN,transcription corepressor activity,2.0
23038,23013,GO:0003723,SPEN,RNA binding,2.0
23039,23013,GO:0005515,SPEN,protein binding,2.0
23040,23013,GO:0005634,SPEN,nucleus,2.0
23041,23013,GO:0005654,SPEN,nucleoplasm,2.0
23042,23013,GO:0007219,SPEN,Notch signaling pathway,2.0
23043,23013,GO:0016032,SPEN,viral process,2.0
23044,23013,GO:0017053,SPEN,transcription repressor complex,2.0
23045,23013,GO:0045892,SPEN,"negative regulation of transcription, DNA-templated",2.0
23046,23013,GO:0050769,SPEN,positive regulation of neurogenesis,2.0
23047,23013,GO:0070062,SPEN,extracellular exosome,2.0
23090,9295,GO:0000398,SRSF11,"mRNA splicing, via spliceosome",2.0
23091,9295,GO:0003723,SRSF11,RNA binding,2.0
23093,9295,GO:0005515,SRSF11,protein binding,2.0
23094,9295,GO:0005634,SRSF11,nucleus,2.0
23095,9295,GO:0005654,SRSF11,nucleoplasm,2.0
23097,9295,GO:0006397,SRSF11,mRNA processing,2.0
23098,9295,GO:0006405,SRSF11,RNA export from nucleus,2.0
23099,9295,GO:0006406,SRSF11,mRNA export from nucleus,2.0
23100,9295,GO:0008380,SRSF11,RNA splicing,2.0
23101,9295,GO:0016607,SRSF11,nuclear speck,2.0
23102,9295,GO:0031124,SRSF11,mRNA 3'-end processing,2.0
23122,8128,GO:0000139,ST8SIA2,Golgi membrane,2.0
23123,8128,GO:0001574,ST8SIA2,ganglioside biosynthetic process,2.0
23124,8128,GO:0003828,ST8SIA2,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity",2.0
23126,8128,GO:0005769,ST8SIA2,early endosome,2.0
23127,8128,GO:0005975,ST8SIA2,carbohydrate metabolic process,2.0
23128,8128,GO:0006464,ST8SIA2,cellular protein modification process,2.0
23129,8128,GO:0006486,ST8SIA2,protein glycosylation,2.0
23132,8128,GO:0006491,ST8SIA2,N-glycan processing,2.0
23134,8128,GO:0007399,ST8SIA2,nervous system development,2.0
23135,8128,GO:0009311,ST8SIA2,oligosaccharide metabolic process,2.0
23137,8128,GO:0016021,ST8SIA2,integral component of membrane,2.0
23138,8128,GO:0033691,ST8SIA2,sialic acid binding,2.0
23139,8128,GO:0055037,ST8SIA2,recycling endosome,2.0
23140,8128,GO:0097503,ST8SIA2,sialylation,2.0
23287,22986,GO:0005515,SORCS3,protein binding,2.0
23288,22986,GO:0007218,SORCS3,neuropeptide signaling pathway,2.0
23289,22986,GO:0007612,SORCS3,learning,2.0
23290,22986,GO:0007613,SORCS3,memory,2.0
23291,22986,GO:0008188,SORCS3,neuropeptide receptor activity,2.0
23292,22986,GO:0016020,SORCS3,membrane,2.0
23293,22986,GO:0016021,SORCS3,integral component of membrane,2.0
23294,22986,GO:0098978,SORCS3,glutamatergic synapse,2.0
23295,22986,GO:0099061,SORCS3,integral component of postsynaptic density membrane,2.0
23296,22986,GO:1900452,SORCS3,regulation of long-term synaptic depression,2.0
23336,134957,GO:0005096,STXBP5,GTPase activator activity,2.0
23337,134957,GO:0005737,STXBP5,cytoplasm,2.0
23338,134957,GO:0005829,STXBP5,cytosol,2.0
23339,134957,GO:0005886,STXBP5,plasma membrane,2.0
23340,134957,GO:0005892,STXBP5,acetylcholine-gated channel complex,2.0
23341,134957,GO:0006887,STXBP5,exocytosis,2.0
23342,134957,GO:0008021,STXBP5,synaptic vesicle,2.0
23343,134957,GO:0015031,STXBP5,protein transport,2.0
23344,134957,GO:0017075,STXBP5,syntaxin-1 binding,2.0
23345,134957,GO:0017157,STXBP5,regulation of exocytosis,2.0
23347,134957,GO:0019905,STXBP5,syntaxin binding,2.0
23348,134957,GO:0030659,STXBP5,cytoplasmic vesicle membrane,2.0
23349,134957,GO:0031201,STXBP5,SNARE complex,2.0
23350,134957,GO:0031267,STXBP5,small GTPase binding,2.0
23351,134957,GO:0043547,STXBP5,positive regulation of GTPase activity,2.0
23352,134957,GO:0045159,STXBP5,myosin II binding,2.0
23353,134957,GO:0045921,STXBP5,positive regulation of exocytosis,2.0
23354,134957,GO:0050708,STXBP5,regulation of protein secretion,2.0
23355,134957,GO:0098888,STXBP5,extrinsic component of presynaptic membrane,2.0
23723,6878,GO:0000124,TAF6,SAGA complex,2.0
23724,6878,GO:0003677,TAF6,DNA binding,2.0
23725,6878,GO:0003713,TAF6,transcription coactivator activity,2.0
23726,6878,GO:0005515,TAF6,protein binding,2.0
23727,6878,GO:0005654,TAF6,nucleoplasm,2.0
23729,6878,GO:0005669,TAF6,transcription factor TFIID complex,2.0
23731,6878,GO:0005829,TAF6,cytosol,2.0
23732,6878,GO:0006352,TAF6,"DNA-templated transcription, initiation",2.0
23733,6878,GO:0006366,TAF6,transcription by RNA polymerase II,2.0
23735,6878,GO:0006367,TAF6,transcription initiation from RNA polymerase II promoter,2.0
23738,6878,GO:0006915,TAF6,apoptotic process,2.0
23739,6878,GO:0016251,TAF6,RNA polymerase II general transcription initiation factor activity,2.0
23742,6878,GO:0016573,TAF6,histone acetylation,2.0
23743,6878,GO:0017162,TAF6,aryl hydrocarbon receptor binding,2.0
23744,6878,GO:0032991,TAF6,protein-containing complex,2.0
23745,6878,GO:0033276,TAF6,transcription factor TFTC complex,2.0
23746,6878,GO:0042795,TAF6,snRNA transcription by RNA polymerase II,2.0
23747,6878,GO:0045786,TAF6,negative regulation of cell cycle,2.0
23748,6878,GO:0045944,TAF6,positive regulation of transcription by RNA polymerase II,2.0
23749,6878,GO:0046695,TAF6,SLIK (SAGA-like) complex,2.0
23750,6878,GO:0046982,TAF6,protein heterodimerization activity,2.0
23751,6878,GO:0071339,TAF6,MLL1 complex,2.0
23752,6878,GO:1901796,TAF6,regulation of signal transduction by p53 class mediator,2.0
23805,9344,GO:0000165,TAOK2,MAPK cascade,2.0
23806,9344,GO:0000186,TAOK2,activation of MAPKK activity,2.0
23807,9344,GO:0000187,TAOK2,activation of MAPK activity,2.0
23808,9344,GO:0001558,TAOK2,regulation of cell growth,2.0
23809,9344,GO:0004674,TAOK2,protein serine/threonine kinase activity,2.0
23812,9344,GO:0004709,TAOK2,MAP kinase kinase kinase activity,2.0
23813,9344,GO:0005515,TAOK2,protein binding,2.0
23814,9344,GO:0005524,TAOK2,ATP binding,2.0
23815,9344,GO:0005654,TAOK2,nucleoplasm,2.0
23816,9344,GO:0005730,TAOK2,nucleolus,2.0
23817,9344,GO:0005737,TAOK2,cytoplasm,2.0
23818,9344,GO:0005829,TAOK2,cytosol,2.0
23819,9344,GO:0006612,TAOK2,protein targeting to membrane,2.0
23820,9344,GO:0006915,TAOK2,apoptotic process,2.0
23821,9344,GO:0006974,TAOK2,cellular response to DNA damage stimulus,2.0
23822,9344,GO:0007095,TAOK2,mitotic G2 DNA damage checkpoint,2.0
23823,9344,GO:0007409,TAOK2,axonogenesis,2.0
23825,9344,GO:0008360,TAOK2,regulation of cell shape,2.0
23826,9344,GO:0015629,TAOK2,actin cytoskeleton,2.0
23827,9344,GO:0016021,TAOK2,integral component of membrane,2.0
23828,9344,GO:0016477,TAOK2,cell migration,2.0
23829,9344,GO:0023014,TAOK2,signal transduction by protein phosphorylation,2.0
23830,9344,GO:0030036,TAOK2,actin cytoskeleton organization,2.0
23831,9344,GO:0030424,TAOK2,axon,2.0
23832,9344,GO:0030659,TAOK2,cytoplasmic vesicle membrane,2.0
23833,9344,GO:0031098,TAOK2,stress-activated protein kinase signaling cascade,2.0
23834,9344,GO:0031410,TAOK2,cytoplasmic vesicle,2.0
23835,9344,GO:0031434,TAOK2,mitogen-activated protein kinase kinase binding,2.0
23836,9344,GO:0031954,TAOK2,positive regulation of protein autophosphorylation,2.0
23837,9344,GO:0032147,TAOK2,activation of protein kinase activity,2.0
23839,9344,GO:0032874,TAOK2,positive regulation of stress-activated MAPK cascade,2.0
23840,9344,GO:0032956,TAOK2,regulation of actin cytoskeleton organization,2.0
23841,9344,GO:0038191,TAOK2,neuropilin binding,2.0
23842,9344,GO:0043005,TAOK2,neuron projection,2.0
23843,9344,GO:0043235,TAOK2,receptor complex,2.0
23844,9344,GO:0044294,TAOK2,dendritic growth cone,2.0
23845,9344,GO:0044295,TAOK2,axonal growth cone,2.0
23846,9344,GO:0046330,TAOK2,positive regulation of JNK cascade,2.0
23848,9344,GO:0046777,TAOK2,protein autophosphorylation,2.0
23849,9344,GO:0048041,TAOK2,focal adhesion assembly,2.0
23850,9344,GO:0048156,TAOK2,tau protein binding,2.0
23851,9344,GO:0048812,TAOK2,neuron projection morphogenesis,2.0
23852,9344,GO:0050321,TAOK2,tau-protein kinase activity,2.0
23853,9344,GO:0051403,TAOK2,stress-activated MAPK cascade,2.0
23854,9344,GO:0106310,TAOK2,protein serine kinase activity,2.0
23855,9344,GO:0106311,TAOK2,protein threonine kinase activity,2.0
23856,9344,GO:0150019,TAOK2,basal dendrite morphogenesis,2.0
23857,9344,GO:0150020,TAOK2,basal dendrite arborization,2.0
23878,93594,GO:0005813,TBC1D31,centrosome,2.0
24111,11198,GO:0003723,SUPT16H,RNA binding,2.0
24112,11198,GO:0005515,SUPT16H,protein binding,2.0
24113,11198,GO:0005654,SUPT16H,nucleoplasm,2.0
24115,11198,GO:0006260,SUPT16H,DNA replication,2.0
24116,11198,GO:0006281,SUPT16H,DNA repair,2.0
24117,11198,GO:0006337,SUPT16H,nucleosome disassembly,2.0
24118,11198,GO:0006366,SUPT16H,transcription by RNA polymerase II,2.0
24119,11198,GO:0006368,SUPT16H,transcription elongation from RNA polymerase II promoter,2.0
24121,11198,GO:0016032,SUPT16H,viral process,2.0
24122,11198,GO:0031491,SUPT16H,nucleosome binding,2.0
24123,11198,GO:0032786,SUPT16H,"positive regulation of DNA-templated transcription, elongation",2.0
24124,11198,GO:0032968,SUPT16H,positive regulation of transcription elongation from RNA polymerase II promoter,2.0
24125,11198,GO:0034724,SUPT16H,DNA replication-independent nucleosome organization,2.0
24126,11198,GO:0035101,SUPT16H,FACT complex,2.0
24127,11198,GO:1901796,SUPT16H,regulation of signal transduction by p53 class mediator,2.0
24418,7014,GO:0000723,TERF2,telomere maintenance,2.0
24419,7014,GO:0000781,TERF2,"chromosome, telomeric region",2.0
24421,7014,GO:0000783,TERF2,nuclear telomere cap complex,2.0
24422,7014,GO:0003691,TERF2,double-stranded telomeric DNA binding,2.0
24425,7014,GO:0003720,TERF2,telomerase activity,2.0
24427,7014,GO:0005515,TERF2,protein binding,2.0
24428,7014,GO:0005634,TERF2,nucleus,2.0
24429,7014,GO:0005654,TERF2,nucleoplasm,2.0
24431,7014,GO:0006278,TERF2,RNA-dependent DNA biosynthetic process,2.0
24432,7014,GO:0007049,TERF2,cell cycle,2.0
24433,7014,GO:0008022,TERF2,protein C-terminus binding,2.0
24434,7014,GO:0010628,TERF2,positive regulation of gene expression,2.0
24435,7014,GO:0010629,TERF2,negative regulation of gene expression,2.0
24436,7014,GO:0016233,TERF2,telomere capping,2.0
24439,7014,GO:0016604,TERF2,nuclear body,2.0
24440,7014,GO:0019899,TERF2,enzyme binding,2.0
24441,7014,GO:0030870,TERF2,Mre11 complex,2.0
24442,7014,GO:0031627,TERF2,telomeric loop formation,2.0
24444,7014,GO:0031848,TERF2,protection from non-homologous end joining at telomere,2.0
24447,7014,GO:0032204,TERF2,regulation of telomere maintenance,2.0
24448,7014,GO:0032205,TERF2,negative regulation of telomere maintenance,2.0
24449,7014,GO:0032208,TERF2,negative regulation of telomere maintenance via recombination,2.0
24452,7014,GO:0032210,TERF2,regulation of telomere maintenance via telomerase,2.0
24455,7014,GO:0032211,TERF2,negative regulation of telomere maintenance via telomerase,2.0
24458,7014,GO:0032214,TERF2,negative regulation of telomere maintenance via semi-conservative replication,2.0
24459,7014,GO:0042162,TERF2,telomeric DNA binding,2.0
24460,7014,GO:0042803,TERF2,protein homodimerization activity,2.0
24461,7014,GO:0044877,TERF2,protein-containing complex binding,2.0
24462,7014,GO:0051000,TERF2,positive regulation of nitric-oxide synthase activity,2.0
24463,7014,GO:0061820,TERF2,telomeric D-loop disassembly,2.0
24465,7014,GO:0070187,TERF2,shelterin complex,2.0
24469,7014,GO:0070198,TERF2,"protein localization to chromosome, telomeric region",2.0
24471,7014,GO:0090398,TERF2,cellular senescence,2.0
24472,7014,GO:0098505,TERF2,G-rich strand telomeric DNA binding,2.0
24474,7014,GO:1903770,TERF2,negative regulation of beta-galactosidase activity,2.0
24475,7014,GO:1903824,TERF2,negative regulation of telomere single strand break repair,2.0
24476,7014,GO:1904354,TERF2,negative regulation of telomere capping,2.0
24477,7014,GO:1904357,TERF2,negative regulation of telomere maintenance via telomere lengthening,2.0
24478,7014,GO:1904430,TERF2,negative regulation of t-circle formation,2.0
24480,7014,GO:1905778,TERF2,negative regulation of exonuclease activity,2.0
24481,7014,GO:1905839,TERF2,negative regulation of telomeric D-loop disassembly,2.0
24483,7014,GO:2000773,TERF2,negative regulation of cellular senescence,2.0
24494,54790,GO:0003677,TET2,DNA binding,2.0
24495,54790,GO:0005515,TET2,protein binding,2.0
24496,54790,GO:0005634,TET2,nucleus,2.0
24497,54790,GO:0006211,TET2,5-methylcytosine catabolic process,2.0
24498,54790,GO:0006493,TET2,protein O-linked glycosylation,2.0
24500,54790,GO:0007049,TET2,cell cycle,2.0
24501,54790,GO:0008198,TET2,ferrous iron binding,2.0
24502,54790,GO:0008270,TET2,zinc ion binding,2.0
24503,54790,GO:0014070,TET2,response to organic cyclic compound,2.0
24504,54790,GO:0030099,TET2,myeloid cell differentiation,2.0
24506,54790,GO:0045944,TET2,positive regulation of transcription by RNA polymerase II,2.0
24508,54790,GO:0070579,TET2,methylcytosine dioxygenase activity,2.0
24512,54790,GO:0070989,TET2,oxidative demethylation,2.0
24513,54790,GO:0080111,TET2,DNA demethylation,2.0
24515,54790,GO:0080182,TET2,histone H3-K4 trimethylation,2.0
24708,55217,GO:0005506,TMLHE,iron ion binding,2.0
24709,55217,GO:0005739,TMLHE,mitochondrion,2.0
24711,55217,GO:0005759,TMLHE,mitochondrial matrix,2.0
24712,55217,GO:0016702,TMLHE,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",2.0
24713,55217,GO:0045329,TMLHE,carnitine biosynthetic process,2.0
24717,55217,GO:0050353,TMLHE,trimethyllysine dioxygenase activity,2.0
24718,55217,GO:0055114,TMLHE,oxidation-reduction process,2.0
24719,23112,GO:0000932,TNRC6B,P-body,2.0
24720,23112,GO:0003723,TNRC6B,RNA binding,2.0
24721,23112,GO:0005515,TNRC6B,protein binding,2.0
24722,23112,GO:0005654,TNRC6B,nucleoplasm,2.0
24723,23112,GO:0005829,TNRC6B,cytosol,2.0
24724,23112,GO:0007223,TNRC6B,"Wnt signaling pathway, calcium modulating pathway",2.0
24725,23112,GO:0010628,TNRC6B,positive regulation of gene expression,2.0
24726,23112,GO:0010629,TNRC6B,negative regulation of gene expression,2.0
24727,23112,GO:0031047,TNRC6B,gene silencing by RNA,2.0
24728,23112,GO:0035194,TNRC6B,post-transcriptional gene silencing by RNA,2.0
24729,23112,GO:0035195,TNRC6B,gene silencing by miRNA,2.0
24730,23112,GO:0035278,TNRC6B,miRNA mediated inhibition of translation,2.0
24731,23112,GO:0045652,TNRC6B,regulation of megakaryocyte differentiation,2.0
24732,23112,GO:0060213,TNRC6B,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,2.0
24734,23112,GO:1900153,TNRC6B,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2.0
24735,23112,GO:1905618,TNRC6B,positive regulation of miRNA mediated inhibition of translation,2.0
24771,83696,GO:0000139,TRAPPC9,Golgi membrane,2.0
24772,83696,GO:0005515,TRAPPC9,protein binding,2.0
24773,83696,GO:0005783,TRAPPC9,endoplasmic reticulum,2.0
24774,83696,GO:0005802,TRAPPC9,trans-Golgi network,2.0
24775,83696,GO:0005829,TRAPPC9,cytosol,2.0
24776,83696,GO:0021987,TRAPPC9,cerebral cortex development,2.0
24777,83696,GO:0030008,TRAPPC9,TRAPP complex,2.0
24778,83696,GO:0030182,TRAPPC9,neuron differentiation,2.0
24779,83696,GO:0048208,TRAPPC9,COPII vesicle coating,2.0
24780,83696,GO:0051092,TRAPPC9,positive regulation of NF-kappaB transcription factor activity,2.0
24820,7225,GO:0003779,TRPC6,actin binding,2.0
24821,7225,GO:0005261,TRPC6,cation channel activity,2.0
24822,7225,GO:0005515,TRPC6,protein binding,2.0
24823,7225,GO:0005737,TRPC6,cytoplasm,2.0
24824,7225,GO:0005886,TRPC6,plasma membrane,2.0
24826,7225,GO:0005887,TRPC6,integral component of plasma membrane,2.0
24827,7225,GO:0006812,TRPC6,cation transport,2.0
24828,7225,GO:0006828,TRPC6,manganese ion transport,2.0
24829,7225,GO:0007204,TRPC6,positive regulation of cytosolic calcium ion concentration,2.0
24830,7225,GO:0007338,TRPC6,single fertilization,2.0
24831,7225,GO:0007568,TRPC6,aging,2.0
24832,7225,GO:0010800,TRPC6,positive regulation of peptidyl-threonine phosphorylation,2.0
24833,7225,GO:0015279,TRPC6,store-operated calcium channel activity,2.0
24834,7225,GO:0016020,TRPC6,membrane,2.0
24835,7225,GO:0030168,TRPC6,platelet activation,2.0
24836,7225,GO:0030182,TRPC6,neuron differentiation,2.0
24837,7225,GO:0030276,TRPC6,clathrin binding,2.0
24838,7225,GO:0032414,TRPC6,positive regulation of ion transmembrane transporter activity,2.0
24839,7225,GO:0034703,TRPC6,cation channel complex,2.0
24840,7225,GO:0036057,TRPC6,slit diaphragm,2.0
24841,7225,GO:0042803,TRPC6,protein homodimerization activity,2.0
24842,7225,GO:0042805,TRPC6,actinin binding,2.0
24843,7225,GO:0045666,TRPC6,positive regulation of neuron differentiation,2.0
24844,7225,GO:0050774,TRPC6,negative regulation of dendrite morphogenesis,2.0
24845,7225,GO:0051117,TRPC6,ATPase binding,2.0
24846,7225,GO:0051480,TRPC6,regulation of cytosolic calcium ion concentration,2.0
24847,7225,GO:0051928,TRPC6,positive regulation of calcium ion transport,2.0
24848,7225,GO:0070301,TRPC6,cellular response to hydrogen peroxide,2.0
24849,7225,GO:0070588,TRPC6,calcium ion transmembrane transport,2.0
24851,7225,GO:0070679,TRPC6,"inositol 1,4,5 trisphosphate binding",2.0
24853,7225,GO:0071456,TRPC6,cellular response to hypoxia,2.0
24854,4308,GO:0005261,TRPM1,cation channel activity,2.0
24855,4308,GO:0005262,TRPM1,calcium channel activity,2.0
24857,4308,GO:0005886,TRPM1,plasma membrane,2.0
24858,4308,GO:0005887,TRPM1,integral component of plasma membrane,2.0
24859,4308,GO:0007216,TRPM1,G protein-coupled glutamate receptor signaling pathway,2.0
24860,4308,GO:0007601,TRPM1,visual perception,2.0
24861,4308,GO:0035841,TRPM1,new growing cell tip,2.0
24862,4308,GO:0046548,TRPM1,retinal rod cell development,2.0
24863,4308,GO:0051262,TRPM1,protein tetramerization,2.0
24864,4308,GO:0060402,TRPM1,calcium ion transport into cytosol,2.0
24866,4308,GO:0070588,TRPM1,calcium ion transmembrane transport,2.0
24867,4308,GO:0070838,TRPM1,divalent metal ion transport,2.0
24868,4308,GO:0071482,TRPM1,cellular response to light stimulus,2.0
24869,4308,GO:0098655,TRPM1,cation transmembrane transport,2.0
25413,9690,GO:0000209,UBE3C,protein polyubiquitination,2.0
25415,9690,GO:0000502,UBE3C,proteasome complex,2.0
25416,9690,GO:0005515,UBE3C,protein binding,2.0
25417,9690,GO:0005634,UBE3C,nucleus,2.0
25418,9690,GO:0006511,UBE3C,ubiquitin-dependent protein catabolic process,2.0
25419,9690,GO:0061630,UBE3C,ubiquitin protein ligase activity,2.0
25420,254048,GO:0005615,UBN2,extracellular space,2.0
25421,254048,GO:0005654,UBN2,nucleoplasm,2.0
25422,51366,GO:0000209,UBR5,protein polyubiquitination,2.0
25424,51366,GO:0003723,UBR5,RNA binding,2.0
25425,51366,GO:0005515,UBR5,protein binding,2.0
25426,51366,GO:0005634,UBR5,nucleus,2.0
25428,51366,GO:0005654,UBR5,nucleoplasm,2.0
25429,51366,GO:0005829,UBR5,cytosol,2.0
25430,51366,GO:0006281,UBR5,DNA repair,2.0
25431,51366,GO:0006974,UBR5,cellular response to DNA damage stimulus,2.0
25434,51366,GO:0008270,UBR5,zinc ion binding,2.0
25435,51366,GO:0010628,UBR5,positive regulation of gene expression,2.0
25436,51366,GO:0016020,UBR5,membrane,2.0
25437,51366,GO:0016032,UBR5,viral process,2.0
25438,51366,GO:0032991,UBR5,protein-containing complex,2.0
25439,51366,GO:0034450,UBR5,ubiquitin-ubiquitin ligase activity,2.0
25440,51366,GO:0042307,UBR5,positive regulation of protein import into nucleus,2.0
25441,51366,GO:0043130,UBR5,ubiquitin binding,2.0
25442,51366,GO:0048471,UBR5,perinuclear region of cytoplasm,2.0
25443,51366,GO:0050847,UBR5,progesterone receptor signaling pathway,2.0
25444,51366,GO:0061630,UBR5,ubiquitin protein ligase activity,2.0
25445,51366,GO:0070936,UBR5,protein K48-linked ubiquitination,2.0
25446,51366,GO:0090263,UBR5,positive regulation of canonical Wnt signaling pathway,2.0
25447,51366,GO:1901315,UBR5,negative regulation of histone H2A K63-linked ubiquitination,2.0
25449,51366,GO:2000779,UBR5,regulation of double-strand break repair,2.0
25450,51366,GO:2000780,UBR5,negative regulation of double-strand break repair,2.0
25511,57578,GO:0005886,UNC79,plasma membrane,2.0
25512,57578,GO:0016021,UNC79,integral component of membrane,2.0
25513,57578,GO:0034220,UNC79,ion transmembrane transport,2.0
25514,57578,GO:0035264,UNC79,multicellular organism growth,2.0
25515,57578,GO:0048149,UNC79,behavioral response to ethanol,2.0
25602,9958,GO:0004197,USP15,cysteine-type endopeptidase activity,2.0
25603,9958,GO:0004843,USP15,thiol-dependent ubiquitin-specific protease activity,2.0
25604,9958,GO:0005160,USP15,transforming growth factor beta receptor binding,2.0
25605,9958,GO:0005515,USP15,protein binding,2.0
25606,9958,GO:0005634,USP15,nucleus,2.0
25608,9958,GO:0005737,USP15,cytoplasm,2.0
25609,9958,GO:0005739,USP15,mitochondrion,2.0
25610,9958,GO:0005829,USP15,cytosol,2.0
25612,9958,GO:0006511,USP15,ubiquitin-dependent protein catabolic process,2.0
25613,9958,GO:0007179,USP15,transforming growth factor beta receptor signaling pathway,2.0
25615,9958,GO:0016032,USP15,viral process,2.0
25616,9958,GO:0016579,USP15,protein deubiquitination,2.0
25618,9958,GO:0030509,USP15,BMP signaling pathway,2.0
25619,9958,GO:0035520,USP15,monoubiquitinated protein deubiquitination,2.0
25620,9958,GO:0035616,USP15,histone H2B conserved C-terminal lysine deubiquitination,2.0
25621,9958,GO:0042802,USP15,identical protein binding,2.0
25622,9958,GO:0046332,USP15,SMAD binding,2.0
25623,9958,GO:0060389,USP15,pathway-restricted SMAD protein phosphorylation,2.0
25624,9958,GO:0061649,USP15,ubiquitin modification-dependent histone binding,2.0
25625,9958,GO:0071108,USP15,protein K48-linked deubiquitination,2.0
25626,9958,GO:1900246,USP15,positive regulation of RIG-I signaling pathway,2.0
25627,9958,GO:1990380,USP15,Lys48-specific deubiquitinase activity,2.0
25628,85015,GO:0001917,USP45,photoreceptor inner segment,2.0
25629,85015,GO:0003407,USP45,neural retina development,2.0
25630,85015,GO:0004843,USP45,thiol-dependent ubiquitin-specific protease activity,2.0
25633,85015,GO:0005515,USP45,protein binding,2.0
25634,85015,GO:0005634,USP45,nucleus,2.0
25635,85015,GO:0005654,USP45,nucleoplasm,2.0
25636,85015,GO:0005737,USP45,cytoplasm,2.0
25637,85015,GO:0006281,USP45,DNA repair,2.0
25638,85015,GO:0006511,USP45,ubiquitin-dependent protein catabolic process,2.0
25639,85015,GO:0008234,USP45,cysteine-type peptidase activity,2.0
25640,85015,GO:0008270,USP45,zinc ion binding,2.0
25641,85015,GO:0016477,USP45,cell migration,2.0
25642,85015,GO:0016579,USP45,protein deubiquitination,2.0
25644,85015,GO:0045494,USP45,photoreceptor cell maintenance,2.0
25645,85015,GO:0070911,USP45,global genome nucleotide-excision repair,2.0
25646,7874,GO:0002039,USP7,p53 binding,2.0
25647,7874,GO:0004197,USP7,cysteine-type endopeptidase activity,2.0
25649,7874,GO:0004843,USP7,thiol-dependent ubiquitin-specific protease activity,2.0
25653,7874,GO:0005515,USP7,protein binding,2.0
25654,7874,GO:0005634,USP7,nucleus,2.0
25657,7874,GO:0005654,USP7,nucleoplasm,2.0
25658,7874,GO:0005694,USP7,chromosome,2.0
25659,7874,GO:0005829,USP7,cytosol,2.0
25662,7874,GO:0006111,USP7,regulation of gluconeogenesis,2.0
25663,7874,GO:0006283,USP7,transcription-coupled nucleotide-excision repair,2.0
25665,7874,GO:0006511,USP7,ubiquitin-dependent protein catabolic process,2.0
25666,7874,GO:0007275,USP7,multicellular organism development,2.0
25667,7874,GO:0008022,USP7,protein C-terminus binding,2.0
25668,7874,GO:0008134,USP7,transcription factor binding,2.0
25669,7874,GO:0010216,USP7,maintenance of DNA methylation,2.0
25670,7874,GO:0016032,USP7,viral process,2.0
25671,7874,GO:0016567,USP7,protein ubiquitination,2.0
25672,7874,GO:0016579,USP7,protein deubiquitination,2.0
25676,7874,GO:0016604,USP7,nuclear body,2.0
25677,7874,GO:0016605,USP7,PML body,2.0
25678,7874,GO:0031625,USP7,ubiquitin protein ligase binding,2.0
25679,7874,GO:0031647,USP7,regulation of protein stability,2.0
25681,7874,GO:0032088,USP7,negative regulation of NF-kappaB transcription factor activity,2.0
25682,7874,GO:0032435,USP7,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,2.0
25683,7874,GO:0032991,USP7,protein-containing complex,2.0
25684,7874,GO:0035520,USP7,monoubiquitinated protein deubiquitination,2.0
25685,7874,GO:0035616,USP7,histone H2B conserved C-terminal lysine deubiquitination,2.0
25686,7874,GO:0042752,USP7,regulation of circadian rhythm,2.0
25687,7874,GO:0048511,USP7,rhythmic process,2.0
25688,7874,GO:0050821,USP7,protein stabilization,2.0
25690,7874,GO:0051090,USP7,regulation of DNA-binding transcription factor activity,2.0
25691,7874,GO:0070536,USP7,protein K63-linked deubiquitination,2.0
25692,7874,GO:0071108,USP7,protein K48-linked deubiquitination,2.0
25693,7874,GO:0101005,USP7,ubiquitinyl hydrolase activity,2.0
25694,7874,GO:1901537,USP7,positive regulation of DNA demethylation,2.0
25695,7874,GO:1904353,USP7,regulation of telomere capping,2.0
25696,7874,GO:1990380,USP7,Lys48-specific deubiquitinase activity,2.0
25823,7429,GO:0001726,VIL1,ruffle,2.0
25824,7429,GO:0001951,VIL1,intestinal D-glucose absorption,2.0
25825,7429,GO:0005509,VIL1,calcium ion binding,2.0
25827,7429,GO:0005515,VIL1,protein binding,2.0
25828,7429,GO:0005546,VIL1,"phosphatidylinositol-4,5-bisphosphate binding",2.0
25830,7429,GO:0005737,VIL1,cytoplasm,2.0
25831,7429,GO:0005886,VIL1,plasma membrane,2.0
25832,7429,GO:0005902,VIL1,microvillus,2.0
25833,7429,GO:0005903,VIL1,brush border,2.0
25834,7429,GO:0006915,VIL1,apoptotic process,2.0
25835,7429,GO:0007173,VIL1,epidermal growth factor receptor signaling pathway,2.0
25836,7429,GO:0008154,VIL1,actin polymerization or depolymerization,2.0
25837,7429,GO:0008360,VIL1,regulation of cell shape,2.0
25838,7429,GO:0009617,VIL1,response to bacterium,2.0
25839,7429,GO:0010634,VIL1,positive regulation of epithelial cell migration,2.0
25842,7429,GO:0015629,VIL1,actin cytoskeleton,2.0
25843,7429,GO:0030027,VIL1,lamellipodium,2.0
25845,7429,GO:0030041,VIL1,actin filament polymerization,2.0
25846,7429,GO:0030042,VIL1,actin filament depolymerization,2.0
25847,7429,GO:0030175,VIL1,filopodium,2.0
25848,7429,GO:0030335,VIL1,positive regulation of cell migration,2.0
25849,7429,GO:0030836,VIL1,positive regulation of actin filament depolymerization,2.0
25850,7429,GO:0030855,VIL1,epithelial cell differentiation,2.0
25851,7429,GO:0032233,VIL1,positive regulation of actin filament bundle assembly,2.0
25852,7429,GO:0032432,VIL1,actin filament bundle,2.0
25853,7429,GO:0032433,VIL1,filopodium tip,2.0
25854,7429,GO:0032532,VIL1,regulation of microvillus length,2.0
25855,7429,GO:0035727,VIL1,lysophosphatidic acid binding,2.0
25856,7429,GO:0035729,VIL1,cellular response to hepatocyte growth factor stimulus,2.0
25857,7429,GO:0040018,VIL1,positive regulation of multicellular organism growth,2.0
25858,7429,GO:0042802,VIL1,identical protein binding,2.0
25859,7429,GO:0042803,VIL1,protein homodimerization activity,2.0
25860,7429,GO:0043027,VIL1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,2.0
25861,7429,GO:0043154,VIL1,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,2.0
25862,7429,GO:0045010,VIL1,actin nucleation,2.0
25863,7429,GO:0051014,VIL1,actin filament severing,2.0
25865,7429,GO:0051015,VIL1,actin filament binding,2.0
25867,7429,GO:0051016,VIL1,barbed-end actin filament capping,2.0
25869,7429,GO:0051125,VIL1,regulation of actin nucleation,2.0
25870,7429,GO:0051693,VIL1,actin filament capping,2.0
25871,7429,GO:0060327,VIL1,cytoplasmic actin-based contraction involved in cell motility,2.0
25872,7429,GO:0061041,VIL1,regulation of wound healing,2.0
25873,7429,GO:0065003,VIL1,protein-containing complex assembly,2.0
25874,7429,GO:0070062,VIL1,extracellular exosome,2.0
25875,7429,GO:0071364,VIL1,cellular response to epidermal growth factor stimulus,2.0
25876,7429,GO:1902896,VIL1,terminal web assembly,2.0
25877,7429,GO:1903078,VIL1,positive regulation of protein localization to plasma membrane,2.0
25878,7429,GO:2000392,VIL1,regulation of lamellipodium morphogenesis,2.0
25880,7429,GO:2000394,VIL1,positive regulation of lamellipodium morphogenesis,2.0
26126,57705,GO:0005769,WDFY4,early endosome,2.0
26127,57705,GO:0005783,WDFY4,endoplasmic reticulum,2.0
26128,57705,GO:0006914,WDFY4,autophagy,2.0
26261,51741,GO:0000122,WWOX,negative regulation of transcription by RNA polymerase II,2.0
26262,51741,GO:0001649,WWOX,osteoblast differentiation,2.0
26263,51741,GO:0003713,WWOX,transcription coactivator activity,2.0
26264,51741,GO:0005515,WWOX,protein binding,2.0
26265,51741,GO:0005634,WWOX,nucleus,2.0
26266,51741,GO:0005654,WWOX,nucleoplasm,2.0
26267,51741,GO:0005737,WWOX,cytoplasm,2.0
26268,51741,GO:0005739,WWOX,mitochondrion,2.0
26269,51741,GO:0005794,WWOX,Golgi apparatus,2.0
26270,51741,GO:0005829,WWOX,cytosol,2.0
26272,51741,GO:0005886,WWOX,plasma membrane,2.0
26273,51741,GO:0005902,WWOX,microvillus,2.0
26274,51741,GO:0016055,WWOX,Wnt signaling pathway,2.0
26275,51741,GO:0016491,WWOX,oxidoreductase activity,2.0
26276,51741,GO:0019899,WWOX,enzyme binding,2.0
26277,51741,GO:0030178,WWOX,negative regulation of Wnt signaling pathway,2.0
26278,51741,GO:0045944,WWOX,positive regulation of transcription by RNA polymerase II,2.0
26279,51741,GO:0048705,WWOX,skeletal system morphogenesis,2.0
26280,51741,GO:0055114,WWOX,oxidation-reduction process,2.0
26281,51741,GO:0071560,WWOX,cellular response to transforming growth factor beta stimulus,2.0
26282,51741,GO:0072332,WWOX,intrinsic apoptotic signaling pathway by p53 class mediator,2.0
26283,51741,GO:0090575,WWOX,RNA polymerase II transcription regulator complex,2.0
26284,51741,GO:0097191,WWOX,extrinsic apoptotic signaling pathway,2.0
26285,51741,GO:2001238,WWOX,positive regulation of extrinsic apoptotic signaling pathway,2.0
26286,51741,GO:2001241,WWOX,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,2.0
26706,23211,GO:0000785,ZC3H4,chromatin,2.0
26707,23211,GO:0000981,ZC3H4,"DNA-binding transcription factor activity, RNA polymerase II-specific",2.0
26708,23211,GO:0003723,ZC3H4,RNA binding,2.0
26709,23211,GO:0005634,ZC3H4,nucleus,2.0
26710,23211,GO:0005654,ZC3H4,nucleoplasm,2.0
26711,23211,GO:0005829,ZC3H4,cytosol,2.0
26712,23211,GO:0006357,ZC3H4,regulation of transcription by RNA polymerase II,2.0
26713,23211,GO:0046872,ZC3H4,metal ion binding,2.0
26727,10771,GO:0003690,ZMYND11,double-stranded DNA binding,2.0
26728,10771,GO:0003714,ZMYND11,transcription corepressor activity,2.0
26729,10771,GO:0005515,ZMYND11,protein binding,2.0
26730,10771,GO:0005634,ZMYND11,nucleus,2.0
26731,10771,GO:0005654,ZMYND11,nucleoplasm,2.0
26732,10771,GO:0005694,ZMYND11,chromosome,2.0
26733,10771,GO:0006325,ZMYND11,chromatin organization,2.0
26734,10771,GO:0007049,ZMYND11,cell cycle,2.0
26735,10771,GO:0008270,ZMYND11,zinc ion binding,2.0
26737,10771,GO:0016032,ZMYND11,viral process,2.0
26738,10771,GO:0034243,ZMYND11,regulation of transcription elongation from RNA polymerase II promoter,2.0
26739,10771,GO:0035064,ZMYND11,methylated histone binding,2.0
26741,10771,GO:0043124,ZMYND11,negative regulation of I-kappaB kinase/NF-kappaB signaling,2.0
26742,10771,GO:0045892,ZMYND11,"negative regulation of transcription, DNA-templated",2.0
26743,10771,GO:0046329,ZMYND11,negative regulation of JNK cascade,2.0
26744,10771,GO:0051607,ZMYND11,defense response to virus,2.0
26745,10771,GO:2001237,ZMYND11,negative regulation of extrinsic apoptotic signaling pathway,2.0
26758,57178,GO:0000785,ZMIZ1,chromatin,2.0
26759,57178,GO:0001570,ZMIZ1,vasculogenesis,2.0
26760,57178,GO:0001701,ZMIZ1,in utero embryonic development,2.0
26761,57178,GO:0003007,ZMIZ1,heart morphogenesis,2.0
26762,57178,GO:0003713,ZMIZ1,transcription coactivator activity,2.0
26763,57178,GO:0005634,ZMIZ1,nucleus,2.0
26764,57178,GO:0005654,ZMIZ1,nucleoplasm,2.0
26765,57178,GO:0005737,ZMIZ1,cytoplasm,2.0
26766,57178,GO:0006357,ZMIZ1,regulation of transcription by RNA polymerase II,2.0
26767,57178,GO:0007179,ZMIZ1,transforming growth factor beta receptor signaling pathway,2.0
26768,57178,GO:0007296,ZMIZ1,vitellogenesis,2.0
26769,57178,GO:0007569,ZMIZ1,cell aging,2.0
26770,57178,GO:0008270,ZMIZ1,zinc ion binding,2.0
26771,57178,GO:0021852,ZMIZ1,pyramidal neuron migration,2.0
26772,57178,GO:0030374,ZMIZ1,nuclear receptor coactivator activity,2.0
26773,57178,GO:0030521,ZMIZ1,androgen receptor signaling pathway,2.0
26774,57178,GO:0033233,ZMIZ1,regulation of protein sumoylation,2.0
26775,57178,GO:0043231,ZMIZ1,intracellular membrane-bounded organelle,2.0
26776,57178,GO:0045582,ZMIZ1,positive regulation of T cell differentiation,2.0
26777,57178,GO:0045747,ZMIZ1,positive regulation of Notch signaling pathway,2.0
26778,57178,GO:0045944,ZMIZ1,positive regulation of transcription by RNA polymerase II,2.0
26779,57178,GO:0046332,ZMIZ1,SMAD binding,2.0
26780,57178,GO:0048096,ZMIZ1,chromatin-mediated maintenance of transcription,2.0
26781,57178,GO:0048146,ZMIZ1,positive regulation of fibroblast proliferation,2.0
26782,57178,GO:0048589,ZMIZ1,developmental growth,2.0
26783,57178,GO:0048844,ZMIZ1,artery morphogenesis,2.0
26784,57178,GO:0060395,ZMIZ1,SMAD protein signal transduction,2.0
26785,57178,GO:1903508,ZMIZ1,positive regulation of nucleic acid-templated transcription,2.0
26861,91752,GO:0003674,ZNF804A,molecular_function,2.0
26862,91752,GO:0005634,ZNF804A,nucleus,2.0
26864,91752,GO:0005737,ZNF804A,cytoplasm,2.0
26865,91752,GO:0005886,ZNF804A,plasma membrane,2.0
26866,91752,GO:0010628,ZNF804A,positive regulation of gene expression,2.0
26867,91752,GO:0010975,ZNF804A,regulation of neuron projection development,2.0
26868,91752,GO:0010976,ZNF804A,positive regulation of neuron projection development,2.0
26869,91752,GO:0030426,ZNF804A,growth cone,2.0
26870,91752,GO:0043025,ZNF804A,neuronal cell body,2.0
26871,91752,GO:0043197,ZNF804A,dendritic spine,2.0
26872,91752,GO:0043198,ZNF804A,dendritic shaft,2.0
26873,91752,GO:0046872,ZNF804A,metal ion binding,2.0
26874,91752,GO:0098793,ZNF804A,presynapse,2.0
26875,91752,GO:0098794,ZNF804A,postsynapse,2.0
26876,91752,GO:1901588,ZNF804A,dendritic microtubule,2.0
26877,91752,GO:1902952,ZNF804A,positive regulation of dendritic spine maintenance,2.0
26900,339145,GO:0005515,FAM92B,protein binding,2.0
26901,339145,GO:0005737,FAM92B,cytoplasm,2.0
26902,339145,GO:0005814,FAM92B,centriole,2.0
26903,339145,GO:0030030,FAM92B,cell projection organization,2.0
26904,339145,GO:0042995,FAM92B,cell projection,2.0
